#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


#Text=Abnormalities in hubs location and nodes centrality predict cognitive slowing and increased performance variability in first-episode schizophrenia patients
#Text=Introducing the Minimum Spanning Tree (MST) algorithms to neural networks science eliminated the problem of arbitrary setting of the threshold for connectivity strength.
1-1	0-13	Abnormalities	_	
1-2	14-16	in	_	
1-3	17-21	hubs	_	
1-4	22-30	location	_	
1-5	31-34	and	_	
1-6	35-40	nodes	_	
1-7	41-51	centrality	_	
1-8	52-59	predict	_	
1-9	60-69	cognitive	_	
1-10	70-77	slowing	_	
1-11	78-81	and	_	
1-12	82-91	increased	_	
1-13	92-103	performance	_	
1-14	104-115	variability	_	
1-15	116-118	in	_	
1-16	119-132	first-episode	_	
1-17	133-146	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
1-18	147-155	patients	_	
1-19	156-167	Introducing	_	
1-20	168-171	the	_	
1-21	172-179	Minimum	_	
1-22	180-188	Spanning	_	
1-23	189-193	Tree	_	
1-24	194-195	(	_	
1-25	195-198	MST	_	
1-26	198-199	)	_	
1-27	200-210	algorithms	_	
1-28	211-213	to	_	
1-29	214-220	neural	_	
1-30	221-229	networks	_	
1-31	230-237	science	_	
1-32	238-248	eliminated	_	
1-33	249-252	the	_	
1-34	253-260	problem	_	
1-35	261-263	of	_	
1-36	264-273	arbitrary	_	
1-37	274-281	setting	_	
1-38	282-284	of	_	
1-39	285-288	the	_	
1-40	289-298	threshold	_	
1-41	299-302	for	_	
1-42	303-315	connectivity	_	
1-43	316-324	strength	_	
1-44	324-325	.	_	

#Text=Despite these advantages, MST has been rarely used to study network abnormalities in schizophrenia.
2-1	326-333	Despite	_	
2-2	334-339	these	_	
2-3	340-350	advantages	_	
2-4	350-351	,	_	
2-5	352-355	MST	_	
2-6	356-359	has	_	
2-7	360-364	been	_	
2-8	365-371	rarely	_	
2-9	372-376	used	_	
2-10	377-379	to	_	
2-11	380-385	study	_	
2-12	386-393	network	_	
2-13	394-407	abnormalities	_	
2-14	408-410	in	_	
2-15	411-424	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
2-16	424-425	.	_	

#Text=An MST graph mapping a network structure is its simplification, therefore, it is important to verify whether the reconfigured network is significantly related to the behavioural dimensions of the clinical picture of schizophrenia. 35 first-episode schizophrenia patients and 35 matched healthy controls underwent an assessment of information processing speed, cognitive inter-trial variability modelled with ex-Gaussian distributional analysis of reaction times and resting-state EEG recordings to obtain frequency-specific functional connectivity matrices from which MST graphs were computed.
3-1	426-428	An	_	
3-2	429-432	MST	_	
3-3	433-438	graph	_	
3-4	439-446	mapping	_	
3-5	447-448	a	_	
3-6	449-456	network	_	
3-7	457-466	structure	_	
3-8	467-469	is	_	
3-9	470-473	its	_	
3-10	474-488	simplification	_	
3-11	488-489	,	_	
3-12	490-499	therefore	_	
3-13	499-500	,	_	
3-14	501-503	it	_	
3-15	504-506	is	_	
3-16	507-516	important	_	
3-17	517-519	to	_	
3-18	520-526	verify	_	
3-19	527-534	whether	_	
3-20	535-538	the	_	
3-21	539-551	reconfigured	_	
3-22	552-559	network	_	
3-23	560-562	is	_	
3-24	563-576	significantly	_	
3-25	577-584	related	_	
3-26	585-587	to	_	
3-27	588-591	the	_	
3-28	592-603	behavioural	_	
3-29	604-614	dimensions	_	
3-30	615-617	of	_	
3-31	618-621	the	_	
3-32	622-630	clinical	_	
3-33	631-638	picture	_	
3-34	639-641	of	_	
3-35	642-655	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-36	655-656	.	_	
3-37	657-659	35	_	
3-38	660-673	first-episode	_	
3-39	674-687	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
3-40	688-696	patients	_	
3-41	697-700	and	_	
3-42	701-703	35	_	
3-43	704-711	matched	_	
3-44	712-719	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
3-45	720-728	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[1]	
3-46	729-738	underwent	_	
3-47	739-741	an	_	
3-48	742-752	assessment	_	
3-49	753-755	of	_	
3-50	756-767	information	_	
3-51	768-778	processing	_	
3-52	779-784	speed	_	
3-53	784-785	,	_	
3-54	786-795	cognitive	_	
3-55	796-807	inter-trial	_	
3-56	808-819	variability	_	
3-57	820-828	modelled	_	
3-58	829-833	with	_	
3-59	834-845	ex-Gaussian	_	
3-60	846-860	distributional	_	
3-61	861-869	analysis	_	
3-62	870-872	of	_	
3-63	873-881	reaction	_	
3-64	882-887	times	_	
3-65	888-891	and	_	
3-66	892-905	resting-state	_	
3-67	906-909	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
3-68	910-920	recordings	_	
3-69	921-923	to	_	
3-70	924-930	obtain	_	
3-71	931-949	frequency-specific	_	
3-72	950-960	functional	_	
3-73	961-973	connectivity	_	
3-74	974-982	matrices	_	
3-75	983-987	from	_	
3-76	988-993	which	_	
3-77	994-997	MST	_	
3-78	998-1004	graphs	_	
3-79	1005-1009	were	_	
3-80	1010-1018	computed	_	
3-81	1018-1019	.	_	

#Text=The patients’ network had a more random structure and star-like arrangement with overloaded hubs positioned more posteriorly than it was in the case of the control group.
4-1	1020-1023	The	_	
4-2	1024-1032	patients	_	
4-3	1032-1033	’	_	
4-4	1034-1041	network	_	
4-5	1042-1045	had	_	
4-6	1046-1047	a	_	
4-7	1048-1052	more	_	
4-8	1053-1059	random	_	
4-9	1060-1069	structure	_	
4-10	1070-1073	and	_	
4-11	1074-1083	star-like	_	
4-12	1084-1095	arrangement	_	
4-13	1096-1100	with	_	
4-14	1101-1111	overloaded	_	
4-15	1112-1116	hubs	_	
4-16	1117-1127	positioned	_	
4-17	1128-1132	more	_	
4-18	1133-1144	posteriorly	_	
4-19	1145-1149	than	_	
4-20	1150-1152	it	_	
4-21	1153-1156	was	_	
4-22	1157-1159	in	_	
4-23	1160-1163	the	_	
4-24	1164-1168	case	_	
4-25	1169-1171	of	_	
4-26	1172-1175	the	_	
4-27	1176-1183	control	_	
4-28	1184-1189	group	_	
4-29	1189-1190	.	_	

#Text=Deficient processing speed in the group of patients was predicted by increased maximal betweenness centrality in beta and gamma bands, while decreased consistency in cognitive processing was predicted by the betweenness centrality of posterior nodes in the gamma band, together with duration of illness.
5-1	1191-1200	Deficient	_	
5-2	1201-1211	processing	_	
5-3	1212-1217	speed	_	
5-4	1218-1220	in	_	
5-5	1221-1224	the	_	
5-6	1225-1230	group	_	
5-7	1231-1233	of	_	
5-8	1234-1242	patients	_	
5-9	1243-1246	was	_	
5-10	1247-1256	predicted	_	
5-11	1257-1259	by	_	
5-12	1260-1269	increased	_	
5-13	1270-1277	maximal	_	
5-14	1278-1289	betweenness	_	
5-15	1290-1300	centrality	_	
5-16	1301-1303	in	_	
5-17	1304-1308	beta	_	
5-18	1309-1312	and	_	
5-19	1313-1318	gamma	_	
5-20	1319-1324	bands	_	
5-21	1324-1325	,	_	
5-22	1326-1331	while	_	
5-23	1332-1341	decreased	_	
5-24	1342-1353	consistency	_	
5-25	1354-1356	in	_	
5-26	1357-1366	cognitive	_	
5-27	1367-1377	processing	_	
5-28	1378-1381	was	_	
5-29	1382-1391	predicted	_	
5-30	1392-1394	by	_	
5-31	1395-1398	the	_	
5-32	1399-1410	betweenness	_	
5-33	1411-1421	centrality	_	
5-34	1422-1424	of	_	
5-35	1425-1434	posterior	_	
5-36	1435-1440	nodes	_	
5-37	1441-1443	in	_	
5-38	1444-1447	the	_	
5-39	1448-1453	gamma	_	
5-40	1454-1458	band	_	
5-41	1458-1459	,	_	
5-42	1460-1468	together	_	
5-43	1469-1473	with	_	
5-44	1474-1482	duration	_	
5-45	1483-1485	of	_	
5-46	1486-1493	illness	_	
5-47	1493-1494	.	_	

#Text=The betweenness centrality of posterior nodes in the gamma band was also significantly correlated with positive psychotic symptoms in the clinical group.
6-1	1495-1498	The	_	
6-2	1499-1510	betweenness	_	
6-3	1511-1521	centrality	_	
6-4	1522-1524	of	_	
6-5	1525-1534	posterior	_	
6-6	1535-1540	nodes	_	
6-7	1541-1543	in	_	
6-8	1544-1547	the	_	
6-9	1548-1553	gamma	_	
6-10	1554-1558	band	_	
6-11	1559-1562	was	_	
6-12	1563-1567	also	_	
6-13	1568-1581	significantly	_	
6-14	1582-1592	correlated	_	
6-15	1593-1597	with	_	
6-16	1598-1606	positive	_	
6-17	1607-1616	psychotic	_	
6-18	1617-1625	symptoms	_	
6-19	1626-1628	in	_	
6-20	1629-1632	the	_	
6-21	1633-1641	clinical	_	
6-22	1642-1647	group	_	
6-23	1647-1648	.	_	

#Text=Introduction
#Text=Schizophrenia is a progressive disease characterized by complex psychopathology and cognitive dysfunctions impeding the abilities of independent living.
7-1	1649-1661	Introduction	_	
7-2	1662-1675	Schizophrenia	_	
7-3	1676-1678	is	_	
7-4	1679-1680	a	_	
7-5	1681-1692	progressive	_	
7-6	1693-1700	disease	_	
7-7	1701-1714	characterized	_	
7-8	1715-1717	by	_	
7-9	1718-1725	complex	_	
7-10	1726-1741	psychopathology	_	
7-11	1742-1745	and	_	
7-12	1746-1755	cognitive	_	
7-13	1756-1768	dysfunctions	_	
7-14	1769-1777	impeding	_	
7-15	1778-1781	the	_	
7-16	1782-1791	abilities	_	
7-17	1792-1794	of	_	
7-18	1795-1806	independent	_	
7-19	1807-1813	living	_	
7-20	1813-1814	.	_	

#Text=A significant part of modern studies concerning the neural underpinnings of the disorder are focused on recognizing the patterns of aberrant brain integration.
8-1	1815-1816	A	_	
8-2	1817-1828	significant	_	
8-3	1829-1833	part	_	
8-4	1834-1836	of	_	
8-5	1837-1843	modern	_	
8-6	1844-1851	studies	_	
8-7	1852-1862	concerning	_	
8-8	1863-1866	the	_	
8-9	1867-1873	neural	_	
8-10	1874-1887	underpinnings	_	
8-11	1888-1890	of	_	
8-12	1891-1894	the	_	
8-13	1895-1903	disorder	_	
8-14	1904-1907	are	_	
8-15	1908-1915	focused	_	
8-16	1916-1918	on	_	
8-17	1919-1930	recognizing	_	
8-18	1931-1934	the	_	
8-19	1935-1943	patterns	_	
8-20	1944-1946	of	_	
8-21	1947-1955	aberrant	_	
8-22	1956-1961	brain	_	
8-23	1962-1973	integration	_	
8-24	1973-1974	.	_	

#Text=It resulted from the assumption that schizophrenia (SZ) might be understood as a pathological state of disconnection within the neural system.
9-1	1975-1977	It	_	
9-2	1978-1986	resulted	_	
9-3	1987-1991	from	_	
9-4	1992-1995	the	_	
9-5	1996-2006	assumption	_	
9-6	2007-2011	that	_	
9-7	2012-2025	schizophrenia	_	
9-8	2026-2027	(	_	
9-9	2027-2029	SZ	_	
9-10	2029-2030	)	_	
9-11	2031-2036	might	_	
9-12	2037-2039	be	_	
9-13	2040-2050	understood	_	
9-14	2051-2053	as	_	
9-15	2054-2055	a	_	
9-16	2056-2068	pathological	_	
9-17	2069-2074	state	_	
9-18	2075-2077	of	_	
9-19	2078-2091	disconnection	_	
9-20	2092-2098	within	_	
9-21	2099-2102	the	_	
9-22	2103-2109	neural	_	
9-23	2110-2116	system	_	
9-24	2116-2117	.	_	

#Text=The disconnection or neural miswiring refers to a pathology in the coordination of brain elements from the level of cellular signalling to aberrant axonal connections between various neuroanatomical structures.
10-1	2118-2121	The	_	
10-2	2122-2135	disconnection	_	
10-3	2136-2138	or	_	
10-4	2139-2145	neural	_	
10-5	2146-2155	miswiring	_	
10-6	2156-2162	refers	_	
10-7	2163-2165	to	_	
10-8	2166-2167	a	_	
10-9	2168-2177	pathology	_	
10-10	2178-2180	in	_	
10-11	2181-2184	the	_	
10-12	2185-2197	coordination	_	
10-13	2198-2200	of	_	
10-14	2201-2206	brain	_	
10-15	2207-2215	elements	_	
10-16	2216-2220	from	_	
10-17	2221-2224	the	_	
10-18	2225-2230	level	_	
10-19	2231-2233	of	_	
10-20	2234-2242	cellular	_	
10-21	2243-2253	signalling	_	
10-22	2254-2256	to	_	
10-23	2257-2265	aberrant	_	
10-24	2266-2272	axonal	_	
10-25	2273-2284	connections	_	
10-26	2285-2292	between	_	
10-27	2293-2300	various	_	
10-28	2301-2316	neuroanatomical	_	
10-29	2317-2327	structures	_	
10-30	2327-2328	.	_	

#Text=Much of the evidence for desynchronized neural activity in SZ comes from research using resting-state functional magnetic resonance methods (r-s fMRI), aimed at finding enhanced or reduced functional connectivity between numerous brain areas and networks.
11-1	2329-2333	Much	_	
11-2	2334-2336	of	_	
11-3	2337-2340	the	_	
11-4	2341-2349	evidence	_	
11-5	2350-2353	for	_	
11-6	2354-2368	desynchronized	_	
11-7	2369-2375	neural	_	
11-8	2376-2384	activity	_	
11-9	2385-2387	in	_	
11-10	2388-2390	SZ	_	
11-11	2391-2396	comes	_	
11-12	2397-2401	from	_	
11-13	2402-2410	research	_	
11-14	2411-2416	using	_	
11-15	2417-2430	resting-state	_	
11-16	2431-2441	functional	_	
11-17	2442-2450	magnetic	_	
11-18	2451-2460	resonance	_	
11-19	2461-2468	methods	_	
11-20	2469-2470	(	_	
11-21	2470-2473	r-s	_	
11-22	2474-2478	fMRI	_	
11-23	2478-2479	)	_	
11-24	2479-2480	,	_	
11-25	2481-2486	aimed	_	
11-26	2487-2489	at	_	
11-27	2490-2497	finding	_	
11-28	2498-2506	enhanced	_	
11-29	2507-2509	or	_	
11-30	2510-2517	reduced	_	
11-31	2518-2528	functional	_	
11-32	2529-2541	connectivity	_	
11-33	2542-2549	between	_	
11-34	2550-2558	numerous	_	
11-35	2559-2564	brain	_	
11-36	2565-2570	areas	_	
11-37	2571-2574	and	_	
11-38	2575-2583	networks	_	
11-39	2583-2584	.	_	

#Text=Functional connectivity (FC) might be defined as the statistical association between spatially distributed neurophysiological time series.
12-1	2585-2595	Functional	_	
12-2	2596-2608	connectivity	_	
12-3	2609-2610	(	_	
12-4	2610-2612	FC	_	
12-5	2612-2613	)	_	
12-6	2614-2619	might	_	
12-7	2620-2622	be	_	
12-8	2623-2630	defined	_	
12-9	2631-2633	as	_	
12-10	2634-2637	the	_	
12-11	2638-2649	statistical	_	
12-12	2650-2661	association	_	
12-13	2662-2669	between	_	
12-14	2670-2679	spatially	_	
12-15	2680-2691	distributed	_	
12-16	2692-2710	neurophysiological	_	
12-17	2711-2715	time	_	
12-18	2716-2722	series	_	
12-19	2722-2723	.	_	

#Text=Despite a substantial increase in the scope of knowledge regarding abnormal FC in SZ individuals, an infinite number of possible connections between different brain regions makes it difficult to assess the condition of the network in a global dimension.
13-1	2724-2731	Despite	_	
13-2	2732-2733	a	_	
13-3	2734-2745	substantial	_	
13-4	2746-2754	increase	_	
13-5	2755-2757	in	_	
13-6	2758-2761	the	_	
13-7	2762-2767	scope	_	
13-8	2768-2770	of	_	
13-9	2771-2780	knowledge	_	
13-10	2781-2790	regarding	_	
13-11	2791-2799	abnormal	_	
13-12	2800-2802	FC	_	
13-13	2803-2805	in	_	
13-14	2806-2808	SZ	_	
13-15	2809-2820	individuals	_	
13-16	2820-2821	,	_	
13-17	2822-2824	an	_	
13-18	2825-2833	infinite	_	
13-19	2834-2840	number	_	
13-20	2841-2843	of	_	
13-21	2844-2852	possible	_	
13-22	2853-2864	connections	_	
13-23	2865-2872	between	_	
13-24	2873-2882	different	_	
13-25	2883-2888	brain	_	
13-26	2889-2896	regions	_	
13-27	2897-2902	makes	_	
13-28	2903-2905	it	_	
13-29	2906-2915	difficult	_	
13-30	2916-2918	to	_	
13-31	2919-2925	assess	_	
13-32	2926-2929	the	_	
13-33	2930-2939	condition	_	
13-34	2940-2942	of	_	
13-35	2943-2946	the	_	
13-36	2947-2954	network	_	
13-37	2955-2957	in	_	
13-38	2958-2959	a	_	
13-39	2960-2966	global	_	
13-40	2967-2976	dimension	_	
13-41	2976-2977	.	_	

#Text=To circumvent this problem, a graph theorem has been implemented to evaluate the complex whole-brain functional and structural networks.
14-1	2978-2980	To	_	
14-2	2981-2991	circumvent	_	
14-3	2992-2996	this	_	
14-4	2997-3004	problem	_	
14-5	3004-3005	,	_	
14-6	3006-3007	a	_	
14-7	3008-3013	graph	_	
14-8	3014-3021	theorem	_	
14-9	3022-3025	has	_	
14-10	3026-3030	been	_	
14-11	3031-3042	implemented	_	
14-12	3043-3045	to	_	
14-13	3046-3054	evaluate	_	
14-14	3055-3058	the	_	
14-15	3059-3066	complex	_	
14-16	3067-3078	whole-brain	_	
14-17	3079-3089	functional	_	
14-18	3090-3093	and	_	
14-19	3094-3104	structural	_	
14-20	3105-3113	networks	_	
14-21	3113-3114	.	_	

#Text=Moreover, implementation of graph theory makes possible the transition from investigating associations between a given number of structures to interpreting overall connectivity configuration.
15-1	3115-3123	Moreover	_	
15-2	3123-3124	,	_	
15-3	3125-3139	implementation	_	
15-4	3140-3142	of	_	
15-5	3143-3148	graph	_	
15-6	3149-3155	theory	_	
15-7	3156-3161	makes	_	
15-8	3162-3170	possible	_	
15-9	3170-3171	 	_	
15-10	3171-3174	the	_	
15-11	3175-3185	transition	_	
15-12	3186-3190	from	_	
15-13	3191-3204	investigating	_	
15-14	3205-3217	associations	_	
15-15	3218-3225	between	_	
15-16	3226-3227	a	_	
15-17	3228-3233	given	_	
15-18	3234-3240	number	_	
15-19	3241-3243	of	_	
15-20	3244-3254	structures	_	
15-21	3255-3257	to	_	
15-22	3258-3270	interpreting	_	
15-23	3271-3278	overall	_	
15-24	3279-3291	connectivity	_	
15-25	3292-3305	configuration	_	
15-26	3305-3306	.	_	

#Text=Previous studies of neural networks organization in schizophrenia confirmed various types of pathologies, however, a substantial inconsistency of detailed results has been noted.
16-1	3307-3315	Previous	_	
16-2	3316-3323	studies	_	
16-3	3324-3326	of	_	
16-4	3327-3333	neural	_	
16-5	3334-3342	networks	_	
16-6	3343-3355	organization	_	
16-7	3356-3358	in	_	
16-8	3359-3372	schizophrenia	_	
16-9	3373-3382	confirmed	_	
16-10	3383-3390	various	_	
16-11	3391-3396	types	_	
16-12	3397-3399	of	_	
16-13	3400-3411	pathologies	_	
16-14	3411-3412	,	_	
16-15	3413-3420	however	_	
16-16	3420-3421	,	_	
16-17	3422-3423	a	_	
16-18	3424-3435	substantial	_	
16-19	3436-3449	inconsistency	_	
16-20	3450-3452	of	_	
16-21	3453-3461	detailed	_	
16-22	3462-3469	results	_	
16-23	3470-3473	has	_	
16-24	3474-3478	been	_	
16-25	3479-3484	noted	_	
16-26	3484-3485	.	_	

#Text=The inconsistency was mainly due to the application of various solutions regarding networks and connectivity metrics and dissimilar modalities of neuroimaging technics.
17-1	3486-3489	The	_	
17-2	3490-3503	inconsistency	_	
17-3	3504-3507	was	_	
17-4	3508-3514	mainly	_	
17-5	3515-3518	due	_	
17-6	3519-3521	to	_	
17-7	3522-3525	the	_	
17-8	3526-3537	application	_	
17-9	3538-3540	of	_	
17-10	3541-3548	various	_	
17-11	3549-3558	solutions	_	
17-12	3559-3568	regarding	_	
17-13	3569-3577	networks	_	
17-14	3578-3581	and	_	
17-15	3582-3594	connectivity	_	
17-16	3595-3602	metrics	_	
17-17	3603-3606	and	_	
17-18	3607-3617	dissimilar	_	
17-19	3618-3628	modalities	_	
17-20	3629-3631	of	_	
17-21	3632-3644	neuroimaging	_	
17-22	3645-3653	technics	_	
17-23	3653-3654	.	_	

#Text=Kambeitz with co-workers conducted a meta-analysis of the whole-brain network architecture to verify whether the integrity of brain functioning is globally disrupted in schizophrenia.
18-1	3655-3663	Kambeitz	_	
18-2	3664-3668	with	_	
18-3	3669-3679	co-workers	_	
18-4	3680-3689	conducted	_	
18-5	3690-3691	a	_	
18-6	3692-3705	meta-analysis	_	
18-7	3706-3708	of	_	
18-8	3709-3712	the	_	
18-9	3713-3724	whole-brain	_	
18-10	3725-3732	network	_	
18-11	3733-3745	architecture	_	
18-12	3746-3748	to	_	
18-13	3749-3755	verify	_	
18-14	3756-3763	whether	_	
18-15	3764-3767	the	_	
18-16	3768-3777	integrity	_	
18-17	3778-3780	of	_	
18-18	3781-3786	brain	_	
18-19	3787-3798	functioning	_	
18-20	3799-3801	is	_	
18-21	3802-3810	globally	_	
18-22	3811-3820	disrupted	_	
18-23	3821-3823	in	_	
18-24	3824-3837	schizophrenia	_	
18-25	3837-3838	.	_	

#Text=The authors selected eight fMRI and five EEG studies.
19-1	3839-3842	The	_	
19-2	3843-3850	authors	_	
19-3	3851-3859	selected	_	
19-4	3860-3865	eight	_	
19-5	3866-3870	fMRI	_	
19-6	3871-3874	and	_	
19-7	3875-3879	five	_	
19-8	3880-3883	EEG	_	
19-9	3884-3891	studies	_	
19-10	3891-3892	.	_	

#Text=In general, the results based on three r-s fMRI studies of SZ samples showed significant decrease of the small-worldness, a metric indicative of appropriate balance between local segregation and global integration of the network.
20-1	3893-3895	In	_	
20-2	3896-3903	general	_	
20-3	3903-3904	,	_	
20-4	3905-3908	the	_	
20-5	3909-3916	results	_	
20-6	3917-3922	based	_	
20-7	3923-3925	on	_	
20-8	3926-3931	three	_	
20-9	3932-3935	r-s	_	
20-10	3936-3940	fMRI	_	
20-11	3941-3948	studies	_	
20-12	3949-3951	of	_	
20-13	3952-3954	SZ	_	
20-14	3955-3962	samples	_	
20-15	3963-3969	showed	_	
20-16	3970-3981	significant	_	
20-17	3982-3990	decrease	_	
20-18	3991-3993	of	_	
20-19	3994-3997	the	_	
20-20	3998-4013	small-worldness	_	
20-21	4013-4014	,	_	
20-22	4015-4016	a	_	
20-23	4017-4023	metric	_	
20-24	4024-4034	indicative	_	
20-25	4035-4037	of	_	
20-26	4038-4049	appropriate	_	
20-27	4050-4057	balance	_	
20-28	4058-4065	between	_	
20-29	4066-4071	local	_	
20-30	4072-4083	segregation	_	
20-31	4084-4087	and	_	
20-32	4088-4094	global	_	
20-33	4095-4106	integration	_	
20-34	4107-4109	of	_	
20-35	4110-4113	the	_	
20-36	4114-4121	network	_	
20-37	4121-4122	.	_	

#Text=What is more, patients also had a significantly reduced clustering coefficient, showing the extent of regional density or a tendency toward the development of cliquishness within the network, and diminished local efficiency indexing the fault tolerance of the network.
21-1	4123-4127	What	_	
21-2	4128-4130	is	_	
21-3	4131-4135	more	_	
21-4	4135-4136	,	_	
21-5	4137-4145	patients	_	
21-6	4146-4150	also	_	
21-7	4151-4154	had	_	
21-8	4155-4156	a	_	
21-9	4157-4170	significantly	_	
21-10	4171-4178	reduced	_	
21-11	4179-4189	clustering	_	
21-12	4190-4201	coefficient	_	
21-13	4201-4202	,	_	
21-14	4203-4210	showing	_	
21-15	4211-4214	the	_	
21-16	4215-4221	extent	_	
21-17	4222-4224	of	_	
21-18	4225-4233	regional	_	
21-19	4234-4241	density	_	
21-20	4242-4244	or	_	
21-21	4245-4246	a	_	
21-22	4247-4255	tendency	_	
21-23	4256-4262	toward	_	
21-24	4263-4266	the	_	
21-25	4267-4278	development	_	
21-26	4279-4281	of	_	
21-27	4282-4294	cliquishness	_	
21-28	4295-4301	within	_	
21-29	4302-4305	the	_	
21-30	4306-4313	network	_	
21-31	4313-4314	,	_	
21-32	4315-4318	and	_	
21-33	4319-4329	diminished	_	
21-34	4330-4335	local	_	
21-35	4336-4346	efficiency	_	
21-36	4347-4355	indexing	_	
21-37	4356-4359	the	_	
21-38	4360-4365	fault	_	
21-39	4366-4375	tolerance	_	
21-40	4376-4378	of	_	
21-41	4379-4382	the	_	
21-42	4383-4390	network	_	
21-43	4390-4391	.	_	

#Text=Two r-s EEG studies demonstrated non-significant decrease in minimal path-length, a measure associated with integration of the network.
22-1	4392-4395	Two	_	
22-2	4396-4399	r-s	_	
22-3	4400-4403	EEG	_	
22-4	4404-4411	studies	_	
22-5	4412-4424	demonstrated	_	
22-6	4425-4440	non-significant	_	
22-7	4441-4449	decrease	_	
22-8	4450-4452	in	_	
22-9	4453-4460	minimal	_	
22-10	4461-4472	path-length	_	
22-11	4472-4473	,	_	
22-12	4474-4475	a	_	
22-13	4476-4483	measure	_	
22-14	4484-4494	associated	_	
22-15	4495-4499	with	_	
22-16	4500-4511	integration	_	
22-17	4512-4514	of	_	
22-18	4515-4518	the	_	
22-19	4519-4526	network	_	
22-20	4526-4527	.	_	

#Text=Another r-s EEG study also confirmed the decreased clustering coefficient in the SZ group.
23-1	4528-4535	Another	_	
23-2	4536-4539	r-s	_	
23-3	4540-4543	EEG	_	
23-4	4544-4549	study	_	
23-5	4550-4554	also	_	
23-6	4555-4564	confirmed	_	
23-7	4565-4568	the	_	
23-8	4569-4578	decreased	_	
23-9	4579-4589	clustering	_	
23-10	4590-4601	coefficient	_	
23-11	4602-4604	in	_	
23-12	4605-4608	the	_	
23-13	4609-4611	SZ	_	
23-14	4612-4617	group	_	
23-15	4617-4618	.	_	

#Text=Analytical results showed reduced local organization of the patients’ network, but also marked that the main limitation of the included research concerned arbitrariness in setting a threshold for connectivity strength, which could be a major reason for the heterogeneity of the results.
24-1	4619-4629	Analytical	_	
24-2	4630-4637	results	_	
24-3	4638-4644	showed	_	
24-4	4645-4652	reduced	_	
24-5	4653-4658	local	_	
24-6	4659-4671	organization	_	
24-7	4672-4674	of	_	
24-8	4675-4678	the	_	
24-9	4679-4687	patients	_	
24-10	4687-4688	’	_	
24-11	4689-4696	network	_	
24-12	4696-4697	,	_	
24-13	4698-4701	but	_	
24-14	4702-4706	also	_	
24-15	4707-4713	marked	_	
24-16	4714-4718	that	_	
24-17	4719-4722	the	_	
24-18	4723-4727	main	_	
24-19	4728-4738	limitation	_	
24-20	4739-4741	of	_	
24-21	4742-4745	the	_	
24-22	4746-4754	included	_	
24-23	4755-4763	research	_	
24-24	4764-4773	concerned	_	
24-25	4774-4787	arbitrariness	_	
24-26	4788-4790	in	_	
24-27	4791-4798	setting	_	
24-28	4799-4800	a	_	
24-29	4801-4810	threshold	_	
24-30	4811-4814	for	_	
24-31	4815-4827	connectivity	_	
24-32	4828-4836	strength	_	
24-33	4836-4837	,	_	
24-34	4838-4843	which	_	
24-35	4844-4849	could	_	
24-36	4850-4852	be	_	
24-37	4853-4854	a	_	
24-38	4855-4860	major	_	
24-39	4861-4867	reason	_	
24-40	4868-4871	for	_	
24-41	4872-4875	the	_	
24-42	4876-4889	heterogeneity	_	
24-43	4890-4892	of	_	
24-44	4893-4896	the	_	
24-45	4897-4904	results	_	
24-46	4904-4905	.	_	

#Text=It is also worth noting that Kambeitz et al. were able to find only two r-s EEG studies which significantly differentiated the global network’s organization of SZ patients and controls.
25-1	4906-4908	It	_	
25-2	4909-4911	is	_	
25-3	4912-4916	also	_	
25-4	4917-4922	worth	_	
25-5	4923-4929	noting	_	
25-6	4930-4934	that	_	
25-7	4935-4943	Kambeitz	_	
25-8	4944-4946	et	_	
25-9	4947-4949	al	_	
25-10	4949-4950	.	_	
25-11	4951-4955	were	_	
25-12	4956-4960	able	_	
25-13	4961-4963	to	_	
25-14	4964-4968	find	_	
25-15	4969-4973	only	_	
25-16	4974-4977	two	_	
25-17	4978-4981	r-s	_	
25-18	4982-4985	EEG	_	
25-19	4986-4993	studies	_	
25-20	4994-4999	which	_	
25-21	5000-5013	significantly	_	
25-22	5014-5028	differentiated	_	
25-23	5029-5032	the	_	
25-24	5033-5039	global	_	
25-25	5040-5047	network	_	
25-26	5047-5048	’	_	
25-27	5048-5049	s	_	
25-28	5050-5062	organization	_	
25-29	5063-5065	of	_	
25-30	5066-5068	SZ	_	
25-31	5069-5077	patients	_	
25-32	5078-5081	and	_	
25-33	5082-5090	controls	_	
25-34	5090-5091	.	_	

#Text=Apart from the assessment of the overall neural activity arrangement, the research also concerned the evaluation of networks at the regional level, in order to identify neural circuits differentiating SZ patients and controls in functional connectivity strength.
26-1	5092-5097	Apart	_	
26-2	5098-5102	from	_	
26-3	5103-5106	the	_	
26-4	5107-5117	assessment	_	
26-5	5118-5120	of	_	
26-6	5121-5124	the	_	
26-7	5125-5132	overall	_	
26-8	5133-5139	neural	_	
26-9	5140-5148	activity	_	
26-10	5149-5160	arrangement	_	
26-11	5160-5161	,	_	
26-12	5162-5165	the	_	
26-13	5166-5174	research	_	
26-14	5175-5179	also	_	
26-15	5180-5189	concerned	_	
26-16	5190-5193	the	_	
26-17	5194-5204	evaluation	_	
26-18	5205-5207	of	_	
26-19	5208-5216	networks	_	
26-20	5217-5219	at	_	
26-21	5220-5223	the	_	
26-22	5224-5232	regional	_	
26-23	5233-5238	level	_	
26-24	5238-5239	,	_	
26-25	5240-5242	in	_	
26-26	5243-5248	order	_	
26-27	5249-5251	to	_	
26-28	5252-5260	identify	_	
26-29	5261-5267	neural	_	
26-30	5268-5276	circuits	_	
26-31	5277-5292	differentiating	_	
26-32	5293-5295	SZ	_	
26-33	5296-5304	patients	_	
26-34	5305-5308	and	_	
26-35	5309-5317	controls	_	
26-36	5318-5320	in	_	
26-37	5321-5331	functional	_	
26-38	5332-5344	connectivity	_	
26-39	5345-5353	strength	_	
26-40	5353-5354	.	_	

#Text=Alamian and co-workers have attempted to indicate results typical for patients across various neuroimaging modalities (MEG, EEG, fMRI), and suggested that FC within the frontal cortex can be assumed as definitively altered in SZ, regardless of the neuroimaging method used.
27-1	5355-5362	Alamian	_	
27-2	5363-5366	and	_	
27-3	5367-5377	co-workers	_	
27-4	5378-5382	have	_	
27-5	5383-5392	attempted	_	
27-6	5393-5395	to	_	
27-7	5396-5404	indicate	_	
27-8	5405-5412	results	_	
27-9	5413-5420	typical	_	
27-10	5421-5424	for	_	
27-11	5425-5433	patients	_	
27-12	5434-5440	across	_	
27-13	5441-5448	various	_	
27-14	5449-5461	neuroimaging	_	
27-15	5462-5472	modalities	_	
27-16	5473-5474	(	_	
27-17	5474-5477	MEG	_	
27-18	5477-5478	,	_	
27-19	5479-5482	EEG	_	
27-20	5482-5483	,	_	
27-21	5484-5488	fMRI	_	
27-22	5488-5489	)	_	
27-23	5489-5490	,	_	
27-24	5491-5494	and	_	
27-25	5495-5504	suggested	_	
27-26	5505-5509	that	_	
27-27	5510-5512	FC	_	
27-28	5513-5519	within	_	
27-29	5520-5523	the	_	
27-30	5524-5531	frontal	_	
27-31	5532-5538	cortex	_	
27-32	5539-5542	can	_	
27-33	5543-5545	be	_	
27-34	5546-5553	assumed	_	
27-35	5554-5556	as	_	
27-36	5557-5569	definitively	_	
27-37	5570-5577	altered	_	
27-38	5578-5580	in	_	
27-39	5581-5583	SZ	_	
27-40	5583-5584	,	_	
27-41	5585-5595	regardless	_	
27-42	5596-5598	of	_	
27-43	5599-5602	the	_	
27-44	5603-5615	neuroimaging	_	
27-45	5616-5622	method	_	
27-46	5623-5627	used	_	
27-47	5627-5628	.	_	

#Text=For example, Zhu et al. showed that SZ patients exhibited increased nodal centrality in central and posterior regions and decreased centrality in anterior and subcortical structures compared with controls.
28-1	5629-5632	For	_	
28-2	5633-5640	example	_	
28-3	5640-5641	,	_	
28-4	5642-5645	Zhu	_	
28-5	5646-5648	et	_	
28-6	5649-5651	al	_	
28-7	5651-5652	.	_	
28-8	5653-5659	showed	_	
28-9	5660-5664	that	_	
28-10	5665-5667	SZ	_	
28-11	5668-5676	patients	_	
28-12	5677-5686	exhibited	_	
28-13	5687-5696	increased	_	
28-14	5697-5702	nodal	_	
28-15	5703-5713	centrality	_	
28-16	5714-5716	in	_	
28-17	5717-5724	central	_	
28-18	5725-5728	and	_	
28-19	5729-5738	posterior	_	
28-20	5739-5746	regions	_	
28-21	5747-5750	and	_	
28-22	5751-5760	decreased	_	
28-23	5761-5771	centrality	_	
28-24	5772-5774	in	_	
28-25	5775-5783	anterior	_	
28-26	5784-5787	and	_	
28-27	5788-5799	subcortical	_	
28-28	5800-5810	structures	_	
28-29	5811-5819	compared	_	
28-30	5820-5824	with	_	
28-31	5825-5833	controls	_	
28-32	5833-5834	.	_	

#Text=Additionally, almost all graph theory-driven research in SZ refers to the number and the location of the so called central hubs.
29-1	5835-5847	Additionally	_	
29-2	5847-5848	,	_	
29-3	5849-5855	almost	_	
29-4	5856-5859	all	_	
29-5	5860-5865	graph	_	
29-6	5866-5879	theory-driven	_	
29-7	5880-5888	research	_	
29-8	5889-5891	in	_	
29-9	5892-5894	SZ	_	
29-10	5895-5901	refers	_	
29-11	5902-5904	to	_	
29-12	5905-5908	the	_	
29-13	5909-5915	number	_	
29-14	5916-5919	and	_	
29-15	5920-5923	the	_	
29-16	5924-5932	location	_	
29-17	5933-5935	of	_	
29-18	5936-5939	the	_	
29-19	5940-5942	so	_	
29-20	5943-5949	called	_	
29-21	5950-5957	central	_	
29-22	5958-5962	hubs	_	
29-23	5962-5963	.	_	

#Text=Hubs are highly connected nodes, characterized by strategic connectivity facilitating the integration of the network.
30-1	5964-5968	Hubs	_	
30-2	5969-5972	are	_	
30-3	5973-5979	highly	_	
30-4	5980-5989	connected	_	
30-5	5990-5995	nodes	_	
30-6	5995-5996	,	_	
30-7	5997-6010	characterized	_	
30-8	6011-6013	by	_	
30-9	6014-6023	strategic	_	
30-10	6024-6036	connectivity	_	
30-11	6037-6049	facilitating	_	
30-12	6050-6053	the	_	
30-13	6054-6065	integration	_	
30-14	6066-6068	of	_	
30-15	6069-6072	the	_	
30-16	6073-6080	network	_	
30-17	6080-6081	.	_	

#Text=In healthy individuals, central hubs have been located mainly, though not exclusively, within the anterior areas including the prefrontal cortex and, according to Rubinov and Bullmore, various abnormalities regarding the anterior hubs, with fewer hubs located in the frontal cortex and the emergence of more non-frontal hubs, are typical features of SZ patients’ networks.
31-1	6082-6084	In	_	
31-2	6085-6092	healthy	_	
31-3	6093-6104	individuals	_	
31-4	6104-6105	,	_	
31-5	6106-6113	central	_	
31-6	6114-6118	hubs	_	
31-7	6119-6123	have	_	
31-8	6124-6128	been	_	
31-9	6129-6136	located	_	
31-10	6137-6143	mainly	_	
31-11	6143-6144	,	_	
31-12	6145-6151	though	_	
31-13	6152-6155	not	_	
31-14	6156-6167	exclusively	_	
31-15	6167-6168	,	_	
31-16	6169-6175	within	_	
31-17	6176-6179	the	_	
31-18	6180-6188	anterior	_	
31-19	6189-6194	areas	_	
31-20	6195-6204	including	_	
31-21	6205-6208	the	_	
31-22	6209-6219	prefrontal	_	
31-23	6220-6226	cortex	_	
31-24	6227-6230	and	_	
31-25	6230-6231	,	_	
31-26	6232-6241	according	_	
31-27	6242-6244	to	_	
31-28	6245-6252	Rubinov	_	
31-29	6253-6256	and	_	
31-30	6257-6265	Bullmore	_	
31-31	6265-6266	,	_	
31-32	6267-6274	various	_	
31-33	6275-6288	abnormalities	_	
31-34	6289-6298	regarding	_	
31-35	6299-6302	the	_	
31-36	6303-6311	anterior	_	
31-37	6312-6316	hubs	_	
31-38	6316-6317	,	_	
31-39	6318-6322	with	_	
31-40	6323-6328	fewer	_	
31-41	6329-6333	hubs	_	
31-42	6334-6341	located	_	
31-43	6342-6344	in	_	
31-44	6345-6348	the	_	
31-45	6349-6356	frontal	_	
31-46	6357-6363	cortex	_	
31-47	6364-6367	and	_	
31-48	6368-6371	the	_	
31-49	6372-6381	emergence	_	
31-50	6382-6384	of	_	
31-51	6385-6389	more	_	
31-52	6390-6401	non-frontal	_	
31-53	6402-6406	hubs	_	
31-54	6406-6407	,	_	
31-55	6408-6411	are	_	
31-56	6412-6419	typical	_	
31-57	6420-6428	features	_	
31-58	6429-6431	of	_	
31-59	6432-6434	SZ	_	
31-60	6435-6443	patients	_	
31-61	6443-6444	’	_	
31-62	6445-6453	networks	_	
31-63	6453-6454	.	_	

#Text=Compared to various types of imaging methods based on magnetic resonance, electro- and magnetoencephalography (MEG) enables the identification of altered oscillatory synchronization occurring in millisecond-range resolution, grasped in several frequencies, including the fastest ones, e.g. above 30 Hz, which are beyond the temporal range for methods based on MRI.
32-1	6455-6463	Compared	_	
32-2	6464-6466	to	_	
32-3	6467-6474	various	_	
32-4	6475-6480	types	_	
32-5	6481-6483	of	_	
32-6	6484-6491	imaging	_	
32-7	6492-6499	methods	_	
32-8	6500-6505	based	_	
32-9	6506-6508	on	_	
32-10	6509-6517	magnetic	_	
32-11	6518-6527	resonance	_	
32-12	6527-6528	,	_	
32-13	6529-6536	electro	_	
32-14	6536-6537	-	_	
32-15	6538-6541	and	_	
32-16	6542-6564	magnetoencephalography	_	
32-17	6565-6566	(	_	
32-18	6566-6569	MEG	_	
32-19	6569-6570	)	_	
32-20	6571-6578	enables	_	
32-21	6579-6582	the	_	
32-22	6583-6597	identification	_	
32-23	6598-6600	of	_	
32-24	6601-6608	altered	_	
32-25	6609-6620	oscillatory	_	
32-26	6621-6636	synchronization	_	
32-27	6637-6646	occurring	_	
32-28	6647-6649	in	_	
32-29	6650-6667	millisecond-range	_	
32-30	6668-6678	resolution	_	
32-31	6678-6679	,	_	
32-32	6680-6687	grasped	_	
32-33	6688-6690	in	_	
32-34	6691-6698	several	_	
32-35	6699-6710	frequencies	_	
32-36	6710-6711	,	_	
32-37	6712-6721	including	_	
32-38	6722-6725	the	_	
32-39	6726-6733	fastest	_	
32-40	6734-6738	ones	_	
32-41	6738-6739	,	_	
32-42	6740-6743	e.g	_	
32-43	6743-6744	.	_	
32-44	6745-6750	above	_	
32-45	6751-6753	30	_	
32-46	6754-6756	Hz	_	
32-47	6756-6757	,	_	
32-48	6758-6763	which	_	
32-49	6764-6767	are	_	
32-50	6768-6774	beyond	_	
32-51	6775-6778	the	_	
32-52	6779-6787	temporal	_	
32-53	6788-6793	range	_	
32-54	6794-6797	for	_	
32-55	6798-6805	methods	_	
32-56	6806-6811	based	_	
32-57	6812-6814	on	_	
32-58	6815-6818	MRI	_	
32-59	6818-6819	.	_	

#Text=Therefore, new neurophysiological studies are needed, with an application of graph-theory algorithms not burdened with computational issues such as the arbitrary setting of the threshold for the connectivity strength, and including a regional analysis of neural networks.
33-1	6820-6829	Therefore	_	
33-2	6829-6830	,	_	
33-3	6831-6834	new	_	
33-4	6835-6853	neurophysiological	_	
33-5	6854-6861	studies	_	
33-6	6862-6865	are	_	
33-7	6866-6872	needed	_	
33-8	6872-6873	,	_	
33-9	6874-6878	with	_	
33-10	6879-6881	an	_	
33-11	6882-6893	application	_	
33-12	6894-6896	of	_	
33-13	6897-6909	graph-theory	_	
33-14	6910-6920	algorithms	_	
33-15	6921-6924	not	_	
33-16	6925-6933	burdened	_	
33-17	6934-6938	with	_	
33-18	6939-6952	computational	_	
33-19	6953-6959	issues	_	
33-20	6960-6964	such	_	
33-21	6965-6967	as	_	
33-22	6968-6971	the	_	
33-23	6972-6981	arbitrary	_	
33-24	6982-6989	setting	_	
33-25	6990-6992	of	_	
33-26	6993-6996	the	_	
33-27	6997-7006	threshold	_	
33-28	7007-7010	for	_	
33-29	7011-7014	the	_	
33-30	7015-7027	connectivity	_	
33-31	7028-7036	strength	_	
33-32	7036-7037	,	_	
33-33	7038-7041	and	_	
33-34	7042-7051	including	_	
33-35	7052-7053	a	_	
33-36	7054-7062	regional	_	
33-37	7063-7071	analysis	_	
33-38	7072-7074	of	_	
33-39	7075-7081	neural	_	
33-40	7082-7090	networks	_	
33-41	7090-7091	.	_	

#Text=Schematic illustration of MST-networks formation from the resting-state EEG recordings: (a) selection of thirty EEG artifacts-free epochs, each containing 4096 samples (approximately 8 seconds per epoch) from each participants, (b) computation of the functional connectivity matrices based on phase lag index (PLI) for every selected EEG epochs for each possible electrodes pairs, in every frequency band, (c) minimum spanning tree (MST) matrix calculation, based on previously obtained PLI matrices for all frequencies, (d) the MST graph reconstruction, being an output from the Brainwave software, (e) illustrative reconstruction of topological distribution of hubs and leaf nodes posted on a simplified cortical surface, created from averaged MST matrix in a given frequency band.
34-1	7092-7101	Schematic	_	
34-2	7102-7114	illustration	_	
34-3	7115-7117	of	_	
34-4	7118-7130	MST-networks	_	
34-5	7131-7140	formation	_	
34-6	7141-7145	from	_	
34-7	7146-7149	the	_	
34-8	7150-7163	resting-state	_	
34-9	7164-7167	EEG	_	
34-10	7168-7178	recordings	_	
34-11	7178-7179	:	_	
34-12	7180-7181	(	_	
34-13	7181-7182	a	_	
34-14	7182-7183	)	_	
34-15	7184-7193	selection	_	
34-16	7194-7196	of	_	
34-17	7197-7203	thirty	_	
34-18	7204-7207	EEG	_	
34-19	7208-7222	artifacts-free	_	
34-20	7223-7229	epochs	_	
34-21	7229-7230	,	_	
34-22	7231-7235	each	_	
34-23	7236-7246	containing	_	
34-24	7247-7251	4096	_	
34-25	7252-7259	samples	_	
34-26	7260-7261	(	_	
34-27	7261-7274	approximately	_	
34-28	7275-7276	8	_	
34-29	7277-7284	seconds	_	
34-30	7285-7288	per	_	
34-31	7289-7294	epoch	_	
34-32	7294-7295	)	_	
34-33	7296-7300	from	_	
34-34	7301-7305	each	_	
34-35	7306-7318	participants	_	
34-36	7318-7319	,	_	
34-37	7320-7321	(	_	
34-38	7321-7322	b	_	
34-39	7322-7323	)	_	
34-40	7324-7335	computation	_	
34-41	7336-7338	of	_	
34-42	7339-7342	the	_	
34-43	7343-7353	functional	_	
34-44	7354-7366	connectivity	_	
34-45	7367-7375	matrices	_	
34-46	7376-7381	based	_	
34-47	7382-7384	on	_	
34-48	7385-7390	phase	_	
34-49	7391-7394	lag	_	
34-50	7395-7400	index	_	
34-51	7401-7402	(	_	
34-52	7402-7405	PLI	_	
34-53	7405-7406	)	_	
34-54	7407-7410	for	_	
34-55	7411-7416	every	_	
34-56	7417-7425	selected	_	
34-57	7426-7429	EEG	_	
34-58	7430-7436	epochs	_	
34-59	7437-7440	for	_	
34-60	7441-7445	each	_	
34-61	7446-7454	possible	_	
34-62	7455-7465	electrodes	_	
34-63	7466-7471	pairs	_	
34-64	7471-7472	,	_	
34-65	7473-7475	in	_	
34-66	7476-7481	every	_	
34-67	7482-7491	frequency	_	
34-68	7492-7496	band	_	
34-69	7496-7497	,	_	
34-70	7498-7499	(	_	
34-71	7499-7500	c	_	
34-72	7500-7501	)	_	
34-73	7502-7509	minimum	_	
34-74	7510-7518	spanning	_	
34-75	7519-7523	tree	_	
34-76	7524-7525	(	_	
34-77	7525-7528	MST	_	
34-78	7528-7529	)	_	
34-79	7530-7536	matrix	_	
34-80	7537-7548	calculation	_	
34-81	7548-7549	,	_	
34-82	7550-7555	based	_	
34-83	7556-7558	on	_	
34-84	7559-7569	previously	_	
34-85	7570-7578	obtained	_	
34-86	7579-7582	PLI	_	
34-87	7583-7591	matrices	_	
34-88	7592-7595	for	_	
34-89	7596-7599	all	_	
34-90	7600-7611	frequencies	_	
34-91	7611-7612	,	_	
34-92	7613-7614	(	_	
34-93	7614-7615	d	_	
34-94	7615-7616	)	_	
34-95	7617-7620	the	_	
34-96	7621-7624	MST	_	
34-97	7625-7630	graph	_	
34-98	7631-7645	reconstruction	_	
34-99	7645-7646	,	_	
34-100	7647-7652	being	_	
34-101	7653-7655	an	_	
34-102	7656-7662	output	_	
34-103	7663-7667	from	_	
34-104	7668-7671	the	_	
34-105	7672-7681	Brainwave	_	
34-106	7682-7690	software	_	
34-107	7690-7691	,	_	
34-108	7692-7693	(	_	
34-109	7693-7694	e	_	
34-110	7694-7695	)	_	
34-111	7696-7708	illustrative	_	
34-112	7709-7723	reconstruction	_	
34-113	7724-7726	of	_	
34-114	7727-7738	topological	_	
34-115	7739-7751	distribution	_	
34-116	7752-7754	of	_	
34-117	7755-7759	hubs	_	
34-118	7760-7763	and	_	
34-119	7764-7768	leaf	_	
34-120	7769-7774	nodes	_	
34-121	7775-7781	posted	_	
34-122	7782-7784	on	_	
34-123	7785-7786	a	_	
34-124	7787-7797	simplified	_	
34-125	7798-7806	cortical	_	
34-126	7807-7814	surface	_	
34-127	7814-7815	,	_	
34-128	7816-7823	created	_	
34-129	7824-7828	from	_	
34-130	7829-7837	averaged	_	
34-131	7838-7841	MST	_	
34-132	7842-7848	matrix	_	
34-133	7849-7851	in	_	
34-134	7852-7853	a	_	
34-135	7854-7859	given	_	
34-136	7860-7869	frequency	_	
34-137	7870-7874	band	_	
34-138	7874-7875	.	_	

#Text=Network was reconstructed keeping the rule of generating loop-less connections between the nodes.
35-1	7876-7883	Network	_	
35-2	7884-7887	was	_	
35-3	7888-7901	reconstructed	_	
35-4	7902-7909	keeping	_	
35-5	7910-7913	the	_	
35-6	7914-7918	rule	_	
35-7	7919-7921	of	_	
35-8	7922-7932	generating	_	
35-9	7933-7942	loop-less	_	
35-10	7943-7954	connections	_	
35-11	7955-7962	between	_	
35-12	7963-7966	the	_	
35-13	7967-7972	nodes	_	
35-14	7972-7973	.	_	

#Text=Analyses and computations depicted in points (a–d) were performed for each individual participant, while the topological network reconstruction (point e) has been prepared for groups, to show a qualitative model of networks with the approximate neuronal location of hubs, leaf nodes and connections.
36-1	7974-7982	Analyses	_	
36-2	7983-7986	and	_	
36-3	7987-7999	computations	_	
36-4	8000-8008	depicted	_	
36-5	8009-8011	in	_	
36-6	8012-8018	points	_	
36-7	8019-8020	(	_	
36-8	8020-8023	a–d	_	
36-9	8023-8024	)	_	
36-10	8025-8029	were	_	
36-11	8030-8039	performed	_	
36-12	8040-8043	for	_	
36-13	8044-8048	each	_	
36-14	8049-8059	individual	_	
36-15	8060-8071	participant	_	
36-16	8071-8072	,	_	
36-17	8073-8078	while	_	
36-18	8079-8082	the	_	
36-19	8083-8094	topological	_	
36-20	8095-8102	network	_	
36-21	8103-8117	reconstruction	_	
36-22	8118-8119	(	_	
36-23	8119-8124	point	_	
36-24	8125-8126	e	_	
36-25	8126-8127	)	_	
36-26	8128-8131	has	_	
36-27	8132-8136	been	_	
36-28	8137-8145	prepared	_	
36-29	8146-8149	for	_	
36-30	8150-8156	groups	_	
36-31	8156-8157	,	_	
36-32	8158-8160	to	_	
36-33	8161-8165	show	_	
36-34	8166-8167	a	_	
36-35	8168-8179	qualitative	_	
36-36	8180-8185	model	_	
36-37	8186-8188	of	_	
36-38	8189-8197	networks	_	
36-39	8198-8202	with	_	
36-40	8203-8206	the	_	
36-41	8207-8218	approximate	_	
36-42	8219-8227	neuronal	_	
36-43	8228-8236	location	_	
36-44	8237-8239	of	_	
36-45	8240-8244	hubs	_	
36-46	8244-8245	,	_	
36-47	8246-8250	leaf	_	
36-48	8251-8256	nodes	_	
36-49	8257-8260	and	_	
36-50	8261-8272	connections	_	
36-51	8272-8273	.	_	

#Text=One of the methods eliminating the thresholding problem is the application of the Minimum Spanning Tree (MST).
37-1	8274-8277	One	_	
37-2	8278-8280	of	_	
37-3	8281-8284	the	_	
37-4	8285-8292	methods	_	
37-5	8293-8304	eliminating	_	
37-6	8305-8308	the	_	
37-7	8309-8321	thresholding	_	
37-8	8322-8329	problem	_	
37-9	8330-8332	is	_	
37-10	8333-8336	the	_	
37-11	8337-8348	application	_	
37-12	8349-8351	of	_	
37-13	8352-8355	the	_	
37-14	8356-8363	Minimum	_	
37-15	8364-8372	Spanning	_	
37-16	8373-8377	Tree	_	
37-17	8378-8379	(	_	
37-18	8379-8382	MST	_	
37-19	8382-8383	)	_	
37-20	8383-8384	.	_	

#Text=MST enables the reconstruction of an acyclic, loop-less subgraph of the original undirected, weighted graph in which all nodes are connected.
38-1	8385-8388	MST	_	
38-2	8389-8396	enables	_	
38-3	8397-8400	the	_	
38-4	8401-8415	reconstruction	_	
38-5	8416-8418	of	_	
38-6	8419-8421	an	_	
38-7	8422-8429	acyclic	_	
38-8	8429-8430	,	_	
38-9	8431-8440	loop-less	_	
38-10	8441-8449	subgraph	_	
38-11	8450-8452	of	_	
38-12	8453-8456	the	_	
38-13	8457-8465	original	_	
38-14	8466-8476	undirected	_	
38-15	8476-8477	,	_	
38-16	8478-8486	weighted	_	
38-17	8487-8492	graph	_	
38-18	8493-8495	in	_	
38-19	8496-8501	which	_	
38-20	8502-8505	all	_	
38-21	8506-8511	nodes	_	
38-22	8512-8515	are	_	
38-23	8516-8525	connected	_	
38-24	8525-8526	.	_	

#Text=The output of the MST analysis contains only a subset of the strongest connections representing a stable network’s core and allows an unbiased comparison of networks differing in its density (Fig. 1).
39-1	8527-8530	The	_	
39-2	8531-8537	output	_	
39-3	8538-8540	of	_	
39-4	8541-8544	the	_	
39-5	8545-8548	MST	_	
39-6	8549-8557	analysis	_	
39-7	8558-8566	contains	_	
39-8	8567-8571	only	_	
39-9	8572-8573	a	_	
39-10	8574-8580	subset	_	
39-11	8581-8583	of	_	
39-12	8584-8587	the	_	
39-13	8588-8597	strongest	_	
39-14	8598-8609	connections	_	
39-15	8610-8622	representing	_	
39-16	8623-8624	a	_	
39-17	8625-8631	stable	_	
39-18	8632-8639	network	_	
39-19	8639-8640	’	_	
39-20	8640-8641	s	_	
39-21	8642-8646	core	_	
39-22	8647-8650	and	_	
39-23	8651-8657	allows	_	
39-24	8658-8660	an	_	
39-25	8661-8669	unbiased	_	
39-26	8670-8680	comparison	_	
39-27	8681-8683	of	_	
39-28	8684-8692	networks	_	
39-29	8693-8702	differing	_	
39-30	8703-8705	in	_	
39-31	8706-8709	its	_	
39-32	8710-8717	density	_	
39-33	8718-8719	(	_	
39-34	8719-8722	Fig	_	
39-35	8722-8723	.	_	
39-36	8723-8724	 	_	
39-37	8724-8725	1	_	
39-38	8725-8726	)	_	
39-39	8726-8727	.	_	

#Text=To date, many studies have been carried out using MST to reconstruct the global neural networks in such clinical conditions as, for example, epilepsy, stuttering, Alzheimer’s disease and in brain maturation research.
40-1	8728-8730	To	_	
40-2	8731-8735	date	_	
40-3	8735-8736	,	_	
40-4	8737-8741	many	_	
40-5	8742-8749	studies	_	
40-6	8750-8754	have	_	
40-7	8755-8759	been	_	
40-8	8760-8767	carried	_	
40-9	8768-8771	out	_	
40-10	8772-8777	using	_	
40-11	8778-8781	MST	_	
40-12	8782-8784	to	_	
40-13	8785-8796	reconstruct	_	
40-14	8797-8800	the	_	
40-15	8801-8807	global	_	
40-16	8808-8814	neural	_	
40-17	8815-8823	networks	_	
40-18	8824-8826	in	_	
40-19	8827-8831	such	_	
40-20	8832-8840	clinical	_	
40-21	8841-8851	conditions	_	
40-22	8852-8854	as	_	
40-23	8854-8855	,	_	
40-24	8856-8859	for	_	
40-25	8860-8867	example	_	
40-26	8867-8868	,	_	
40-27	8869-8877	epilepsy	_	
40-28	8877-8878	,	_	
40-29	8879-8889	stuttering	_	
40-30	8889-8890	,	_	
40-31	8891-8900	Alzheimer	_	
40-32	8900-8901	’	_	
40-33	8901-8902	s	_	
40-34	8903-8910	disease	_	
40-35	8911-8914	and	_	
40-36	8915-8917	in	_	
40-37	8918-8923	brain	_	
40-38	8924-8934	maturation	_	
40-39	8935-8943	research	_	
40-40	8943-8944	.	_	

#Text=These studies confirmed the usefulness of the MST algorithms to identify network irregularities in the mentioned populations.
41-1	8945-8950	These	_	
41-2	8951-8958	studies	_	
41-3	8959-8968	confirmed	_	
41-4	8969-8972	the	_	
41-5	8973-8983	usefulness	_	
41-6	8984-8986	of	_	
41-7	8987-8990	the	_	
41-8	8991-8994	MST	_	
41-9	8995-9005	algorithms	_	
41-10	9006-9008	to	_	
41-11	9009-9017	identify	_	
41-12	9018-9025	network	_	
41-13	9026-9040	irregularities	_	
41-14	9041-9043	in	_	
41-15	9044-9047	the	_	
41-16	9048-9057	mentioned	_	
41-17	9058-9069	populations	_	
41-18	9069-9070	.	_	

#Text=Moreover, van Diessen with co-workers proved that MST metrics differentiated epileptic patients better from controls in terms of their network’s organization than the conventional graph-theory indicators.
42-1	9071-9079	Moreover	_	
42-2	9079-9080	,	_	
42-3	9081-9084	van	_	
42-4	9085-9092	Diessen	_	
42-5	9093-9097	with	_	
42-6	9098-9108	co-workers	_	
42-7	9109-9115	proved	_	
42-8	9116-9120	that	_	
42-9	9121-9124	MST	_	
42-10	9125-9132	metrics	_	
42-11	9133-9147	differentiated	_	
42-12	9148-9157	epileptic	_	
42-13	9158-9166	patients	_	
42-14	9167-9173	better	_	
42-15	9174-9178	from	_	
42-16	9179-9187	controls	_	
42-17	9188-9190	in	_	
42-18	9191-9196	terms	_	
42-19	9197-9199	of	_	
42-20	9200-9205	their	_	
42-21	9206-9213	network	_	
42-22	9213-9214	’	_	
42-23	9214-9215	s	_	
42-24	9216-9228	organization	_	
42-25	9229-9233	than	_	
42-26	9234-9237	the	_	
42-27	9238-9250	conventional	_	
42-28	9251-9263	graph-theory	_	
42-29	9264-9274	indicators	_	
42-30	9274-9275	.	_	

#Text=As it was demonstrated in the study of Engels et al., MST might be also applied to regional analysis of the network, by establishing the betweenness centrality (BC, a measure of the hub-status) for each node (EEG electrodes) and then averaging BC results for nodes assigned to anterior, central and posterior regions.
43-1	9276-9278	As	_	
43-2	9279-9281	it	_	
43-3	9282-9285	was	_	
43-4	9286-9298	demonstrated	_	
43-5	9299-9301	in	_	
43-6	9302-9305	the	_	
43-7	9306-9311	study	_	
43-8	9312-9314	of	_	
43-9	9315-9321	Engels	_	
43-10	9322-9324	et	_	
43-11	9325-9327	al	_	
43-12	9327-9328	.	_	
43-13	9328-9329	,	_	
43-14	9330-9333	MST	_	
43-15	9334-9339	might	_	
43-16	9340-9342	be	_	
43-17	9343-9347	also	_	
43-18	9348-9355	applied	_	
43-19	9356-9358	to	_	
43-20	9359-9367	regional	_	
43-21	9368-9376	analysis	_	
43-22	9377-9379	of	_	
43-23	9380-9383	the	_	
43-24	9384-9391	network	_	
43-25	9391-9392	,	_	
43-26	9393-9395	by	_	
43-27	9396-9408	establishing	_	
43-28	9409-9412	the	_	
43-29	9413-9424	betweenness	_	
43-30	9425-9435	centrality	_	
43-31	9436-9437	(	_	
43-32	9437-9439	BC	_	
43-33	9439-9440	,	_	
43-34	9441-9442	a	_	
43-35	9443-9450	measure	_	
43-36	9451-9453	of	_	
43-37	9454-9457	the	_	
43-38	9458-9468	hub-status	_	
43-39	9468-9469	)	_	
43-40	9470-9473	for	_	
43-41	9474-9478	each	_	
43-42	9479-9483	node	_	
43-43	9484-9485	(	_	
43-44	9485-9488	EEG	_	
43-45	9489-9499	electrodes	_	
43-46	9499-9500	)	_	
43-47	9501-9504	and	_	
43-48	9505-9509	then	_	
43-49	9510-9519	averaging	_	
43-50	9520-9522	BC	_	
43-51	9523-9530	results	_	
43-52	9531-9534	for	_	
43-53	9535-9540	nodes	_	
43-54	9541-9549	assigned	_	
43-55	9550-9552	to	_	
43-56	9553-9561	anterior	_	
43-57	9561-9562	,	_	
43-58	9563-9570	central	_	
43-59	9571-9574	and	_	
43-60	9575-9584	posterior	_	
43-61	9585-9592	regions	_	
43-62	9592-9593	.	_	

#Text=This method yielded valuable results since it was shown that BC of central and anterior regions increased with accumulating disease severity associated with progressive neurodegeneration of more posterior areas.
44-1	9594-9598	This	_	
44-2	9599-9605	method	_	
44-3	9606-9613	yielded	_	
44-4	9614-9622	valuable	_	
44-5	9623-9630	results	_	
44-6	9631-9636	since	_	
44-7	9637-9639	it	_	
44-8	9640-9643	was	_	
44-9	9644-9649	shown	_	
44-10	9650-9654	that	_	
44-11	9655-9657	BC	_	
44-12	9658-9660	of	_	
44-13	9661-9668	central	_	
44-14	9669-9672	and	_	
44-15	9673-9681	anterior	_	
44-16	9682-9689	regions	_	
44-17	9690-9699	increased	_	
44-18	9700-9704	with	_	
44-19	9705-9717	accumulating	_	
44-20	9718-9725	disease	_	
44-21	9726-9734	severity	_	
44-22	9735-9745	associated	_	
44-23	9746-9750	with	_	
44-24	9751-9762	progressive	_	
44-25	9763-9780	neurodegeneration	_	
44-26	9781-9783	of	_	
44-27	9784-9788	more	_	
44-28	9789-9798	posterior	_	
44-29	9799-9804	areas	_	
44-30	9804-9805	.	_	

#Text=In SZ studies, MST has been implemented to a small extent so far.
45-1	9806-9808	In	_	
45-2	9809-9811	SZ	_	
45-3	9812-9819	studies	_	
45-4	9819-9820	,	_	
45-5	9821-9824	MST	_	
45-6	9825-9828	has	_	
45-7	9829-9833	been	_	
45-8	9834-9845	implemented	_	
45-9	9846-9848	to	_	
45-10	9849-9850	a	_	
45-11	9851-9856	small	_	
45-12	9857-9863	extent	_	
45-13	9864-9866	so	_	
45-14	9867-9870	far	_	
45-15	9870-9871	.	_	

#Text=Van Dellen et al. assessed structural brain networks with an application of MST to DTI data in groups of subclinical and clinical psychosis.
46-1	9872-9875	Van	_	
46-2	9876-9882	Dellen	_	
46-3	9883-9885	et	_	
46-4	9886-9888	al	_	
46-5	9888-9889	.	_	
46-6	9890-9898	assessed	_	
46-7	9899-9909	structural	_	
46-8	9910-9915	brain	_	
46-9	9916-9924	networks	_	
46-10	9925-9929	with	_	
46-11	9930-9932	an	_	
46-12	9933-9944	application	_	
46-13	9945-9947	of	_	
46-14	9948-9951	MST	_	
46-15	9952-9954	to	_	
46-16	9955-9958	DTI	_	
46-17	9959-9963	data	_	
46-18	9964-9966	in	_	
46-19	9967-9973	groups	_	
46-20	9974-9976	of	_	
46-21	9977-9988	subclinical	_	
46-22	9989-9992	and	_	
46-23	9993-10001	clinical	_	
46-24	10002-10011	psychosis	_	
46-25	10011-10012	.	_	

#Text=Authors corroborated decreased centrality of parietal and language areas in both clinical samples.
47-1	10013-10020	Authors	_	
47-2	10021-10033	corroborated	_	
47-3	10034-10043	decreased	_	
47-4	10044-10054	centrality	_	
47-5	10055-10057	of	_	
47-6	10058-10066	parietal	_	
47-7	10067-10070	and	_	
47-8	10071-10079	language	_	
47-9	10080-10085	areas	_	
47-10	10086-10088	in	_	
47-11	10089-10093	both	_	
47-12	10094-10102	clinical	_	
47-13	10103-10110	samples	_	
47-14	10110-10111	.	_	

#Text=Another MST-based study showed higher connection entropy in gamma frequency in the SZ group than in the controls’ group, yet, MST metrics such as diameter, leaf  fraction or BC were not compared between the included groups.
48-1	10112-10119	Another	_	
48-2	10120-10129	MST-based	_	
48-3	10130-10135	study	_	
48-4	10136-10142	showed	_	
48-5	10143-10149	higher	_	
48-6	10150-10160	connection	_	
48-7	10161-10168	entropy	_	
48-8	10169-10171	in	_	
48-9	10172-10177	gamma	_	
48-10	10178-10187	frequency	_	
48-11	10188-10190	in	_	
48-12	10191-10194	the	_	
48-13	10195-10197	SZ	_	
48-14	10198-10203	group	_	
48-15	10204-10208	than	_	
48-16	10209-10211	in	_	
48-17	10212-10215	the	_	
48-18	10216-10224	controls	_	
48-19	10224-10225	’	_	
48-20	10226-10231	group	_	
48-21	10231-10232	,	_	
48-22	10233-10236	yet	_	
48-23	10236-10237	,	_	
48-24	10238-10241	MST	_	
48-25	10242-10249	metrics	_	
48-26	10250-10254	such	_	
48-27	10255-10257	as	_	
48-28	10258-10266	diameter	_	
48-29	10266-10267	,	_	
48-30	10268-10272	leaf	_	
48-31	10272-10273	 	_	
48-32	10274-10282	fraction	_	
48-33	10283-10285	or	_	
48-34	10286-10288	BC	_	
48-35	10289-10293	were	_	
48-36	10294-10297	not	_	
48-37	10298-10306	compared	_	
48-38	10307-10314	between	_	
48-39	10315-10318	the	_	
48-40	10319-10327	included	_	
48-41	10328-10334	groups	_	
48-42	10334-10335	.	_	

#Text=Jonak with co-workers conducted an r-s EEG study to contrast MST-derived networks indices in first-episode and multi-episode SZ patients.
49-1	10336-10341	Jonak	_	
49-2	10342-10346	with	_	
49-3	10347-10357	co-workers	_	
49-4	10358-10367	conducted	_	
49-5	10368-10370	an	_	
49-6	10371-10374	r-s	_	
49-7	10375-10378	EEG	_	
49-8	10379-10384	study	_	
49-9	10385-10387	to	_	
49-10	10388-10396	contrast	_	
49-11	10397-10408	MST-derived	_	
49-12	10409-10417	networks	_	
49-13	10418-10425	indices	_	
49-14	10426-10428	in	_	
49-15	10429-10442	first-episode	_	
49-16	10443-10446	and	_	
49-17	10447-10460	multi-episode	_	
49-18	10461-10463	SZ	_	
49-19	10464-10472	patients	_	
49-20	10472-10473	.	_	

#Text=They demonstrated that the network of multi-episode patients was more centralized as compared to the first-episode sample, however, a group of healthy controls did not participate in this analysis.
50-1	10474-10478	They	_	
50-2	10479-10491	demonstrated	_	
50-3	10492-10496	that	_	
50-4	10497-10500	the	_	
50-5	10501-10508	network	_	
50-6	10509-10511	of	_	
50-7	10512-10525	multi-episode	_	
50-8	10526-10534	patients	_	
50-9	10535-10538	was	_	
50-10	10539-10543	more	_	
50-11	10544-10555	centralized	_	
50-12	10556-10558	as	_	
50-13	10559-10567	compared	_	
50-14	10568-10570	to	_	
50-15	10571-10574	the	_	
50-16	10575-10588	first-episode	_	
50-17	10589-10595	sample	_	
50-18	10595-10596	,	_	
50-19	10597-10604	however	_	
50-20	10604-10605	,	_	
50-21	10606-10607	a	_	
50-22	10608-10613	group	_	
50-23	10614-10616	of	_	
50-24	10617-10624	healthy	_	
50-25	10625-10633	controls	_	
50-26	10634-10637	did	_	
50-27	10638-10641	not	_	
50-28	10642-10653	participate	_	
50-29	10654-10656	in	_	
50-30	10657-10661	this	_	
50-31	10662-10670	analysis	_	
50-32	10670-10671	.	_	

#Text=Taking the presented data into account, it seems reasonable to broaden the existing findings regarding the global organization of the network in schizophrenia with a study based on the r-s EEG recordings in which the network will be reconstructed using well-validated MST metrics in SZ patients and healthy controls.
51-1	10672-10678	Taking	_	
51-2	10679-10682	the	_	
51-3	10683-10692	presented	_	
51-4	10693-10697	data	_	
51-5	10698-10702	into	_	
51-6	10703-10710	account	_	
51-7	10710-10711	,	_	
51-8	10712-10714	it	_	
51-9	10715-10720	seems	_	
51-10	10721-10731	reasonable	_	
51-11	10732-10734	to	_	
51-12	10735-10742	broaden	_	
51-13	10743-10746	the	_	
51-14	10747-10755	existing	_	
51-15	10756-10764	findings	_	
51-16	10765-10774	regarding	_	
51-17	10775-10778	the	_	
51-18	10779-10785	global	_	
51-19	10786-10798	organization	_	
51-20	10799-10801	of	_	
51-21	10802-10805	the	_	
51-22	10806-10813	network	_	
51-23	10814-10816	in	_	
51-24	10817-10830	schizophrenia	_	
51-25	10831-10835	with	_	
51-26	10836-10837	a	_	
51-27	10838-10843	study	_	
51-28	10844-10849	based	_	
51-29	10850-10852	on	_	
51-30	10853-10856	the	_	
51-31	10857-10860	r-s	_	
51-32	10861-10864	EEG	_	
51-33	10865-10875	recordings	_	
51-34	10876-10878	in	_	
51-35	10879-10884	which	_	
51-36	10885-10888	the	_	
51-37	10889-10896	network	_	
51-38	10897-10901	will	_	
51-39	10902-10904	be	_	
51-40	10905-10918	reconstructed	_	
51-41	10919-10924	using	_	
51-42	10925-10939	well-validated	_	
51-43	10940-10943	MST	_	
51-44	10944-10951	metrics	_	
51-45	10952-10954	in	_	
51-46	10955-10957	SZ	_	
51-47	10958-10966	patients	_	
51-48	10967-10970	and	_	
51-49	10971-10978	healthy	_	
51-50	10979-10987	controls	_	
51-51	10987-10988	.	_	

#Text=In addition, to our knowledge, no study has yet been conducted to verify whether the expected abnormalities in SZ patients’ EEG-derived networks, measured by MST, are significant predictors of cognitive deficits and psychopathological symptoms typical for schizophrenia.
52-1	10989-10991	In	_	
52-2	10992-11000	addition	_	
52-3	11000-11001	,	_	
52-4	11002-11004	to	_	
52-5	11005-11008	our	_	
52-6	11009-11018	knowledge	_	
52-7	11018-11019	,	_	
52-8	11020-11022	no	_	
52-9	11023-11028	study	_	
52-10	11029-11032	has	_	
52-11	11033-11036	yet	_	
52-12	11037-11041	been	_	
52-13	11042-11051	conducted	_	
52-14	11052-11054	to	_	
52-15	11055-11061	verify	_	
52-16	11062-11069	whether	_	
52-17	11070-11073	the	_	
52-18	11074-11082	expected	_	
52-19	11083-11096	abnormalities	_	
52-20	11097-11099	in	_	
52-21	11100-11102	SZ	_	
52-22	11103-11111	patients	_	
52-23	11111-11112	’	_	
52-24	11113-11124	EEG-derived	_	
52-25	11125-11133	networks	_	
52-26	11133-11134	,	_	
52-27	11135-11143	measured	_	
52-28	11144-11146	by	_	
52-29	11147-11150	MST	_	
52-30	11150-11151	,	_	
52-31	11152-11155	are	_	
52-32	11156-11167	significant	_	
52-33	11168-11178	predictors	_	
52-34	11179-11181	of	_	
52-35	11182-11191	cognitive	_	
52-36	11192-11200	deficits	_	
52-37	11201-11204	and	_	
52-38	11205-11223	psychopathological	_	
52-39	11224-11232	symptoms	_	
52-40	11233-11240	typical	_	
52-41	11241-11244	for	_	
52-42	11245-11258	schizophrenia	_	
52-43	11258-11259	.	_	

#Text=This is of special importance, considering that although MST provides well-defined subnetworks, yet, to some extent generates only a simplified model of the original network, without connections forming loops.
53-1	11260-11264	This	_	
53-2	11265-11267	is	_	
53-3	11268-11270	of	_	
53-4	11271-11278	special	_	
53-5	11279-11289	importance	_	
53-6	11289-11290	,	_	
53-7	11291-11302	considering	_	
53-8	11303-11307	that	_	
53-9	11308-11316	although	_	
53-10	11317-11320	MST	_	
53-11	11321-11329	provides	_	
53-12	11330-11342	well-defined	_	
53-13	11343-11354	subnetworks	_	
53-14	11354-11355	,	_	
53-15	11356-11359	yet	_	
53-16	11359-11360	,	_	
53-17	11361-11363	to	_	
53-18	11364-11368	some	_	
53-19	11369-11375	extent	_	
53-20	11376-11385	generates	_	
53-21	11386-11390	only	_	
53-22	11391-11392	a	_	
53-23	11393-11403	simplified	_	
53-24	11404-11409	model	_	
53-25	11410-11412	of	_	
53-26	11413-11416	the	_	
53-27	11417-11425	original	_	
53-28	11426-11433	network	_	
53-29	11433-11434	,	_	
53-30	11435-11442	without	_	
53-31	11443-11454	connections	_	
53-32	11455-11462	forming	_	
53-33	11463-11468	loops	_	
53-34	11468-11469	.	_	

#Text=Consequently, it should be validated, whether the neural network reconstructed with the use of MST adequately reflects the abnormal organization of neuronal activity of SZ patients, and is associated with behavioural indicators.
54-1	11470-11482	Consequently	_	
54-2	11482-11483	,	_	
54-3	11484-11486	it	_	
54-4	11487-11493	should	_	
54-5	11494-11496	be	_	
54-6	11497-11506	validated	_	
54-7	11506-11507	,	_	
54-8	11508-11515	whether	_	
54-9	11516-11519	the	_	
54-10	11520-11526	neural	_	
54-11	11527-11534	network	_	
54-12	11535-11548	reconstructed	_	
54-13	11549-11553	with	_	
54-14	11554-11557	the	_	
54-15	11558-11561	use	_	
54-16	11562-11564	of	_	
54-17	11565-11568	MST	_	
54-18	11569-11579	adequately	_	
54-19	11580-11588	reflects	_	
54-20	11589-11592	the	_	
54-21	11593-11601	abnormal	_	
54-22	11602-11614	organization	_	
54-23	11615-11617	of	_	
54-24	11618-11626	neuronal	_	
54-25	11627-11635	activity	_	
54-26	11636-11638	of	_	
54-27	11639-11641	SZ	_	
54-28	11642-11650	patients	_	
54-29	11650-11651	,	_	
54-30	11652-11655	and	_	
54-31	11656-11658	is	_	
54-32	11659-11669	associated	_	
54-33	11670-11674	with	_	
54-34	11675-11686	behavioural	_	
54-35	11687-11697	indicators	_	
54-36	11697-11698	.	_	

#Text=Therefore, the main goal of this study was to evaluate the architecture of neural networks in a group of SZ patients and controls based on r-s EEG recordings, with an application of such global MST metrics as diameter, leaf fraction and betweenness centrality.
55-1	11699-11708	Therefore	_	
55-2	11708-11709	,	_	
55-3	11710-11713	the	_	
55-4	11714-11718	main	_	
55-5	11719-11723	goal	_	
55-6	11724-11726	of	_	
55-7	11727-11731	this	_	
55-8	11732-11737	study	_	
55-9	11738-11741	was	_	
55-10	11742-11744	to	_	
55-11	11745-11753	evaluate	_	
55-12	11754-11757	the	_	
55-13	11758-11770	architecture	_	
55-14	11771-11773	of	_	
55-15	11774-11780	neural	_	
55-16	11781-11789	networks	_	
55-17	11790-11792	in	_	
55-18	11793-11794	a	_	
55-19	11795-11800	group	_	
55-20	11801-11803	of	_	
55-21	11804-11806	SZ	_	
55-22	11807-11815	patients	_	
55-23	11816-11819	and	_	
55-24	11820-11828	controls	_	
55-25	11829-11834	based	_	
55-26	11835-11837	on	_	
55-27	11838-11841	r-s	_	
55-28	11842-11845	EEG	_	
55-29	11846-11856	recordings	_	
55-30	11856-11857	,	_	
55-31	11858-11862	with	_	
55-32	11863-11865	an	_	
55-33	11866-11877	application	_	
55-34	11878-11880	of	_	
55-35	11881-11885	such	_	
55-36	11886-11892	global	_	
55-37	11893-11896	MST	_	
55-38	11897-11904	metrics	_	
55-39	11905-11907	as	_	
55-40	11908-11916	diameter	_	
55-41	11916-11917	,	_	
55-42	11918-11922	leaf	_	
55-43	11923-11931	fraction	_	
55-44	11932-11935	and	_	
55-45	11936-11947	betweenness	_	
55-46	11948-11958	centrality	_	
55-47	11958-11959	.	_	

#Text=Additionally, we also intend to compare the groups in terms of regional characteristics, similarly as in Engels et al. study.
56-1	11960-11972	Additionally	_	
56-2	11972-11973	,	_	
56-3	11974-11976	we	_	
56-4	11977-11981	also	_	
56-5	11982-11988	intend	_	
56-6	11989-11991	to	_	
56-7	11992-11999	compare	_	
56-8	12000-12003	the	_	
56-9	12004-12010	groups	_	
56-10	12011-12013	in	_	
56-11	12014-12019	terms	_	
56-12	12020-12022	of	_	
56-13	12023-12031	regional	_	
56-14	12032-12047	characteristics	_	
56-15	12047-12048	,	_	
56-16	12049-12058	similarly	_	
56-17	12059-12061	as	_	
56-18	12062-12064	in	_	
56-19	12065-12071	Engels	_	
56-20	12072-12074	et	_	
56-21	12075-12077	al	_	
56-22	12077-12078	.	_	
56-23	12079-12084	study	_	
56-24	12084-12085	.	_	

#Text=Basing on the previously described results, we expect that the patient network will contain more hubs in the posterior cortical areas compared with controls.
57-1	12086-12092	Basing	_	
57-2	12093-12095	on	_	
57-3	12096-12099	the	_	
57-4	12100-12110	previously	_	
57-5	12111-12120	described	_	
57-6	12121-12128	results	_	
57-7	12128-12129	,	_	
57-8	12130-12132	we	_	
57-9	12133-12139	expect	_	
57-10	12140-12144	that	_	
57-11	12145-12148	the	_	
57-12	12149-12156	patient	_	
57-13	12157-12164	network	_	
57-14	12165-12169	will	_	
57-15	12170-12177	contain	_	
57-16	12178-12182	more	_	
57-17	12183-12187	hubs	_	
57-18	12188-12190	in	_	
57-19	12191-12194	the	_	
57-20	12195-12204	posterior	_	
57-21	12205-12213	cortical	_	
57-22	12214-12219	areas	_	
57-23	12220-12228	compared	_	
57-24	12229-12233	with	_	
57-25	12234-12242	controls	_	
57-26	12242-12243	.	_	

#Text=Another aim was to investigate which of the network features will significantly predict the expected cognitive dysfunctions such as cognitive slowing and increased variability of information processing.
58-1	12244-12251	Another	_	
58-2	12252-12255	aim	_	
58-3	12256-12259	was	_	
58-4	12260-12262	to	_	
58-5	12263-12274	investigate	_	
58-6	12275-12280	which	_	
58-7	12281-12283	of	_	
58-8	12284-12287	the	_	
58-9	12288-12295	network	_	
58-10	12296-12304	features	_	
58-11	12305-12309	will	_	
58-12	12310-12323	significantly	_	
58-13	12324-12331	predict	_	
58-14	12332-12335	the	_	
58-15	12336-12344	expected	_	
58-16	12345-12354	cognitive	_	
58-17	12355-12367	dysfunctions	_	
58-18	12368-12372	such	_	
58-19	12373-12375	as	_	
58-20	12376-12385	cognitive	_	
58-21	12386-12393	slowing	_	
58-22	12394-12397	and	_	
58-23	12398-12407	increased	_	
58-24	12408-12419	variability	_	
58-25	12420-12422	of	_	
58-26	12423-12434	information	_	
58-27	12435-12445	processing	_	
58-28	12445-12446	.	_	

#Text=We chose these two cognitive dimensions for two reasons: earlier studies demonstrated that impaired processing speed significantly contributes to differences between patients, their siblings and healthy individuals regarding any other cognitive dimensions.
59-1	12447-12449	We	_	
59-2	12450-12455	chose	_	
59-3	12456-12461	these	_	
59-4	12462-12465	two	_	
59-5	12466-12475	cognitive	_	
59-6	12476-12486	dimensions	_	
59-7	12487-12490	for	_	
59-8	12491-12494	two	_	
59-9	12495-12502	reasons	_	
59-10	12502-12503	:	_	
59-11	12504-12511	earlier	_	
59-12	12512-12519	studies	_	
59-13	12520-12532	demonstrated	_	
59-14	12533-12537	that	_	
59-15	12538-12546	impaired	_	
59-16	12547-12557	processing	_	
59-17	12558-12563	speed	_	
59-18	12564-12577	significantly	_	
59-19	12578-12589	contributes	_	
59-20	12590-12592	to	_	
59-21	12593-12604	differences	_	
59-22	12605-12612	between	_	
59-23	12613-12621	patients	_	
59-24	12621-12622	,	_	
59-25	12623-12628	their	_	
59-26	12629-12637	siblings	_	
59-27	12638-12641	and	_	
59-28	12642-12649	healthy	_	
59-29	12650-12661	individuals	_	
59-30	12662-12671	regarding	_	
59-31	12672-12675	any	_	
59-32	12676-12681	other	_	
59-33	12682-12691	cognitive	_	
59-34	12692-12702	dimensions	_	
59-35	12702-12703	.	_	

#Text=Because cognitive speed in SZ patients is related to white matter integrity and strength of long-range synchronization, we assumed that its disruption should be associated with global network properties, such as centrality or assortativity.
60-1	12704-12711	Because	_	
60-2	12712-12721	cognitive	_	
60-3	12722-12727	speed	_	
60-4	12728-12730	in	_	
60-5	12731-12733	SZ	_	
60-6	12734-12742	patients	_	
60-7	12743-12745	is	_	
60-8	12746-12753	related	_	
60-9	12754-12756	to	_	
60-10	12757-12762	white	_	
60-11	12763-12769	matter	_	
60-12	12770-12779	integrity	_	
60-13	12780-12783	and	_	
60-14	12784-12792	strength	_	
60-15	12793-12795	of	_	
60-16	12796-12806	long-range	_	
60-17	12807-12822	synchronization	_	
60-18	12822-12823	,	_	
60-19	12824-12826	we	_	
60-20	12827-12834	assumed	_	
60-21	12835-12839	that	_	
60-22	12840-12843	its	_	
60-23	12844-12854	disruption	_	
60-24	12855-12861	should	_	
60-25	12862-12864	be	_	
60-26	12865-12875	associated	_	
60-27	12876-12880	with	_	
60-28	12881-12887	global	_	
60-29	12888-12895	network	_	
60-30	12896-12906	properties	_	
60-31	12906-12907	,	_	
60-32	12908-12912	such	_	
60-33	12913-12915	as	_	
60-34	12916-12926	centrality	_	
60-35	12927-12929	or	_	
60-36	12930-12943	assortativity	_	
60-37	12943-12944	.	_	

#Text=Secondly, much of the research carried out so far has confirmed universally heightened cognitive variability in SZ subjects and their healthy siblings.
61-1	12945-12953	Secondly	_	
61-2	12953-12954	,	_	
61-3	12955-12959	much	_	
61-4	12960-12962	of	_	
61-5	12963-12966	the	_	
61-6	12967-12975	research	_	
61-7	12976-12983	carried	_	
61-8	12984-12987	out	_	
61-9	12988-12990	so	_	
61-10	12991-12994	far	_	
61-11	12995-12998	has	_	
61-12	12999-13008	confirmed	_	
61-13	13009-13020	universally	_	
61-14	13021-13031	heightened	_	
61-15	13032-13041	cognitive	_	
61-16	13042-13053	variability	_	
61-17	13054-13056	in	_	
61-18	13057-13059	SZ	_	
61-19	13060-13068	subjects	_	
61-20	13069-13072	and	_	
61-21	13073-13078	their	_	
61-22	13079-13086	healthy	_	
61-23	13087-13095	siblings	_	
61-24	13095-13096	.	_	

#Text=According to fundamental ideas of Fox and Raichle regarding the nature of resting-state brain dynamics, behavioural inter-trial variability is considered as the genuine manifestation of spontaneous fluctuations within the intrinsic, distributed cortical systems.
62-1	13097-13106	According	_	
62-2	13107-13109	to	_	
62-3	13110-13121	fundamental	_	
62-4	13122-13127	ideas	_	
62-5	13128-13130	of	_	
62-6	13131-13134	Fox	_	
62-7	13135-13138	and	_	
62-8	13139-13146	Raichle	_	
62-9	13147-13156	regarding	_	
62-10	13157-13160	the	_	
62-11	13161-13167	nature	_	
62-12	13168-13170	of	_	
62-13	13171-13184	resting-state	_	
62-14	13185-13190	brain	_	
62-15	13191-13199	dynamics	_	
62-16	13199-13200	,	_	
62-17	13201-13212	behavioural	_	
62-18	13213-13224	inter-trial	_	
62-19	13225-13236	variability	_	
62-20	13237-13239	is	_	
62-21	13240-13250	considered	_	
62-22	13251-13253	as	_	
62-23	13254-13257	the	_	
62-24	13258-13265	genuine	_	
62-25	13266-13279	manifestation	_	
62-26	13280-13282	of	_	
62-27	13283-13294	spontaneous	_	
62-28	13295-13307	fluctuations	_	
62-29	13308-13314	within	_	
62-30	13315-13318	the	_	
62-31	13319-13328	intrinsic	_	
62-32	13328-13329	,	_	
62-33	13330-13341	distributed	_	
62-34	13342-13350	cortical	_	
62-35	13351-13358	systems	_	
62-36	13358-13359	.	_	

#Text=Therefore, we postulate that the network abnormalities examined in the off-task condition should also be associated with increased cognitive variability in SZ.
63-1	13360-13369	Therefore	_	
63-2	13369-13370	,	_	
63-3	13371-13373	we	_	
63-4	13374-13383	postulate	_	
63-5	13384-13388	that	_	
63-6	13389-13392	the	_	
63-7	13393-13400	network	_	
63-8	13401-13414	abnormalities	_	
63-9	13415-13423	examined	_	
63-10	13424-13426	in	_	
63-11	13427-13430	the	_	
63-12	13431-13439	off-task	_	
63-13	13440-13449	condition	_	
63-14	13450-13456	should	_	
63-15	13457-13461	also	_	
63-16	13462-13464	be	_	
63-17	13465-13475	associated	_	
63-18	13476-13480	with	_	
63-19	13481-13490	increased	_	
63-20	13491-13500	cognitive	_	
63-21	13501-13512	variability	_	
63-22	13513-13515	in	_	
63-23	13516-13518	SZ	_	
63-24	13518-13519	.	_	

#Text=Specifically, increased intra-individual variability should be associated with altered centrality of anterior/frontal region, considering the neuropsychological models of cognitive inconsistency emphasizing its correlations with dysexecutive syndrome.
64-1	13520-13532	Specifically	_	
64-2	13532-13533	,	_	
64-3	13534-13543	increased	_	
64-4	13544-13560	intra-individual	_	
64-5	13561-13572	variability	_	
64-6	13573-13579	should	_	
64-7	13580-13582	be	_	
64-8	13583-13593	associated	_	
64-9	13594-13598	with	_	
64-10	13599-13606	altered	_	
64-11	13607-13617	centrality	_	
64-12	13618-13620	of	_	
64-13	13621-13629	anterior	_	
64-14	13629-13630	/	_	
64-15	13630-13637	frontal	_	
64-16	13638-13644	region	_	
64-17	13644-13645	,	_	
64-18	13646-13657	considering	_	
64-19	13658-13661	the	_	
64-20	13662-13680	neuropsychological	_	
64-21	13681-13687	models	_	
64-22	13688-13690	of	_	
64-23	13691-13700	cognitive	_	
64-24	13701-13714	inconsistency	_	
64-25	13715-13726	emphasizing	_	
64-26	13727-13730	its	_	
64-27	13731-13743	correlations	_	
64-28	13744-13748	with	_	
64-29	13749-13761	dysexecutive	_	
64-30	13762-13770	syndrome	_	
64-31	13770-13771	.	_	

#Text=Results
#Text=Clinical and cognitive data
#Text=Demographic, clinical and cognitive characteristics of the studied groups
#Text=Characteristics\tSZ (n = 35) M (SD)\tHC (n = 35) M (SD)\tStatistic value\t \tAge (years)\t21.14 (2.95)\t21.54 (0.70)\tF (1, 68) = 0.60, p = 0.438, ηp2 = 0.008\t \tMale/female\t17/18\t15/20\tχ2 = 0.23, df = 1, p = 0.631\t \tEducation (years)\t13.85 (1.86)\t14.20 (1.36)\tF (1, 68) = 0.76, p = 0.383, ηp2 = 0.011\t \tPremorbid IQ\t107.60 (6.66)\t107.82 (7.52)\tF (1, 68) = 0.06, p = 0.893, ηp2 = 0.001\t \tDuration of illness (months)\t12.31 (5.65)\tNA\tNA\t \tDuration of untreated psychosis (months)\t4.85 (4.79)\tNA\tNA\t \tPANSS positive\t14.34 (4.73)\tNA\tNA\t \tPANSS negative\t19.25 (6.14)\tNA\tNA\t \tPANSS general\t34.87 (6.12)\tNA\tNA\t \tPANSS total\t68.34 (10.53)\tNA\tNA\t \tRisperidone equivalents\t4.37 (1.48)\tNA\tNA\t \tCognitive speed:\t \tTotal number of processed stimuli\t55.20 (13.16)\t74.20 (7.24)\tF(1, 65) = 54.60, p < 0.0001, ηp2 = 0.456b\t \tTotal number of errors\t3.11 (3.17)\t1.85 (2.39)\tF(1, 65) = 3.51, p = 0.065, ηp2 = 0.051b\t \tRTmean\t1685.76a (414.15)\t1212.39 (121.16)\tF(1, 65) = 41.74, p < 0.0001, ηp2 = 0.381b\t \tiSD\t967.09a (599.86)\t602.55 (327.48)\tF(1, 65) = 11.19, p = 0.001, ηp2 = 0.146b\t \tEx-Gaussian indicators:\t \tμ\t990.44a (170.91)\t765.19 (68.91)\tF(1, 65) = 51.52, p < 0.0001, ηp2 = 0.442b\t \tσ\t78.31a (63.78)\t90.81 (62.52)\tF(1, 65) = 1.37, p = 0.244, ηp2 = 0.019b\t \tτ\t673.93a (333.09)\t455.23 (143.84)\tF(1, 65) = 13.65, p = 0.0004, ηp2 = 0.173b\t \t
#Text=Notes: SZ = first-episode schizophrenia patients, HC = healthy controls, PANSS = Positive and Negative Syndrome Scale, assessed during remission phase, NA = not applicable, RTmean = mean reaction time, iSD = individual standard deviation.
#Text=aall data given in milliseconds, bANCOVA with age, education and premorbid IQ as controlled covariates.
65-1	13772-13779	Results	_	
65-2	13780-13788	Clinical	_	
65-3	13789-13792	and	_	
65-4	13793-13802	cognitive	_	
65-5	13803-13807	data	_	
65-6	13808-13819	Demographic	_	
65-7	13819-13820	,	_	
65-8	13821-13829	clinical	_	
65-9	13830-13833	and	_	
65-10	13834-13843	cognitive	_	
65-11	13844-13859	characteristics	_	
65-12	13860-13862	of	_	
65-13	13863-13866	the	_	
65-14	13867-13874	studied	_	
65-15	13875-13881	groups	_	
65-16	13882-13897	Characteristics	_	
65-17	13898-13900	SZ	_	
65-18	13901-13902	(	_	
65-19	13902-13903	n	_	
65-20	13904-13905	=	_	
65-21	13906-13908	35	_	
65-22	13908-13909	)	_	
65-23	13910-13911	M	_	
65-24	13912-13913	(	_	
65-25	13913-13915	SD	_	
65-26	13915-13916	)	_	
65-27	13917-13919	HC	_	
65-28	13920-13921	(	_	
65-29	13921-13922	n	_	
65-30	13923-13924	=	_	
65-31	13925-13927	35	_	
65-32	13927-13928	)	_	
65-33	13929-13930	M	_	
65-34	13931-13932	(	_	
65-35	13932-13934	SD	_	
65-36	13934-13935	)	_	
65-37	13936-13945	Statistic	_	
65-38	13946-13951	value	_	
65-39	13954-13957	Age	_	
65-40	13958-13959	(	_	
65-41	13959-13964	years	_	
65-42	13964-13965	)	_	
65-43	13966-13971	21.14	_	
65-44	13972-13973	(	_	
65-45	13973-13977	2.95	_	
65-46	13977-13978	)	_	
65-47	13979-13984	21.54	_	
65-48	13985-13986	(	_	
65-49	13986-13990	0.70	_	
65-50	13990-13991	)	_	
65-51	13992-13993	F	_	
65-52	13994-13995	(	_	
65-53	13995-13996	1	_	
65-54	13996-13997	,	_	
65-55	13998-14000	68	_	
65-56	14000-14001	)	_	
65-57	14002-14003	=	_	
65-58	14004-14008	0.60	_	
65-59	14008-14009	,	_	
65-60	14010-14011	p	_	
65-61	14012-14013	=	_	
65-62	14014-14019	0.438	_	
65-63	14019-14020	,	_	
65-64	14021-14024	ηp2	_	
65-65	14025-14026	=	_	
65-66	14027-14032	0.008	_	
65-67	14035-14039	Male	_	
65-68	14039-14040	/	_	
65-69	14040-14046	female	_	
65-70	14047-14049	17	_	
65-71	14049-14050	/	_	
65-72	14050-14052	18	_	
65-73	14053-14055	15	_	
65-74	14055-14056	/	_	
65-75	14056-14058	20	_	
65-76	14059-14061	χ2	_	
65-77	14062-14063	=	_	
65-78	14064-14068	0.23	_	
65-79	14068-14069	,	_	
65-80	14070-14072	df	_	
65-81	14073-14074	=	_	
65-82	14075-14076	1	_	
65-83	14076-14077	,	_	
65-84	14078-14079	p	_	
65-85	14080-14081	=	_	
65-86	14082-14087	0.631	_	
65-87	14090-14099	Education	_	
65-88	14100-14101	(	_	
65-89	14101-14106	years	_	
65-90	14106-14107	)	_	
65-91	14108-14113	13.85	_	
65-92	14114-14115	(	_	
65-93	14115-14119	1.86	_	
65-94	14119-14120	)	_	
65-95	14121-14126	14.20	_	
65-96	14127-14128	(	_	
65-97	14128-14132	1.36	_	
65-98	14132-14133	)	_	
65-99	14134-14135	F	_	
65-100	14136-14137	(	_	
65-101	14137-14138	1	_	
65-102	14138-14139	,	_	
65-103	14140-14142	68	_	
65-104	14142-14143	)	_	
65-105	14144-14145	=	_	
65-106	14146-14150	0.76	_	
65-107	14150-14151	,	_	
65-108	14152-14153	p	_	
65-109	14154-14155	=	_	
65-110	14156-14161	0.383	_	
65-111	14161-14162	,	_	
65-112	14163-14166	ηp2	_	
65-113	14167-14168	=	_	
65-114	14169-14174	0.011	_	
65-115	14177-14186	Premorbid	_	
65-116	14187-14189	IQ	_	
65-117	14190-14196	107.60	_	
65-118	14197-14198	(	_	
65-119	14198-14202	6.66	_	
65-120	14202-14203	)	_	
65-121	14204-14210	107.82	_	
65-122	14211-14212	(	_	
65-123	14212-14216	7.52	_	
65-124	14216-14217	)	_	
65-125	14218-14219	F	_	
65-126	14220-14221	(	_	
65-127	14221-14222	1	_	
65-128	14222-14223	,	_	
65-129	14224-14226	68	_	
65-130	14226-14227	)	_	
65-131	14228-14229	=	_	
65-132	14230-14234	0.06	_	
65-133	14234-14235	,	_	
65-134	14236-14237	p	_	
65-135	14238-14239	=	_	
65-136	14240-14245	0.893	_	
65-137	14245-14246	,	_	
65-138	14247-14250	ηp2	_	
65-139	14251-14252	=	_	
65-140	14253-14258	0.001	_	
65-141	14261-14269	Duration	_	
65-142	14270-14272	of	_	
65-143	14273-14280	illness	_	
65-144	14281-14282	(	_	
65-145	14282-14288	months	_	
65-146	14288-14289	)	_	
65-147	14290-14295	12.31	_	
65-148	14296-14297	(	_	
65-149	14297-14301	5.65	_	
65-150	14301-14302	)	_	
65-151	14303-14305	NA	_	
65-152	14306-14308	NA	_	
65-153	14311-14319	Duration	_	
65-154	14320-14322	of	_	
65-155	14323-14332	untreated	_	
65-156	14333-14342	psychosis	_	
65-157	14343-14344	(	_	
65-158	14344-14350	months	_	
65-159	14350-14351	)	_	
65-160	14352-14356	4.85	_	
65-161	14357-14358	(	_	
65-162	14358-14362	4.79	_	
65-163	14362-14363	)	_	
65-164	14364-14366	NA	_	
65-165	14367-14369	NA	_	
65-166	14372-14377	PANSS	_	
65-167	14378-14386	positive	_	
65-168	14387-14392	14.34	_	
65-169	14393-14394	(	_	
65-170	14394-14398	4.73	_	
65-171	14398-14399	)	_	
65-172	14400-14402	NA	_	
65-173	14403-14405	NA	_	
65-174	14408-14413	PANSS	_	
65-175	14414-14422	negative	_	
65-176	14423-14428	19.25	_	
65-177	14429-14430	(	_	
65-178	14430-14434	6.14	_	
65-179	14434-14435	)	_	
65-180	14436-14438	NA	_	
65-181	14439-14441	NA	_	
65-182	14444-14449	PANSS	_	
65-183	14450-14457	general	_	
65-184	14458-14463	34.87	_	
65-185	14464-14465	(	_	
65-186	14465-14469	6.12	_	
65-187	14469-14470	)	_	
65-188	14471-14473	NA	_	
65-189	14474-14476	NA	_	
65-190	14479-14484	PANSS	_	
65-191	14485-14490	total	_	
65-192	14491-14496	68.34	_	
65-193	14497-14498	(	_	
65-194	14498-14503	10.53	_	
65-195	14503-14504	)	_	
65-196	14505-14507	NA	_	
65-197	14508-14510	NA	_	
65-198	14513-14524	Risperidone	_	
65-199	14525-14536	equivalents	_	
65-200	14537-14541	4.37	_	
65-201	14542-14543	(	_	
65-202	14543-14547	1.48	_	
65-203	14547-14548	)	_	
65-204	14549-14551	NA	_	
65-205	14552-14554	NA	_	
65-206	14557-14566	Cognitive	_	
65-207	14567-14572	speed	_	
65-208	14572-14573	:	_	
65-209	14576-14581	Total	_	
65-210	14582-14588	number	_	
65-211	14589-14591	of	_	
65-212	14592-14601	processed	_	
65-213	14602-14609	stimuli	_	
65-214	14610-14615	55.20	_	
65-215	14616-14617	(	_	
65-216	14617-14622	13.16	_	
65-217	14622-14623	)	_	
65-218	14624-14629	74.20	_	
65-219	14630-14631	(	_	
65-220	14631-14635	7.24	_	
65-221	14635-14636	)	_	
65-222	14637-14638	F	_	
65-223	14638-14639	(	_	
65-224	14639-14640	1	_	
65-225	14640-14641	,	_	
65-226	14642-14644	65	_	
65-227	14644-14645	)	_	
65-228	14646-14647	=	_	
65-229	14648-14653	54.60	_	
65-230	14653-14654	,	_	
65-231	14655-14656	p	_	
65-232	14657-14658	<	_	
65-233	14659-14665	0.0001	_	
65-234	14665-14666	,	_	
65-235	14667-14670	ηp2	_	
65-236	14671-14672	=	_	
65-237	14673-14679	0.456b	_	
65-238	14682-14687	Total	_	
65-239	14688-14694	number	_	
65-240	14695-14697	of	_	
65-241	14698-14704	errors	_	
65-242	14705-14709	3.11	_	
65-243	14710-14711	(	_	
65-244	14711-14715	3.17	_	
65-245	14715-14716	)	_	
65-246	14717-14721	1.85	_	
65-247	14722-14723	(	_	
65-248	14723-14727	2.39	_	
65-249	14727-14728	)	_	
65-250	14729-14730	F	_	
65-251	14730-14731	(	_	
65-252	14731-14732	1	_	
65-253	14732-14733	,	_	
65-254	14734-14736	65	_	
65-255	14736-14737	)	_	
65-256	14738-14739	=	_	
65-257	14740-14744	3.51	_	
65-258	14744-14745	,	_	
65-259	14746-14747	p	_	
65-260	14748-14749	=	_	
65-261	14750-14755	0.065	_	
65-262	14755-14756	,	_	
65-263	14757-14760	ηp2	_	
65-264	14761-14762	=	_	
65-265	14763-14769	0.051b	_	
65-266	14772-14778	RTmean	_	
65-267	14779-14787	1685.76a	_	
65-268	14788-14789	(	_	
65-269	14789-14795	414.15	_	
65-270	14795-14796	)	_	
65-271	14797-14804	1212.39	_	
65-272	14805-14806	(	_	
65-273	14806-14812	121.16	_	
65-274	14812-14813	)	_	
65-275	14814-14815	F	_	
65-276	14815-14816	(	_	
65-277	14816-14817	1	_	
65-278	14817-14818	,	_	
65-279	14819-14821	65	_	
65-280	14821-14822	)	_	
65-281	14823-14824	=	_	
65-282	14825-14830	41.74	_	
65-283	14830-14831	,	_	
65-284	14832-14833	p	_	
65-285	14834-14835	<	_	
65-286	14836-14842	0.0001	_	
65-287	14842-14843	,	_	
65-288	14844-14847	ηp2	_	
65-289	14848-14849	=	_	
65-290	14850-14856	0.381b	_	
65-291	14859-14862	iSD	_	
65-292	14863-14870	967.09a	_	
65-293	14871-14872	(	_	
65-294	14872-14878	599.86	_	
65-295	14878-14879	)	_	
65-296	14880-14886	602.55	_	
65-297	14887-14888	(	_	
65-298	14888-14894	327.48	_	
65-299	14894-14895	)	_	
65-300	14896-14897	F	_	
65-301	14897-14898	(	_	
65-302	14898-14899	1	_	
65-303	14899-14900	,	_	
65-304	14901-14903	65	_	
65-305	14903-14904	)	_	
65-306	14905-14906	=	_	
65-307	14907-14912	11.19	_	
65-308	14912-14913	,	_	
65-309	14914-14915	p	_	
65-310	14916-14917	=	_	
65-311	14918-14923	0.001	_	
65-312	14923-14924	,	_	
65-313	14925-14928	ηp2	_	
65-314	14929-14930	=	_	
65-315	14931-14937	0.146b	_	
65-316	14940-14951	Ex-Gaussian	_	
65-317	14952-14962	indicators	_	
65-318	14962-14963	:	_	
65-319	14966-14967	μ	_	
65-320	14968-14975	990.44a	_	
65-321	14976-14977	(	_	
65-322	14977-14983	170.91	_	
65-323	14983-14984	)	_	
65-324	14985-14991	765.19	_	
65-325	14992-14993	(	_	
65-326	14993-14998	68.91	_	
65-327	14998-14999	)	_	
65-328	15000-15001	F	_	
65-329	15001-15002	(	_	
65-330	15002-15003	1	_	
65-331	15003-15004	,	_	
65-332	15005-15007	65	_	
65-333	15007-15008	)	_	
65-334	15009-15010	=	_	
65-335	15011-15016	51.52	_	
65-336	15016-15017	,	_	
65-337	15018-15019	p	_	
65-338	15020-15021	<	_	
65-339	15022-15028	0.0001	_	
65-340	15028-15029	,	_	
65-341	15030-15033	ηp2	_	
65-342	15034-15035	=	_	
65-343	15036-15042	0.442b	_	
65-344	15045-15046	σ	_	
65-345	15047-15053	78.31a	_	
65-346	15054-15055	(	_	
65-347	15055-15060	63.78	_	
65-348	15060-15061	)	_	
65-349	15062-15067	90.81	_	
65-350	15068-15069	(	_	
65-351	15069-15074	62.52	_	
65-352	15074-15075	)	_	
65-353	15076-15077	F	_	
65-354	15077-15078	(	_	
65-355	15078-15079	1	_	
65-356	15079-15080	,	_	
65-357	15081-15083	65	_	
65-358	15083-15084	)	_	
65-359	15085-15086	=	_	
65-360	15087-15091	1.37	_	
65-361	15091-15092	,	_	
65-362	15093-15094	p	_	
65-363	15095-15096	=	_	
65-364	15097-15102	0.244	_	
65-365	15102-15103	,	_	
65-366	15104-15107	ηp2	_	
65-367	15108-15109	=	_	
65-368	15110-15116	0.019b	_	
65-369	15119-15120	τ	_	
65-370	15121-15128	673.93a	_	
65-371	15129-15130	(	_	
65-372	15130-15136	333.09	_	
65-373	15136-15137	)	_	
65-374	15138-15144	455.23	_	
65-375	15145-15146	(	_	
65-376	15146-15152	143.84	_	
65-377	15152-15153	)	_	
65-378	15154-15155	F	_	
65-379	15155-15156	(	_	
65-380	15156-15157	1	_	
65-381	15157-15158	,	_	
65-382	15159-15161	65	_	
65-383	15161-15162	)	_	
65-384	15163-15164	=	_	
65-385	15165-15170	13.65	_	
65-386	15170-15171	,	_	
65-387	15172-15173	p	_	
65-388	15174-15175	=	_	
65-389	15176-15182	0.0004	_	
65-390	15182-15183	,	_	
65-391	15184-15187	ηp2	_	
65-392	15188-15189	=	_	
65-393	15190-15196	0.173b	_	
65-394	15200-15205	Notes	_	
65-395	15205-15206	:	_	
65-396	15207-15209	SZ	_	
65-397	15210-15211	=	_	
65-398	15212-15225	first-episode	_	
65-399	15226-15239	schizophrenia	_	
65-400	15240-15248	patients	_	
65-401	15248-15249	,	_	
65-402	15250-15252	HC	_	
65-403	15253-15254	=	_	
65-404	15255-15262	healthy	_	
65-405	15263-15271	controls	_	
65-406	15271-15272	,	_	
65-407	15273-15278	PANSS	_	
65-408	15279-15280	=	_	
65-409	15281-15289	Positive	_	
65-410	15290-15293	and	_	
65-411	15294-15302	Negative	_	
65-412	15303-15311	Syndrome	_	
65-413	15312-15317	Scale	_	
65-414	15317-15318	,	_	
65-415	15319-15327	assessed	_	
65-416	15328-15334	during	_	
65-417	15335-15344	remission	_	
65-418	15345-15350	phase	_	
65-419	15350-15351	,	_	
65-420	15352-15354	NA	_	
65-421	15355-15356	=	_	
65-422	15357-15360	not	_	
65-423	15361-15371	applicable	_	
65-424	15371-15372	,	_	
65-425	15373-15379	RTmean	_	
65-426	15380-15381	=	_	
65-427	15382-15386	mean	_	
65-428	15387-15395	reaction	_	
65-429	15396-15400	time	_	
65-430	15400-15401	,	_	
65-431	15402-15405	iSD	_	
65-432	15406-15407	=	_	
65-433	15408-15418	individual	_	
65-434	15419-15427	standard	_	
65-435	15428-15437	deviation	_	
65-436	15437-15438	.	_	
65-437	15439-15443	aall	_	
65-438	15444-15448	data	_	
65-439	15449-15454	given	_	
65-440	15455-15457	in	_	
65-441	15458-15470	milliseconds	_	
65-442	15470-15471	,	_	
65-443	15472-15479	bANCOVA	_	
65-444	15480-15484	with	_	
65-445	15485-15488	age	_	
65-446	15488-15489	,	_	
65-447	15490-15499	education	_	
65-448	15500-15503	and	_	
65-449	15504-15513	premorbid	_	
65-450	15514-15516	IQ	_	
65-451	15517-15519	as	_	
65-452	15520-15530	controlled	_	
65-453	15531-15541	covariates	_	
65-454	15541-15542	.	_	

#Text=Bold font indicates statistically significant effects, including Bonferroni correction for multiple testing.
66-1	15543-15547	Bold	_	
66-2	15548-15552	font	_	
66-3	15553-15562	indicates	_	
66-4	15563-15576	statistically	_	
66-5	15577-15588	significant	_	
66-6	15589-15596	effects	_	
66-7	15596-15597	,	_	
66-8	15598-15607	including	_	
66-9	15608-15618	Bonferroni	_	
66-10	15619-15629	correction	_	
66-11	15630-15633	for	_	
66-12	15634-15642	multiple	_	
66-13	15643-15650	testing	_	
66-14	15650-15651	.	_	

#Text=Table 1 presents demographic, clinical and cognitive characteristics of the studied groups.
67-1	15652-15657	Table	_	
67-2	15657-15658	 	_	
67-3	15658-15659	1	_	
67-4	15660-15668	presents	_	
67-5	15669-15680	demographic	_	
67-6	15680-15681	,	_	
67-7	15682-15690	clinical	_	
67-8	15691-15694	and	_	
67-9	15695-15704	cognitive	_	
67-10	15705-15720	characteristics	_	
67-11	15721-15723	of	_	
67-12	15724-15727	the	_	
67-13	15728-15735	studied	_	
67-14	15736-15742	groups	_	
67-15	15742-15743	.	_	

#Text=Samples did not differ in terms of age (SZ = 21.14; HC = 21.54), gender (SZ = 48.% male; HC = 42.8% male), years of education (SZ = 13.85; HC = 14.20) and premorbid intelligence (SZ = 107.60; HC = 107.82).
68-1	15744-15751	Samples	_	
68-2	15752-15755	did	_	
68-3	15756-15759	not	_	
68-4	15760-15766	differ	_	
68-5	15767-15769	in	_	
68-6	15770-15775	terms	_	
68-7	15776-15778	of	_	
68-8	15779-15782	age	_	
68-9	15783-15784	(	_	
68-10	15784-15786	SZ	_	
68-11	15787-15788	=	_	
68-12	15789-15794	21.14	_	
68-13	15794-15795	;	_	
68-14	15796-15798	HC	_	
68-15	15799-15800	=	_	
68-16	15801-15806	21.54	_	
68-17	15806-15807	)	_	
68-18	15807-15808	,	_	
68-19	15809-15815	gender	_	
68-20	15816-15817	(	_	
68-21	15817-15819	SZ	_	
68-22	15820-15821	=	_	
68-23	15822-15824	48	_	
68-24	15824-15825	.	_	
68-25	15825-15826	%	_	
68-26	15827-15831	male	_	
68-27	15831-15832	;	_	
68-28	15833-15835	HC	_	
68-29	15836-15837	=	_	
68-30	15838-15843	42.8%	_	
68-31	15844-15848	male	_	
68-32	15848-15849	)	_	
68-33	15849-15850	,	_	
68-34	15851-15856	years	_	
68-35	15857-15859	of	_	
68-36	15860-15869	education	_	
68-37	15870-15871	(	_	
68-38	15871-15873	SZ	_	
68-39	15874-15875	=	_	
68-40	15876-15881	13.85	_	
68-41	15881-15882	;	_	
68-42	15883-15885	HC	_	
68-43	15886-15887	=	_	
68-44	15888-15893	14.20	_	
68-45	15893-15894	)	_	
68-46	15895-15898	and	_	
68-47	15899-15908	premorbid	_	
68-48	15909-15921	intelligence	_	
68-49	15922-15923	(	_	
68-50	15923-15925	SZ	_	
68-51	15926-15927	=	_	
68-52	15928-15934	107.60	_	
68-53	15934-15935	;	_	
68-54	15936-15938	HC	_	
68-55	15939-15940	=	_	
68-56	15941-15947	107.82	_	
68-57	15947-15948	)	_	
68-58	15948-15949	.	_	

#Text=In SZ group, the duration of illness was about 1 year, and the average time of untreated psychosis lasted no more than half a year.
69-1	15950-15952	In	_	
69-2	15953-15955	SZ	_	
69-3	15956-15961	group	_	
69-4	15961-15962	,	_	
69-5	15963-15966	the	_	
69-6	15967-15975	duration	_	
69-7	15976-15978	of	_	
69-8	15979-15986	illness	_	
69-9	15987-15990	was	_	
69-10	15991-15996	about	_	
69-11	15997-15998	1	_	
69-12	15999-16003	year	_	
69-13	16003-16004	,	_	
69-14	16005-16008	and	_	
69-15	16009-16012	the	_	
69-16	16013-16020	average	_	
69-17	16021-16025	time	_	
69-18	16026-16028	of	_	
69-19	16029-16038	untreated	_	
69-20	16039-16048	psychosis	_	
69-21	16049-16055	lasted	_	
69-22	16056-16058	no	_	
69-23	16059-16063	more	_	
69-24	16064-16068	than	_	
69-25	16069-16073	half	_	
69-26	16074-16075	a	_	
69-27	16076-16080	year	_	
69-28	16080-16081	.	_	

#Text=All patients were treated with atypical antipsychotics: 65.62% of patients with Olanzapine, 22.85% were taking Risperidone and 11.53% Aripiprazole.
70-1	16082-16085	All	_	
70-2	16086-16094	patients	_	
70-3	16095-16099	were	_	
70-4	16100-16107	treated	_	
70-5	16108-16112	with	_	
70-6	16113-16121	atypical	_	
70-7	16122-16136	antipsychotics	_	
70-8	16136-16137	:	_	
70-9	16138-16144	65.62%	_	
70-10	16145-16147	of	_	
70-11	16148-16156	patients	_	
70-12	16157-16161	with	_	
70-13	16162-16172	Olanzapine	_	
70-14	16172-16173	,	_	
70-15	16174-16180	22.85%	_	
70-16	16181-16185	were	_	
70-17	16186-16192	taking	_	
70-18	16193-16204	Risperidone	_	
70-19	16205-16208	and	_	
70-20	16209-16215	11.53%	_	
70-21	16216-16228	Aripiprazole	_	
70-22	16228-16229	.	_	

#Text=As for the cognitive results concerning the processing speed and variability, SZ patients had a significantly worse outcome comparing with controls.
71-1	16230-16232	As	_	
71-2	16233-16236	for	_	
71-3	16237-16240	the	_	
71-4	16241-16250	cognitive	_	
71-5	16251-16258	results	_	
71-6	16259-16269	concerning	_	
71-7	16270-16273	the	_	
71-8	16274-16284	processing	_	
71-9	16285-16290	speed	_	
71-10	16291-16294	and	_	
71-11	16295-16306	variability	_	
71-12	16306-16307	,	_	
71-13	16308-16310	SZ	_	
71-14	16311-16319	patients	_	
71-15	16320-16323	had	_	
71-16	16324-16325	a	_	
71-17	16326-16339	significantly	_	
71-18	16340-16345	worse	_	
71-19	16346-16353	outcome	_	
71-20	16354-16363	comparing	_	
71-21	16364-16368	with	_	
71-22	16369-16377	controls	_	
71-23	16377-16378	.	_	

#Text=Specifically, they processed less stimuli in a given amount of time and their mean RT was longer.
72-1	16379-16391	Specifically	_	
72-2	16391-16392	,	_	
72-3	16393-16397	they	_	
72-4	16398-16407	processed	_	
72-5	16408-16412	less	_	
72-6	16413-16420	stimuli	_	
72-7	16421-16423	in	_	
72-8	16424-16425	a	_	
72-9	16426-16431	given	_	
72-10	16432-16438	amount	_	
72-11	16439-16441	of	_	
72-12	16442-16446	time	_	
72-13	16447-16450	and	_	
72-14	16451-16456	their	_	
72-15	16457-16461	mean	_	
72-16	16462-16464	RT	_	
72-17	16465-16468	was	_	
72-18	16469-16475	longer	_	
72-19	16475-16476	.	_	

#Text=Moreover, the application of RTs ex-Gaussian modelling indicated significantly longer average RT (μ parameter) and heightened variability of processing referring to the exponential part of the distribution with the most prolonged RTs (τ parameter, Table 1).
73-1	16477-16485	Moreover	_	
73-2	16485-16486	,	_	
73-3	16487-16490	the	_	
73-4	16491-16502	application	_	
73-5	16503-16505	of	_	
73-6	16506-16509	RTs	_	
73-7	16510-16521	ex-Gaussian	_	
73-8	16522-16531	modelling	_	
73-9	16532-16541	indicated	_	
73-10	16542-16555	significantly	_	
73-11	16556-16562	longer	_	
73-12	16563-16570	average	_	
73-13	16571-16573	RT	_	
73-14	16574-16575	(	_	
73-15	16575-16576	μ	_	
73-16	16577-16586	parameter	_	
73-17	16586-16587	)	_	
73-18	16588-16591	and	_	
73-19	16592-16602	heightened	_	
73-20	16603-16614	variability	_	
73-21	16615-16617	of	_	
73-22	16618-16628	processing	_	
73-23	16629-16638	referring	_	
73-24	16639-16641	to	_	
73-25	16642-16645	the	_	
73-26	16646-16657	exponential	_	
73-27	16658-16662	part	_	
73-28	16663-16665	of	_	
73-29	16666-16669	the	_	
73-30	16670-16682	distribution	_	
73-31	16683-16687	with	_	
73-32	16688-16691	the	_	
73-33	16692-16696	most	_	
73-34	16697-16706	prolonged	_	
73-35	16707-16710	RTs	_	
73-36	16711-16712	(	_	
73-37	16712-16713	τ	_	
73-38	16714-16723	parameter	_	
73-39	16723-16724	,	_	
73-40	16725-16730	Table	_	
73-41	16730-16731	 	_	
73-42	16731-16732	1	_	
73-43	16732-16733	)	_	
73-44	16733-16734	.	_	

#Text=No significant group difference emerged concerning the number of errors committed in the cognitive speed task.
74-1	16735-16737	No	_	
74-2	16738-16749	significant	_	
74-3	16750-16755	group	_	
74-4	16756-16766	difference	_	
74-5	16767-16774	emerged	_	
74-6	16775-16785	concerning	_	
74-7	16786-16789	the	_	
74-8	16790-16796	number	_	
74-9	16797-16799	of	_	
74-10	16800-16806	errors	_	
74-11	16807-16816	committed	_	
74-12	16817-16819	in	_	
74-13	16820-16823	the	_	
74-14	16824-16833	cognitive	_	
74-15	16834-16839	speed	_	
74-16	16840-16844	task	_	
74-17	16844-16845	.	_	

#Text=In the SZ sample, there was no significant correlation between μ and τ (r = 0.03, p = 0.864), whereas it emerged in HC group: r = −0.53, p = 0.001.
75-1	16846-16848	In	_	
75-2	16849-16852	the	_	
75-3	16853-16855	SZ	_	
75-4	16856-16862	sample	_	
75-5	16862-16863	,	_	
75-6	16864-16869	there	_	
75-7	16870-16873	was	_	
75-8	16874-16876	no	_	
75-9	16877-16888	significant	_	
75-10	16889-16900	correlation	_	
75-11	16901-16908	between	_	
75-12	16909-16910	μ	_	
75-13	16911-16914	and	_	
75-14	16915-16916	τ	_	
75-15	16917-16918	(	_	
75-16	16918-16919	r	_	
75-17	16920-16921	=	_	
75-18	16922-16926	0.03	_	
75-19	16926-16927	,	_	
75-20	16928-16929	p	_	
75-21	16930-16931	=	_	
75-22	16932-16937	0.864	_	
75-23	16937-16938	)	_	
75-24	16938-16939	,	_	
75-25	16940-16947	whereas	_	
75-26	16948-16950	it	_	
75-27	16951-16958	emerged	_	
75-28	16959-16961	in	_	
75-29	16962-16964	HC	_	
75-30	16965-16970	group	_	
75-31	16970-16971	:	_	
75-32	16972-16973	r	_	
75-33	16974-16975	=	_	
75-34	16976-16977	−	_	
75-35	16977-16981	0.53	_	
75-36	16981-16982	,	_	
75-37	16983-16984	p	_	
75-38	16985-16986	=	_	
75-39	16987-16992	0.001	_	
75-40	16992-16993	.	_	

#Text=Further, in SZ group, the total number of stimuli processed in DST was significantly predicted by τ (β = −0.79) and μ parameters (β = −0.54): R2 = 0.97, F(6, 28) = 235.44, p < 0.0001.
76-1	16994-17001	Further	_	
76-2	17001-17002	,	_	
76-3	17003-17005	in	_	
76-4	17006-17008	SZ	_	
76-5	17009-17014	group	_	
76-6	17014-17015	,	_	
76-7	17016-17019	the	_	
76-8	17020-17025	total	_	
76-9	17026-17032	number	_	
76-10	17033-17035	of	_	
76-11	17036-17043	stimuli	_	
76-12	17044-17053	processed	_	
76-13	17054-17056	in	_	
76-14	17057-17060	DST	_	
76-15	17061-17064	was	_	
76-16	17065-17078	significantly	_	
76-17	17079-17088	predicted	_	
76-18	17089-17091	by	_	
76-19	17092-17093	τ	_	
76-20	17094-17095	(	_	
76-21	17095-17096	β	_	
76-22	17097-17098	=	_	
76-23	17099-17100	−	_	
76-24	17100-17104	0.79	_	
76-25	17104-17105	)	_	
76-26	17106-17109	and	_	
76-27	17110-17111	μ	_	
76-28	17112-17122	parameters	_	
76-29	17123-17124	(	_	
76-30	17124-17125	β	_	
76-31	17126-17127	=	_	
76-32	17128-17129	−	_	
76-33	17129-17133	0.54	_	
76-34	17133-17134	)	_	
76-35	17134-17135	:	_	
76-36	17136-17138	R2	_	
76-37	17139-17140	=	_	
76-38	17141-17145	0.97	_	
76-39	17145-17146	,	_	
76-40	17147-17148	F	_	
76-41	17148-17149	(	_	
76-42	17149-17150	6	_	
76-43	17150-17151	,	_	
76-44	17152-17154	28	_	
76-45	17154-17155	)	_	
76-46	17156-17157	=	_	
76-47	17158-17164	235.44	_	
76-48	17164-17165	,	_	
76-49	17166-17167	p	_	
76-50	17168-17169	<	_	
76-51	17170-17176	0.0001	_	
76-52	17176-17177	.	_	

#Text=An indicator of cognitive inconsistency (τ) correlated with the subscale of negative symptoms from PANSS administrated in remission phase (R = 0.48, p = 0.002).
77-1	17178-17180	An	_	
77-2	17181-17190	indicator	_	
77-3	17191-17193	of	_	
77-4	17194-17203	cognitive	_	
77-5	17204-17217	inconsistency	_	
77-6	17218-17219	(	_	
77-7	17219-17220	τ	_	
77-8	17220-17221	)	_	
77-9	17222-17232	correlated	_	
77-10	17233-17237	with	_	
77-11	17238-17241	the	_	
77-12	17242-17250	subscale	_	
77-13	17251-17253	of	_	
77-14	17254-17262	negative	_	
77-15	17263-17271	symptoms	_	
77-16	17272-17276	from	_	
77-17	17277-17282	PANSS	_	
77-18	17283-17296	administrated	_	
77-19	17297-17299	in	_	
77-20	17300-17309	remission	_	
77-21	17310-17315	phase	_	
77-22	17316-17317	(	_	
77-23	17317-17318	R	_	
77-24	17319-17320	=	_	
77-25	17321-17325	0.48	_	
77-26	17325-17326	,	_	
77-27	17327-17328	p	_	
77-28	17329-17330	=	_	
77-29	17331-17336	0.002	_	
77-30	17336-17337	)	_	
77-31	17337-17338	.	_	

#Text=Functional connectivity and networks organization in the studied groups
#Text=PLI and MST metrics significantly differentiated the studied groups and correlations between these indicators and ex-Gaussian parameters μ and τ in first-episode schizophrenia group (SZ).
78-1	17339-17349	Functional	_	
78-2	17350-17362	connectivity	_	
78-3	17363-17366	and	_	
78-4	17367-17375	networks	_	
78-5	17376-17388	organization	_	
78-6	17389-17391	in	_	
78-7	17392-17395	the	_	
78-8	17396-17403	studied	_	
78-9	17404-17410	groups	_	
78-10	17411-17414	PLI	_	
78-11	17415-17418	and	_	
78-12	17419-17422	MST	_	
78-13	17423-17430	metrics	_	
78-14	17431-17444	significantly	_	
78-15	17445-17459	differentiated	_	
78-16	17460-17463	the	_	
78-17	17464-17471	studied	_	
78-18	17472-17478	groups	_	
78-19	17479-17482	and	_	
78-20	17483-17495	correlations	_	
78-21	17496-17503	between	_	
78-22	17504-17509	these	_	
78-23	17510-17520	indicators	_	
78-24	17521-17524	and	_	
78-25	17525-17536	ex-Gaussian	_	
78-26	17537-17547	parameters	_	
78-27	17548-17549	μ	_	
78-28	17550-17553	and	_	
78-29	17554-17555	τ	_	
78-30	17556-17558	in	_	
78-31	17559-17572	first-episode	_	
78-32	17573-17586	schizophrenia	_	
78-33	17587-17592	group	_	
78-34	17593-17594	(	_	
78-35	17594-17596	SZ	_	
78-36	17596-17597	)	_	
78-37	17597-17598	.	_	

#Text=PLI and MST results\tSZ versus HC\tηp2\tCorrelations between MST and ex-Gaussian parameters\t \tμ\tτ\t \tDelta\t \tPLI\t—\t0.007\t\t\t \tDiameter\t↓\t0.100\t−0.04\t0.14\t \tLeaf fraction\t↑\t0.131\t−0.11\t−0.22\t \tR\t↑\t0.139\t0.17\t−0.28\t \tBCmax\t—\t0.025\t\t\t \tBC global\t—\t0.042\t\t\t \tBC anterior\t—\t0.001\t\t\t \tBC posterior\t↑\t0.128\t0.06\t−0.05\t \tTheta\t \tPLI\t↑\t0.321\t0.15\t0.28\t \tDiameter\t—\t0.021\t\t\t \tLeaf fraction\t—\t0.076\t\t\t \tR\t—\t0.067\t\t\t \tBCmax\t—\t0.018\t\t\t \tBC global\t—\t0.007\t\t\t \tBC anterior\t—\t0.035\t\t\t \tBC posterior\t—\t0.045\t\t\t \tLower alpha\t \tPLI\t↓\t0.136\t−0.26\t0.28\t \tDiameter\t—\t0.001\t\t\t \tLeaf fraction\t—\t0.002\t\t\t \tR\t—\t0.003\t\t\t \tBCmax\t—\t0.001\t\t\t \tBC global\t—\t0.001\t\t\t \tBC anterior\t—\t0.007\t\t\t \tBC posterior\t—\t0.073\t\t\t \tUpper alpha\t \tPLI\t—\t0.006\t\t\t \tDiameter\t—\t0.015\t\t\t \tLeaf fraction\t—\t0.001\t\t\t \tR\t—\t0.026\t\t\t \tBCmax\t—\t0.023\t\t\t \tBC global\t—\t0.001\t\t\t \tBC anterior\t—\t0.007\t\t\t \tBC posterior\t—\t0.074\t\t\t \tBeta\t \tPLI\t—\t0.052\t\t\t \tDiameter\t↓\t0.093\t−0.08\t0.013\t \tLeaf fraction\t—\t0.045\t\t\t \tR\t—\t0.003\t\t\t \tBCmax\t↑\t0.122\t0.45*\t−0.19\t \tBC global\t↓\t0.100\t−0.39\t0.21\t \tBC anterior\t—\t0.001\t\t\t \tBC posterior\t—\t0.048\t\t\t \tGamma\t \tPLI\t—\t0.076\t\t\t \tDiameter\t↓\t0.234\t−0.45*\t0.17\t \tLeaf fraction\t↑\t0.244\t0.23\t0.21\t \tR\t—\t0.035\t\t\t \tBCmax\t↑\t0.205\t0.47*\t0.29\t \tBC global\t—\t0.019\t\t\t \tBC anterior\t—\t0.006\t\t\t \tBC posterior\t↑\t0.235\t0.01\t0.72**\t \t
#Text=Note.
79-1	17599-17602	PLI	_	
79-2	17603-17606	and	_	
79-3	17607-17610	MST	_	
79-4	17611-17618	results	_	
79-5	17619-17621	SZ	_	
79-6	17622-17628	versus	_	
79-7	17629-17631	HC	_	
79-8	17632-17635	ηp2	_	
79-9	17636-17648	Correlations	_	
79-10	17649-17656	between	_	
79-11	17657-17660	MST	_	
79-12	17661-17664	and	_	
79-13	17665-17676	ex-Gaussian	_	
79-14	17677-17687	parameters	_	
79-15	17690-17691	μ	_	
79-16	17692-17693	τ	_	
79-17	17696-17701	Delta	_	
79-18	17704-17707	PLI	_	
79-19	17708-17709	—	_	
79-20	17710-17715	0.007	_	
79-21	17720-17728	Diameter	_	
79-22	17729-17730	↓	_	
79-23	17731-17736	0.100	_	
79-24	17737-17738	−	_	
79-25	17738-17742	0.04	_	
79-26	17743-17747	0.14	_	
79-27	17750-17754	Leaf	_	
79-28	17755-17763	fraction	_	
79-29	17764-17765	↑	_	
79-30	17766-17771	0.131	_	
79-31	17772-17773	−	_	
79-32	17773-17777	0.11	_	
79-33	17778-17779	−	_	
79-34	17779-17783	0.22	_	
79-35	17786-17787	R	_	
79-36	17788-17789	↑	_	
79-37	17790-17795	0.139	_	
79-38	17796-17800	0.17	_	
79-39	17801-17802	−	_	
79-40	17802-17806	0.28	_	
79-41	17809-17814	BCmax	_	
79-42	17815-17816	—	_	
79-43	17817-17822	0.025	_	
79-44	17827-17829	BC	_	
79-45	17830-17836	global	_	
79-46	17837-17838	—	_	
79-47	17839-17844	0.042	_	
79-48	17849-17851	BC	_	
79-49	17852-17860	anterior	_	
79-50	17861-17862	—	_	
79-51	17863-17868	0.001	_	
79-52	17873-17875	BC	_	
79-53	17876-17885	posterior	_	
79-54	17886-17887	↑	_	
79-55	17888-17893	0.128	_	
79-56	17894-17898	0.06	_	
79-57	17899-17900	−	_	
79-58	17900-17904	0.05	_	
79-59	17907-17912	Theta	_	
79-60	17915-17918	PLI	_	
79-61	17919-17920	↑	_	
79-62	17921-17926	0.321	_	
79-63	17927-17931	0.15	_	
79-64	17932-17936	0.28	_	
79-65	17939-17947	Diameter	_	
79-66	17948-17949	—	_	
79-67	17950-17955	0.021	_	
79-68	17960-17964	Leaf	_	
79-69	17965-17973	fraction	_	
79-70	17974-17975	—	_	
79-71	17976-17981	0.076	_	
79-72	17986-17987	R	_	
79-73	17988-17989	—	_	
79-74	17990-17995	0.067	_	
79-75	18000-18005	BCmax	_	
79-76	18006-18007	—	_	
79-77	18008-18013	0.018	_	
79-78	18018-18020	BC	_	
79-79	18021-18027	global	_	
79-80	18028-18029	—	_	
79-81	18030-18035	0.007	_	
79-82	18040-18042	BC	_	
79-83	18043-18051	anterior	_	
79-84	18052-18053	—	_	
79-85	18054-18059	0.035	_	
79-86	18064-18066	BC	_	
79-87	18067-18076	posterior	_	
79-88	18077-18078	—	_	
79-89	18079-18084	0.045	_	
79-90	18089-18094	Lower	_	
79-91	18095-18100	alpha	_	
79-92	18103-18106	PLI	_	
79-93	18107-18108	↓	_	
79-94	18109-18114	0.136	_	
79-95	18115-18116	−	_	
79-96	18116-18120	0.26	_	
79-97	18121-18125	0.28	_	
79-98	18128-18136	Diameter	_	
79-99	18137-18138	—	_	
79-100	18139-18144	0.001	_	
79-101	18149-18153	Leaf	_	
79-102	18154-18162	fraction	_	
79-103	18163-18164	—	_	
79-104	18165-18170	0.002	_	
79-105	18175-18176	R	_	
79-106	18177-18178	—	_	
79-107	18179-18184	0.003	_	
79-108	18189-18194	BCmax	_	
79-109	18195-18196	—	_	
79-110	18197-18202	0.001	_	
79-111	18207-18209	BC	_	
79-112	18210-18216	global	_	
79-113	18217-18218	—	_	
79-114	18219-18224	0.001	_	
79-115	18229-18231	BC	_	
79-116	18232-18240	anterior	_	
79-117	18241-18242	—	_	
79-118	18243-18248	0.007	_	
79-119	18253-18255	BC	_	
79-120	18256-18265	posterior	_	
79-121	18266-18267	—	_	
79-122	18268-18273	0.073	_	
79-123	18278-18283	Upper	_	
79-124	18284-18289	alpha	_	
79-125	18292-18295	PLI	_	
79-126	18296-18297	—	_	
79-127	18298-18303	0.006	_	
79-128	18308-18316	Diameter	_	
79-129	18317-18318	—	_	
79-130	18319-18324	0.015	_	
79-131	18329-18333	Leaf	_	
79-132	18334-18342	fraction	_	
79-133	18343-18344	—	_	
79-134	18345-18350	0.001	_	
79-135	18355-18356	R	_	
79-136	18357-18358	—	_	
79-137	18359-18364	0.026	_	
79-138	18369-18374	BCmax	_	
79-139	18375-18376	—	_	
79-140	18377-18382	0.023	_	
79-141	18387-18389	BC	_	
79-142	18390-18396	global	_	
79-143	18397-18398	—	_	
79-144	18399-18404	0.001	_	
79-145	18409-18411	BC	_	
79-146	18412-18420	anterior	_	
79-147	18421-18422	—	_	
79-148	18423-18428	0.007	_	
79-149	18433-18435	BC	_	
79-150	18436-18445	posterior	_	
79-151	18446-18447	—	_	
79-152	18448-18453	0.074	_	
79-153	18458-18462	Beta	_	
79-154	18465-18468	PLI	_	
79-155	18469-18470	—	_	
79-156	18471-18476	0.052	_	
79-157	18481-18489	Diameter	_	
79-158	18490-18491	↓	_	
79-159	18492-18497	0.093	_	
79-160	18498-18499	−	_	
79-161	18499-18503	0.08	_	
79-162	18504-18509	0.013	_	
79-163	18512-18516	Leaf	_	
79-164	18517-18525	fraction	_	
79-165	18526-18527	—	_	
79-166	18528-18533	0.045	_	
79-167	18538-18539	R	_	
79-168	18540-18541	—	_	
79-169	18542-18547	0.003	_	
79-170	18552-18557	BCmax	_	
79-171	18558-18559	↑	_	
79-172	18560-18565	0.122	_	
79-173	18566-18570	0.45	_	
79-174	18570-18571	*	_	
79-175	18572-18573	−	_	
79-176	18573-18577	0.19	_	
79-177	18580-18582	BC	_	
79-178	18583-18589	global	_	
79-179	18590-18591	↓	_	
79-180	18592-18597	0.100	_	
79-181	18598-18599	−	_	
79-182	18599-18603	0.39	_	
79-183	18604-18608	0.21	_	
79-184	18611-18613	BC	_	
79-185	18614-18622	anterior	_	
79-186	18623-18624	—	_	
79-187	18625-18630	0.001	_	
79-188	18635-18637	BC	_	
79-189	18638-18647	posterior	_	
79-190	18648-18649	—	_	
79-191	18650-18655	0.048	_	
79-192	18660-18665	Gamma	_	
79-193	18668-18671	PLI	_	
79-194	18672-18673	—	_	
79-195	18674-18679	0.076	_	
79-196	18684-18692	Diameter	_	
79-197	18693-18694	↓	_	
79-198	18695-18700	0.234	_	
79-199	18701-18702	−	_	
79-200	18702-18706	0.45	_	
79-201	18706-18707	*	_	
79-202	18708-18712	0.17	_	
79-203	18715-18719	Leaf	_	
79-204	18720-18728	fraction	_	
79-205	18729-18730	↑	_	
79-206	18731-18736	0.244	_	
79-207	18737-18741	0.23	_	
79-208	18742-18746	0.21	_	
79-209	18749-18750	R	_	
79-210	18751-18752	—	_	
79-211	18753-18758	0.035	_	
79-212	18763-18768	BCmax	_	
79-213	18769-18770	↑	_	
79-214	18771-18776	0.205	_	
79-215	18777-18781	0.47	_	
79-216	18781-18782	*	_	
79-217	18783-18787	0.29	_	
79-218	18790-18792	BC	_	
79-219	18793-18799	global	_	
79-220	18800-18801	—	_	
79-221	18802-18807	0.019	_	
79-222	18812-18814	BC	_	
79-223	18815-18823	anterior	_	
79-224	18824-18825	—	_	
79-225	18826-18831	0.006	_	
79-226	18836-18838	BC	_	
79-227	18839-18848	posterior	_	
79-228	18849-18850	↑	_	
79-229	18851-18856	0.235	_	
79-230	18857-18861	0.01	_	
79-231	18862-18866	0.72	_	
79-232	18866-18867	*	_	
79-233	18867-18868	*	_	
79-234	18872-18876	Note	_	
79-235	18876-18877	.	_	

#Text=Bold ηp2 represents significant effect sizes, ↑ result significantly (p < 0.01) higher in SZ group (n = 35, HC n = 35), ↓ result significantly (p < 0.01) lower in SZ group, -n.s.
80-1	18878-18882	Bold	_	
80-2	18883-18886	ηp2	_	
80-3	18887-18897	represents	_	
80-4	18898-18909	significant	_	
80-5	18910-18916	effect	_	
80-6	18917-18922	sizes	_	
80-7	18922-18923	,	_	
80-8	18924-18925	↑	_	
80-9	18926-18932	result	_	
80-10	18933-18946	significantly	_	
80-11	18947-18948	(	_	
80-12	18948-18949	p	_	
80-13	18950-18951	<	_	
80-14	18952-18956	0.01	_	
80-15	18956-18957	)	_	
80-16	18958-18964	higher	_	
80-17	18965-18967	in	_	
80-18	18968-18970	SZ	_	
80-19	18971-18976	group	_	
80-20	18977-18978	(	_	
80-21	18978-18979	n	_	
80-22	18980-18981	=	_	
80-23	18982-18984	35	_	
80-24	18984-18985	,	_	
80-25	18986-18988	HC	_	
80-26	18989-18990	n	_	
80-27	18991-18992	=	_	
80-28	18993-18995	35	_	
80-29	18995-18996	)	_	
80-30	18996-18997	,	_	
80-31	18998-18999	↓	_	
80-32	19000-19006	result	_	
80-33	19007-19020	significantly	_	
80-34	19021-19022	(	_	
80-35	19022-19023	p	_	
80-36	19024-19025	<	_	
80-37	19026-19030	0.01	_	
80-38	19030-19031	)	_	
80-39	19032-19037	lower	_	
80-40	19038-19040	in	_	
80-41	19041-19043	SZ	_	
80-42	19044-19049	group	_	
80-43	19049-19050	,	_	
80-44	19051-19052	-	_	
80-45	19052-19055	n.s	_	
80-46	19055-19056	.	_	

#Text=Correlations significance *p < 0.01, **p < 0.001
#Text=Bold font indicates statistically significant effects, including Bonferroni correction for multiple testing
#Text=Delineative representation of minimum spanning trees with reference to the network types.
81-1	19057-19069	Correlations	_	
81-2	19070-19082	significance	_	
81-3	19083-19084	*	_	
81-4	19084-19085	p	_	
81-5	19086-19087	<	_	
81-6	19088-19092	0.01	_	
81-7	19092-19093	,	_	
81-8	19094-19095	*	_	
81-9	19095-19096	*	_	
81-10	19096-19097	p	_	
81-11	19098-19099	<	_	
81-12	19100-19105	0.001	_	
81-13	19106-19110	Bold	_	
81-14	19111-19115	font	_	
81-15	19116-19125	indicates	_	
81-16	19126-19139	statistically	_	
81-17	19140-19151	significant	_	
81-18	19152-19159	effects	_	
81-19	19159-19160	,	_	
81-20	19161-19170	including	_	
81-21	19171-19181	Bonferroni	_	
81-22	19182-19192	correction	_	
81-23	19193-19196	for	_	
81-24	19197-19205	multiple	_	
81-25	19206-19213	testing	_	
81-26	19214-19225	Delineative	_	
81-27	19226-19240	representation	_	
81-28	19241-19243	of	_	
81-29	19244-19251	minimum	_	
81-30	19252-19260	spanning	_	
81-31	19261-19266	trees	_	
81-32	19267-19271	with	_	
81-33	19272-19281	reference	_	
81-34	19282-19284	to	_	
81-35	19285-19288	the	_	
81-36	19289-19296	network	_	
81-37	19297-19302	types	_	
81-38	19302-19303	.	_	

#Text=(a) shows a path-like configuration, in which two end nodes are the leafs (light green) of the tree.
82-1	19304-19305	(	_	
82-2	19305-19306	a	_	
82-3	19306-19307	)	_	
82-4	19308-19313	shows	_	
82-5	19314-19315	a	_	
82-6	19316-19325	path-like	_	
82-7	19326-19339	configuration	_	
82-8	19339-19340	,	_	
82-9	19341-19343	in	_	
82-10	19344-19349	which	_	
82-11	19350-19353	two	_	
82-12	19354-19357	end	_	
82-13	19358-19363	nodes	_	
82-14	19364-19367	are	_	
82-15	19368-19371	the	_	
82-16	19372-19377	leafs	_	
82-17	19378-19379	(	_	
82-18	19379-19384	light	_	
82-19	19385-19390	green	_	
82-20	19390-19391	)	_	
82-21	19392-19394	of	_	
82-22	19395-19398	the	_	
82-23	19399-19403	tree	_	
82-24	19403-19404	.	_	

#Text=Such model network has low leaf fraction, high diameter and low betweenness centrality.
83-1	19405-19409	Such	_	
83-2	19410-19415	model	_	
83-3	19416-19423	network	_	
83-4	19424-19427	has	_	
83-5	19428-19431	low	_	
83-6	19432-19436	leaf	_	
83-7	19437-19445	fraction	_	
83-8	19445-19446	,	_	
83-9	19447-19451	high	_	
83-10	19452-19460	diameter	_	
83-11	19461-19464	and	_	
83-12	19465-19468	low	_	
83-13	19469-19480	betweenness	_	
83-14	19481-19491	centrality	_	
83-15	19491-19492	.	_	

#Text=(b) presents a diagram of a well-balanced network containing five nodes and two hubs creating a “rich club”, constituted by two directly connected nodes with increased centrality.
84-1	19493-19494	(	_	
84-2	19494-19495	b	_	
84-3	19495-19496	)	_	
84-4	19497-19505	presents	_	
84-5	19506-19507	a	_	
84-6	19508-19515	diagram	_	
84-7	19516-19518	of	_	
84-8	19519-19520	a	_	
84-9	19521-19534	well-balanced	_	
84-10	19535-19542	network	_	
84-11	19543-19553	containing	_	
84-12	19554-19558	five	_	
84-13	19559-19564	nodes	_	
84-14	19565-19568	and	_	
84-15	19569-19572	two	_	
84-16	19573-19577	hubs	_	
84-17	19578-19586	creating	_	
84-18	19587-19588	a	_	
84-19	19589-19590	“	_	
84-20	19590-19594	rich	_	
84-21	19595-19599	club	_	
84-22	19599-19600	”	_	
84-23	19600-19601	,	_	
84-24	19602-19613	constituted	_	
84-25	19614-19616	by	_	
84-26	19617-19620	two	_	
84-27	19621-19629	directly	_	
84-28	19630-19639	connected	_	
84-29	19640-19645	nodes	_	
84-30	19646-19650	with	_	
84-31	19651-19660	increased	_	
84-32	19661-19671	centrality	_	
84-33	19671-19672	.	_	

#Text=Relatively small amount of leaf nodes prevents the hubs from overloading.
85-1	19673-19683	Relatively	_	
85-2	19684-19689	small	_	
85-3	19690-19696	amount	_	
85-4	19697-19699	of	_	
85-5	19700-19704	leaf	_	
85-6	19705-19710	nodes	_	
85-7	19711-19719	prevents	_	
85-8	19720-19723	the	_	
85-9	19724-19728	hubs	_	
85-10	19729-19733	from	_	
85-11	19734-19745	overloading	_	
85-12	19745-19746	.	_	

#Text=(c) is an example of a star-like tree, having a central, overloaded hub (red) connected with all nodes.
86-1	19747-19748	(	_	
86-2	19748-19749	c	_	
86-3	19749-19750	)	_	
86-4	19751-19753	is	_	
86-5	19754-19756	an	_	
86-6	19757-19764	example	_	
86-7	19765-19767	of	_	
86-8	19768-19769	a	_	
86-9	19770-19779	star-like	_	
86-10	19780-19784	tree	_	
86-11	19784-19785	,	_	
86-12	19786-19792	having	_	
86-13	19793-19794	a	_	
86-14	19795-19802	central	_	
86-15	19802-19803	,	_	
86-16	19804-19814	overloaded	_	
86-17	19815-19818	hub	_	
86-18	19819-19820	(	_	
86-19	19820-19823	red	_	
86-20	19823-19824	)	_	
86-21	19825-19834	connected	_	
86-22	19835-19839	with	_	
86-23	19840-19843	all	_	
86-24	19844-19849	nodes	_	
86-25	19849-19850	.	_	

#Text=This network is characterized by high leaf fraction, low diameter and high betweenness centrality.
87-1	19851-19855	This	_	
87-2	19856-19863	network	_	
87-3	19864-19866	is	_	
87-4	19867-19880	characterized	_	
87-5	19881-19883	by	_	
87-6	19884-19888	high	_	
87-7	19889-19893	leaf	_	
87-8	19894-19902	fraction	_	
87-9	19902-19903	,	_	
87-10	19904-19907	low	_	
87-11	19908-19916	diameter	_	
87-12	19917-19920	and	_	
87-13	19921-19925	high	_	
87-14	19926-19937	betweenness	_	
87-15	19938-19948	centrality	_	
87-16	19948-19949	.	_	

#Text=In an extreme form of a path-like network segregation processes prevail, because it takes a lot of steps to transfer information from the initial to the last node, while an extreme star-like network is dominated by integration processes because information flow from all nodes reaches one central hub and overload it.
88-1	19950-19952	In	_	
88-2	19953-19955	an	_	
88-3	19956-19963	extreme	_	
88-4	19964-19968	form	_	
88-5	19969-19971	of	_	
88-6	19972-19973	a	_	
88-7	19974-19983	path-like	_	
88-8	19984-19991	network	_	
88-9	19992-20003	segregation	_	
88-10	20004-20013	processes	_	
88-11	20014-20021	prevail	_	
88-12	20021-20022	,	_	
88-13	20023-20030	because	_	
88-14	20031-20033	it	_	
88-15	20034-20039	takes	_	
88-16	20040-20041	a	_	
88-17	20042-20045	lot	_	
88-18	20046-20048	of	_	
88-19	20049-20054	steps	_	
88-20	20055-20057	to	_	
88-21	20058-20066	transfer	_	
88-22	20067-20078	information	_	
88-23	20079-20083	from	_	
88-24	20084-20087	the	_	
88-25	20088-20095	initial	_	
88-26	20096-20098	to	_	
88-27	20099-20102	the	_	
88-28	20103-20107	last	_	
88-29	20108-20112	node	_	
88-30	20112-20113	,	_	
88-31	20114-20119	while	_	
88-32	20120-20122	an	_	
88-33	20123-20130	extreme	_	
88-34	20131-20140	star-like	_	
88-35	20141-20148	network	_	
88-36	20149-20151	is	_	
88-37	20152-20161	dominated	_	
88-38	20162-20164	by	_	
88-39	20165-20176	integration	_	
88-40	20177-20186	processes	_	
88-41	20187-20194	because	_	
88-42	20195-20206	information	_	
88-43	20207-20211	flow	_	
88-44	20212-20216	from	_	
88-45	20217-20220	all	_	
88-46	20221-20226	nodes	_	
88-47	20227-20234	reaches	_	
88-48	20235-20238	one	_	
88-49	20239-20246	central	_	
88-50	20247-20250	hub	_	
88-51	20251-20254	and	_	
88-52	20255-20263	overload	_	
88-53	20264-20266	it	_	
88-54	20266-20267	.	_	

#Text=An illustrative comparison of the MST topologies differing with respect to: increased and decreased maximal betweenness centrality (a), and comparison of regionally diversified topologies with regard to betweenness centrality of nodes located in anterior versus posterior areas (b).
89-1	20268-20270	An	_	
89-2	20271-20283	illustrative	_	
89-3	20284-20294	comparison	_	
89-4	20295-20297	of	_	
89-5	20298-20301	the	_	
89-6	20302-20305	MST	_	
89-7	20306-20316	topologies	_	
89-8	20317-20326	differing	_	
89-9	20327-20331	with	_	
89-10	20332-20339	respect	_	
89-11	20340-20342	to	_	
89-12	20342-20343	:	_	
89-13	20344-20353	increased	_	
89-14	20354-20357	and	_	
89-15	20358-20367	decreased	_	
89-16	20368-20375	maximal	_	
89-17	20376-20387	betweenness	_	
89-18	20388-20398	centrality	_	
89-19	20399-20400	(	_	
89-20	20400-20401	a	_	
89-21	20401-20402	)	_	
89-22	20402-20403	,	_	
89-23	20404-20407	and	_	
89-24	20408-20418	comparison	_	
89-25	20419-20421	of	_	
89-26	20422-20432	regionally	_	
89-27	20433-20444	diversified	_	
89-28	20445-20455	topologies	_	
89-29	20456-20460	with	_	
89-30	20461-20467	regard	_	
89-31	20468-20470	to	_	
89-32	20471-20482	betweenness	_	
89-33	20483-20493	centrality	_	
89-34	20494-20496	of	_	
89-35	20497-20502	nodes	_	
89-36	20503-20510	located	_	
89-37	20511-20513	in	_	
89-38	20514-20522	anterior	_	
89-39	20523-20529	versus	_	
89-40	20530-20539	posterior	_	
89-41	20540-20545	areas	_	
89-42	20546-20547	(	_	
89-43	20547-20548	b	_	
89-44	20548-20549	)	_	
89-45	20549-20550	.	_	

#Text=Blue nodes are hubs, while light green nodes are leafs.
90-1	20551-20555	Blue	_	
90-2	20556-20561	nodes	_	
90-3	20562-20565	are	_	
90-4	20566-20570	hubs	_	
90-5	20570-20571	,	_	
90-6	20572-20577	while	_	
90-7	20578-20583	light	_	
90-8	20584-20589	green	_	
90-9	20590-20595	nodes	_	
90-10	20596-20599	are	_	
90-11	20600-20605	leafs	_	
90-12	20605-20606	.	_	

#Text=The thickness of the lines corresponds to functional connectivity values based on the phase lag index algorithm.
91-1	20607-20610	The	_	
91-2	20611-20620	thickness	_	
91-3	20621-20623	of	_	
91-4	20624-20627	the	_	
91-5	20628-20633	lines	_	
91-6	20634-20645	corresponds	_	
91-7	20646-20648	to	_	
91-8	20649-20659	functional	_	
91-9	20660-20672	connectivity	_	
91-10	20673-20679	values	_	
91-11	20680-20685	based	_	
91-12	20686-20688	on	_	
91-13	20689-20692	the	_	
91-14	20693-20698	phase	_	
91-15	20699-20702	lag	_	
91-16	20703-20708	index	_	
91-17	20709-20718	algorithm	_	
91-18	20718-20719	.	_	

#Text=(a).
92-1	20720-20721	(	_	
92-2	20721-20722	a	_	
92-3	20722-20723	)	_	
92-4	20723-20724	.	_	

#Text=Topography on the right side contains severely overloaded central hub (T5 electrode) positioned in the left temporal lobe, directly connected to seven other nodes.
93-1	20725-20735	Topography	_	
93-2	20736-20738	on	_	
93-3	20739-20742	the	_	
93-4	20743-20748	right	_	
93-5	20749-20753	side	_	
93-6	20754-20762	contains	_	
93-7	20763-20771	severely	_	
93-8	20772-20782	overloaded	_	
93-9	20783-20790	central	_	
93-10	20791-20794	hub	_	
93-11	20795-20796	(	_	
93-12	20796-20798	T5	_	
93-13	20799-20808	electrode	_	
93-14	20808-20809	)	_	
93-15	20810-20820	positioned	_	
93-16	20821-20823	in	_	
93-17	20824-20827	the	_	
93-18	20828-20832	left	_	
93-19	20833-20841	temporal	_	
93-20	20842-20846	lobe	_	
93-21	20846-20847	,	_	
93-22	20848-20856	directly	_	
93-23	20857-20866	connected	_	
93-24	20867-20869	to	_	
93-25	20870-20875	seven	_	
93-26	20876-20881	other	_	
93-27	20882-20887	nodes	_	
93-28	20887-20888	.	_	

#Text=Compared with this substantially centralized topology, network organization showed on the left does not lead to hubs overloading, due to more balanced and dispersed distribution of connections between individual nodes.
94-1	20889-20897	Compared	_	
94-2	20898-20902	with	_	
94-3	20903-20907	this	_	
94-4	20908-20921	substantially	_	
94-5	20922-20933	centralized	_	
94-6	20934-20942	topology	_	
94-7	20942-20943	,	_	
94-8	20944-20951	network	_	
94-9	20952-20964	organization	_	
94-10	20965-20971	showed	_	
94-11	20972-20974	on	_	
94-12	20975-20978	the	_	
94-13	20979-20983	left	_	
94-14	20984-20988	does	_	
94-15	20989-20992	not	_	
94-16	20993-20997	lead	_	
94-17	20998-21000	to	_	
94-18	21001-21005	hubs	_	
94-19	21006-21017	overloading	_	
94-20	21017-21018	,	_	
94-21	21019-21022	due	_	
94-22	21023-21025	to	_	
94-23	21026-21030	more	_	
94-24	21031-21039	balanced	_	
94-25	21040-21043	and	_	
94-26	21044-21053	dispersed	_	
94-27	21054-21066	distribution	_	
94-28	21067-21069	of	_	
94-29	21070-21081	connections	_	
94-30	21082-21089	between	_	
94-31	21090-21100	individual	_	
94-32	21101-21106	nodes	_	
94-33	21106-21107	.	_	

#Text=(b).
95-1	21108-21109	(	_	
95-2	21109-21110	b	_	
95-3	21110-21111	)	_	
95-4	21111-21112	.	_	

#Text=The organization shown on the right contains more hubs located in the posterior part of cortical surface, especially in the right temporal and parietal lobes.
96-1	21113-21116	The	_	
96-2	21117-21129	organization	_	
96-3	21130-21135	shown	_	
96-4	21136-21138	on	_	
96-5	21139-21142	the	_	
96-6	21143-21148	right	_	
96-7	21149-21157	contains	_	
96-8	21158-21162	more	_	
96-9	21163-21167	hubs	_	
96-10	21168-21175	located	_	
96-11	21176-21178	in	_	
96-12	21179-21182	the	_	
96-13	21183-21192	posterior	_	
96-14	21193-21197	part	_	
96-15	21198-21200	of	_	
96-16	21201-21209	cortical	_	
96-17	21210-21217	surface	_	
96-18	21217-21218	,	_	
96-19	21219-21229	especially	_	
96-20	21230-21232	in	_	
96-21	21233-21236	the	_	
96-22	21237-21242	right	_	
96-23	21243-21251	temporal	_	
96-24	21252-21255	and	_	
96-25	21256-21264	parietal	_	
96-26	21265-21270	lobes	_	
96-27	21270-21271	.	_	

#Text=The central hub, with the maximal BC in the entire network is located in the right temporal lobe (electrode T6).
97-1	21272-21275	The	_	
97-2	21276-21283	central	_	
97-3	21284-21287	hub	_	
97-4	21287-21288	,	_	
97-5	21289-21293	with	_	
97-6	21294-21297	the	_	
97-7	21298-21305	maximal	_	
97-8	21306-21308	BC	_	
97-9	21309-21311	in	_	
97-10	21312-21315	the	_	
97-11	21316-21322	entire	_	
97-12	21323-21330	network	_	
97-13	21331-21333	is	_	
97-14	21334-21341	located	_	
97-15	21342-21344	in	_	
97-16	21345-21348	the	_	
97-17	21349-21354	right	_	
97-18	21355-21363	temporal	_	
97-19	21364-21368	lobe	_	
97-20	21369-21370	(	_	
97-21	21370-21379	electrode	_	
97-22	21380-21382	T6	_	
97-23	21382-21383	)	_	
97-24	21383-21384	.	_	

#Text=The topology displayed on the left contains more hubs in the anterior area and the central hub positioned within the right prefrontal cortex (electrode Fp2).
98-1	21385-21388	The	_	
98-2	21389-21397	topology	_	
98-3	21398-21407	displayed	_	
98-4	21408-21410	on	_	
98-5	21411-21414	the	_	
98-6	21415-21419	left	_	
98-7	21420-21428	contains	_	
98-8	21429-21433	more	_	
98-9	21434-21438	hubs	_	
98-10	21439-21441	in	_	
98-11	21442-21445	the	_	
98-12	21446-21454	anterior	_	
98-13	21455-21459	area	_	
98-14	21460-21463	and	_	
98-15	21464-21467	the	_	
98-16	21468-21475	central	_	
98-17	21476-21479	hub	_	
98-18	21480-21490	positioned	_	
98-19	21491-21497	within	_	
98-20	21498-21501	the	_	
98-21	21502-21507	right	_	
98-22	21508-21518	prefrontal	_	
98-23	21519-21525	cortex	_	
98-24	21526-21527	(	_	
98-25	21527-21536	electrode	_	
98-26	21537-21540	Fp2	_	
98-27	21540-21541	)	_	
98-28	21541-21542	.	_	

#Text=Shown topologies were reconstructed according to pipeline presented in Fig. 1., on the basis of MST results obtained from our SZ patients (on the right) and healthy controls (on the left) in beta (a) and gamma (b) frequencies (see Supplementary Information: Figs S1 and S2. for row MST graph of both groups).
99-1	21543-21548	Shown	_	
99-2	21549-21559	topologies	_	
99-3	21560-21564	were	_	
99-4	21565-21578	reconstructed	_	
99-5	21579-21588	according	_	
99-6	21589-21591	to	_	
99-7	21592-21600	pipeline	_	
99-8	21601-21610	presented	_	
99-9	21611-21613	in	_	
99-10	21614-21617	Fig	_	
99-11	21617-21618	.	_	
99-12	21618-21619	 	_	
99-13	21619-21620	1	_	
99-14	21620-21621	.	_	
99-15	21621-21622	,	_	
99-16	21623-21625	on	_	
99-17	21626-21629	the	_	
99-18	21630-21635	basis	_	
99-19	21636-21638	of	_	
99-20	21639-21642	MST	_	
99-21	21643-21650	results	_	
99-22	21651-21659	obtained	_	
99-23	21660-21664	from	_	
99-24	21665-21668	our	_	
99-25	21669-21671	SZ	_	
99-26	21672-21680	patients	_	
99-27	21681-21682	(	_	
99-28	21682-21684	on	_	
99-29	21685-21688	the	_	
99-30	21689-21694	right	_	
99-31	21694-21695	)	_	
99-32	21696-21699	and	_	
99-33	21700-21707	healthy	_	
99-34	21708-21716	controls	_	
99-35	21717-21718	(	_	
99-36	21718-21720	on	_	
99-37	21721-21724	the	_	
99-38	21725-21729	left	_	
99-39	21729-21730	)	_	
99-40	21731-21733	in	_	
99-41	21734-21738	beta	_	
99-42	21739-21740	(	_	
99-43	21740-21741	a	_	
99-44	21741-21742	)	_	
99-45	21743-21746	and	_	
99-46	21747-21752	gamma	_	
99-47	21753-21754	(	_	
99-48	21754-21755	b	_	
99-49	21755-21756	)	_	
99-50	21757-21768	frequencies	_	
99-51	21769-21770	(	_	
99-52	21770-21773	see	_	
99-53	21774-21787	Supplementary	_	
99-54	21788-21799	Information	_	
99-55	21799-21800	:	_	
99-56	21801-21805	Figs	_	
99-57	21805-21806	 	_	
99-58	21806-21808	S1	_	
99-59	21809-21812	and	_	
99-60	21813-21815	S2	_	
99-61	21815-21816	.	_	
99-62	21817-21820	for	_	
99-63	21821-21824	row	_	
99-64	21825-21828	MST	_	
99-65	21829-21834	graph	_	
99-66	21835-21837	of	_	
99-67	21838-21842	both	_	
99-68	21843-21849	groups	_	
99-69	21849-21850	)	_	
99-70	21850-21851	.	_	

#Text=Described between-groups differences were confirmed in statistical comparisons regarding BCmax in beta band and regional betweenness centrality in gamma frequency (Table 2).
100-1	21852-21861	Described	_	
100-2	21862-21876	between-groups	_	
100-3	21877-21888	differences	_	
100-4	21889-21893	were	_	
100-5	21894-21903	confirmed	_	
100-6	21904-21906	in	_	
100-7	21907-21918	statistical	_	
100-8	21919-21930	comparisons	_	
100-9	21931-21940	regarding	_	
100-10	21941-21946	BCmax	_	
100-11	21947-21949	in	_	
100-12	21950-21954	beta	_	
100-13	21955-21959	band	_	
100-14	21960-21963	and	_	
100-15	21964-21972	regional	_	
100-16	21973-21984	betweenness	_	
100-17	21985-21995	centrality	_	
100-18	21996-21998	in	_	
100-19	21999-22004	gamma	_	
100-20	22005-22014	frequency	_	
100-21	22015-22016	(	_	
100-22	22016-22021	Table	_	
100-23	22021-22022	 	_	
100-24	22022-22023	2	_	
100-25	22023-22024	)	_	
100-26	22024-22025	.	_	

#Text=MST analysis revealed significant group effects for the majority of the studied frequencies (Table 2).
101-1	22026-22029	MST	_	
101-2	22030-22038	analysis	_	
101-3	22039-22047	revealed	_	
101-4	22048-22059	significant	_	
101-5	22060-22065	group	_	
101-6	22066-22073	effects	_	
101-7	22074-22077	for	_	
101-8	22078-22081	the	_	
101-9	22082-22090	majority	_	
101-10	22091-22093	of	_	
101-11	22094-22097	the	_	
101-12	22098-22105	studied	_	
101-13	22106-22117	frequencies	_	
101-14	22118-22119	(	_	
101-15	22119-22124	Table	_	
101-16	22124-22125	 	_	
101-17	22125-22126	2	_	
101-18	22126-22127	)	_	
101-19	22127-22128	.	_	

#Text=In delta band, SZ patients had a lower diameter and higher leaf fraction relative to the control group, indicating that their network contained a higher amount of the shortest paths and increased number of nodes with only one connection.
102-1	22129-22131	In	_	
102-2	22132-22137	delta	_	
102-3	22138-22142	band	_	
102-4	22142-22143	,	_	
102-5	22144-22146	SZ	_	
102-6	22147-22155	patients	_	
102-7	22156-22159	had	_	
102-8	22160-22161	a	_	
102-9	22162-22167	lower	_	
102-10	22168-22176	diameter	_	
102-11	22177-22180	and	_	
102-12	22181-22187	higher	_	
102-13	22188-22192	leaf	_	
102-14	22193-22201	fraction	_	
102-15	22202-22210	relative	_	
102-16	22211-22213	to	_	
102-17	22214-22217	the	_	
102-18	22218-22225	control	_	
102-19	22226-22231	group	_	
102-20	22231-22232	,	_	
102-21	22233-22243	indicating	_	
102-22	22244-22248	that	_	
102-23	22249-22254	their	_	
102-24	22255-22262	network	_	
102-25	22263-22272	contained	_	
102-26	22273-22274	a	_	
102-27	22275-22281	higher	_	
102-28	22282-22288	amount	_	
102-29	22289-22291	of	_	
102-30	22292-22295	the	_	
102-31	22296-22304	shortest	_	
102-32	22305-22310	paths	_	
102-33	22311-22314	and	_	
102-34	22315-22324	increased	_	
102-35	22325-22331	number	_	
102-36	22332-22334	of	_	
102-37	22335-22340	nodes	_	
102-38	22341-22345	with	_	
102-39	22346-22350	only	_	
102-40	22351-22354	one	_	
102-41	22355-22365	connection	_	
102-42	22365-22366	.	_	

#Text=Degree correlation in patients (R = −0.45) was higher than in the control group (R = −0.31) confirming increased network disassortativity in the SZ group.
103-1	22367-22373	Degree	_	
103-2	22374-22385	correlation	_	
103-3	22386-22388	in	_	
103-4	22389-22397	patients	_	
103-5	22398-22399	(	_	
103-6	22399-22400	R	_	
103-7	22401-22402	=	_	
103-8	22403-22404	−	_	
103-9	22404-22408	0.45	_	
103-10	22408-22409	)	_	
103-11	22410-22413	was	_	
103-12	22414-22420	higher	_	
103-13	22421-22425	than	_	
103-14	22426-22428	in	_	
103-15	22429-22432	the	_	
103-16	22433-22440	control	_	
103-17	22441-22446	group	_	
103-18	22447-22448	(	_	
103-19	22448-22449	R	_	
103-20	22450-22451	=	_	
103-21	22452-22453	−	_	
103-22	22453-22457	0.31	_	
103-23	22457-22458	)	_	
103-24	22459-22469	confirming	_	
103-25	22470-22479	increased	_	
103-26	22480-22487	network	_	
103-27	22488-22504	disassortativity	_	
103-28	22505-22507	in	_	
103-29	22508-22511	the	_	
103-30	22512-22514	SZ	_	
103-31	22515-22520	group	_	
103-32	22520-22521	.	_	

#Text=Additionally, a regional analysis showed higher BC for the posterior region in SZ, compared to the control group.
104-1	22522-22534	Additionally	_	
104-2	22534-22535	,	_	
104-3	22536-22537	a	_	
104-4	22538-22546	regional	_	
104-5	22547-22555	analysis	_	
104-6	22556-22562	showed	_	
104-7	22563-22569	higher	_	
104-8	22570-22572	BC	_	
104-9	22573-22576	for	_	
104-10	22577-22580	the	_	
104-11	22581-22590	posterior	_	
104-12	22591-22597	region	_	
104-13	22598-22600	in	_	
104-14	22601-22603	SZ	_	
104-15	22603-22604	,	_	
104-16	22605-22613	compared	_	
104-17	22614-22616	to	_	
104-18	22617-22620	the	_	
104-19	22621-22628	control	_	
104-20	22629-22634	group	_	
104-21	22634-22635	.	_	

#Text=Between-groups effects in theta band concerned stronger oscillatory synchronization (PLI) in SZ patients compared to the control group.
105-1	22636-22650	Between-groups	_	
105-2	22651-22658	effects	_	
105-3	22659-22661	in	_	
105-4	22662-22667	theta	_	
105-5	22668-22672	band	_	
105-6	22673-22682	concerned	_	
105-7	22683-22691	stronger	_	
105-8	22692-22703	oscillatory	_	
105-9	22704-22719	synchronization	_	
105-10	22720-22721	(	_	
105-11	22721-22724	PLI	_	
105-12	22724-22725	)	_	
105-13	22726-22728	in	_	
105-14	22729-22731	SZ	_	
105-15	22732-22740	patients	_	
105-16	22741-22749	compared	_	
105-17	22750-22752	to	_	
105-18	22753-22756	the	_	
105-19	22757-22764	control	_	
105-20	22765-22770	group	_	
105-21	22770-22771	.	_	

#Text=The reverse result in terms of synchronization strength was determined in the lower alpha frequency range.
106-1	22772-22775	The	_	
106-2	22776-22783	reverse	_	
106-3	22784-22790	result	_	
106-4	22791-22793	in	_	
106-5	22794-22799	terms	_	
106-6	22800-22802	of	_	
106-7	22803-22818	synchronization	_	
106-8	22819-22827	strength	_	
106-9	22828-22831	was	_	
106-10	22832-22842	determined	_	
106-11	22843-22845	in	_	
106-12	22846-22849	the	_	
106-13	22850-22855	lower	_	
106-14	22856-22861	alpha	_	
106-15	22862-22871	frequency	_	
106-16	22872-22877	range	_	
106-17	22877-22878	.	_	

#Text=No intergroup differences were recorded in the upper alpha frequency.
107-1	22879-22881	No	_	
107-2	22882-22892	intergroup	_	
107-3	22893-22904	differences	_	
107-4	22905-22909	were	_	
107-5	22910-22918	recorded	_	
107-6	22919-22921	in	_	
107-7	22922-22925	the	_	
107-8	22926-22931	upper	_	
107-9	22932-22937	alpha	_	
107-10	22938-22947	frequency	_	
107-11	22947-22948	.	_	

#Text=Similarly to the delta band, the network of SZ patients in the beta frequency was characterized by the increased number of shortest paths (diameter) and lower global centrality.
108-1	22949-22958	Similarly	_	
108-2	22959-22961	to	_	
108-3	22962-22965	the	_	
108-4	22966-22971	delta	_	
108-5	22972-22976	band	_	
108-6	22976-22977	,	_	
108-7	22978-22981	the	_	
108-8	22982-22989	network	_	
108-9	22990-22992	of	_	
108-10	22993-22995	SZ	_	
108-11	22996-23004	patients	_	
108-12	23005-23007	in	_	
108-13	23008-23011	the	_	
108-14	23012-23016	beta	_	
108-15	23017-23026	frequency	_	
108-16	23027-23030	was	_	
108-17	23031-23044	characterized	_	
108-18	23045-23047	by	_	
108-19	23048-23051	the	_	
108-20	23052-23061	increased	_	
108-21	23062-23068	number	_	
108-22	23069-23071	of	_	
108-23	23072-23080	shortest	_	
108-24	23081-23086	paths	_	
108-25	23087-23088	(	_	
108-26	23088-23096	diameter	_	
108-27	23096-23097	)	_	
108-28	23098-23101	and	_	
108-29	23102-23107	lower	_	
108-30	23108-23114	global	_	
108-31	23115-23125	centrality	_	
108-32	23125-23126	.	_	

#Text=Moreover, in the SZ group, the network had a stronger tendency to develop individual hubs with substantially increased maximal betweenness centrality (BCmax).
109-1	23127-23135	Moreover	_	
109-2	23135-23136	,	_	
109-3	23137-23139	in	_	
109-4	23140-23143	the	_	
109-5	23144-23146	SZ	_	
109-6	23147-23152	group	_	
109-7	23152-23153	,	_	
109-8	23154-23157	the	_	
109-9	23158-23165	network	_	
109-10	23166-23169	had	_	
109-11	23170-23171	a	_	
109-12	23172-23180	stronger	_	
109-13	23181-23189	tendency	_	
109-14	23190-23192	to	_	
109-15	23193-23200	develop	_	
109-16	23201-23211	individual	_	
109-17	23212-23216	hubs	_	
109-18	23217-23221	with	_	
109-19	23222-23235	substantially	_	
109-20	23236-23245	increased	_	
109-21	23246-23253	maximal	_	
109-22	23254-23265	betweenness	_	
109-23	23266-23276	centrality	_	
109-24	23277-23278	(	_	
109-25	23278-23283	BCmax	_	
109-26	23283-23284	)	_	
109-27	23284-23285	.	_	

#Text=Significant between-group effects concerning functional connectivity and MST metrics were also identified in gamma frequency.
110-1	23286-23297	Significant	_	
110-2	23298-23311	between-group	_	
110-3	23312-23319	effects	_	
110-4	23320-23330	concerning	_	
110-5	23331-23341	functional	_	
110-6	23342-23354	connectivity	_	
110-7	23355-23358	and	_	
110-8	23359-23362	MST	_	
110-9	23363-23370	metrics	_	
110-10	23371-23375	were	_	
110-11	23376-23380	also	_	
110-12	23381-23391	identified	_	
110-13	23392-23394	in	_	
110-14	23395-23400	gamma	_	
110-15	23401-23410	frequency	_	
110-16	23410-23411	.	_	

#Text=Generally, the SZ sample had a shorter largest distance between any two nodes (diameter), accompanied with higher leaf fraction.
111-1	23412-23421	Generally	_	
111-2	23421-23422	,	_	
111-3	23423-23426	the	_	
111-4	23427-23429	SZ	_	
111-5	23430-23436	sample	_	
111-6	23437-23440	had	_	
111-7	23441-23442	a	_	
111-8	23443-23450	shorter	_	
111-9	23451-23458	largest	_	
111-10	23459-23467	distance	_	
111-11	23468-23475	between	_	
111-12	23476-23479	any	_	
111-13	23480-23483	two	_	
111-14	23484-23489	nodes	_	
111-15	23490-23491	(	_	
111-16	23491-23499	diameter	_	
111-17	23499-23500	)	_	
111-18	23500-23501	,	_	
111-19	23502-23513	accompanied	_	
111-20	23514-23518	with	_	
111-21	23519-23525	higher	_	
111-22	23526-23530	leaf	_	
111-23	23531-23539	fraction	_	
111-24	23539-23540	.	_	

#Text=The patients’ network was substantially more centralized as indicated by more hubs with maximum centrality (BCmax) positioned mainly in the posterior region as compared to the control group (see Figs 2 and 3).
112-1	23541-23544	The	_	
112-2	23545-23553	patients	_	
112-3	23553-23554	’	_	
112-4	23555-23562	network	_	
112-5	23563-23566	was	_	
112-6	23567-23580	substantially	_	
112-7	23581-23585	more	_	
112-8	23586-23597	centralized	_	
112-9	23598-23600	as	_	
112-10	23601-23610	indicated	_	
112-11	23611-23613	by	_	
112-12	23614-23618	more	_	
112-13	23619-23623	hubs	_	
112-14	23624-23628	with	_	
112-15	23629-23636	maximum	_	
112-16	23637-23647	centrality	_	
112-17	23648-23649	(	_	
112-18	23649-23654	BCmax	_	
112-19	23654-23655	)	_	
112-20	23656-23666	positioned	_	
112-21	23667-23673	mainly	_	
112-22	23674-23676	in	_	
112-23	23677-23680	the	_	
112-24	23681-23690	posterior	_	
112-25	23691-23697	region	_	
112-26	23698-23700	as	_	
112-27	23701-23709	compared	_	
112-28	23710-23712	to	_	
112-29	23713-23716	the	_	
112-30	23717-23724	control	_	
112-31	23725-23730	group	_	
112-32	23731-23732	(	_	
112-33	23732-23735	see	_	
112-34	23736-23740	Figs	_	
112-35	23740-23741	 	_	
112-36	23741-23742	2	_	
112-37	23743-23746	and	_	
112-38	23747-23748	3	_	
112-39	23748-23749	)	_	
112-40	23749-23750	.	_	

#Text=Within the theta and lower alpha bands, the PLI parameters were not correlated with the MST indices that significantly differentiated the studied groups.
113-1	23751-23757	Within	_	
113-2	23758-23761	the	_	
113-3	23762-23767	theta	_	
113-4	23768-23771	and	_	
113-5	23772-23777	lower	_	
113-6	23778-23783	alpha	_	
113-7	23784-23789	bands	_	
113-8	23789-23790	,	_	
113-9	23791-23794	the	_	
113-10	23795-23798	PLI	_	
113-11	23799-23809	parameters	_	
113-12	23810-23814	were	_	
113-13	23815-23818	not	_	
113-14	23819-23829	correlated	_	
113-15	23830-23834	with	_	
113-16	23835-23838	the	_	
113-17	23839-23842	MST	_	
113-18	23843-23850	indices	_	
113-19	23851-23855	that	_	
113-20	23856-23869	significantly	_	
113-21	23870-23884	differentiated	_	
113-22	23885-23888	the	_	
113-23	23889-23896	studied	_	
113-24	23897-23903	groups	_	
113-25	23903-23904	.	_	

#Text=Correlations between MST metrics, demographic and clinical variables in the SZ group
#Text=There were no significant correlations between the network parameters differentiating the studied groups and age, education, premorbid IQ, duration of disease, DUP and risperidone equivalent in the SZ sample (p > 0.05).
114-1	23905-23917	Correlations	_	
114-2	23918-23925	between	_	
114-3	23926-23929	MST	_	
114-4	23930-23937	metrics	_	
114-5	23937-23938	,	_	
114-6	23939-23950	demographic	_	
114-7	23951-23954	and	_	
114-8	23955-23963	clinical	_	
114-9	23964-23973	variables	_	
114-10	23974-23976	in	_	
114-11	23977-23980	the	_	
114-12	23981-23983	SZ	_	
114-13	23984-23989	group	_	
114-14	23990-23995	There	_	
114-15	23996-24000	were	_	
114-16	24001-24003	no	_	
114-17	24004-24015	significant	_	
114-18	24016-24028	correlations	_	
114-19	24029-24036	between	_	
114-20	24037-24040	the	_	
114-21	24041-24048	network	_	
114-22	24049-24059	parameters	_	
114-23	24060-24075	differentiating	_	
114-24	24076-24079	the	_	
114-25	24080-24087	studied	_	
114-26	24088-24094	groups	_	
114-27	24095-24098	and	_	
114-28	24099-24102	age	_	
114-29	24102-24103	,	_	
114-30	24104-24113	education	_	
114-31	24113-24114	,	_	
114-32	24115-24124	premorbid	_	
114-33	24125-24127	IQ	_	
114-34	24127-24128	,	_	
114-35	24129-24137	duration	_	
114-36	24138-24140	of	_	
114-37	24141-24148	disease	_	
114-38	24148-24149	,	_	
114-39	24150-24153	DUP	_	
114-40	24154-24157	and	_	
114-41	24158-24169	risperidone	_	
114-42	24170-24180	equivalent	_	
114-43	24181-24183	in	_	
114-44	24184-24187	the	_	
114-45	24188-24190	SZ	_	
114-46	24191-24197	sample	_	
114-47	24198-24199	(	_	
114-48	24199-24200	p	_	
114-49	24201-24202	>	_	
114-50	24203-24207	0.05	_	
114-51	24207-24208	)	_	
114-52	24208-24209	.	_	

#Text=Only one significant correlation was found between MST metrics and PANSS scale, which concerned the relationship between the subscale of positive symptoms and BCposterior in gamma band (R = 0.51, p = 0.002).
115-1	24210-24214	Only	_	
115-2	24215-24218	one	_	
115-3	24219-24230	significant	_	
115-4	24231-24242	correlation	_	
115-5	24243-24246	was	_	
115-6	24247-24252	found	_	
115-7	24253-24260	between	_	
115-8	24261-24264	MST	_	
115-9	24265-24272	metrics	_	
115-10	24273-24276	and	_	
115-11	24277-24282	PANSS	_	
115-12	24283-24288	scale	_	
115-13	24288-24289	,	_	
115-14	24290-24295	which	_	
115-15	24296-24305	concerned	_	
115-16	24306-24309	the	_	
115-17	24310-24322	relationship	_	
115-18	24323-24330	between	_	
115-19	24331-24334	the	_	
115-20	24335-24343	subscale	_	
115-21	24344-24346	of	_	
115-22	24347-24355	positive	_	
115-23	24356-24364	symptoms	_	
115-24	24365-24368	and	_	
115-25	24369-24380	BCposterior	_	
115-26	24381-24383	in	_	
115-27	24384-24389	gamma	_	
115-28	24390-24394	band	_	
115-29	24395-24396	(	_	
115-30	24396-24397	R	_	
115-31	24398-24399	=	_	
115-32	24400-24404	0.51	_	
115-33	24404-24405	,	_	
115-34	24406-24407	p	_	
115-35	24408-24409	=	_	
115-36	24410-24415	0.002	_	
115-37	24415-24416	)	_	
115-38	24416-24417	.	_	

#Text=Associations between networks’ characteristics and ex-Gaussian indicators of cognitive speed and variability in the SZ group
#Text=As presented in Table 2, in the SZ group μ parameter significantly correlated with BCmax (r = 0.45, p = 0.006) in beta frequency and with BCmax (r = 0.47, p = 0.004) and diameter (r = −0.45, p = 0.006) in gamma frequency.
116-1	24418-24430	Associations	_	
116-2	24431-24438	between	_	
116-3	24439-24447	networks	_	
116-4	24447-24448	’	_	
116-5	24449-24464	characteristics	_	
116-6	24465-24468	and	_	
116-7	24469-24480	ex-Gaussian	_	
116-8	24481-24491	indicators	_	
116-9	24492-24494	of	_	
116-10	24495-24504	cognitive	_	
116-11	24505-24510	speed	_	
116-12	24511-24514	and	_	
116-13	24515-24526	variability	_	
116-14	24527-24529	in	_	
116-15	24530-24533	the	_	
116-16	24534-24536	SZ	_	
116-17	24537-24542	group	_	
116-18	24543-24545	As	_	
116-19	24546-24555	presented	_	
116-20	24556-24558	in	_	
116-21	24559-24564	Table	_	
116-22	24564-24565	 	_	
116-23	24565-24566	2	_	
116-24	24566-24567	,	_	
116-25	24568-24570	in	_	
116-26	24571-24574	the	_	
116-27	24575-24577	SZ	_	
116-28	24578-24583	group	_	
116-29	24584-24585	μ	_	
116-30	24586-24595	parameter	_	
116-31	24596-24609	significantly	_	
116-32	24610-24620	correlated	_	
116-33	24621-24625	with	_	
116-34	24626-24631	BCmax	_	
116-35	24632-24633	(	_	
116-36	24633-24634	r	_	
116-37	24635-24636	=	_	
116-38	24637-24641	0.45	_	
116-39	24641-24642	,	_	
116-40	24643-24644	p	_	
116-41	24645-24646	=	_	
116-42	24647-24652	0.006	_	
116-43	24652-24653	)	_	
116-44	24654-24656	in	_	
116-45	24657-24661	beta	_	
116-46	24662-24671	frequency	_	
116-47	24672-24675	and	_	
116-48	24676-24680	with	_	
116-49	24681-24686	BCmax	_	
116-50	24687-24688	(	_	
116-51	24688-24689	r	_	
116-52	24690-24691	=	_	
116-53	24692-24696	0.47	_	
116-54	24696-24697	,	_	
116-55	24698-24699	p	_	
116-56	24700-24701	=	_	
116-57	24702-24707	0.004	_	
116-58	24707-24708	)	_	
116-59	24709-24712	and	_	
116-60	24713-24721	diameter	_	
116-61	24722-24723	(	_	
116-62	24723-24724	r	_	
116-63	24725-24726	=	_	
116-64	24727-24728	−	_	
116-65	24728-24732	0.45	_	
116-66	24732-24733	,	_	
116-67	24734-24735	p	_	
116-68	24736-24737	=	_	
116-69	24738-24743	0.006	_	
116-70	24743-24744	)	_	
116-71	24745-24747	in	_	
116-72	24748-24753	gamma	_	
116-73	24754-24763	frequency	_	
116-74	24763-24764	.	_	

#Text=The exponential part of the distribution with the most prolonged RTs (τ) correlated with betweenness centrality of posterior nodes in gamma (r = 0.72, p < 0.001) frequency.
117-1	24765-24768	The	_	
117-2	24769-24780	exponential	_	
117-3	24781-24785	part	_	
117-4	24786-24788	of	_	
117-5	24789-24792	the	_	
117-6	24793-24805	distribution	_	
117-7	24806-24810	with	_	
117-8	24811-24814	the	_	
117-9	24815-24819	most	_	
117-10	24820-24829	prolonged	_	
117-11	24830-24833	RTs	_	
117-12	24834-24835	(	_	
117-13	24835-24836	τ	_	
117-14	24836-24837	)	_	
117-15	24838-24848	correlated	_	
117-16	24849-24853	with	_	
117-17	24854-24865	betweenness	_	
117-18	24866-24876	centrality	_	
117-19	24877-24879	of	_	
117-20	24880-24889	posterior	_	
117-21	24890-24895	nodes	_	
117-22	24896-24898	in	_	
117-23	24899-24904	gamma	_	
117-24	24905-24906	(	_	
117-25	24906-24907	r	_	
117-26	24908-24909	=	_	
117-27	24910-24914	0.72	_	
117-28	24914-24915	,	_	
117-29	24916-24917	p	_	
117-30	24918-24919	<	_	
117-31	24920-24925	0.001	_	
117-32	24925-24926	)	_	
117-33	24927-24936	frequency	_	
117-34	24936-24937	.	_	

#Text=Because the ex-Gaussian parameters’ distribution, taking into account the Kolmogorov-Smirnov test results (p > 0.1), did not deviate from normal, regression analysis was performed to verify whether the network characteristics analyzed with MST prove to be significant predictors of information processing speed and variability, also when such variables as the duration of illness, DUP and the risperidon equivalent were controlled.
118-1	24938-24945	Because	_	
118-2	24946-24949	the	_	
118-3	24950-24961	ex-Gaussian	_	
118-4	24962-24972	parameters	_	
118-5	24972-24973	’	_	
118-6	24974-24986	distribution	_	
118-7	24986-24987	,	_	
118-8	24988-24994	taking	_	
118-9	24995-24999	into	_	
118-10	25000-25007	account	_	
118-11	25008-25011	the	_	
118-12	25012-25030	Kolmogorov-Smirnov	_	
118-13	25031-25035	test	_	
118-14	25036-25043	results	_	
118-15	25044-25045	(	_	
118-16	25045-25046	p	_	
118-17	25047-25048	>	_	
118-18	25049-25052	0.1	_	
118-19	25052-25053	)	_	
118-20	25053-25054	,	_	
118-21	25055-25058	did	_	
118-22	25059-25062	not	_	
118-23	25063-25070	deviate	_	
118-24	25071-25075	from	_	
118-25	25076-25082	normal	_	
118-26	25082-25083	,	_	
118-27	25084-25094	regression	_	
118-28	25095-25103	analysis	_	
118-29	25104-25107	was	_	
118-30	25108-25117	performed	_	
118-31	25118-25120	to	_	
118-32	25121-25127	verify	_	
118-33	25128-25135	whether	_	
118-34	25136-25139	the	_	
118-35	25140-25147	network	_	
118-36	25148-25163	characteristics	_	
118-37	25164-25172	analyzed	_	
118-38	25173-25177	with	_	
118-39	25178-25181	MST	_	
118-40	25182-25187	prove	_	
118-41	25188-25190	to	_	
118-42	25191-25193	be	_	
118-43	25194-25205	significant	_	
118-44	25206-25216	predictors	_	
118-45	25217-25219	of	_	
118-46	25220-25231	information	_	
118-47	25232-25242	processing	_	
118-48	25243-25248	speed	_	
118-49	25249-25252	and	_	
118-50	25253-25264	variability	_	
118-51	25264-25265	,	_	
118-52	25266-25270	also	_	
118-53	25271-25275	when	_	
118-54	25276-25280	such	_	
118-55	25281-25290	variables	_	
118-56	25291-25293	as	_	
118-57	25294-25297	the	_	
118-58	25298-25306	duration	_	
118-59	25307-25309	of	_	
118-60	25310-25317	illness	_	
118-61	25317-25318	,	_	
118-62	25319-25322	DUP	_	
118-63	25323-25326	and	_	
118-64	25327-25330	the	_	
118-65	25331-25341	risperidon	_	
118-66	25342-25352	equivalent	_	
118-67	25353-25357	were	_	
118-68	25358-25368	controlled	_	
118-69	25368-25369	.	_	

#Text=Correlation plots showing relationships between selected neural networks metrics and the ex-Gaussian parameters characterizing the distribution of reaction times (RTs) derived from the cognitive speed task performed by patients with first-episode schizophrenia.
119-1	25370-25381	Correlation	_	
119-2	25382-25387	plots	_	
119-3	25388-25395	showing	_	
119-4	25396-25409	relationships	_	
119-5	25410-25417	between	_	
119-6	25418-25426	selected	_	
119-7	25427-25433	neural	_	
119-8	25434-25442	networks	_	
119-9	25443-25450	metrics	_	
119-10	25451-25454	and	_	
119-11	25455-25458	the	_	
119-12	25459-25470	ex-Gaussian	_	
119-13	25471-25481	parameters	_	
119-14	25482-25496	characterizing	_	
119-15	25497-25500	the	_	
119-16	25501-25513	distribution	_	
119-17	25514-25516	of	_	
119-18	25517-25525	reaction	_	
119-19	25526-25531	times	_	
119-20	25532-25533	(	_	
119-21	25533-25536	RTs	_	
119-22	25536-25537	)	_	
119-23	25538-25545	derived	_	
119-24	25546-25550	from	_	
119-25	25551-25554	the	_	
119-26	25555-25564	cognitive	_	
119-27	25565-25570	speed	_	
119-28	25571-25575	task	_	
119-29	25576-25585	performed	_	
119-30	25586-25588	by	_	
119-31	25589-25597	patients	_	
119-32	25598-25602	with	_	
119-33	25603-25616	first-episode	_	
119-34	25617-25630	schizophrenia	_	
119-35	25630-25631	.	_	

#Text=Left panel represents correlations between maximal betweenness centrality in gamma frequency and the average RTs (μ parameter), while the right panel displays the correlation between the centrality of nodes localized in the posterior part of the cortex and the most prolonged RTs being an indicator of processing inconsistency (τ parameter).
120-1	25632-25636	Left	_	
120-2	25637-25642	panel	_	
120-3	25643-25653	represents	_	
120-4	25654-25666	correlations	_	
120-5	25667-25674	between	_	
120-6	25675-25682	maximal	_	
120-7	25683-25694	betweenness	_	
120-8	25695-25705	centrality	_	
120-9	25706-25708	in	_	
120-10	25709-25714	gamma	_	
120-11	25715-25724	frequency	_	
120-12	25725-25728	and	_	
120-13	25729-25732	the	_	
120-14	25733-25740	average	_	
120-15	25741-25744	RTs	_	
120-16	25745-25746	(	_	
120-17	25746-25747	μ	_	
120-18	25748-25757	parameter	_	
120-19	25757-25758	)	_	
120-20	25758-25759	,	_	
120-21	25760-25765	while	_	
120-22	25766-25769	the	_	
120-23	25770-25775	right	_	
120-24	25776-25781	panel	_	
120-25	25782-25790	displays	_	
120-26	25791-25794	the	_	
120-27	25795-25806	correlation	_	
120-28	25807-25814	between	_	
120-29	25815-25818	the	_	
120-30	25819-25829	centrality	_	
120-31	25830-25832	of	_	
120-32	25833-25838	nodes	_	
120-33	25839-25848	localized	_	
120-34	25849-25851	in	_	
120-35	25852-25855	the	_	
120-36	25856-25865	posterior	_	
120-37	25866-25870	part	_	
120-38	25871-25873	of	_	
120-39	25874-25877	the	_	
120-40	25878-25884	cortex	_	
120-41	25885-25888	and	_	
120-42	25889-25892	the	_	
120-43	25893-25897	most	_	
120-44	25898-25907	prolonged	_	
120-45	25908-25911	RTs	_	
120-46	25912-25917	being	_	
120-47	25918-25920	an	_	
120-48	25921-25930	indicator	_	
120-49	25931-25933	of	_	
120-50	25934-25944	processing	_	
120-51	25945-25958	inconsistency	_	
120-52	25959-25960	(	_	
120-53	25960-25961	τ	_	
120-54	25962-25971	parameter	_	
120-55	25971-25972	)	_	
120-56	25972-25973	.	_	

#Text=In both cases, depicted associations were significant also after controlling for duration of untreated psychosis, duration of illness and risperidone equivalent.
121-1	25974-25976	In	_	
121-2	25977-25981	both	_	
121-3	25982-25987	cases	_	
121-4	25987-25988	,	_	
121-5	25989-25997	depicted	_	
121-6	25998-26010	associations	_	
121-7	26011-26015	were	_	
121-8	26016-26027	significant	_	
121-9	26028-26032	also	_	
121-10	26033-26038	after	_	
121-11	26039-26050	controlling	_	
121-12	26051-26054	for	_	
121-13	26055-26063	duration	_	
121-14	26064-26066	of	_	
121-15	26067-26076	untreated	_	
121-16	26077-26086	psychosis	_	
121-17	26086-26087	,	_	
121-18	26088-26096	duration	_	
121-19	26097-26099	of	_	
121-20	26100-26107	illness	_	
121-21	26108-26111	and	_	
121-22	26112-26123	risperidone	_	
121-23	26124-26134	equivalent	_	
121-24	26134-26135	.	_	

#Text=Multivariate regression analysis revealed that average RTs (μ) was significantly predicted by BCmax in gamma frequency (β = 0.47), BCmax in beta frequency (β = 0.45) and DUP (β = 0.32): R2 = 0.58, F(7, 27) = 9.12, p < 0.0001, also after controlling for duration of illness and risperidone equivalent.
122-1	26136-26148	Multivariate	_	
122-2	26149-26159	regression	_	
122-3	26160-26168	analysis	_	
122-4	26169-26177	revealed	_	
122-5	26178-26182	that	_	
122-6	26183-26190	average	_	
122-7	26191-26194	RTs	_	
122-8	26195-26196	(	_	
122-9	26196-26197	μ	_	
122-10	26197-26198	)	_	
122-11	26199-26202	was	_	
122-12	26203-26216	significantly	_	
122-13	26217-26226	predicted	_	
122-14	26227-26229	by	_	
122-15	26230-26235	BCmax	_	
122-16	26236-26238	in	_	
122-17	26239-26244	gamma	_	
122-18	26245-26254	frequency	_	
122-19	26255-26256	(	_	
122-20	26256-26257	β	_	
122-21	26258-26259	=	_	
122-22	26260-26264	0.47	_	
122-23	26264-26265	)	_	
122-24	26265-26266	,	_	
122-25	26267-26272	BCmax	_	
122-26	26273-26275	in	_	
122-27	26276-26280	beta	_	
122-28	26281-26290	frequency	_	
122-29	26291-26292	(	_	
122-30	26292-26293	β	_	
122-31	26294-26295	=	_	
122-32	26296-26300	0.45	_	
122-33	26300-26301	)	_	
122-34	26302-26305	and	_	
122-35	26306-26309	DUP	_	
122-36	26310-26311	(	_	
122-37	26311-26312	β	_	
122-38	26313-26314	=	_	
122-39	26315-26319	0.32	_	
122-40	26319-26320	)	_	
122-41	26320-26321	:	_	
122-42	26322-26324	R2	_	
122-43	26325-26326	=	_	
122-44	26327-26331	0.58	_	
122-45	26331-26332	,	_	
122-46	26333-26334	F	_	
122-47	26334-26335	(	_	
122-48	26335-26336	7	_	
122-49	26336-26337	,	_	
122-50	26338-26340	27	_	
122-51	26340-26341	)	_	
122-52	26342-26343	=	_	
122-53	26344-26348	9.12	_	
122-54	26348-26349	,	_	
122-55	26350-26351	p	_	
122-56	26352-26353	<	_	
122-57	26354-26360	0.0001	_	
122-58	26360-26361	,	_	
122-59	26362-26366	also	_	
122-60	26367-26372	after	_	
122-61	26373-26384	controlling	_	
122-62	26385-26388	for	_	
122-63	26389-26397	duration	_	
122-64	26398-26400	of	_	
122-65	26401-26408	illness	_	
122-66	26409-26412	and	_	
122-67	26413-26424	risperidone	_	
122-68	26425-26435	equivalent	_	
122-69	26435-26436	.	_	

#Text=Significant predictors were not correlated with each other (p > 0.05).
123-1	26437-26448	Significant	_	
123-2	26449-26459	predictors	_	
123-3	26460-26464	were	_	
123-4	26465-26468	not	_	
123-5	26469-26479	correlated	_	
123-6	26480-26484	with	_	
123-7	26485-26489	each	_	
123-8	26490-26495	other	_	
123-9	26496-26497	(	_	
123-10	26497-26498	p	_	
123-11	26499-26500	>	_	
123-12	26501-26505	0.05	_	
123-13	26505-26506	)	_	
123-14	26506-26507	.	_	

#Text=The betweenness centrality of posterior nodes in gamma band (β = 0.65), together with duration of illness (β = 0.26) turn out to significantly predict the cognitive variability (τ) in SZ group: R2 = 0.62, F(5, 29) = 9.47, p < 0.0001, also when the rest of the controlled clinical variables were included (Fig. 4).
124-1	26508-26511	The	_	
124-2	26512-26523	betweenness	_	
124-3	26524-26534	centrality	_	
124-4	26535-26537	of	_	
124-5	26538-26547	posterior	_	
124-6	26548-26553	nodes	_	
124-7	26554-26556	in	_	
124-8	26557-26562	gamma	_	
124-9	26563-26567	band	_	
124-10	26568-26569	(	_	
124-11	26569-26570	β	_	
124-12	26571-26572	=	_	
124-13	26573-26577	0.65	_	
124-14	26577-26578	)	_	
124-15	26578-26579	,	_	
124-16	26580-26588	together	_	
124-17	26589-26593	with	_	
124-18	26594-26602	duration	_	
124-19	26603-26605	of	_	
124-20	26606-26613	illness	_	
124-21	26614-26615	(	_	
124-22	26615-26616	β	_	
124-23	26617-26618	=	_	
124-24	26619-26623	0.26	_	
124-25	26623-26624	)	_	
124-26	26625-26629	turn	_	
124-27	26630-26633	out	_	
124-28	26634-26636	to	_	
124-29	26637-26650	significantly	_	
124-30	26651-26658	predict	_	
124-31	26659-26662	the	_	
124-32	26663-26672	cognitive	_	
124-33	26673-26684	variability	_	
124-34	26685-26686	(	_	
124-35	26686-26687	τ	_	
124-36	26687-26688	)	_	
124-37	26689-26691	in	_	
124-38	26692-26694	SZ	_	
124-39	26695-26700	group	_	
124-40	26700-26701	:	_	
124-41	26702-26704	R2	_	
124-42	26705-26706	=	_	
124-43	26707-26711	0.62	_	
124-44	26711-26712	,	_	
124-45	26713-26714	F	_	
124-46	26714-26715	(	_	
124-47	26715-26716	5	_	
124-48	26716-26717	,	_	
124-49	26718-26720	29	_	
124-50	26720-26721	)	_	
124-51	26722-26723	=	_	
124-52	26724-26728	9.47	_	
124-53	26728-26729	,	_	
124-54	26730-26731	p	_	
124-55	26732-26733	<	_	
124-56	26734-26740	0.0001	_	
124-57	26740-26741	,	_	
124-58	26742-26746	also	_	
124-59	26747-26751	when	_	
124-60	26752-26755	the	_	
124-61	26756-26760	rest	_	
124-62	26761-26763	of	_	
124-63	26764-26767	the	_	
124-64	26768-26778	controlled	_	
124-65	26779-26787	clinical	_	
124-66	26788-26797	variables	_	
124-67	26798-26802	were	_	
124-68	26803-26811	included	_	
124-69	26812-26813	(	_	
124-70	26813-26816	Fig	_	
124-71	26816-26817	.	_	
124-72	26817-26818	 	_	
124-73	26818-26819	4	_	
124-74	26819-26820	)	_	
124-75	26820-26821	.	_	

#Text=Discussion
#Text=The main goal of this study was to verify whether the neural network reconstructed using the MST algorithm on the basis of resting-state EEG recording would significantly differentiate SZ patients from healthy controls.
125-1	26822-26832	Discussion	_	
125-2	26833-26836	The	_	
125-3	26837-26841	main	_	
125-4	26842-26846	goal	_	
125-5	26847-26849	of	_	
125-6	26850-26854	this	_	
125-7	26855-26860	study	_	
125-8	26861-26864	was	_	
125-9	26865-26867	to	_	
125-10	26868-26874	verify	_	
125-11	26875-26882	whether	_	
125-12	26883-26886	the	_	
125-13	26887-26893	neural	_	
125-14	26894-26901	network	_	
125-15	26902-26915	reconstructed	_	
125-16	26916-26921	using	_	
125-17	26922-26925	the	_	
125-18	26926-26929	MST	_	
125-19	26930-26939	algorithm	_	
125-20	26940-26942	on	_	
125-21	26943-26946	the	_	
125-22	26947-26952	basis	_	
125-23	26953-26955	of	_	
125-24	26956-26969	resting-state	_	
125-25	26970-26973	EEG	_	
125-26	26974-26983	recording	_	
125-27	26984-26989	would	_	
125-28	26990-27003	significantly	_	
125-29	27004-27017	differentiate	_	
125-30	27018-27020	SZ	_	
125-31	27021-27029	patients	_	
125-32	27030-27034	from	_	
125-33	27035-27042	healthy	_	
125-34	27043-27051	controls	_	
125-35	27051-27052	.	_	

#Text=The second goal was establishing whether the network parameters differentiating the indicated groups would be associated with behavioural variables such as cognitive deficits and psychopathological symptoms.
126-1	27053-27056	The	_	
126-2	27057-27063	second	_	
126-3	27064-27068	goal	_	
126-4	27069-27072	was	_	
126-5	27073-27085	establishing	_	
126-6	27086-27093	whether	_	
126-7	27094-27097	the	_	
126-8	27098-27105	network	_	
126-9	27106-27116	parameters	_	
126-10	27117-27132	differentiating	_	
126-11	27133-27136	the	_	
126-12	27137-27146	indicated	_	
126-13	27147-27153	groups	_	
126-14	27154-27159	would	_	
126-15	27160-27162	be	_	
126-16	27163-27173	associated	_	
126-17	27174-27178	with	_	
126-18	27179-27190	behavioural	_	
126-19	27191-27200	variables	_	
126-20	27201-27205	such	_	
126-21	27206-27208	as	_	
126-22	27209-27218	cognitive	_	
126-23	27219-27227	deficits	_	
126-24	27228-27231	and	_	
126-25	27232-27250	psychopathological	_	
126-26	27251-27259	symptoms	_	
126-27	27259-27260	.	_	

#Text=Generally, the obtained results partially confirmed the formulated hypotheses.
127-1	27261-27270	Generally	_	
127-2	27270-27271	,	_	
127-3	27272-27275	the	_	
127-4	27276-27284	obtained	_	
127-5	27285-27292	results	_	
127-6	27293-27302	partially	_	
127-7	27303-27312	confirmed	_	
127-8	27313-27316	the	_	
127-9	27317-27327	formulated	_	
127-10	27328-27338	hypotheses	_	
127-11	27338-27339	.	_	

#Text=Our analysis of the MST output showed that patients’ network, as compared to controls, was substantially less efficiently organized, with its arrangement resembling a star-like composition.
128-1	27340-27343	Our	_	
128-2	27344-27352	analysis	_	
128-3	27353-27355	of	_	
128-4	27356-27359	the	_	
128-5	27360-27363	MST	_	
128-6	27364-27370	output	_	
128-7	27371-27377	showed	_	
128-8	27378-27382	that	_	
128-9	27383-27391	patients	_	
128-10	27391-27392	’	_	
128-11	27393-27400	network	_	
128-12	27400-27401	,	_	
128-13	27402-27404	as	_	
128-14	27405-27413	compared	_	
128-15	27414-27416	to	_	
128-16	27417-27425	controls	_	
128-17	27425-27426	,	_	
128-18	27427-27430	was	_	
128-19	27431-27444	substantially	_	
128-20	27445-27449	less	_	
128-21	27450-27461	efficiently	_	
128-22	27462-27471	organized	_	
128-23	27471-27472	,	_	
128-24	27473-27477	with	_	
128-25	27478-27481	its	_	
128-26	27482-27493	arrangement	_	
128-27	27494-27504	resembling	_	
128-28	27505-27506	a	_	
128-29	27507-27516	star-like	_	
128-30	27517-27528	composition	_	
128-31	27528-27529	.	_	

#Text=Moreover, the networks’ disassortativity was also higher in the SZ group, however, this concerned only the delta frequency.
129-1	27530-27538	Moreover	_	
129-2	27538-27539	,	_	
129-3	27540-27543	the	_	
129-4	27544-27552	networks	_	
129-5	27552-27553	’	_	
129-6	27554-27570	disassortativity	_	
129-7	27571-27574	was	_	
129-8	27575-27579	also	_	
129-9	27580-27586	higher	_	
129-10	27587-27589	in	_	
129-11	27590-27593	the	_	
129-12	27594-27596	SZ	_	
129-13	27597-27602	group	_	
129-14	27602-27603	,	_	
129-15	27604-27611	however	_	
129-16	27611-27612	,	_	
129-17	27613-27617	this	_	
129-18	27618-27627	concerned	_	
129-19	27628-27632	only	_	
129-20	27633-27636	the	_	
129-21	27637-27642	delta	_	
129-22	27643-27652	frequency	_	
129-23	27652-27653	.	_	

#Text=A star-like organization in an exaggerated form leads to deficient intra-network communication, due to the overloading of the prominent hubs, impeding the effective exchange of information within the network.
130-1	27654-27655	A	_	
130-2	27656-27665	star-like	_	
130-3	27666-27678	organization	_	
130-4	27679-27681	in	_	
130-5	27682-27684	an	_	
130-6	27685-27696	exaggerated	_	
130-7	27697-27701	form	_	
130-8	27702-27707	leads	_	
130-9	27708-27710	to	_	
130-10	27711-27720	deficient	_	
130-11	27721-27734	intra-network	_	
130-12	27735-27748	communication	_	
130-13	27748-27749	,	_	
130-14	27750-27753	due	_	
130-15	27754-27756	to	_	
130-16	27757-27760	the	_	
130-17	27761-27772	overloading	_	
130-18	27773-27775	of	_	
130-19	27776-27779	the	_	
130-20	27780-27789	prominent	_	
130-21	27790-27794	hubs	_	
130-22	27794-27795	,	_	
130-23	27796-27804	impeding	_	
130-24	27805-27808	the	_	
130-25	27809-27818	effective	_	
130-26	27819-27827	exchange	_	
130-27	27828-27830	of	_	
130-28	27831-27842	information	_	
130-29	27843-27849	within	_	
130-30	27850-27853	the	_	
130-31	27854-27861	network	_	
130-32	27861-27862	.	_	

#Text=In the beta band, increased maximal betweenness centrality (BCmax) was accompanied by decreased mean betweenness centrality, which additionally suggests an imbalance in hubs strength.
131-1	27863-27865	In	_	
131-2	27866-27869	the	_	
131-3	27870-27874	beta	_	
131-4	27875-27879	band	_	
131-5	27879-27880	,	_	
131-6	27881-27890	increased	_	
131-7	27891-27898	maximal	_	
131-8	27899-27910	betweenness	_	
131-9	27911-27921	centrality	_	
131-10	27922-27923	(	_	
131-11	27923-27928	BCmax	_	
131-12	27928-27929	)	_	
131-13	27930-27933	was	_	
131-14	27934-27945	accompanied	_	
131-15	27946-27948	by	_	
131-16	27949-27958	decreased	_	
131-17	27959-27963	mean	_	
131-18	27964-27975	betweenness	_	
131-19	27976-27986	centrality	_	
131-20	27986-27987	,	_	
131-21	27988-27993	which	_	
131-22	27994-28006	additionally	_	
131-23	28007-28015	suggests	_	
131-24	28016-28018	an	_	
131-25	28019-28028	imbalance	_	
131-26	28029-28031	in	_	
131-27	28032-28036	hubs	_	
131-28	28037-28045	strength	_	
131-29	28045-28046	.	_	

#Text=Importantly, such a relationship was not observed among the healthy controls.
132-1	28047-28058	Importantly	_	
132-2	28058-28059	,	_	
132-3	28060-28064	such	_	
132-4	28065-28066	a	_	
132-5	28067-28079	relationship	_	
132-6	28080-28083	was	_	
132-7	28084-28087	not	_	
132-8	28088-28096	observed	_	
132-9	28097-28102	among	_	
132-10	28103-28106	the	_	
132-11	28107-28114	healthy	_	
132-12	28115-28123	controls	_	
132-13	28123-28124	.	_	

#Text=A heightened network randomness in the SZ group refers to a network construction with central hubs directly attached to low degree nodes, preventing the possibility to create the so called “rich clubs”.
133-1	28125-28126	A	_	
133-2	28127-28137	heightened	_	
133-3	28138-28145	network	_	
133-4	28146-28156	randomness	_	
133-5	28157-28159	in	_	
133-6	28160-28163	the	_	
133-7	28164-28166	SZ	_	
133-8	28167-28172	group	_	
133-9	28173-28179	refers	_	
133-10	28180-28182	to	_	
133-11	28183-28184	a	_	
133-12	28185-28192	network	_	
133-13	28193-28205	construction	_	
133-14	28206-28210	with	_	
133-15	28211-28218	central	_	
133-16	28219-28223	hubs	_	
133-17	28224-28232	directly	_	
133-18	28233-28241	attached	_	
133-19	28242-28244	to	_	
133-20	28245-28248	low	_	
133-21	28249-28255	degree	_	
133-22	28256-28261	nodes	_	
133-23	28261-28262	,	_	
133-24	28263-28273	preventing	_	
133-25	28274-28277	the	_	
133-26	28278-28289	possibility	_	
133-27	28290-28292	to	_	
133-28	28293-28299	create	_	
133-29	28300-28303	the	_	
133-30	28304-28306	so	_	
133-31	28307-28313	called	_	
133-32	28314-28315	“	_	
133-33	28315-28319	rich	_	
133-34	28320-28325	clubs	_	
133-35	28325-28326	”	_	
133-36	28326-28327	.	_	

#Text=This means that, if a more integrated, centralized network is concomitant with intensified disassortativity, then it does not provide the optimal level of performance, as in the case of our SZ patients.
134-1	28328-28332	This	_	
134-2	28333-28338	means	_	
134-3	28339-28343	that	_	
134-4	28343-28344	,	_	
134-5	28345-28347	if	_	
134-6	28348-28349	a	_	
134-7	28350-28354	more	_	
134-8	28355-28365	integrated	_	
134-9	28365-28366	,	_	
134-10	28367-28378	centralized	_	
134-11	28379-28386	network	_	
134-12	28387-28389	is	_	
134-13	28390-28401	concomitant	_	
134-14	28402-28406	with	_	
134-15	28407-28418	intensified	_	
134-16	28419-28435	disassortativity	_	
134-17	28435-28436	,	_	
134-18	28437-28441	then	_	
134-19	28442-28444	it	_	
134-20	28445-28449	does	_	
134-21	28450-28453	not	_	
134-22	28454-28461	provide	_	
134-23	28462-28465	the	_	
134-24	28466-28473	optimal	_	
134-25	28474-28479	level	_	
134-26	28480-28482	of	_	
134-27	28483-28494	performance	_	
134-28	28494-28495	,	_	
134-29	28496-28498	as	_	
134-30	28499-28501	in	_	
134-31	28502-28505	the	_	
134-32	28506-28510	case	_	
134-33	28511-28513	of	_	
134-34	28514-28517	our	_	
134-35	28518-28520	SZ	_	
134-36	28521-28529	patients	_	
134-37	28529-28530	.	_	

#Text=Tewarie with co-workers have attempted to translate MST network-specific indices to the terminology of conventional graph theoretical measures, especially average path length and small-worldness.
135-1	28531-28538	Tewarie	_	
135-2	28539-28543	with	_	
135-3	28544-28554	co-workers	_	
135-4	28555-28559	have	_	
135-5	28560-28569	attempted	_	
135-6	28570-28572	to	_	
135-7	28573-28582	translate	_	
135-8	28583-28586	MST	_	
135-9	28587-28603	network-specific	_	
135-10	28604-28611	indices	_	
135-11	28612-28614	to	_	
135-12	28615-28618	the	_	
135-13	28619-28630	terminology	_	
135-14	28631-28633	of	_	
135-15	28634-28646	conventional	_	
135-16	28647-28652	graph	_	
135-17	28653-28664	theoretical	_	
135-18	28665-28673	measures	_	
135-19	28673-28674	,	_	
135-20	28675-28685	especially	_	
135-21	28686-28693	average	_	
135-22	28694-28698	path	_	
135-23	28699-28705	length	_	
135-24	28706-28709	and	_	
135-25	28710-28725	small-worldness	_	
135-26	28725-28726	.	_	

#Text=The authors noted that such a translation is possible, although due to the specifics of the Kruskal’s algorithm, eliminating any loops from the final MST topology, there is probably no direct equivalent of clustering coefficient.
136-1	28727-28730	The	_	
136-2	28731-28738	authors	_	
136-3	28739-28744	noted	_	
136-4	28745-28749	that	_	
136-5	28750-28754	such	_	
136-6	28755-28756	a	_	
136-7	28757-28768	translation	_	
136-8	28769-28771	is	_	
136-9	28772-28780	possible	_	
136-10	28780-28781	,	_	
136-11	28782-28790	although	_	
136-12	28791-28794	due	_	
136-13	28795-28797	to	_	
136-14	28798-28801	the	_	
136-15	28802-28811	specifics	_	
136-16	28812-28814	of	_	
136-17	28815-28818	the	_	
136-18	28819-28826	Kruskal	_	
136-19	28826-28827	’	_	
136-20	28827-28828	s	_	
136-21	28829-28838	algorithm	_	
136-22	28838-28839	,	_	
136-23	28840-28851	eliminating	_	
136-24	28852-28855	any	_	
136-25	28856-28861	loops	_	
136-26	28862-28866	from	_	
136-27	28867-28870	the	_	
136-28	28871-28876	final	_	
136-29	28877-28880	MST	_	
136-30	28881-28889	topology	_	
136-31	28889-28890	,	_	
136-32	28891-28896	there	_	
136-33	28897-28899	is	_	
136-34	28900-28908	probably	_	
136-35	28909-28911	no	_	
136-36	28912-28918	direct	_	
136-37	28919-28929	equivalent	_	
136-38	28930-28932	of	_	
136-39	28933-28943	clustering	_	
136-40	28944-28955	coefficient	_	
136-41	28955-28956	.	_	

#Text=However, considering global MST results in our groups, it can be concluded that the average path length in the SZ group was significantly shorter than in the group of controls.
137-1	28957-28964	However	_	
137-2	28964-28965	,	_	
137-3	28966-28977	considering	_	
137-4	28978-28984	global	_	
137-5	28985-28988	MST	_	
137-6	28989-28996	results	_	
137-7	28997-28999	in	_	
137-8	29000-29003	our	_	
137-9	29004-29010	groups	_	
137-10	29010-29011	,	_	
137-11	29012-29014	it	_	
137-12	29015-29018	can	_	
137-13	29019-29021	be	_	
137-14	29022-29031	concluded	_	
137-15	29032-29036	that	_	
137-16	29037-29040	the	_	
137-17	29041-29048	average	_	
137-18	29049-29053	path	_	
137-19	29054-29060	length	_	
137-20	29061-29063	in	_	
137-21	29064-29067	the	_	
137-22	29068-29070	SZ	_	
137-23	29071-29076	group	_	
137-24	29077-29080	was	_	
137-25	29081-29094	significantly	_	
137-26	29095-29102	shorter	_	
137-27	29103-29107	than	_	
137-28	29108-29110	in	_	
137-29	29111-29114	the	_	
137-30	29115-29120	group	_	
137-31	29121-29123	of	_	
137-32	29124-29132	controls	_	
137-33	29132-29133	.	_	

#Text=Considering that SZ patients’ network might be defined as having a star-like organization, it seems, that it is significantly different from a small-world network, in which local specialization and global integration are well-balanced.
138-1	29134-29145	Considering	_	
138-2	29146-29150	that	_	
138-3	29151-29153	SZ	_	
138-4	29154-29162	patients	_	
138-5	29162-29163	’	_	
138-6	29164-29171	network	_	
138-7	29172-29177	might	_	
138-8	29178-29180	be	_	
138-9	29180-29181	 	_	
138-10	29181-29188	defined	_	
138-11	29189-29191	as	_	
138-12	29192-29198	having	_	
138-13	29199-29200	a	_	
138-14	29201-29210	star-like	_	
138-15	29211-29223	organization	_	
138-16	29223-29224	,	_	
138-17	29225-29227	it	_	
138-18	29228-29233	seems	_	
138-19	29233-29234	,	_	
138-20	29235-29239	that	_	
138-21	29240-29242	it	_	
138-22	29243-29245	is	_	
138-23	29246-29259	significantly	_	
138-24	29260-29269	different	_	
138-25	29270-29274	from	_	
138-26	29275-29276	a	_	
138-27	29277-29288	small-world	_	
138-28	29289-29296	network	_	
138-29	29296-29297	,	_	
138-30	29298-29300	in	_	
138-31	29301-29306	which	_	
138-32	29307-29312	local	_	
138-33	29313-29327	specialization	_	
138-34	29328-29331	and	_	
138-35	29332-29338	global	_	
138-36	29339-29350	integration	_	
138-37	29351-29354	are	_	
138-38	29355-29368	well-balanced	_	
138-39	29368-29369	.	_	

#Text=A star-like network with strong, but overloaded hubs, might be rather classified as scale-free topological organization constructed in accordance with the power law degree principle.
139-1	29370-29371	A	_	
139-2	29372-29381	star-like	_	
139-3	29382-29389	network	_	
139-4	29390-29394	with	_	
139-5	29395-29401	strong	_	
139-6	29401-29402	,	_	
139-7	29403-29406	but	_	
139-8	29407-29417	overloaded	_	
139-9	29418-29422	hubs	_	
139-10	29422-29423	,	_	
139-11	29424-29429	might	_	
139-12	29430-29432	be	_	
139-13	29433-29439	rather	_	
139-14	29440-29450	classified	_	
139-15	29451-29453	as	_	
139-16	29454-29464	scale-free	_	
139-17	29465-29476	topological	_	
139-18	29477-29489	organization	_	
139-19	29490-29501	constructed	_	
139-20	29502-29504	in	_	
139-21	29505-29515	accordance	_	
139-22	29516-29520	with	_	
139-23	29521-29524	the	_	
139-24	29525-29530	power	_	
139-25	29531-29534	law	_	
139-26	29535-29541	degree	_	
139-27	29542-29551	principle	_	
139-28	29551-29552	.	_	

#Text=Although scale-free configurations were observed in researches on brain networks, a significant shift towards over-centralization of the network in SZ group suggest a violation of the small-worldness rule in patients’ topologies.
140-1	29553-29561	Although	_	
140-2	29562-29572	scale-free	_	
140-3	29573-29587	configurations	_	
140-4	29588-29592	were	_	
140-5	29593-29601	observed	_	
140-6	29602-29604	in	_	
140-7	29605-29615	researches	_	
140-8	29616-29618	on	_	
140-9	29619-29624	brain	_	
140-10	29625-29633	networks	_	
140-11	29633-29634	,	_	
140-12	29635-29636	a	_	
140-13	29637-29648	significant	_	
140-14	29649-29654	shift	_	
140-15	29655-29662	towards	_	
140-16	29663-29682	over-centralization	_	
140-17	29683-29685	of	_	
140-18	29686-29689	the	_	
140-19	29690-29697	network	_	
140-20	29698-29700	in	_	
140-21	29701-29703	SZ	_	
140-22	29704-29709	group	_	
140-23	29710-29717	suggest	_	
140-24	29718-29719	a	_	
140-25	29720-29729	violation	_	
140-26	29730-29732	of	_	
140-27	29733-29736	the	_	
140-28	29737-29752	small-worldness	_	
140-29	29753-29757	rule	_	
140-30	29758-29760	in	_	
140-31	29761-29769	patients	_	
140-32	29769-29770	’	_	
140-33	29771-29781	topologies	_	
140-34	29781-29782	.	_	

#Text=Regional network analysis revealed that SZ participants had significantly more hubs located in posterior areas as compared to controls.
141-1	29783-29791	Regional	_	
141-2	29792-29799	network	_	
141-3	29800-29808	analysis	_	
141-4	29809-29817	revealed	_	
141-5	29818-29822	that	_	
141-6	29823-29825	SZ	_	
141-7	29826-29838	participants	_	
141-8	29839-29842	had	_	
141-9	29843-29856	significantly	_	
141-10	29857-29861	more	_	
141-11	29862-29866	hubs	_	
141-12	29867-29874	located	_	
141-13	29875-29877	in	_	
141-14	29878-29887	posterior	_	
141-15	29888-29893	areas	_	
141-16	29894-29896	as	_	
141-17	29897-29905	compared	_	
141-18	29906-29908	to	_	
141-19	29909-29917	controls	_	
141-20	29917-29918	.	_	

#Text=This evaluation seems to confirm the previously discussed observations of other authors who found the presence of a larger number of non-frontal hubs in SZ patients.
142-1	29919-29923	This	_	
142-2	29924-29934	evaluation	_	
142-3	29935-29940	seems	_	
142-4	29941-29943	to	_	
142-5	29944-29951	confirm	_	
142-6	29952-29955	the	_	
142-7	29956-29966	previously	_	
142-8	29967-29976	discussed	_	
142-9	29977-29989	observations	_	
142-10	29990-29992	of	_	
142-11	29993-29998	other	_	
142-12	29999-30006	authors	_	
142-13	30007-30010	who	_	
142-14	30011-30016	found	_	
142-15	30017-30020	the	_	
142-16	30021-30029	presence	_	
142-17	30030-30032	of	_	
142-18	30033-30034	a	_	
142-19	30035-30041	larger	_	
142-20	30042-30048	number	_	
142-21	30049-30051	of	_	
142-22	30052-30063	non-frontal	_	
142-23	30064-30068	hubs	_	
142-24	30069-30071	in	_	
142-25	30072-30074	SZ	_	
142-26	30075-30083	patients	_	
142-27	30083-30084	.	_	

#Text=Generally, the results of this study, providing additional evidence of abnormal network organization in SZ patients, are relatively consistent with the previous findings.
143-1	30085-30094	Generally	_	
143-2	30094-30095	,	_	
143-3	30096-30099	the	_	
143-4	30100-30107	results	_	
143-5	30108-30110	of	_	
143-6	30111-30115	this	_	
143-7	30116-30121	study	_	
143-8	30121-30122	,	_	
143-9	30123-30132	providing	_	
143-10	30133-30143	additional	_	
143-11	30144-30152	evidence	_	
143-12	30153-30155	of	_	
143-13	30156-30164	abnormal	_	
143-14	30165-30172	network	_	
143-15	30173-30185	organization	_	
143-16	30186-30188	in	_	
143-17	30189-30191	SZ	_	
143-18	30192-30200	patients	_	
143-19	30200-30201	,	_	
143-20	30202-30205	are	_	
143-21	30206-30216	relatively	_	
143-22	30217-30227	consistent	_	
143-23	30228-30232	with	_	
143-24	30233-30236	the	_	
143-25	30237-30245	previous	_	
143-26	30246-30254	findings	_	
143-27	30254-30255	.	_	

#Text=Other authors also demonstrated significantly weakened centrality within the frontal regions in SZ, interpreted as a reduced role of the frontal cortex in the network global integration.
144-1	30256-30261	Other	_	
144-2	30262-30269	authors	_	
144-3	30270-30274	also	_	
144-4	30275-30287	demonstrated	_	
144-5	30288-30301	significantly	_	
144-6	30302-30310	weakened	_	
144-7	30311-30321	centrality	_	
144-8	30322-30328	within	_	
144-9	30329-30332	the	_	
144-10	30333-30340	frontal	_	
144-11	30341-30348	regions	_	
144-12	30349-30351	in	_	
144-13	30352-30354	SZ	_	
144-14	30354-30355	,	_	
144-15	30356-30367	interpreted	_	
144-16	30368-30370	as	_	
144-17	30371-30372	a	_	
144-18	30373-30380	reduced	_	
144-19	30381-30385	role	_	
144-20	30386-30388	of	_	
144-21	30389-30392	the	_	
144-22	30393-30400	frontal	_	
144-23	30401-30407	cortex	_	
144-24	30408-30410	in	_	
144-25	30411-30414	the	_	
144-26	30415-30422	network	_	
144-27	30423-30429	global	_	
144-28	30430-30441	integration	_	
144-29	30441-30442	.	_	

#Text=Rubinov et al. revealed decreased overall hubs mean centrality and shorter path length.
145-1	30443-30450	Rubinov	_	
145-2	30451-30453	et	_	
145-3	30454-30456	al	_	
145-4	30456-30457	.	_	
145-5	30458-30466	revealed	_	
145-6	30467-30476	decreased	_	
145-7	30477-30484	overall	_	
145-8	30485-30489	hubs	_	
145-9	30490-30494	mean	_	
145-10	30495-30505	centrality	_	
145-11	30506-30509	and	_	
145-12	30510-30517	shorter	_	
145-13	30518-30522	path	_	
145-14	30523-30529	length	_	
145-15	30529-30530	.	_	

#Text=Additionally, Jalili and Knyazeva, utilizing resting-state EEG also reported shortening of the path length and decreased nodal strength of the anterior hubs in schizophrenia.
146-1	30531-30543	Additionally	_	
146-2	30543-30544	,	_	
146-3	30545-30551	Jalili	_	
146-4	30552-30555	and	_	
146-5	30556-30564	Knyazeva	_	
146-6	30564-30565	,	_	
146-7	30566-30575	utilizing	_	
146-8	30576-30589	resting-state	_	
146-9	30590-30593	EEG	_	
146-10	30594-30598	also	_	
146-11	30599-30607	reported	_	
146-12	30608-30618	shortening	_	
146-13	30619-30621	of	_	
146-14	30622-30625	the	_	
146-15	30626-30630	path	_	
146-16	30631-30637	length	_	
146-17	30638-30641	and	_	
146-18	30642-30651	decreased	_	
146-19	30652-30657	nodal	_	
146-20	30658-30666	strength	_	
146-21	30667-30669	of	_	
146-22	30670-30673	the	_	
146-23	30674-30682	anterior	_	
146-24	30683-30687	hubs	_	
146-25	30688-30690	in	_	
146-26	30691-30704	schizophrenia	_	
146-27	30704-30705	.	_	

#Text=Further, studies using structural imaging methods (MRI, DTI) confirmed the reduction of frontal hubs strength as well as the appearance of non-frontal hubs.
147-1	30706-30713	Further	_	
147-2	30713-30714	,	_	
147-3	30715-30722	studies	_	
147-4	30723-30728	using	_	
147-5	30729-30739	structural	_	
147-6	30740-30747	imaging	_	
147-7	30748-30755	methods	_	
147-8	30756-30757	(	_	
147-9	30757-30760	MRI	_	
147-10	30760-30761	,	_	
147-11	30762-30765	DTI	_	
147-12	30765-30766	)	_	
147-13	30767-30776	confirmed	_	
147-14	30777-30780	the	_	
147-15	30781-30790	reduction	_	
147-16	30791-30793	of	_	
147-17	30794-30801	frontal	_	
147-18	30802-30806	hubs	_	
147-19	30807-30815	strength	_	
147-20	30816-30818	as	_	
147-21	30819-30823	well	_	
147-22	30824-30826	as	_	
147-23	30827-30830	the	_	
147-24	30831-30841	appearance	_	
147-25	30842-30844	of	_	
147-26	30845-30856	non-frontal	_	
147-27	30857-30861	hubs	_	
147-28	30861-30862	.	_	

#Text=As expected, MST metrics which differentiated the studied groups were also associated with behavioural characteristics of SZ patients.
148-1	30863-30865	As	_	
148-2	30866-30874	expected	_	
148-3	30874-30875	,	_	
148-4	30876-30879	MST	_	
148-5	30880-30887	metrics	_	
148-6	30888-30893	which	_	
148-7	30894-30908	differentiated	_	
148-8	30909-30912	the	_	
148-9	30913-30920	studied	_	
148-10	30921-30927	groups	_	
148-11	30928-30932	were	_	
148-12	30933-30937	also	_	
148-13	30938-30948	associated	_	
148-14	30949-30953	with	_	
148-15	30954-30965	behavioural	_	
148-16	30966-30981	characteristics	_	
148-17	30982-30984	of	_	
148-18	30985-30987	SZ	_	
148-19	30988-30996	patients	_	
148-20	30996-30997	.	_	

#Text=A relatively surprising finding was the establishing of only one significant correlation between an abnormal feature of network configuration and the psychopathology of schizophrenia.
149-1	30998-30999	A	_	
149-2	31000-31010	relatively	_	
149-3	31011-31021	surprising	_	
149-4	31022-31029	finding	_	
149-5	31030-31033	was	_	
149-6	31034-31037	the	_	
149-7	31038-31050	establishing	_	
149-8	31051-31053	of	_	
149-9	31054-31058	only	_	
149-10	31059-31062	one	_	
149-11	31063-31074	significant	_	
149-12	31075-31086	correlation	_	
149-13	31087-31094	between	_	
149-14	31095-31097	an	_	
149-15	31098-31106	abnormal	_	
149-16	31107-31114	feature	_	
149-17	31115-31117	of	_	
149-18	31118-31125	network	_	
149-19	31126-31139	configuration	_	
149-20	31140-31143	and	_	
149-21	31144-31147	the	_	
149-22	31148-31163	psychopathology	_	
149-23	31164-31166	of	_	
149-24	31167-31180	schizophrenia	_	
149-25	31180-31181	.	_	

#Text=Specifically, it concerned the association between the subscale of positive psychotic symptoms and the centrality of the posteriorly located nodes in the gamma frequency.
150-1	31182-31194	Specifically	_	
150-2	31194-31195	,	_	
150-3	31196-31198	it	_	
150-4	31199-31208	concerned	_	
150-5	31209-31212	the	_	
150-6	31213-31224	association	_	
150-7	31225-31232	between	_	
150-8	31233-31236	the	_	
150-9	31237-31245	subscale	_	
150-10	31246-31248	of	_	
150-11	31249-31257	positive	_	
150-12	31258-31267	psychotic	_	
150-13	31268-31276	symptoms	_	
150-14	31277-31280	and	_	
150-15	31281-31284	the	_	
150-16	31285-31295	centrality	_	
150-17	31296-31298	of	_	
150-18	31299-31302	the	_	
150-19	31303-31314	posteriorly	_	
150-20	31315-31322	located	_	
150-21	31323-31328	nodes	_	
150-22	31329-31331	in	_	
150-23	31332-31335	the	_	
150-24	31336-31341	gamma	_	
150-25	31342-31351	frequency	_	
150-26	31351-31352	.	_	

#Text=Schoen et al. noticed that heightened connection entropy in gamma band correlated with a pathologically high PANNS outcome collected before starting the antipsychotic treatment, but after treatment and having achieved a significant clinical improvement, these correlations were no longer statistically significant.
151-1	31353-31359	Schoen	_	
151-2	31360-31362	et	_	
151-3	31363-31365	al	_	
151-4	31365-31366	.	_	
151-5	31367-31374	noticed	_	
151-6	31375-31379	that	_	
151-7	31380-31390	heightened	_	
151-8	31391-31401	connection	_	
151-9	31402-31409	entropy	_	
151-10	31410-31412	in	_	
151-11	31413-31418	gamma	_	
151-12	31419-31423	band	_	
151-13	31424-31434	correlated	_	
151-14	31435-31439	with	_	
151-15	31440-31441	a	_	
151-16	31442-31456	pathologically	_	
151-17	31457-31461	high	_	
151-18	31462-31467	PANNS	_	
151-19	31468-31475	outcome	_	
151-20	31476-31485	collected	_	
151-21	31486-31492	before	_	
151-22	31493-31501	starting	_	
151-23	31502-31505	the	_	
151-24	31506-31519	antipsychotic	_	
151-25	31520-31529	treatment	_	
151-26	31529-31530	,	_	
151-27	31531-31534	but	_	
151-28	31535-31540	after	_	
151-29	31541-31550	treatment	_	
151-30	31551-31554	and	_	
151-31	31555-31561	having	_	
151-32	31562-31570	achieved	_	
151-33	31571-31572	a	_	
151-34	31573-31584	significant	_	
151-35	31585-31593	clinical	_	
151-36	31594-31605	improvement	_	
151-37	31605-31606	,	_	
151-38	31607-31612	these	_	
151-39	31613-31625	correlations	_	
151-40	31626-31630	were	_	
151-41	31631-31633	no	_	
151-42	31634-31640	longer	_	
151-43	31641-31654	statistically	_	
151-44	31655-31666	significant	_	
151-45	31666-31667	.	_	

#Text=Considering the mentioned results, Schoen with co-workers suggested that abnormal connectivity formation in patients is correlated with the diagnosis of schizophrenia, but not with symptomatology changing in response to pharmacological treatment.
152-1	31668-31679	Considering	_	
152-2	31680-31683	the	_	
152-3	31684-31693	mentioned	_	
152-4	31694-31701	results	_	
152-5	31701-31702	,	_	
152-6	31703-31709	Schoen	_	
152-7	31710-31714	with	_	
152-8	31715-31725	co-workers	_	
152-9	31726-31735	suggested	_	
152-10	31736-31740	that	_	
152-11	31741-31749	abnormal	_	
152-12	31750-31762	connectivity	_	
152-13	31763-31772	formation	_	
152-14	31773-31775	in	_	
152-15	31776-31784	patients	_	
152-16	31785-31787	is	_	
152-17	31788-31798	correlated	_	
152-18	31799-31803	with	_	
152-19	31804-31807	the	_	
152-20	31808-31817	diagnosis	_	
152-21	31818-31820	of	_	
152-22	31821-31834	schizophrenia	_	
152-23	31834-31835	,	_	
152-24	31836-31839	but	_	
152-25	31840-31843	not	_	
152-26	31844-31848	with	_	
152-27	31849-31863	symptomatology	_	
152-28	31864-31872	changing	_	
152-29	31873-31875	in	_	
152-30	31876-31884	response	_	
152-31	31885-31887	to	_	
152-32	31888-31903	pharmacological	_	
152-33	31904-31913	treatment	_	
152-34	31913-31914	.	_	

#Text=In addition to the analysis of irregularities in the organization of neural networks in schizophrenia, we also demonstrated that the overall poor score in the cognitive speed test in SZ group was predicted by two unrelated variables: the increased average response times (RTs) and processing variability in a form of the most elongated RTs.
153-1	31915-31917	In	_	
153-2	31918-31926	addition	_	
153-3	31927-31929	to	_	
153-4	31930-31933	the	_	
153-5	31934-31942	analysis	_	
153-6	31943-31945	of	_	
153-7	31946-31960	irregularities	_	
153-8	31961-31963	in	_	
153-9	31964-31967	the	_	
153-10	31968-31980	organization	_	
153-11	31981-31983	of	_	
153-12	31984-31990	neural	_	
153-13	31991-31999	networks	_	
153-14	32000-32002	in	_	
153-15	32003-32016	schizophrenia	_	
153-16	32016-32017	,	_	
153-17	32018-32020	we	_	
153-18	32021-32025	also	_	
153-19	32026-32038	demonstrated	_	
153-20	32039-32043	that	_	
153-21	32044-32047	the	_	
153-22	32048-32055	overall	_	
153-23	32056-32060	poor	_	
153-24	32061-32066	score	_	
153-25	32067-32069	in	_	
153-26	32070-32073	the	_	
153-27	32074-32083	cognitive	_	
153-28	32084-32089	speed	_	
153-29	32090-32094	test	_	
153-30	32095-32097	in	_	
153-31	32098-32100	SZ	_	
153-32	32101-32106	group	_	
153-33	32107-32110	was	_	
153-34	32111-32120	predicted	_	
153-35	32121-32123	by	_	
153-36	32124-32127	two	_	
153-37	32128-32137	unrelated	_	
153-38	32138-32147	variables	_	
153-39	32147-32148	:	_	
153-40	32149-32152	the	_	
153-41	32153-32162	increased	_	
153-42	32163-32170	average	_	
153-43	32171-32179	response	_	
153-44	32180-32185	times	_	
153-45	32186-32187	(	_	
153-46	32187-32190	RTs	_	
153-47	32190-32191	)	_	
153-48	32192-32195	and	_	
153-49	32196-32206	processing	_	
153-50	32207-32218	variability	_	
153-51	32219-32221	in	_	
153-52	32222-32223	a	_	
153-53	32224-32228	form	_	
153-54	32229-32231	of	_	
153-55	32232-32235	the	_	
153-56	32236-32240	most	_	
153-57	32241-32250	elongated	_	
153-58	32251-32254	RTs	_	
153-59	32254-32255	.	_	

#Text=The elongated average RTs were predicted by increased BCmax in beta and gamma bands, together with the duration of untreated psychosis.
154-1	32256-32259	The	_	
154-2	32260-32269	elongated	_	
154-3	32270-32277	average	_	
154-4	32278-32281	RTs	_	
154-5	32282-32286	were	_	
154-6	32287-32296	predicted	_	
154-7	32297-32299	by	_	
154-8	32300-32309	increased	_	
154-9	32310-32315	BCmax	_	
154-10	32316-32318	in	_	
154-11	32319-32323	beta	_	
154-12	32324-32327	and	_	
154-13	32328-32333	gamma	_	
154-14	32334-32339	bands	_	
154-15	32339-32340	,	_	
154-16	32341-32349	together	_	
154-17	32350-32354	with	_	
154-18	32355-32358	the	_	
154-19	32359-32367	duration	_	
154-20	32368-32370	of	_	
154-21	32371-32380	untreated	_	
154-22	32381-32390	psychosis	_	
154-23	32390-32391	.	_	

#Text=The positive correlations between BCmax in higher frequencies and the most typical patients’ RTs mean that the response time extended with increasing centralization of the strongest nodes in the network.
155-1	32392-32395	The	_	
155-2	32396-32404	positive	_	
155-3	32405-32417	correlations	_	
155-4	32418-32425	between	_	
155-5	32426-32431	BCmax	_	
155-6	32432-32434	in	_	
155-7	32435-32441	higher	_	
155-8	32442-32453	frequencies	_	
155-9	32454-32457	and	_	
155-10	32458-32461	the	_	
155-11	32462-32466	most	_	
155-12	32467-32474	typical	_	
155-13	32475-32483	patients	_	
155-14	32483-32484	’	_	
155-15	32485-32488	RTs	_	
155-16	32489-32493	mean	_	
155-17	32494-32498	that	_	
155-18	32499-32502	the	_	
155-19	32503-32511	response	_	
155-20	32512-32516	time	_	
155-21	32517-32525	extended	_	
155-22	32526-32530	with	_	
155-23	32531-32541	increasing	_	
155-24	32542-32556	centralization	_	
155-25	32557-32559	of	_	
155-26	32560-32563	the	_	
155-27	32564-32573	strongest	_	
155-28	32574-32579	nodes	_	
155-29	32580-32582	in	_	
155-30	32583-32586	the	_	
155-31	32587-32594	network	_	
155-32	32594-32595	.	_	

#Text=A topological organization of a network not secured against the overload of the central hubs suffers from a serious imbalance between integration and selection in information processing.
156-1	32596-32597	A	_	
156-2	32598-32609	topological	_	
156-3	32610-32622	organization	_	
156-4	32623-32625	of	_	
156-5	32626-32627	a	_	
156-6	32628-32635	network	_	
156-7	32636-32639	not	_	
156-8	32640-32647	secured	_	
156-9	32648-32655	against	_	
156-10	32656-32659	the	_	
156-11	32660-32668	overload	_	
156-12	32669-32671	of	_	
156-13	32672-32675	the	_	
156-14	32676-32683	central	_	
156-15	32684-32688	hubs	_	
156-16	32689-32696	suffers	_	
156-17	32697-32701	from	_	
156-18	32702-32703	a	_	
156-19	32704-32711	serious	_	
156-20	32712-32721	imbalance	_	
156-21	32722-32729	between	_	
156-22	32730-32741	integration	_	
156-23	32742-32745	and	_	
156-24	32746-32755	selection	_	
156-25	32756-32758	in	_	
156-26	32759-32770	information	_	
156-27	32771-32781	processing	_	
156-28	32781-32782	.	_	

#Text=It seems, therefore, that the inefficient selectivity in networks performance might limit the ability of fast cognitive performance.
157-1	32783-32785	It	_	
157-2	32786-32791	seems	_	
157-3	32791-32792	,	_	
157-4	32793-32802	therefore	_	
157-5	32802-32803	,	_	
157-6	32804-32808	that	_	
157-7	32809-32812	the	_	
157-8	32813-32824	inefficient	_	
157-9	32825-32836	selectivity	_	
157-10	32837-32839	in	_	
157-11	32840-32848	networks	_	
157-12	32849-32860	performance	_	
157-13	32861-32866	might	_	
157-14	32867-32872	limit	_	
157-15	32873-32876	the	_	
157-16	32877-32884	ability	_	
157-17	32885-32887	of	_	
157-18	32888-32892	fast	_	
157-19	32893-32902	cognitive	_	
157-20	32903-32914	performance	_	
157-21	32914-32915	.	_	

#Text=The ex-Gaussian indicator of cognitive variability covering the most elongated RTs (τ), which explained even a larger scope of cognitive speed variance than the average RTs, was predicted by betweenness centrality of posterior nodes in gamma band and the duration of illness in the SZ sample.
158-1	32916-32919	The	_	
158-2	32920-32931	ex-Gaussian	_	
158-3	32932-32941	indicator	_	
158-4	32942-32944	of	_	
158-5	32945-32954	cognitive	_	
158-6	32955-32966	variability	_	
158-7	32967-32975	covering	_	
158-8	32976-32979	the	_	
158-9	32980-32984	most	_	
158-10	32985-32994	elongated	_	
158-11	32995-32998	RTs	_	
158-12	32999-33000	(	_	
158-13	33000-33001	τ	_	
158-14	33001-33002	)	_	
158-15	33002-33003	,	_	
158-16	33004-33009	which	_	
158-17	33010-33019	explained	_	
158-18	33020-33024	even	_	
158-19	33025-33026	a	_	
158-20	33027-33033	larger	_	
158-21	33034-33039	scope	_	
158-22	33040-33042	of	_	
158-23	33043-33052	cognitive	_	
158-24	33053-33058	speed	_	
158-25	33059-33067	variance	_	
158-26	33068-33072	than	_	
158-27	33073-33076	the	_	
158-28	33077-33084	average	_	
158-29	33085-33088	RTs	_	
158-30	33088-33089	,	_	
158-31	33090-33093	was	_	
158-32	33094-33103	predicted	_	
158-33	33104-33106	by	_	
158-34	33107-33118	betweenness	_	
158-35	33119-33129	centrality	_	
158-36	33130-33132	of	_	
158-37	33133-33142	posterior	_	
158-38	33143-33148	nodes	_	
158-39	33149-33151	in	_	
158-40	33152-33157	gamma	_	
158-41	33158-33162	band	_	
158-42	33163-33166	and	_	
158-43	33167-33170	the	_	
158-44	33171-33179	duration	_	
158-45	33180-33182	of	_	
158-46	33183-33190	illness	_	
158-47	33191-33193	in	_	
158-48	33194-33197	the	_	
158-49	33198-33200	SZ	_	
158-50	33201-33207	sample	_	
158-51	33207-33208	.	_	

#Text=As marked earlier, schizophrenia is associated with a greater density of highly centralized nodes in the posterior area of the cerebral cortex.
159-1	33209-33211	As	_	
159-2	33212-33218	marked	_	
159-3	33219-33226	earlier	_	
159-4	33226-33227	,	_	
159-5	33228-33241	schizophrenia	_	
159-6	33242-33244	is	_	
159-7	33245-33255	associated	_	
159-8	33256-33260	with	_	
159-9	33261-33262	a	_	
159-10	33263-33270	greater	_	
159-11	33271-33278	density	_	
159-12	33279-33281	of	_	
159-13	33282-33288	highly	_	
159-14	33289-33300	centralized	_	
159-15	33301-33306	nodes	_	
159-16	33307-33309	in	_	
159-17	33310-33313	the	_	
159-18	33314-33323	posterior	_	
159-19	33324-33328	area	_	
159-20	33329-33331	of	_	
159-21	33332-33335	the	_	
159-22	33336-33344	cerebral	_	
159-23	33345-33351	cortex	_	
159-24	33351-33352	.	_	

#Text=The backward-shifting of hubs proved to be a significant predictor of the increasing inconsistency during the cognitive speed task in the SZ group.
160-1	33353-33356	The	_	
160-2	33357-33374	backward-shifting	_	
160-3	33375-33377	of	_	
160-4	33378-33382	hubs	_	
160-5	33383-33389	proved	_	
160-6	33390-33392	to	_	
160-7	33393-33395	be	_	
160-8	33396-33397	a	_	
160-9	33398-33409	significant	_	
160-10	33410-33419	predictor	_	
160-11	33420-33422	of	_	
160-12	33423-33426	the	_	
160-13	33427-33437	increasing	_	
160-14	33438-33451	inconsistency	_	
160-15	33452-33458	during	_	
160-16	33459-33462	the	_	
160-17	33463-33472	cognitive	_	
160-18	33473-33478	speed	_	
160-19	33479-33483	task	_	
160-20	33484-33486	in	_	
160-21	33487-33490	the	_	
160-22	33491-33493	SZ	_	
160-23	33494-33499	group	_	
160-24	33499-33500	.	_	

#Text=Associations between failures of attentional-executive control over processing speed task and more posteriorly located hubs in our SZ group might be interpreted with reference to the previous findings confirming that the strength of anti-correlation between the ‘task-negative’ (e.g. default-mode network) and ‘task-positive’ networks, explained a significant part of cognitive instability variation in healthy participants.
161-1	33501-33513	Associations	_	
161-2	33514-33521	between	_	
161-3	33522-33530	failures	_	
161-4	33531-33533	of	_	
161-5	33534-33555	attentional-executive	_	
161-6	33556-33563	control	_	
161-7	33564-33568	over	_	
161-8	33569-33579	processing	_	
161-9	33580-33585	speed	_	
161-10	33586-33590	task	_	
161-11	33591-33594	and	_	
161-12	33595-33599	more	_	
161-13	33600-33611	posteriorly	_	
161-14	33612-33619	located	_	
161-15	33620-33624	hubs	_	
161-16	33625-33627	in	_	
161-17	33628-33631	our	_	
161-18	33632-33634	SZ	_	
161-19	33635-33640	group	_	
161-20	33641-33646	might	_	
161-21	33647-33649	be	_	
161-22	33650-33661	interpreted	_	
161-23	33662-33666	with	_	
161-24	33667-33676	reference	_	
161-25	33677-33679	to	_	
161-26	33680-33683	the	_	
161-27	33684-33692	previous	_	
161-28	33693-33701	findings	_	
161-29	33702-33712	confirming	_	
161-30	33713-33717	that	_	
161-31	33718-33721	the	_	
161-32	33722-33730	strength	_	
161-33	33731-33733	of	_	
161-34	33734-33750	anti-correlation	_	
161-35	33751-33758	between	_	
161-36	33759-33762	the	_	
161-37	33763-33764	‘	_	
161-38	33764-33777	task-negative	_	
161-39	33777-33778	’	_	
161-40	33779-33780	(	_	
161-41	33780-33783	e.g	_	
161-42	33783-33784	.	_	
161-43	33785-33797	default-mode	_	
161-44	33798-33805	network	_	
161-45	33805-33806	)	_	
161-46	33807-33810	and	_	
161-47	33811-33812	‘	_	
161-48	33812-33825	task-positive	_	
161-49	33825-33826	’	_	
161-50	33827-33835	networks	_	
161-51	33835-33836	,	_	
161-52	33837-33846	explained	_	
161-53	33847-33848	a	_	
161-54	33849-33860	significant	_	
161-55	33861-33865	part	_	
161-56	33866-33868	of	_	
161-57	33869-33878	cognitive	_	
161-58	33879-33890	instability	_	
161-59	33891-33900	variation	_	
161-60	33901-33903	in	_	
161-61	33904-33911	healthy	_	
161-62	33912-33924	participants	_	
161-63	33924-33925	.	_	

#Text=Fassbander et al. also found that reduced activity of the dorsolateral prefrontal cortex in schizophrenia was accompanied by very long RTs during the Stroop task.
162-1	33926-33936	Fassbander	_	
162-2	33937-33939	et	_	
162-3	33940-33942	al	_	
162-4	33942-33943	.	_	
162-5	33944-33948	also	_	
162-6	33949-33954	found	_	
162-7	33955-33959	that	_	
162-8	33960-33967	reduced	_	
162-9	33968-33976	activity	_	
162-10	33977-33979	of	_	
162-11	33980-33983	the	_	
162-12	33984-33996	dorsolateral	_	
162-13	33997-34007	prefrontal	_	
162-14	34008-34014	cortex	_	
162-15	34015-34017	in	_	
162-16	34018-34031	schizophrenia	_	
162-17	34032-34035	was	_	
162-18	34036-34047	accompanied	_	
162-19	34048-34050	by	_	
162-20	34051-34055	very	_	
162-21	34056-34060	long	_	
162-22	34061-34064	RTs	_	
162-23	34065-34071	during	_	
162-24	34072-34075	the	_	
162-25	34076-34082	Stroop	_	
162-26	34083-34087	task	_	
162-27	34087-34088	.	_	

#Text=This effect was interpreted as an evidence of insufficient recruitment of cognitive control networks during trials with prolonged RTs.
163-1	34089-34093	This	_	
163-2	34094-34100	effect	_	
163-3	34101-34104	was	_	
163-4	34105-34116	interpreted	_	
163-5	34117-34119	as	_	
163-6	34120-34122	an	_	
163-7	34123-34131	evidence	_	
163-8	34132-34134	of	_	
163-9	34135-34147	insufficient	_	
163-10	34148-34159	recruitment	_	
163-11	34160-34162	of	_	
163-12	34163-34172	cognitive	_	
163-13	34173-34180	control	_	
163-14	34181-34189	networks	_	
163-15	34190-34196	during	_	
163-16	34197-34203	trials	_	
163-17	34204-34208	with	_	
163-18	34209-34218	prolonged	_	
163-19	34219-34222	RTs	_	
163-20	34222-34223	.	_	

#Text=It should be noted however that the comparison of the groups included in our study did not show that SZ patients had statistically significant lower betweenness centrality across the anterior/frontal area.
164-1	34224-34226	It	_	
164-2	34227-34233	should	_	
164-3	34234-34236	be	_	
164-4	34237-34242	noted	_	
164-5	34243-34250	however	_	
164-6	34251-34255	that	_	
164-7	34256-34259	the	_	
164-8	34260-34270	comparison	_	
164-9	34271-34273	of	_	
164-10	34274-34277	the	_	
164-11	34278-34284	groups	_	
164-12	34285-34293	included	_	
164-13	34294-34296	in	_	
164-14	34297-34300	our	_	
164-15	34301-34306	study	_	
164-16	34307-34310	did	_	
164-17	34311-34314	not	_	
164-18	34315-34319	show	_	
164-19	34320-34324	that	_	
164-20	34325-34327	SZ	_	
164-21	34328-34336	patients	_	
164-22	34337-34340	had	_	
164-23	34341-34354	statistically	_	
164-24	34355-34366	significant	_	
164-25	34367-34372	lower	_	
164-26	34373-34384	betweenness	_	
164-27	34385-34395	centrality	_	
164-28	34396-34402	across	_	
164-29	34403-34406	the	_	
164-30	34407-34415	anterior	_	
164-31	34415-34416	/	_	
164-32	34416-34423	frontal	_	
164-33	34424-34428	area	_	
164-34	34428-34429	.	_	

#Text=Therefore, we cannot fully explain our findings with reference to the indicated relationships between ‘de-frontalization’ of the network and the failure of attentional-executive control, as was suggested in the study of Fassbander et al..
165-1	34430-34439	Therefore	_	
165-2	34439-34440	,	_	
165-3	34441-34443	we	_	
165-4	34444-34450	cannot	_	
165-5	34451-34456	fully	_	
165-6	34457-34464	explain	_	
165-7	34465-34468	our	_	
165-8	34469-34477	findings	_	
165-9	34478-34482	with	_	
165-10	34483-34492	reference	_	
165-11	34493-34495	to	_	
165-12	34496-34499	the	_	
165-13	34500-34509	indicated	_	
165-14	34510-34523	relationships	_	
165-15	34524-34531	between	_	
165-16	34532-34533	‘	_	
165-17	34533-34550	de-frontalization	_	
165-18	34550-34551	’	_	
165-19	34552-34554	of	_	
165-20	34555-34558	the	_	
165-21	34559-34566	network	_	
165-22	34567-34570	and	_	
165-23	34571-34574	the	_	
165-24	34575-34582	failure	_	
165-25	34583-34585	of	_	
165-26	34586-34607	attentional-executive	_	
165-27	34608-34615	control	_	
165-28	34615-34616	,	_	
165-29	34617-34619	as	_	
165-30	34620-34623	was	_	
165-31	34624-34633	suggested	_	
165-32	34634-34636	in	_	
165-33	34637-34640	the	_	
165-34	34641-34646	study	_	
165-35	34647-34649	of	_	
165-36	34650-34660	Fassbander	_	
165-37	34661-34663	et	_	
165-38	34664-34666	al	_	
165-39	34666-34667	.	_	
165-40	34667-34668	.	_	

#Text=Despite several strengths of our investigation, notably, demonstrating that the aberrant properties of the neural networks arrangement reconstructed with the use of MST algorithms in schizophrenia have significant behavioural effects, this research has some limitations which should be addressed.
166-1	34669-34676	Despite	_	
166-2	34677-34684	several	_	
166-3	34685-34694	strengths	_	
166-4	34695-34697	of	_	
166-5	34698-34701	our	_	
166-6	34702-34715	investigation	_	
166-7	34715-34716	,	_	
166-8	34717-34724	notably	_	
166-9	34724-34725	,	_	
166-10	34726-34739	demonstrating	_	
166-11	34740-34744	that	_	
166-12	34745-34748	the	_	
166-13	34749-34757	aberrant	_	
166-14	34758-34768	properties	_	
166-15	34769-34771	of	_	
166-16	34772-34775	the	_	
166-17	34776-34782	neural	_	
166-18	34783-34791	networks	_	
166-19	34792-34803	arrangement	_	
166-20	34804-34817	reconstructed	_	
166-21	34818-34822	with	_	
166-22	34823-34826	the	_	
166-23	34827-34830	use	_	
166-24	34831-34833	of	_	
166-25	34834-34837	MST	_	
166-26	34838-34848	algorithms	_	
166-27	34849-34851	in	_	
166-28	34852-34865	schizophrenia	_	
166-29	34866-34870	have	_	
166-30	34871-34882	significant	_	
166-31	34883-34894	behavioural	_	
166-32	34895-34902	effects	_	
166-33	34902-34903	,	_	
166-34	34904-34908	this	_	
166-35	34909-34917	research	_	
166-36	34918-34921	has	_	
166-37	34922-34926	some	_	
166-38	34927-34938	limitations	_	
166-39	34939-34944	which	_	
166-40	34945-34951	should	_	
166-41	34952-34954	be	_	
166-42	34955-34964	addressed	_	
166-43	34964-34965	.	_	

#Text=First, our study was correlational in its nature, which limited the possibility of experimental manipulation of the assessed variables.
167-1	34966-34971	First	_	
167-2	34971-34972	,	_	
167-3	34973-34976	our	_	
167-4	34977-34982	study	_	
167-5	34983-34986	was	_	
167-6	34987-35000	correlational	_	
167-7	35001-35003	in	_	
167-8	35004-35007	its	_	
167-9	35008-35014	nature	_	
167-10	35014-35015	,	_	
167-11	35016-35021	which	_	
167-12	35022-35029	limited	_	
167-13	35030-35033	the	_	
167-14	35034-35045	possibility	_	
167-15	35046-35048	of	_	
167-16	35049-35061	experimental	_	
167-17	35062-35074	manipulation	_	
167-18	35075-35077	of	_	
167-19	35078-35081	the	_	
167-20	35082-35090	assessed	_	
167-21	35091-35100	variables	_	
167-22	35100-35101	.	_	

#Text=Secondly, fluctuations in cognitive processing and neural activity were not induced by changes of the task requirements.
168-1	35102-35110	Secondly	_	
168-2	35110-35111	,	_	
168-3	35112-35124	fluctuations	_	
168-4	35125-35127	in	_	
168-5	35128-35137	cognitive	_	
168-6	35138-35148	processing	_	
168-7	35149-35152	and	_	
168-8	35153-35159	neural	_	
168-9	35160-35168	activity	_	
168-10	35169-35173	were	_	
168-11	35174-35177	not	_	
168-12	35178-35185	induced	_	
168-13	35186-35188	by	_	
168-14	35189-35196	changes	_	
168-15	35197-35199	of	_	
168-16	35200-35203	the	_	
168-17	35204-35208	task	_	
168-18	35209-35221	requirements	_	
168-19	35221-35222	.	_	

#Text=However, our aim was to register the spontaneous variation in information processing as a function of assumed networks abnormality.
169-1	35223-35230	However	_	
169-2	35230-35231	,	_	
169-3	35232-35235	our	_	
169-4	35236-35239	aim	_	
169-5	35240-35243	was	_	
169-6	35244-35246	to	_	
169-7	35247-35255	register	_	
169-8	35256-35259	the	_	
169-9	35260-35271	spontaneous	_	
169-10	35272-35281	variation	_	
169-11	35282-35284	in	_	
169-12	35285-35296	information	_	
169-13	35297-35307	processing	_	
169-14	35308-35310	as	_	
169-15	35311-35312	a	_	
169-16	35313-35321	function	_	
169-17	35322-35324	of	_	
169-18	35325-35332	assumed	_	
169-19	35333-35341	networks	_	
169-20	35342-35353	abnormality	_	
169-21	35353-35354	.	_	

#Text=The yielded results seem to confirm the validity of the applied methodology since in the present study the specific neural networks’ features in the SZ group explained a substantial range of variance in cognitive performance.
170-1	35355-35358	The	_	
170-2	35359-35366	yielded	_	
170-3	35367-35374	results	_	
170-4	35375-35379	seem	_	
170-5	35380-35382	to	_	
170-6	35383-35390	confirm	_	
170-7	35391-35394	the	_	
170-8	35395-35403	validity	_	
170-9	35404-35406	of	_	
170-10	35407-35410	the	_	
170-11	35411-35418	applied	_	
170-12	35419-35430	methodology	_	
170-13	35431-35436	since	_	
170-14	35437-35439	in	_	
170-15	35440-35443	the	_	
170-16	35444-35451	present	_	
170-17	35452-35457	study	_	
170-18	35458-35461	the	_	
170-19	35462-35470	specific	_	
170-20	35471-35477	neural	_	
170-21	35478-35486	networks	_	
170-22	35486-35487	’	_	
170-23	35488-35496	features	_	
170-24	35497-35499	in	_	
170-25	35500-35503	the	_	
170-26	35504-35506	SZ	_	
170-27	35507-35512	group	_	
170-28	35513-35522	explained	_	
170-29	35523-35524	a	_	
170-30	35525-35536	substantial	_	
170-31	35537-35542	range	_	
170-32	35543-35545	of	_	
170-33	35546-35554	variance	_	
170-34	35555-35557	in	_	
170-35	35558-35567	cognitive	_	
170-36	35567-35568	 	_	
170-37	35568-35579	performance	_	
170-38	35579-35580	.	_	

#Text=Thirdly, to determine the organization of the neural activity, resting-state EEG was used, with a relatively small amount of electrodes, what could have restricted the precision of nodes location.
171-1	35581-35588	Thirdly	_	
171-2	35588-35589	,	_	
171-3	35590-35592	to	_	
171-4	35593-35602	determine	_	
171-5	35603-35606	the	_	
171-6	35607-35619	organization	_	
171-7	35620-35622	of	_	
171-8	35623-35626	the	_	
171-9	35627-35633	neural	_	
171-10	35634-35642	activity	_	
171-11	35642-35643	,	_	
171-12	35644-35657	resting-state	_	
171-13	35658-35661	EEG	_	
171-14	35662-35665	was	_	
171-15	35666-35670	used	_	
171-16	35670-35671	,	_	
171-17	35672-35676	with	_	
171-18	35677-35678	a	_	
171-19	35679-35689	relatively	_	
171-20	35690-35695	small	_	
171-21	35696-35702	amount	_	
171-22	35703-35705	of	_	
171-23	35706-35716	electrodes	_	
171-24	35716-35717	,	_	
171-25	35718-35722	what	_	
171-26	35723-35728	could	_	
171-27	35729-35733	have	_	
171-28	35734-35744	restricted	_	
171-29	35745-35748	the	_	
171-30	35749-35758	precision	_	
171-31	35759-35761	of	_	
171-32	35762-35767	nodes	_	
171-33	35768-35776	location	_	
171-34	35776-35777	.	_	

#Text=Also, due to the application of PLI to measure functional connectivity, this location covers only the cortical surface.
172-1	35778-35782	Also	_	
172-2	35782-35783	,	_	
172-3	35784-35787	due	_	
172-4	35788-35790	to	_	
172-5	35791-35794	the	_	
172-6	35795-35806	application	_	
172-7	35807-35809	of	_	
172-8	35810-35813	PLI	_	
172-9	35814-35816	to	_	
172-10	35817-35824	measure	_	
172-11	35825-35835	functional	_	
172-12	35836-35848	connectivity	_	
172-13	35848-35849	,	_	
172-14	35850-35854	this	_	
172-15	35855-35863	location	_	
172-16	35864-35870	covers	_	
172-17	35871-35875	only	_	
172-18	35876-35879	the	_	
172-19	35880-35888	cortical	_	
172-20	35889-35896	surface	_	
172-21	35896-35897	.	_	

#Text=Nevertheless, since we wanted to characterize the global network organization and its relationship to psychopathology and cognitive impairment, such a procedure seems to be justified, as shown by our and previous studies.
173-1	35898-35910	Nevertheless	_	
173-2	35910-35911	,	_	
173-3	35912-35917	since	_	
173-4	35918-35920	we	_	
173-5	35921-35927	wanted	_	
173-6	35928-35930	to	_	
173-7	35931-35943	characterize	_	
173-8	35944-35947	the	_	
173-9	35948-35954	global	_	
173-10	35955-35962	network	_	
173-11	35963-35975	organization	_	
173-12	35976-35979	and	_	
173-13	35980-35983	its	_	
173-14	35984-35996	relationship	_	
173-15	35997-35999	to	_	
173-16	36000-36015	psychopathology	_	
173-17	36016-36019	and	_	
173-18	36020-36029	cognitive	_	
173-19	36030-36040	impairment	_	
173-20	36040-36041	,	_	
173-21	36042-36046	such	_	
173-22	36047-36048	a	_	
173-23	36049-36058	procedure	_	
173-24	36059-36064	seems	_	
173-25	36065-36067	to	_	
173-26	36068-36070	be	_	
173-27	36071-36080	justified	_	
173-28	36080-36081	,	_	
173-29	36082-36084	as	_	
173-30	36085-36090	shown	_	
173-31	36091-36093	by	_	
173-32	36094-36097	our	_	
173-33	36098-36101	and	_	
173-34	36102-36110	previous	_	
173-35	36111-36118	studies	_	
173-36	36118-36119	.	_	

#Text=In the end, it should be accentuated that the results of our investigation confirm the pivotal role of deficient gamma synchronization in schizophrenia.
174-1	36120-36122	In	_	
174-2	36123-36126	the	_	
174-3	36127-36130	end	_	
174-4	36130-36131	,	_	
174-5	36132-36134	it	_	
174-6	36135-36141	should	_	
174-7	36142-36144	be	_	
174-8	36145-36156	accentuated	_	
174-9	36157-36161	that	_	
174-10	36162-36165	the	_	
174-11	36166-36173	results	_	
174-12	36174-36176	of	_	
174-13	36177-36180	our	_	
174-14	36181-36194	investigation	_	
174-15	36195-36202	confirm	_	
174-16	36203-36206	the	_	
174-17	36207-36214	pivotal	_	
174-18	36215-36219	role	_	
174-19	36220-36222	of	_	
174-20	36223-36232	deficient	_	
174-21	36233-36238	gamma	_	
174-22	36239-36254	synchronization	_	
174-23	36255-36257	in	_	
174-24	36258-36271	schizophrenia	_	
174-25	36271-36272	.	_	

#Text=Within this frequency the largest number of MST metrics differentiated the groups of SZ patients from healthy controls, these metrics most often turned out to be significantly related to clinical symptoms and analyzed neuropsychological deficits.
175-1	36273-36279	Within	_	
175-2	36280-36284	this	_	
175-3	36285-36294	frequency	_	
175-4	36295-36298	the	_	
175-5	36299-36306	largest	_	
175-6	36307-36313	number	_	
175-7	36314-36316	of	_	
175-8	36317-36320	MST	_	
175-9	36321-36328	metrics	_	
175-10	36329-36343	differentiated	_	
175-11	36344-36347	the	_	
175-12	36348-36354	groups	_	
175-13	36355-36357	of	_	
175-14	36358-36360	SZ	_	
175-15	36361-36369	patients	_	
175-16	36370-36374	from	_	
175-17	36375-36382	healthy	_	
175-18	36383-36391	controls	_	
175-19	36391-36392	,	_	
175-20	36393-36398	these	_	
175-21	36399-36406	metrics	_	
175-22	36407-36411	most	_	
175-23	36412-36417	often	_	
175-24	36418-36424	turned	_	
175-25	36425-36428	out	_	
175-26	36429-36431	to	_	
175-27	36432-36434	be	_	
175-28	36435-36448	significantly	_	
175-29	36449-36456	related	_	
175-30	36457-36459	to	_	
175-31	36460-36468	clinical	_	
175-32	36469-36477	symptoms	_	
175-33	36478-36481	and	_	
175-34	36482-36490	analyzed	_	
175-35	36491-36509	neuropsychological	_	
175-36	36510-36518	deficits	_	
175-37	36518-36519	.	_	

#Text=Extensive reviews and empirical research unequivocally confirm the critical engagement of gamma oscillations in the neural underpinning of schizophrenia, its relations with a psychotic onset and disturbed neurochemical processes, especially glutamatergic neurotransmission via the NMDA (N-methyl-D-aspartate) receptors.
176-1	36520-36529	Extensive	_	
176-2	36530-36537	reviews	_	
176-3	36538-36541	and	_	
176-4	36542-36551	empirical	_	
176-5	36552-36560	research	_	
176-6	36561-36574	unequivocally	_	
176-7	36575-36582	confirm	_	
176-8	36583-36586	the	_	
176-9	36587-36595	critical	_	
176-10	36596-36606	engagement	_	
176-11	36607-36609	of	_	
176-12	36610-36615	gamma	_	
176-13	36616-36628	oscillations	_	
176-14	36629-36631	in	_	
176-15	36632-36635	the	_	
176-16	36636-36642	neural	_	
176-17	36643-36655	underpinning	_	
176-18	36656-36658	of	_	
176-19	36659-36672	schizophrenia	_	
176-20	36672-36673	,	_	
176-21	36674-36677	its	_	
176-22	36678-36687	relations	_	
176-23	36688-36692	with	_	
176-24	36693-36694	a	_	
176-25	36695-36704	psychotic	_	
176-26	36705-36710	onset	_	
176-27	36711-36714	and	_	
176-28	36715-36724	disturbed	_	
176-29	36725-36738	neurochemical	_	
176-30	36739-36748	processes	_	
176-31	36748-36749	,	_	
176-32	36750-36760	especially	_	
176-33	36761-36774	glutamatergic	_	
176-34	36775-36792	neurotransmission	_	
176-35	36793-36796	via	_	
176-36	36797-36800	the	_	
176-37	36801-36805	NMDA	_	
176-38	36806-36807	(	_	
176-39	36807-36827	N-methyl-D-aspartate	_	
176-40	36827-36828	)	_	
176-41	36829-36838	receptors	_	
176-42	36838-36839	.	_	

#Text=Therefore future studies focused on establishing links between electrophysiological activity and schizophrenia should always refer to high-frequency neural dynamics.
177-1	36840-36849	Therefore	_	
177-2	36850-36856	future	_	
177-3	36857-36864	studies	_	
177-4	36865-36872	focused	_	
177-5	36873-36875	on	_	
177-6	36876-36888	establishing	_	
177-7	36889-36894	links	_	
177-8	36895-36902	between	_	
177-9	36903-36923	electrophysiological	_	
177-10	36924-36932	activity	_	
177-11	36933-36936	and	_	
177-12	36937-36950	schizophrenia	_	
177-13	36951-36957	should	_	
177-14	36958-36964	always	_	
177-15	36965-36970	refer	_	
177-16	36971-36973	to	_	
177-17	36974-36988	high-frequency	_	
177-18	36989-36995	neural	_	
177-19	36996-37004	dynamics	_	
177-20	37004-37005	.	_	

#Text=Methods
#Text=Participants
#Text=All participants met the following inclusion criteria: age between 18 and 25 years old, right-handedness and at least 12 years of education, while the exclusion criteria concerned taking benzodiazepines, anticholinergic agents and mood stabilizers up to three months before the assessment.
178-1	37006-37013	Methods	http://www.case.edu/ProvCaRe/provcare#StudyMethod	
178-2	37014-37026	Participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
178-3	37027-37030	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-4	37031-37043	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-5	37044-37047	met	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-6	37048-37051	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-7	37052-37061	following	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-8	37062-37071	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-9	37072-37080	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-10	37080-37081	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-11	37082-37085	age	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-12	37086-37093	between	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-13	37094-37096	18	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-14	37097-37100	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-15	37101-37103	25	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-16	37104-37109	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-17	37110-37113	old	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-18	37113-37114	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-19	37115-37131	right-handedness	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-20	37132-37135	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-21	37136-37138	at	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-22	37139-37144	least	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-23	37145-37147	12	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-24	37148-37153	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-25	37154-37156	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-26	37157-37166	education	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-27	37166-37167	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-28	37168-37173	while	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-29	37174-37177	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-30	37178-37187	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-31	37188-37196	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-32	37197-37206	concerned	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-33	37207-37213	taking	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-34	37214-37229	benzodiazepines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-35	37229-37230	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-36	37231-37246	anticholinergic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-37	37247-37253	agents	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-38	37254-37257	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-39	37258-37262	mood	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-40	37263-37274	stabilizers	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-41	37275-37277	up	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-42	37278-37280	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-43	37281-37286	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-44	37287-37293	months	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-45	37294-37300	before	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-46	37301-37304	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-47	37305-37315	assessment	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	
178-48	37315-37316	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[3]	

#Text=Ultimately, a group of 35 inpatients diagnosed as first-episode schizophrenia (SZ) according to DSM-5 classification (Structured Clinical Interview for DSM-5, SCI) and 35 healthy controls (HC) participated in this study.
179-1	37317-37327	Ultimately	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
179-2	37327-37328	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
179-3	37329-37330	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-4	37331-37336	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-5	37337-37339	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-6	37340-37342	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-7	37343-37353	inpatients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-8	37354-37363	diagnosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-9	37364-37366	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-10	37367-37380	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-11	37381-37394	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
179-12	37395-37396	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
179-13	37396-37398	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
179-14	37398-37399	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[5]	
179-15	37400-37409	according	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-16	37410-37412	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-17	37413-37416	DSM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-18	37416-37417	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-19	37417-37418	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-20	37419-37433	classification	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-21	37434-37435	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-22	37435-37445	Structured	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-23	37446-37454	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-24	37455-37464	Interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-25	37465-37468	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-26	37469-37472	DSM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-27	37472-37473	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-28	37473-37474	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-29	37474-37475	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-30	37476-37479	SCI	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-31	37479-37480	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-32	37481-37484	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-33	37485-37487	35	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-34	37488-37495	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
179-35	37496-37504	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
179-36	37505-37506	(	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
179-37	37506-37508	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[6]	
179-38	37508-37509	)	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-39	37510-37522	participated	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-40	37523-37525	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-41	37526-37530	this	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-42	37531-37536	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	
179-43	37536-37537	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[4]	

#Text=Patients assigned to the research group were recruited from the Department and Clinic of Psychiatry, Psychotherapy and Early Intervention of the Medical University of Lublin, Poland.
180-1	37538-37546	Patients	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-2	37547-37555	assigned	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-3	37556-37558	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-4	37559-37562	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-5	37563-37571	research	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-6	37572-37577	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-7	37578-37582	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-8	37583-37592	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-9	37593-37597	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-10	37598-37601	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-11	37602-37612	Department	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-12	37613-37616	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-13	37617-37623	Clinic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-14	37624-37626	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-15	37627-37637	Psychiatry	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-16	37637-37638	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-17	37639-37652	Psychotherapy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-18	37653-37656	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-19	37657-37662	Early	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-20	37663-37675	Intervention	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-21	37676-37678	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-22	37679-37682	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-23	37683-37690	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-24	37691-37701	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-25	37702-37704	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-26	37705-37711	Lublin	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-27	37711-37712	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-28	37713-37719	Poland	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	
180-29	37719-37720	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[7]	

#Text=The HC group was recruited from the local community after the clinical group was completed to guarantee the demographic matching of individuals from both samples.
181-1	37721-37724	The	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-2	37725-37727	HC	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder[8]	
181-3	37728-37733	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-4	37734-37737	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-5	37738-37747	recruited	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-6	37748-37752	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-7	37753-37756	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-8	37757-37762	local	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-9	37763-37772	community	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-10	37773-37778	after	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-11	37779-37782	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-12	37783-37791	clinical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-13	37792-37797	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-14	37798-37801	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-15	37802-37811	completed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-16	37812-37814	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-17	37815-37824	guarantee	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-18	37825-37828	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-19	37829-37840	demographic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-20	37841-37849	matching	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-21	37850-37852	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-22	37853-37864	individuals	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-23	37865-37869	from	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-24	37870-37874	both	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-25	37875-37882	samples	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
181-26	37882-37883	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=In addition to the mentioned general inclusion and exclusion criteria, healthy controls had to meet additional conditions such as: lack of positive family history of psychotic and affective diseases disclosed, no personal history of Axis I diagnoses as established by the SCID for DSM-5 Axis I Disorders, neurological injuries or brain disease revealed during the initial interview.
182-1	37884-37886	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-2	37887-37895	addition	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-3	37896-37898	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-4	37899-37902	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-5	37903-37912	mentioned	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-6	37913-37920	general	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-7	37921-37930	inclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-8	37931-37934	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-9	37935-37944	exclusion	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-10	37945-37953	criteria	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-11	37953-37954	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-12	37955-37962	healthy	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-13	37963-37971	controls	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-14	37972-37975	had	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-15	37976-37978	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-16	37979-37983	meet	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-17	37984-37994	additional	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-18	37995-38005	conditions	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-19	38006-38010	such	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-20	38011-38013	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-21	38013-38014	:	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-22	38015-38019	lack	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-23	38020-38022	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-24	38023-38031	positive	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-25	38032-38038	family	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-26	38039-38046	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-27	38047-38049	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-28	38050-38059	psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-29	38060-38063	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-30	38064-38073	affective	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-31	38074-38082	diseases	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-32	38083-38092	disclosed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-33	38092-38093	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-34	38094-38096	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-35	38097-38105	personal	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-36	38106-38113	history	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-37	38114-38116	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-38	38117-38121	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-39	38122-38123	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-40	38124-38133	diagnoses	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-41	38134-38136	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-42	38137-38148	established	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-43	38149-38151	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-44	38152-38155	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-45	38156-38160	SCID	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders[9]	
182-46	38161-38164	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-47	38165-38168	DSM	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-48	38168-38169	-	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-49	38169-38170	5	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-50	38171-38175	Axis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-51	38176-38177	I	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-52	38178-38187	Disorders	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-53	38187-38188	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-54	38189-38201	neurological	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-55	38202-38210	injuries	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-56	38211-38213	or	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-57	38214-38219	brain	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-58	38220-38227	disease	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-59	38228-38236	revealed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-60	38237-38243	during	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-61	38244-38247	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-62	38248-38255	initial	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-63	38256-38265	interview	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
182-64	38265-38266	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=In the SZ group, the first-episode status was defined as having received the first psychiatric diagnosis less than one year prior to being engaged in the study, and by the presence of any form of psychotic symptoms for no longer than three years.
183-1	38267-38269	In	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-2	38270-38273	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-3	38274-38276	SZ	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]|http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia[10]	
183-4	38277-38282	group	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-5	38282-38283	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-6	38284-38287	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-7	38288-38301	first-episode	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-8	38302-38308	status	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-9	38309-38312	was	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-10	38313-38320	defined	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-11	38321-38323	as	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-12	38324-38330	having	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-13	38331-38339	received	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-14	38340-38343	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-15	38344-38349	first	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-16	38350-38361	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-17	38362-38371	diagnosis	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-18	38372-38376	less	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-19	38377-38381	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-20	38382-38385	one	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-21	38386-38390	year	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-22	38391-38396	prior	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-23	38397-38399	to	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-24	38400-38405	being	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-25	38406-38413	engaged	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-26	38414-38416	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-27	38417-38420	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-28	38421-38426	study	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-29	38426-38427	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-30	38428-38431	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-31	38432-38434	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-32	38435-38438	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-33	38439-38447	presence	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-34	38448-38450	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-35	38451-38454	any	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-36	38455-38459	form	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-37	38460-38462	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-38	38463-38472	psychotic	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-39	38473-38481	symptoms	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-40	38482-38485	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-41	38486-38488	no	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-42	38489-38495	longer	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-43	38496-38500	than	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-44	38501-38506	three	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-45	38507-38512	years	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	
183-46	38512-38513	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[2]	

#Text=SZ subjects underwent brain structural imaging (MRI) about a month before participation in order to exclude those with any acquired brain injuries (tumors, cerebrovascular changes, signs of TBI etc.).
184-1	38514-38516	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
184-2	38517-38525	subjects	_	
184-3	38526-38535	underwent	_	
184-4	38536-38541	brain	_	
184-5	38542-38552	structural	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]	
184-6	38553-38560	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]	
184-7	38561-38562	(	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]	
184-8	38562-38565	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]	
184-9	38565-38566	)	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging[11]	
184-10	38567-38572	about	_	
184-11	38573-38574	a	_	
184-12	38575-38580	month	_	
184-13	38581-38587	before	_	
184-14	38588-38601	participation	_	
184-15	38602-38604	in	_	
184-16	38605-38610	order	_	
184-17	38611-38613	to	_	
184-18	38614-38621	exclude	_	
184-19	38622-38627	those	_	
184-20	38628-38632	with	_	
184-21	38633-38636	any	_	
184-22	38637-38645	acquired	_	
184-23	38646-38651	brain	_	
184-24	38652-38660	injuries	_	
184-25	38661-38662	(	_	
184-26	38662-38668	tumors	_	
184-27	38668-38669	,	_	
184-28	38670-38685	cerebrovascular	_	
184-29	38686-38693	changes	_	
184-30	38693-38694	,	_	
184-31	38695-38700	signs	_	
184-32	38701-38703	of	_	
184-33	38704-38707	TBI	_	
184-34	38708-38711	etc	_	
184-35	38711-38712	.	_	
184-36	38712-38713	)	_	
184-37	38713-38714	.	_	

#Text=All patients were treated with stable doses of atypical antipsychotics during cognitive and electrophysiological assessment, which took place in the last week of hospitalization when a significant clinical improvement had been determined by treatment providing psychiatrists.
185-1	38715-38718	All	_	
185-2	38719-38727	patients	_	
185-3	38728-38732	were	_	
185-4	38733-38740	treated	_	
185-5	38741-38745	with	_	
185-6	38746-38752	stable	_	
185-7	38753-38758	doses	_	
185-8	38759-38761	of	_	
185-9	38762-38770	atypical	_	
185-10	38771-38785	antipsychotics	_	
185-11	38786-38792	during	_	
185-12	38793-38802	cognitive	_	
185-13	38803-38806	and	_	
185-14	38807-38827	electrophysiological	_	
185-15	38828-38838	assessment	_	
185-16	38838-38839	,	_	
185-17	38840-38845	which	_	
185-18	38846-38850	took	_	
185-19	38851-38856	place	_	
185-20	38857-38859	in	_	
185-21	38860-38863	the	_	
185-22	38864-38868	last	_	
185-23	38869-38873	week	_	
185-24	38874-38876	of	_	
185-25	38877-38892	hospitalization	_	
185-26	38893-38897	when	_	
185-27	38898-38899	a	_	
185-28	38900-38911	significant	_	
185-29	38912-38920	clinical	_	
185-30	38921-38932	improvement	_	
185-31	38933-38936	had	_	
185-32	38937-38941	been	_	
185-33	38942-38952	determined	_	
185-34	38953-38955	by	_	
185-35	38956-38965	treatment	_	
185-36	38966-38975	providing	_	
185-37	38976-38989	psychiatrists	_	
185-38	38989-38990	.	_	

#Text=The PANSS total score lower than 75 points was considered as confirming symptomatic remission, which concerned 85.71% of the finally compiled patients’ group.
186-1	38991-38994	The	_	
186-2	38995-39000	PANSS	http://maven.renci.org/NeuroBridge/neurobridge#PositiveandNegativeSyndromeScale	
186-3	39001-39006	total	_	
186-4	39007-39012	score	_	
186-5	39013-39018	lower	_	
186-6	39019-39023	than	_	
186-7	39024-39026	75	_	
186-8	39027-39033	points	_	
186-9	39034-39037	was	_	
186-10	39038-39048	considered	_	
186-11	39049-39051	as	_	
186-12	39052-39062	confirming	_	
186-13	39063-39074	symptomatic	_	
186-14	39075-39084	remission	_	
186-15	39084-39085	,	_	
186-16	39086-39091	which	_	
186-17	39092-39101	concerned	_	
186-18	39102-39108	85.71%	_	
186-19	39109-39111	of	_	
186-20	39112-39115	the	_	
186-21	39116-39123	finally	_	
186-22	39124-39132	compiled	_	
186-23	39133-39141	patients	_	
186-24	39141-39142	’	_	
186-25	39143-39148	group	_	
186-26	39148-39149	.	_	

#Text=The premorbid IQ of all participants was estimated with Polish Adult Reading Test (PART) - a validated, standardized, and normalized Polish version of NART.
187-1	39150-39153	The	_	
187-2	39154-39163	premorbid	_	
187-3	39164-39166	IQ	_	
187-4	39167-39169	of	_	
187-5	39170-39173	all	_	
187-6	39174-39186	participants	_	
187-7	39187-39190	was	_	
187-8	39191-39200	estimated	_	
187-9	39201-39205	with	_	
187-10	39206-39212	Polish	_	
187-11	39213-39218	Adult	_	
187-12	39219-39226	Reading	_	
187-13	39227-39231	Test	_	
187-14	39232-39233	(	_	
187-15	39233-39237	PART	_	
187-16	39237-39238	)	_	
187-17	39239-39240	-	_	
187-18	39241-39242	a	_	
187-19	39243-39252	validated	_	
187-20	39252-39253	,	_	
187-21	39254-39266	standardized	_	
187-22	39266-39267	,	_	
187-23	39268-39271	and	_	
187-24	39272-39282	normalized	_	
187-25	39283-39289	Polish	_	
187-26	39290-39297	version	_	
187-27	39298-39300	of	_	
187-28	39301-39305	NART	_	
187-29	39305-39306	.	_	

#Text=All participants provided informed consent for a protocol approved by the Bioethical Commission of the Medical University of Lublin, Poland, all methods were performed in accordance with relevant guidelines and regulations.
188-1	39307-39310	All	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-2	39311-39323	participants	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-3	39324-39332	provided	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-4	39333-39341	informed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-5	39342-39349	consent	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-6	39350-39353	for	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-7	39354-39355	a	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-8	39356-39364	protocol	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-9	39365-39373	approved	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-10	39374-39376	by	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-11	39377-39380	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-12	39381-39391	Bioethical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-13	39392-39402	Commission	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-14	39403-39405	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-15	39406-39409	the	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-16	39410-39417	Medical	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-17	39418-39428	University	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-18	39429-39431	of	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-19	39432-39438	Lublin	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-20	39438-39439	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-21	39440-39446	Poland	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-22	39446-39447	,	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-23	39448-39451	all	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-24	39452-39459	methods	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-25	39460-39464	were	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-26	39465-39474	performed	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-27	39475-39477	in	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-28	39478-39488	accordance	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-29	39489-39493	with	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-30	39494-39502	relevant	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-31	39503-39513	guidelines	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-32	39514-39517	and	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-33	39518-39529	regulations	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	
188-34	39529-39530	.	http://maven.renci.org/NeuroBridge/neurobridge#RecruitmentProtocol[12]	

#Text=Cognitive assessment
#Text=A digitized version of a processing speed test (Digit Symbols Test, DST) was applied to measure cognitive speed.
189-1	39531-39540	Cognitive	_	
189-2	39541-39551	assessment	_	
189-3	39552-39553	A	_	
189-4	39554-39563	digitized	_	
189-5	39564-39571	version	_	
189-6	39572-39574	of	_	
189-7	39575-39576	a	_	
189-8	39577-39587	processing	_	
189-9	39588-39593	speed	_	
189-10	39594-39598	test	_	
189-11	39599-39600	(	_	
189-12	39600-39605	Digit	_	
189-13	39606-39613	Symbols	_	
189-14	39614-39618	Test	_	
189-15	39618-39619	,	_	
189-16	39620-39623	DST	_	
189-17	39623-39624	)	_	
189-18	39625-39628	was	_	
189-19	39629-39636	applied	_	
189-20	39637-39639	to	_	
189-21	39640-39647	measure	_	
189-22	39648-39657	cognitive	_	
189-23	39658-39663	speed	_	
189-24	39663-39664	.	_	

#Text=A comprehensive description of this task has been reported elsewhere.
190-1	39665-39666	A	_	
190-2	39667-39680	comprehensive	_	
190-3	39681-39692	description	_	
190-4	39693-39695	of	_	
190-5	39696-39700	this	_	
190-6	39701-39705	task	_	
190-7	39706-39709	has	_	
190-8	39710-39714	been	_	
190-9	39715-39723	reported	_	
190-10	39724-39733	elsewhere	_	
190-11	39733-39734	.	_	

#Text=Generally, the task used in this study is based on Symbol Coding/Digit Symbol tests or similar methods included in various cognitive batteries, e.g., WAIS or BACS.
191-1	39735-39744	Generally	_	
191-2	39744-39745	,	_	
191-3	39746-39749	the	_	
191-4	39750-39754	task	_	
191-5	39755-39759	used	_	
191-6	39760-39762	in	_	
191-7	39763-39767	this	_	
191-8	39768-39773	study	_	
191-9	39774-39776	is	_	
191-10	39777-39782	based	_	
191-11	39783-39785	on	_	
191-12	39786-39792	Symbol	_	
191-13	39793-39799	Coding	_	
191-14	39799-39800	/	_	
191-15	39800-39805	Digit	_	
191-16	39806-39812	Symbol	_	
191-17	39813-39818	tests	_	
191-18	39819-39821	or	_	
191-19	39822-39829	similar	_	
191-20	39830-39837	methods	_	
191-21	39838-39846	included	_	
191-22	39847-39849	in	_	
191-23	39850-39857	various	_	
191-24	39858-39867	cognitive	_	
191-25	39868-39877	batteries	_	
191-26	39877-39878	,	_	
191-27	39879-39882	e.g	_	
191-28	39882-39883	.	_	
191-29	39883-39884	,	_	
191-30	39885-39889	WAIS	_	
191-31	39890-39892	or	_	
191-32	39893-39897	BACS	_	
191-33	39897-39898	.	_	

#Text=The task of the participant is to match numbers to abstract symbols as fast as possible.
192-1	39899-39902	The	_	
192-2	39903-39907	task	_	
192-3	39908-39910	of	_	
192-4	39911-39914	the	_	
192-5	39915-39926	participant	_	
192-6	39927-39929	is	_	
192-7	39930-39932	to	_	
192-8	39933-39938	match	_	
192-9	39939-39946	numbers	_	
192-10	39947-39949	to	_	
192-11	39950-39958	abstract	_	
192-12	39959-39966	symbols	_	
192-13	39967-39969	as	_	
192-14	39970-39974	fast	_	
192-15	39975-39977	as	_	
192-16	39978-39986	possible	_	
192-17	39986-39987	.	_	

#Text=The idea to develop an original computerized version of the test in a form of a tablet application resulted from the necessity to provide access to all the raw data containing temporal parameters of task performance (in milliseconds).
193-1	39988-39991	The	_	
193-2	39992-39996	idea	_	
193-3	39997-39999	to	_	
193-4	40000-40007	develop	_	
193-5	40008-40010	an	_	
193-6	40011-40019	original	_	
193-7	40020-40032	computerized	_	
193-8	40033-40040	version	_	
193-9	40041-40043	of	_	
193-10	40044-40047	the	_	
193-11	40048-40052	test	_	
193-12	40053-40055	in	_	
193-13	40056-40057	a	_	
193-14	40058-40062	form	_	
193-15	40063-40065	of	_	
193-16	40066-40067	a	_	
193-17	40068-40074	tablet	_	
193-18	40075-40086	application	_	
193-19	40087-40095	resulted	_	
193-20	40096-40100	from	_	
193-21	40101-40104	the	_	
193-22	40105-40114	necessity	_	
193-23	40115-40117	to	_	
193-24	40118-40125	provide	_	
193-25	40126-40132	access	_	
193-26	40133-40135	to	_	
193-27	40136-40139	all	_	
193-28	40140-40143	the	_	
193-29	40144-40147	raw	_	
193-30	40148-40152	data	_	
193-31	40153-40163	containing	_	
193-32	40164-40172	temporal	_	
193-33	40173-40183	parameters	_	
193-34	40184-40186	of	_	
193-35	40187-40191	task	_	
193-36	40192-40203	performance	_	
193-37	40204-40205	(	_	
193-38	40205-40207	in	_	
193-39	40208-40220	milliseconds	_	
193-40	40220-40221	)	_	
193-41	40221-40222	.	_	

#Text=The raw data contain a set of reaction times (RTs) covering the intervals between displaying a given symbol and the indication of the corresponding digit.
194-1	40223-40226	The	_	
194-2	40227-40230	raw	_	
194-3	40231-40235	data	_	
194-4	40236-40243	contain	_	
194-5	40244-40245	a	_	
194-6	40246-40249	set	_	
194-7	40250-40252	of	_	
194-8	40253-40261	reaction	_	
194-9	40262-40267	times	_	
194-10	40268-40269	(	_	
194-11	40269-40272	RTs	_	
194-12	40272-40273	)	_	
194-13	40274-40282	covering	_	
194-14	40283-40286	the	_	
194-15	40287-40296	intervals	_	
194-16	40297-40304	between	_	
194-17	40305-40315	displaying	_	
194-18	40316-40317	a	_	
194-19	40318-40323	given	_	
194-20	40324-40330	symbol	_	
194-21	40331-40334	and	_	
194-22	40335-40338	the	_	
194-23	40339-40349	indication	_	
194-24	40350-40352	of	_	
194-25	40353-40356	the	_	
194-26	40357-40370	corresponding	_	
194-27	40371-40376	digit	_	
194-28	40376-40377	.	_	

#Text=Further, we used this task in a digital form to reduce the potential impact of motoric disorders that might affect the results of paper-pencil tests, such as in Symbol Coding.
195-1	40378-40385	Further	_	
195-2	40385-40386	,	_	
195-3	40387-40389	we	_	
195-4	40390-40394	used	_	
195-5	40395-40399	this	_	
195-6	40400-40404	task	_	
195-7	40405-40407	in	_	
195-8	40408-40409	a	_	
195-9	40410-40417	digital	_	
195-10	40418-40422	form	_	
195-11	40423-40425	to	_	
195-12	40426-40432	reduce	_	
195-13	40433-40436	the	_	
195-14	40437-40446	potential	_	
195-15	40447-40453	impact	_	
195-16	40454-40456	of	_	
195-17	40457-40464	motoric	_	
195-18	40465-40474	disorders	_	
195-19	40475-40479	that	_	
195-20	40480-40485	might	_	
195-21	40486-40492	affect	_	
195-22	40493-40496	the	_	
195-23	40497-40504	results	_	
195-24	40505-40507	of	_	
195-25	40508-40520	paper-pencil	_	
195-26	40521-40526	tests	_	
195-27	40526-40527	,	_	
195-28	40528-40532	such	_	
195-29	40533-40535	as	_	
195-30	40536-40538	in	_	
195-31	40539-40545	Symbol	_	
195-32	40546-40552	Coding	_	
195-33	40552-40553	.	_	

#Text=In the applied version, participants had to only touch the appropriate stimulus.
196-1	40554-40556	In	_	
196-2	40557-40560	the	_	
196-3	40561-40568	applied	_	
196-4	40569-40576	version	_	
196-5	40576-40577	,	_	
196-6	40578-40590	participants	_	
196-7	40591-40594	had	_	
196-8	40595-40597	to	_	
196-9	40598-40602	only	_	
196-10	40603-40608	touch	_	
196-11	40609-40612	the	_	
196-12	40613-40624	appropriate	_	
196-13	40625-40633	stimulus	_	
196-14	40633-40634	.	_	

#Text=All subjects were tested with the same software and hardware (Lenovo Yoga 2 tablet with 13, 3″ screen, resolution Quad HD 2560 × 1440 IPS, Android™ 4.4 system).
197-1	40635-40638	All	_	
197-2	40639-40647	subjects	_	
197-3	40648-40652	were	_	
197-4	40653-40659	tested	_	
197-5	40660-40664	with	_	
197-6	40665-40668	the	_	
197-7	40669-40673	same	_	
197-8	40674-40682	software	_	
197-9	40683-40686	and	_	
197-10	40687-40695	hardware	_	
197-11	40696-40697	(	_	
197-12	40697-40703	Lenovo	_	
197-13	40704-40708	Yoga	_	
197-14	40709-40710	2	_	
197-15	40711-40717	tablet	_	
197-16	40718-40722	with	_	
197-17	40723-40725	13	_	
197-18	40725-40726	,	_	
197-19	40727-40728	3	_	
197-20	40728-40729	″	_	
197-21	40730-40736	screen	_	
197-22	40736-40737	,	_	
197-23	40738-40748	resolution	_	
197-24	40749-40753	Quad	_	
197-25	40754-40756	HD	_	
197-26	40757-40761	2560	_	
197-27	40762-40763	×	_	
197-28	40764-40768	1440	_	
197-29	40769-40772	IPS	_	
197-30	40772-40773	,	_	
197-31	40774-40781	Android	_	
197-32	40781-40782	™	_	
197-33	40783-40786	4.4	_	
197-34	40787-40793	system	_	
197-35	40793-40794	)	_	
197-36	40794-40795	.	_	

#Text=Having all the reaction times from the cognitive speed test, it was possible to determine the intergroup difference regarding the extent of variability in information processing with the individual standard deviation (iSD) indicator.
198-1	40796-40802	Having	_	
198-2	40803-40806	all	_	
198-3	40807-40810	the	_	
198-4	40811-40819	reaction	_	
198-5	40820-40825	times	_	
198-6	40826-40830	from	_	
198-7	40831-40834	the	_	
198-8	40835-40844	cognitive	_	
198-9	40845-40850	speed	_	
198-10	40851-40855	test	_	
198-11	40855-40856	,	_	
198-12	40857-40859	it	_	
198-13	40860-40863	was	_	
198-14	40864-40872	possible	_	
198-15	40873-40875	to	_	
198-16	40876-40885	determine	_	
198-17	40886-40889	the	_	
198-18	40890-40900	intergroup	_	
198-19	40901-40911	difference	_	
198-20	40912-40921	regarding	_	
198-21	40922-40925	the	_	
198-22	40926-40932	extent	_	
198-23	40933-40935	of	_	
198-24	40936-40947	variability	_	
198-25	40948-40950	in	_	
198-26	40951-40962	information	_	
198-27	40963-40973	processing	_	
198-28	40974-40978	with	_	
198-29	40979-40982	the	_	
198-30	40983-40993	individual	_	
198-31	40994-41002	standard	_	
198-32	41003-41012	deviation	_	
198-33	41013-41014	(	_	
198-34	41014-41017	iSD	_	
198-35	41017-41018	)	_	
198-36	41019-41028	indicator	_	
198-37	41028-41029	.	_	

#Text=However, in clinical populations the distribution of RTs deviates from the Gaussian model, therefore, to circumvent this limitation, the so-called ex-Gaussian modelling methods were applied, providing quantitative data regarding the properties of RTs distribution, in a form of three independent parameters: (1) mu (μ) representing the mean of the normal component and reflecting average performance, (2) sigma (σ) being a symmetrical standard deviation of the normal component, and (3) tau (τ), the exponential part of the distribution with the most prolonged RTs.
199-1	41030-41037	However	_	
199-2	41037-41038	,	_	
199-3	41039-41041	in	_	
199-4	41042-41050	clinical	_	
199-5	41051-41062	populations	_	
199-6	41063-41066	the	_	
199-7	41067-41079	distribution	_	
199-8	41080-41082	of	_	
199-9	41083-41086	RTs	_	
199-10	41087-41095	deviates	_	
199-11	41096-41100	from	_	
199-12	41101-41104	the	_	
199-13	41105-41113	Gaussian	_	
199-14	41114-41119	model	_	
199-15	41119-41120	,	_	
199-16	41121-41130	therefore	_	
199-17	41130-41131	,	_	
199-18	41132-41134	to	_	
199-19	41135-41145	circumvent	_	
199-20	41146-41150	this	_	
199-21	41151-41161	limitation	_	
199-22	41161-41162	,	_	
199-23	41163-41166	the	_	
199-24	41167-41176	so-called	_	
199-25	41177-41188	ex-Gaussian	_	
199-26	41189-41198	modelling	_	
199-27	41199-41206	methods	_	
199-28	41207-41211	were	_	
199-29	41212-41219	applied	_	
199-30	41219-41220	,	_	
199-31	41221-41230	providing	_	
199-32	41231-41243	quantitative	_	
199-33	41244-41248	data	_	
199-34	41249-41258	regarding	_	
199-35	41259-41262	the	_	
199-36	41263-41273	properties	_	
199-37	41274-41276	of	_	
199-38	41277-41280	RTs	_	
199-39	41281-41293	distribution	_	
199-40	41293-41294	,	_	
199-41	41295-41297	in	_	
199-42	41298-41299	a	_	
199-43	41300-41304	form	_	
199-44	41305-41307	of	_	
199-45	41308-41313	three	_	
199-46	41314-41325	independent	_	
199-47	41326-41336	parameters	_	
199-48	41336-41337	:	_	
199-49	41338-41339	(	_	
199-50	41339-41340	1	_	
199-51	41340-41341	)	_	
199-52	41342-41344	mu	_	
199-53	41345-41346	(	_	
199-54	41346-41347	μ	_	
199-55	41347-41348	)	_	
199-56	41349-41361	representing	_	
199-57	41362-41365	the	_	
199-58	41366-41370	mean	_	
199-59	41371-41373	of	_	
199-60	41374-41377	the	_	
199-61	41378-41384	normal	_	
199-62	41385-41394	component	_	
199-63	41395-41398	and	_	
199-64	41399-41409	reflecting	_	
199-65	41410-41417	average	_	
199-66	41418-41429	performance	_	
199-67	41429-41430	,	_	
199-68	41431-41432	(	_	
199-69	41432-41433	2	_	
199-70	41433-41434	)	_	
199-71	41435-41440	sigma	_	
199-72	41441-41442	(	_	
199-73	41442-41443	σ	_	
199-74	41443-41444	)	_	
199-75	41445-41450	being	_	
199-76	41451-41452	a	_	
199-77	41453-41464	symmetrical	_	
199-78	41465-41473	standard	_	
199-79	41474-41483	deviation	_	
199-80	41484-41486	of	_	
199-81	41487-41490	the	_	
199-82	41491-41497	normal	_	
199-83	41498-41507	component	_	
199-84	41507-41508	,	_	
199-85	41509-41512	and	_	
199-86	41513-41514	(	_	
199-87	41514-41515	3	_	
199-88	41515-41516	)	_	
199-89	41517-41520	tau	_	
199-90	41521-41522	(	_	
199-91	41522-41523	τ	_	
199-92	41523-41524	)	_	
199-93	41524-41525	,	_	
199-94	41526-41529	the	_	
199-95	41530-41541	exponential	_	
199-96	41542-41546	part	_	
199-97	41547-41549	of	_	
199-98	41550-41553	the	_	
199-99	41554-41566	distribution	_	
199-100	41567-41571	with	_	
199-101	41572-41575	the	_	
199-102	41576-41580	most	_	
199-103	41581-41590	prolonged	_	
199-104	41591-41594	RTs	_	
199-105	41594-41595	.	_	

#Text=Typically τ was considered as an indicator of “attentional lapses” or “off-task behaviours” caused by a transient failure of goal maintenance.
200-1	41596-41605	Typically	_	
200-2	41606-41607	τ	_	
200-3	41608-41611	was	_	
200-4	41612-41622	considered	_	
200-5	41623-41625	as	_	
200-6	41626-41628	an	_	
200-7	41629-41638	indicator	_	
200-8	41639-41641	of	_	
200-9	41642-41643	“	_	
200-10	41643-41654	attentional	_	
200-11	41655-41661	lapses	_	
200-12	41661-41662	”	_	
200-13	41663-41665	or	_	
200-14	41666-41667	“	_	
200-15	41667-41675	off-task	_	
200-16	41676-41686	behaviours	_	
200-17	41686-41687	”	_	
200-18	41688-41694	caused	_	
200-19	41695-41697	by	_	
200-20	41698-41699	a	_	
200-21	41700-41709	transient	_	
200-22	41710-41717	failure	_	
200-23	41718-41720	of	_	
200-24	41721-41725	goal	_	
200-25	41726-41737	maintenance	_	
200-26	41737-41738	.	_	

#Text=Therefore, the analysis of the RTs distribution derived from tests of cognitive speed showed to what extent the SZ patients’ test outcome results from an elongation of average RTs, or from being off-task due to dysfunctions of executive control over the ongoing cognitive activity.
201-1	41739-41748	Therefore	_	
201-2	41748-41749	,	_	
201-3	41750-41753	the	_	
201-4	41754-41762	analysis	_	
201-5	41763-41765	of	_	
201-6	41766-41769	the	_	
201-7	41770-41773	RTs	_	
201-8	41774-41786	distribution	_	
201-9	41787-41794	derived	_	
201-10	41795-41799	from	_	
201-11	41800-41805	tests	_	
201-12	41806-41808	of	_	
201-13	41809-41818	cognitive	_	
201-14	41819-41824	speed	_	
201-15	41825-41831	showed	_	
201-16	41832-41834	to	_	
201-17	41835-41839	what	_	
201-18	41840-41846	extent	_	
201-19	41847-41850	the	_	
201-20	41851-41853	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia	
201-21	41854-41862	patients	_	
201-22	41862-41863	’	_	
201-23	41864-41868	test	_	
201-24	41869-41876	outcome	_	
201-25	41877-41884	results	_	
201-26	41885-41889	from	_	
201-27	41890-41892	an	_	
201-28	41893-41903	elongation	_	
201-29	41904-41906	of	_	
201-30	41907-41914	average	_	
201-31	41915-41918	RTs	_	
201-32	41918-41919	,	_	
201-33	41920-41922	or	_	
201-34	41923-41927	from	_	
201-35	41928-41933	being	_	
201-36	41934-41942	off-task	_	
201-37	41943-41946	due	_	
201-38	41947-41949	to	_	
201-39	41950-41962	dysfunctions	_	
201-40	41963-41965	of	_	
201-41	41966-41975	executive	_	
201-42	41976-41983	control	_	
201-43	41984-41988	over	_	
201-44	41989-41992	the	_	
201-45	41993-42000	ongoing	_	
201-46	42001-42010	cognitive	_	
201-47	42011-42019	activity	_	
201-48	42019-42020	.	_	

#Text=The modelling of ex-Gaussian parameters (μ, σ, τ) based the raw RTs derived from processing speed task has been conducted with the MATLAB toolbox “DISTRIB” (version: R2017a, Mathworks Inc.
202-1	42021-42024	The	_	
202-2	42025-42034	modelling	_	
202-3	42035-42037	of	_	
202-4	42038-42049	ex-Gaussian	_	
202-5	42050-42060	parameters	_	
202-6	42061-42062	(	_	
202-7	42062-42063	μ	_	
202-8	42063-42064	,	_	
202-9	42065-42066	σ	_	
202-10	42066-42067	,	_	
202-11	42068-42069	τ	_	
202-12	42069-42070	)	_	
202-13	42071-42076	based	_	
202-14	42077-42080	the	_	
202-15	42081-42084	raw	_	
202-16	42085-42088	RTs	_	
202-17	42089-42096	derived	_	
202-18	42097-42101	from	_	
202-19	42102-42112	processing	_	
202-20	42113-42118	speed	_	
202-21	42119-42123	task	_	
202-22	42124-42127	has	_	
202-23	42128-42132	been	_	
202-24	42133-42142	conducted	_	
202-25	42143-42147	with	_	
202-26	42148-42151	the	_	
202-27	42152-42158	MATLAB	_	
202-28	42159-42166	toolbox	_	
202-29	42167-42168	“	_	
202-30	42168-42175	DISTRIB	_	
202-31	42175-42176	”	_	
202-32	42177-42178	(	_	
202-33	42178-42185	version	_	
202-34	42185-42186	:	_	
202-35	42187-42193	R2017a	_	
202-36	42193-42194	,	_	
202-37	42195-42204	Mathworks	_	
202-38	42205-42208	Inc	_	
202-39	42208-42209	.	_	

#Text=Natick, MA, USA).
203-1	42210-42216	Natick	_	
203-2	42216-42217	,	_	
203-3	42218-42220	MA	_	
203-4	42220-42221	,	_	
203-5	42222-42225	USA	_	
203-6	42225-42226	)	_	
203-7	42226-42227	.	_	

#Text=The data were pre-processed to guarantee the correct export of the results to the MATLAB software and proceeded with an individually customized Excel macro.
204-1	42228-42231	The	_	
204-2	42232-42236	data	_	
204-3	42237-42241	were	_	
204-4	42242-42255	pre-processed	_	
204-5	42256-42258	to	_	
204-6	42259-42268	guarantee	_	
204-7	42269-42272	the	_	
204-8	42273-42280	correct	_	
204-9	42281-42287	export	_	
204-10	42288-42290	of	_	
204-11	42291-42294	the	_	
204-12	42295-42302	results	_	
204-13	42303-42305	to	_	
204-14	42306-42309	the	_	
204-15	42310-42316	MATLAB	_	
204-16	42317-42325	software	_	
204-17	42326-42329	and	_	
204-18	42330-42339	proceeded	_	
204-19	42340-42344	with	_	
204-20	42345-42347	an	_	
204-21	42348-42360	individually	_	
204-22	42361-42371	customized	_	
204-23	42372-42377	Excel	_	
204-24	42378-42383	macro	_	
204-25	42383-42384	.	_	

#Text=All further operations were performed according to the recommendations of Lacouture and Cousineau for extracting the ex-Gaussian parameters from experimental data.
205-1	42385-42388	All	_	
205-2	42389-42396	further	_	
205-3	42397-42407	operations	_	
205-4	42408-42412	were	_	
205-5	42413-42422	performed	_	
205-6	42423-42432	according	_	
205-7	42433-42435	to	_	
205-8	42436-42439	the	_	
205-9	42440-42455	recommendations	_	
205-10	42456-42458	of	_	
205-11	42459-42468	Lacouture	_	
205-12	42469-42472	and	_	
205-13	42473-42482	Cousineau	_	
205-14	42483-42486	for	_	
205-15	42487-42497	extracting	_	
205-16	42498-42501	the	_	
205-17	42502-42513	ex-Gaussian	_	
205-18	42514-42524	parameters	_	
205-19	42525-42529	from	_	
205-20	42530-42542	experimental	_	
205-21	42543-42547	data	_	
205-22	42547-42548	.	_	

#Text=Electroencephalographic recording
#Text=For all subjects, ten minutes of resting state (eyes closed) EEG data was recorded using a 21 scalp location Electro-cap (Electro-Cap International Inc., Ohio, USA) and Ag/AgCl disk electrodes.
206-1	42549-42572	Electroencephalographic	_	
206-2	42573-42582	recording	_	
206-3	42583-42586	For	_	
206-4	42587-42590	all	_	
206-5	42591-42599	subjects	_	
206-6	42599-42600	,	_	
206-7	42601-42604	ten	_	
206-8	42605-42612	minutes	_	
206-9	42613-42615	of	_	
206-10	42616-42623	resting	_	
206-11	42624-42629	state	_	
206-12	42630-42631	(	_	
206-13	42631-42635	eyes	_	
206-14	42636-42642	closed	_	
206-15	42642-42643	)	_	
206-16	42644-42647	EEG	_	
206-17	42648-42652	data	_	
206-18	42653-42656	was	_	
206-19	42657-42665	recorded	_	
206-20	42666-42671	using	_	
206-21	42672-42673	a	_	
206-22	42674-42676	21	_	
206-23	42677-42682	scalp	_	
206-24	42683-42691	location	_	
206-25	42692-42703	Electro-cap	_	
206-26	42704-42705	(	_	
206-27	42705-42716	Electro-Cap	_	
206-28	42717-42730	International	_	
206-29	42731-42734	Inc	_	
206-30	42734-42735	.	_	
206-31	42735-42736	,	_	
206-32	42737-42741	Ohio	_	
206-33	42741-42742	,	_	
206-34	42743-42746	USA	_	
206-35	42746-42747	)	_	
206-36	42748-42751	and	_	
206-37	42752-42754	Ag	_	
206-38	42754-42755	/	_	
206-39	42755-42759	AgCl	_	
206-40	42760-42764	disk	_	
206-41	42765-42775	electrodes	_	
206-42	42775-42776	.	_	

#Text=Electrodes have been deployed according to 10–20 International system (Fp1, Fp2, F3, F4, C3, C4, P3, P4, O1, O2, A1, A2, F7, F8, T3, T4, T5, T6, Fz, Pz, and Cz).
207-1	42777-42787	Electrodes	_	
207-2	42788-42792	have	_	
207-3	42793-42797	been	_	
207-4	42798-42806	deployed	_	
207-5	42807-42816	according	_	
207-6	42817-42819	to	_	
207-7	42820-42822	10	_	
207-8	42822-42823	–	_	
207-9	42823-42825	20	_	
207-10	42826-42839	International	_	
207-11	42840-42846	system	_	
207-12	42847-42848	(	_	
207-13	42848-42851	Fp1	_	
207-14	42851-42852	,	_	
207-15	42853-42856	Fp2	_	
207-16	42856-42857	,	_	
207-17	42858-42860	F3	_	
207-18	42860-42861	,	_	
207-19	42862-42864	F4	_	
207-20	42864-42865	,	_	
207-21	42866-42868	C3	_	
207-22	42868-42869	,	_	
207-23	42870-42872	C4	_	
207-24	42872-42873	,	_	
207-25	42874-42876	P3	_	
207-26	42876-42877	,	_	
207-27	42878-42880	P4	_	
207-28	42880-42881	,	_	
207-29	42882-42884	O1	_	
207-30	42884-42885	,	_	
207-31	42886-42888	O2	_	
207-32	42888-42889	,	_	
207-33	42890-42892	A1	_	
207-34	42892-42893	,	_	
207-35	42894-42896	A2	_	
207-36	42896-42897	,	_	
207-37	42898-42900	F7	_	
207-38	42900-42901	,	_	
207-39	42902-42904	F8	_	
207-40	42904-42905	,	_	
207-41	42906-42908	T3	_	
207-42	42908-42909	,	_	
207-43	42910-42912	T4	_	
207-44	42912-42913	,	_	
207-45	42914-42916	T5	_	
207-46	42916-42917	,	_	
207-47	42918-42920	T6	_	
207-48	42920-42921	,	_	
207-49	42922-42924	Fz	_	
207-50	42924-42925	,	_	
207-51	42926-42928	Pz	_	
207-52	42928-42929	,	_	
207-53	42930-42933	and	_	
207-54	42934-42936	Cz	_	
207-55	42936-42937	)	_	
207-56	42937-42938	.	_	

#Text=The reference electrode was placed at the FCz.
208-1	42939-42942	The	_	
208-2	42943-42952	reference	_	
208-3	42953-42962	electrode	_	
208-4	42963-42966	was	_	
208-5	42967-42973	placed	_	
208-6	42974-42976	at	_	
208-7	42977-42980	the	_	
208-8	42981-42984	FCz	_	
208-9	42984-42985	.	_	

#Text=During the recordings, the impedance value of the electrodes was kept below 5 kΩ with the sampling rate of 500 Hz.
209-1	42986-42992	During	_	
209-2	42993-42996	the	_	
209-3	42997-43007	recordings	_	
209-4	43007-43008	,	_	
209-5	43009-43012	the	_	
209-6	43013-43022	impedance	_	
209-7	43023-43028	value	_	
209-8	43029-43031	of	_	
209-9	43032-43035	the	_	
209-10	43036-43046	electrodes	_	
209-11	43047-43050	was	_	
209-12	43051-43055	kept	_	
209-13	43056-43061	below	_	
209-14	43062-43063	5	_	
209-15	43064-43066	kΩ	_	
209-16	43067-43071	with	_	
209-17	43072-43075	the	_	
209-18	43076-43084	sampling	_	
209-19	43085-43089	rate	_	
209-20	43090-43092	of	_	
209-21	43093-43096	500	_	
209-22	43097-43099	Hz	_	
209-23	43099-43100	.	_	

#Text=The data were band-pass filtered from 0.5 to 70 Hz and, with an active notch filter, set at 50 Hz.
210-1	43101-43104	The	_	
210-2	43105-43109	data	_	
210-3	43110-43114	were	_	
210-4	43115-43124	band-pass	_	
210-5	43125-43133	filtered	_	
210-6	43134-43138	from	_	
210-7	43139-43142	0.5	_	
210-8	43143-43145	to	_	
210-9	43146-43148	70	_	
210-10	43149-43151	Hz	_	
210-11	43152-43155	and	_	
210-12	43155-43156	,	_	
210-13	43157-43161	with	_	
210-14	43162-43164	an	_	
210-15	43165-43171	active	_	
210-16	43172-43177	notch	_	
210-17	43178-43184	filter	_	
210-18	43184-43185	,	_	
210-19	43186-43189	set	_	
210-20	43190-43192	at	_	
210-21	43193-43195	50	_	
210-22	43196-43198	Hz	_	
210-23	43198-43199	.	_	

#Text=After having been recorded, the data were exported to ASCII format.
211-1	43200-43205	After	_	
211-2	43206-43212	having	_	
211-3	43213-43217	been	_	
211-4	43218-43226	recorded	_	
211-5	43226-43227	,	_	
211-6	43228-43231	the	_	
211-7	43232-43236	data	_	
211-8	43237-43241	were	_	
211-9	43242-43250	exported	_	
211-10	43251-43253	to	_	
211-11	43254-43259	ASCII	_	
211-12	43260-43266	format	_	
211-13	43266-43267	.	_	

#Text=For further analysis, the ASCII files were imported to EEGLAB v.13.5.4b1, an open source toolbox for MATLAB (Mathworks, Inc.).
212-1	43268-43271	For	_	
212-2	43272-43279	further	_	
212-3	43280-43288	analysis	_	
212-4	43288-43289	,	_	
212-5	43290-43293	the	_	
212-6	43294-43299	ASCII	_	
212-7	43300-43305	files	_	
212-8	43306-43310	were	_	
212-9	43311-43319	imported	_	
212-10	43320-43322	to	_	
212-11	43323-43329	EEGLAB	_	
212-12	43330-43331	v	_	
212-13	43331-43340	.13.5.4b1	_	
212-14	43340-43341	,	_	
212-15	43342-43344	an	_	
212-16	43345-43349	open	_	
212-17	43350-43356	source	_	
212-18	43357-43364	toolbox	_	
212-19	43365-43368	for	_	
212-20	43369-43375	MATLAB	_	
212-21	43376-43377	(	_	
212-22	43377-43386	Mathworks	_	
212-23	43386-43387	,	_	
212-24	43388-43391	Inc	_	
212-25	43391-43392	.	_	
212-26	43392-43393	)	_	
212-27	43393-43394	.	_	

#Text=Then, each EEG recording was offline filtered with a bandpass Hamming window 0.5–45 Hz filter, and re-referenced offline to the common average reference.
213-1	43395-43399	Then	_	
213-2	43399-43400	,	_	
213-3	43401-43405	each	_	
213-4	43406-43409	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
213-5	43410-43419	recording	_	
213-6	43420-43423	was	_	
213-7	43424-43431	offline	_	
213-8	43432-43440	filtered	_	
213-9	43441-43445	with	_	
213-10	43446-43447	a	_	
213-11	43448-43456	bandpass	_	
213-12	43457-43464	Hamming	_	
213-13	43465-43471	window	_	
213-14	43472-43475	0.5	_	
213-15	43475-43476	–	_	
213-16	43476-43478	45	_	
213-17	43479-43481	Hz	_	
213-18	43482-43488	filter	_	
213-19	43488-43489	,	_	
213-20	43490-43493	and	_	
213-21	43494-43507	re-referenced	_	
213-22	43508-43515	offline	_	
213-23	43516-43518	to	_	
213-24	43519-43522	the	_	
213-25	43523-43529	common	_	
213-26	43530-43537	average	_	
213-27	43538-43547	reference	_	
213-28	43547-43548	.	_	

#Text=The common average reference was calculated with the exclusion of Fp1/2 and A1/2 electrodes because of contamination by EMG artifacts, electrodes A1/2 were excluded from further analysis.
214-1	43549-43552	The	_	
214-2	43553-43559	common	_	
214-3	43560-43567	average	_	
214-4	43568-43577	reference	_	
214-5	43578-43581	was	_	
214-6	43582-43592	calculated	_	
214-7	43593-43597	with	_	
214-8	43598-43601	the	_	
214-9	43602-43611	exclusion	_	
214-10	43612-43614	of	_	
214-11	43615-43618	Fp1	_	
214-12	43618-43619	/	_	
214-13	43619-43620	2	_	
214-14	43621-43624	and	_	
214-15	43625-43627	A1	_	
214-16	43627-43628	/	_	
214-17	43628-43629	2	_	
214-18	43630-43640	electrodes	_	
214-19	43641-43648	because	_	
214-20	43649-43651	of	_	
214-21	43652-43665	contamination	_	
214-22	43666-43668	by	_	
214-23	43669-43672	EMG	_	
214-24	43673-43682	artifacts	_	
214-25	43682-43683	,	_	
214-26	43684-43694	electrodes	_	
214-27	43695-43697	A1	_	
214-28	43697-43698	/	_	
214-29	43698-43699	2	_	
214-30	43700-43704	were	_	
214-31	43705-43713	excluded	_	
214-32	43714-43718	from	_	
214-33	43719-43726	further	_	
214-34	43727-43735	analysis	_	
214-35	43735-43736	.	_	

#Text=The data were then segmented into 75 epochs with the duration of 4096 samples (approximately 8 s) each.
215-1	43737-43740	The	_	
215-2	43741-43745	data	_	
215-3	43746-43750	were	_	
215-4	43751-43755	then	_	
215-5	43756-43765	segmented	_	
215-6	43766-43770	into	_	
215-7	43771-43773	75	_	
215-8	43774-43780	epochs	_	
215-9	43781-43785	with	_	
215-10	43786-43789	the	_	
215-11	43790-43798	duration	_	
215-12	43799-43801	of	_	
215-13	43802-43806	4096	_	
215-14	43807-43814	samples	_	
215-15	43815-43816	(	_	
215-16	43816-43829	approximately	_	
215-17	43830-43831	8	_	
215-18	43832-43833	s	_	
215-19	43833-43834	)	_	
215-20	43835-43839	each	_	
215-21	43839-43840	.	_	

#Text=All of the epochs were visually inspected by a certified clinical neurophysiologist who removed from the analysis epochs contained by artifacts, such as head or muscle movements, jaw clinching and electrode cable movements.
216-1	43841-43844	All	_	
216-2	43845-43847	of	_	
216-3	43848-43851	the	_	
216-4	43852-43858	epochs	_	
216-5	43859-43863	were	_	
216-6	43864-43872	visually	_	
216-7	43873-43882	inspected	_	
216-8	43883-43885	by	_	
216-9	43886-43887	a	_	
216-10	43888-43897	certified	_	
216-11	43898-43906	clinical	_	
216-12	43907-43924	neurophysiologist	_	
216-13	43925-43928	who	_	
216-14	43929-43936	removed	_	
216-15	43937-43941	from	_	
216-16	43942-43945	the	_	
216-17	43946-43954	analysis	_	
216-18	43955-43961	epochs	_	
216-19	43962-43971	contained	_	
216-20	43972-43974	by	_	
216-21	43975-43984	artifacts	_	
216-22	43984-43985	,	_	
216-23	43986-43990	such	_	
216-24	43991-43993	as	_	
216-25	43994-43998	head	_	
216-26	43999-44001	or	_	
216-27	44002-44008	muscle	_	
216-28	44009-44018	movements	_	
216-29	44018-44019	,	_	
216-30	44020-44023	jaw	_	
216-31	44024-44033	clinching	_	
216-32	44034-44037	and	_	
216-33	44038-44047	electrode	_	
216-34	44048-44053	cable	_	
216-35	44054-44063	movements	_	
216-36	44063-44064	.	_	

#Text=Finally, for each participant, thirty artifacts free epochs of 4096 samples were selected.
217-1	44065-44072	Finally	_	
217-2	44072-44073	,	_	
217-3	44074-44077	for	_	
217-4	44078-44082	each	_	
217-5	44083-44094	participant	_	
217-6	44094-44095	,	_	
217-7	44096-44102	thirty	_	
217-8	44103-44112	artifacts	_	
217-9	44113-44117	free	_	
217-10	44118-44124	epochs	_	
217-11	44125-44127	of	_	
217-12	44128-44132	4096	_	
217-13	44133-44140	samples	_	
217-14	44141-44145	were	_	
217-15	44146-44154	selected	_	
217-16	44154-44155	.	_	

#Text=As the number of the selected epochs across participants should be equal, and to avoid excluding additional subjects from the analysis, due to the number of artifacts in the recordings, we chose the number of 30 artifacts free epochs as the safe value for further analysis.
218-1	44156-44158	As	_	
218-2	44159-44162	the	_	
218-3	44163-44169	number	_	
218-4	44170-44172	of	_	
218-5	44173-44176	the	_	
218-6	44177-44185	selected	_	
218-7	44186-44192	epochs	_	
218-8	44193-44199	across	_	
218-9	44200-44212	participants	_	
218-10	44213-44219	should	_	
218-11	44220-44222	be	_	
218-12	44223-44228	equal	_	
218-13	44228-44229	,	_	
218-14	44230-44233	and	_	
218-15	44234-44236	to	_	
218-16	44237-44242	avoid	_	
218-17	44243-44252	excluding	_	
218-18	44253-44263	additional	_	
218-19	44264-44272	subjects	_	
218-20	44273-44277	from	_	
218-21	44278-44281	the	_	
218-22	44282-44290	analysis	_	
218-23	44290-44291	,	_	
218-24	44292-44295	due	_	
218-25	44296-44298	to	_	
218-26	44299-44302	the	_	
218-27	44303-44309	number	_	
218-28	44310-44312	of	_	
218-29	44313-44322	artifacts	_	
218-30	44323-44325	in	_	
218-31	44326-44329	the	_	
218-32	44330-44340	recordings	_	
218-33	44340-44341	,	_	
218-34	44342-44344	we	_	
218-35	44345-44350	chose	_	
218-36	44351-44354	the	_	
218-37	44355-44361	number	_	
218-38	44362-44364	of	_	
218-39	44365-44367	30	_	
218-40	44368-44377	artifacts	_	
218-41	44378-44382	free	_	
218-42	44383-44389	epochs	_	
218-43	44390-44392	as	_	
218-44	44393-44396	the	_	
218-45	44397-44401	safe	_	
218-46	44402-44407	value	_	
218-47	44408-44411	for	_	
218-48	44412-44419	further	_	
218-49	44420-44428	analysis	_	
218-50	44428-44429	.	_	

#Text=In the next step, the epochs were band-pass filtered into the frequencies: delta (0.5–4 Hz), theta (4–8 Hz), lower alpha (8–10 Hz), upper alpha (10–12 Hz), beta (13–30 Hz) and low gamma (30–48 Hz).
219-1	44430-44432	In	_	
219-2	44433-44436	the	_	
219-3	44437-44441	next	_	
219-4	44442-44446	step	_	
219-5	44446-44447	,	_	
219-6	44448-44451	the	_	
219-7	44452-44458	epochs	_	
219-8	44459-44463	were	_	
219-9	44464-44473	band-pass	_	
219-10	44474-44482	filtered	_	
219-11	44483-44487	into	_	
219-12	44488-44491	the	_	
219-13	44492-44503	frequencies	_	
219-14	44503-44504	:	_	
219-15	44505-44510	delta	_	
219-16	44511-44512	(	_	
219-17	44512-44515	0.5	_	
219-18	44515-44516	–	_	
219-19	44516-44517	4	_	
219-20	44518-44520	Hz	_	
219-21	44520-44521	)	_	
219-22	44521-44522	,	_	
219-23	44523-44528	theta	_	
219-24	44529-44530	(	_	
219-25	44530-44531	4	_	
219-26	44531-44532	–	_	
219-27	44532-44533	8	_	
219-28	44534-44536	Hz	_	
219-29	44536-44537	)	_	
219-30	44537-44538	,	_	
219-31	44539-44544	lower	_	
219-32	44545-44550	alpha	_	
219-33	44551-44552	(	_	
219-34	44552-44553	8	_	
219-35	44553-44554	–	_	
219-36	44554-44556	10	_	
219-37	44557-44559	Hz	_	
219-38	44559-44560	)	_	
219-39	44560-44561	,	_	
219-40	44562-44567	upper	_	
219-41	44568-44573	alpha	_	
219-42	44574-44575	(	_	
219-43	44575-44577	10	_	
219-44	44577-44578	–	_	
219-45	44578-44580	12	_	
219-46	44581-44583	Hz	_	
219-47	44583-44584	)	_	
219-48	44584-44585	,	_	
219-49	44586-44590	beta	_	
219-50	44591-44592	(	_	
219-51	44592-44594	13	_	
219-52	44594-44595	–	_	
219-53	44595-44597	30	_	
219-54	44598-44600	Hz	_	
219-55	44600-44601	)	_	
219-56	44602-44605	and	_	
219-57	44606-44609	low	_	
219-58	44610-44615	gamma	_	
219-59	44616-44617	(	_	
219-60	44617-44619	30	_	
219-61	44619-44620	–	_	
219-62	44620-44622	48	_	
219-63	44623-44625	Hz	_	
219-64	44625-44626	)	_	
219-65	44626-44627	.	_	

#Text=Due to the fact that different frequency ranges in an alpha band are involved in different cognitive processes, the alpha band was divided into two frequency bands.
220-1	44628-44631	Due	_	
220-2	44632-44634	to	_	
220-3	44635-44638	the	_	
220-4	44639-44643	fact	_	
220-5	44644-44648	that	_	
220-6	44649-44658	different	_	
220-7	44659-44668	frequency	_	
220-8	44669-44675	ranges	_	
220-9	44676-44678	in	_	
220-10	44679-44681	an	_	
220-11	44682-44687	alpha	_	
220-12	44688-44692	band	_	
220-13	44693-44696	are	_	
220-14	44697-44705	involved	_	
220-15	44706-44708	in	_	
220-16	44709-44718	different	_	
220-17	44719-44728	cognitive	_	
220-18	44729-44738	processes	_	
220-19	44738-44739	,	_	
220-20	44740-44743	the	_	
220-21	44744-44749	alpha	_	
220-22	44750-44754	band	_	
220-23	44755-44758	was	_	
220-24	44759-44766	divided	_	
220-25	44767-44771	into	_	
220-26	44772-44775	two	_	
220-27	44776-44785	frequency	_	
220-28	44786-44791	bands	_	
220-29	44791-44792	.	_	

#Text=The activity in gamma frequency was also assessed due to its crucial role in electroencephalographic studies in schizophrenia.
221-1	44793-44796	The	_	
221-2	44797-44805	activity	_	
221-3	44806-44808	in	_	
221-4	44809-44814	gamma	_	
221-5	44815-44824	frequency	_	
221-6	44825-44828	was	_	
221-7	44829-44833	also	_	
221-8	44834-44842	assessed	_	
221-9	44843-44846	due	_	
221-10	44847-44849	to	_	
221-11	44850-44853	its	_	
221-12	44854-44861	crucial	_	
221-13	44862-44866	role	_	
221-14	44867-44869	in	_	
221-15	44870-44893	electroencephalographic	_	
221-16	44894-44901	studies	_	
221-17	44902-44904	in	_	
221-18	44905-44918	schizophrenia	_	
221-19	44918-44919	.	_	

#Text=For the functional connectivity and MST analysis, all epochs in ASCII format were exported to Brainwave 0.9.152.4.1 (available free at http://home.kpn.nl/stam7883/brainwave.html).
222-1	44920-44923	For	_	
222-2	44924-44927	the	_	
222-3	44928-44938	functional	_	
222-4	44939-44951	connectivity	_	
222-5	44952-44955	and	_	
222-6	44956-44959	MST	_	
222-7	44960-44968	analysis	_	
222-8	44968-44969	,	_	
222-9	44970-44973	all	_	
222-10	44974-44980	epochs	_	
222-11	44981-44983	in	_	
222-12	44984-44989	ASCII	_	
222-13	44990-44996	format	_	
222-14	44997-45001	were	_	
222-15	45002-45010	exported	_	
222-16	45011-45013	to	_	
222-17	45014-45023	Brainwave	_	
222-18	45024-45035	0.9.152.4.1	_	
222-19	45036-45037	(	_	
222-20	45037-45046	available	_	
222-21	45047-45051	free	_	
222-22	45052-45054	at	_	
222-23	45055-45059	http	_	
222-24	45059-45060	:	_	
222-25	45060-45061	/	_	
222-26	45061-45062	/	_	
222-27	45062-45073	home.kpn.nl	_	
222-28	45073-45074	/	_	
222-29	45074-45082	stam7883	_	
222-30	45082-45083	/	_	
222-31	45083-45097	brainwave.html	_	
222-32	45097-45098	)	_	
222-33	45098-45099	.	_	

#Text=The EEG recordings took place around noon, between 10 am and 4 pm, in a quiet, well-lit room.
223-1	45100-45103	The	_	
223-2	45104-45107	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram	
223-3	45108-45118	recordings	_	
223-4	45119-45123	took	_	
223-5	45124-45129	place	_	
223-6	45130-45136	around	_	
223-7	45137-45141	noon	_	
223-8	45141-45142	,	_	
223-9	45143-45150	between	_	
223-10	45151-45153	10	_	
223-11	45154-45156	am	_	
223-12	45157-45160	and	_	
223-13	45161-45162	4	_	
223-14	45163-45165	pm	_	
223-15	45165-45166	,	_	
223-16	45167-45169	in	_	
223-17	45170-45171	a	_	
223-18	45172-45177	quiet	_	
223-19	45177-45178	,	_	
223-20	45179-45187	well-lit	_	
223-21	45188-45192	room	_	
223-22	45192-45193	.	_	

#Text=Smokers were asked to refrain from smoking at least an hour before the neurophysiological examination.
224-1	45194-45201	Smokers	_	
224-2	45202-45206	were	_	
224-3	45207-45212	asked	_	
224-4	45213-45215	to	_	
224-5	45216-45223	refrain	_	
224-6	45224-45228	from	_	
224-7	45229-45236	smoking	_	
224-8	45237-45239	at	_	
224-9	45240-45245	least	_	
224-10	45246-45248	an	_	
224-11	45249-45253	hour	_	
224-12	45254-45260	before	_	
224-13	45261-45264	the	_	
224-14	45265-45283	neurophysiological	_	
224-15	45284-45295	examination	_	
224-16	45295-45296	.	_	

#Text=Functional connectivity
#Text=To assess the functional connectivity strength for each frequency epoch separately and also for all possible pairs of electrodes, the phase lag index (PLI) has been applied.
225-1	45297-45307	Functional	_	
225-2	45308-45320	connectivity	_	
225-3	45321-45323	To	_	
225-4	45324-45330	assess	_	
225-5	45331-45334	the	_	
225-6	45335-45345	functional	_	
225-7	45346-45358	connectivity	_	
225-8	45359-45367	strength	_	
225-9	45368-45371	for	_	
225-10	45372-45376	each	_	
225-11	45377-45386	frequency	_	
225-12	45387-45392	epoch	_	
225-13	45393-45403	separately	_	
225-14	45404-45407	and	_	
225-15	45408-45412	also	_	
225-16	45413-45416	for	_	
225-17	45417-45420	all	_	
225-18	45421-45429	possible	_	
225-19	45430-45435	pairs	_	
225-20	45436-45438	of	_	
225-21	45439-45449	electrodes	_	
225-22	45449-45450	,	_	
225-23	45451-45454	the	_	
225-24	45455-45460	phase	_	
225-25	45461-45464	lag	_	
225-26	45465-45470	index	_	
225-27	45471-45472	(	_	
225-28	45472-45475	PLI	_	
225-29	45475-45476	)	_	
225-30	45477-45480	has	_	
225-31	45481-45485	been	_	
225-32	45486-45493	applied	_	
225-33	45493-45494	.	_	

#Text=PLI provides a measure of phase synchronization based on the asymmetry of the distribution of instantaneous phase differences between two time series.
226-1	45495-45498	PLI	_	
226-2	45499-45507	provides	_	
226-3	45508-45509	a	_	
226-4	45510-45517	measure	_	
226-5	45518-45520	of	_	
226-6	45521-45526	phase	_	
226-7	45527-45542	synchronization	_	
226-8	45543-45548	based	_	
226-9	45549-45551	on	_	
226-10	45552-45555	the	_	
226-11	45556-45565	asymmetry	_	
226-12	45566-45568	of	_	
226-13	45569-45572	the	_	
226-14	45573-45585	distribution	_	
226-15	45586-45588	of	_	
226-16	45589-45602	instantaneous	_	
226-17	45603-45608	phase	_	
226-18	45609-45620	differences	_	
226-19	45621-45628	between	_	
226-20	45629-45632	two	_	
226-21	45633-45637	time	_	
226-22	45638-45644	series	_	
226-23	45644-45645	.	_	

#Text=The instantaneous phase differences were computed using the analytical signal concept and the Hilbert transform.
227-1	45646-45649	The	_	
227-2	45650-45663	instantaneous	_	
227-3	45664-45669	phase	_	
227-4	45670-45681	differences	_	
227-5	45682-45686	were	_	
227-6	45687-45695	computed	_	
227-7	45696-45701	using	_	
227-8	45702-45705	the	_	
227-9	45706-45716	analytical	_	
227-10	45717-45723	signal	_	
227-11	45724-45731	concept	_	
227-12	45732-45735	and	_	
227-13	45736-45739	the	_	
227-14	45740-45747	Hilbert	_	
227-15	45748-45757	transform	_	
227-16	45757-45758	.	_	

#Text=Owing to the fact that zero-lag synchronization has been removed from the analysis, the PLI outcome is less affected by the influence of common source in comparison to i.e. synchronization likelihood or phase coherence.
228-1	45759-45764	Owing	_	
228-2	45765-45767	to	_	
228-3	45768-45771	the	_	
228-4	45772-45776	fact	_	
228-5	45777-45781	that	_	
228-6	45782-45790	zero-lag	_	
228-7	45791-45806	synchronization	_	
228-8	45807-45810	has	_	
228-9	45811-45815	been	_	
228-10	45816-45823	removed	_	
228-11	45824-45828	from	_	
228-12	45829-45832	the	_	
228-13	45833-45841	analysis	_	
228-14	45841-45842	,	_	
228-15	45843-45846	the	_	
228-16	45847-45850	PLI	_	
228-17	45851-45858	outcome	_	
228-18	45859-45861	is	_	
228-19	45862-45866	less	_	
228-20	45867-45875	affected	_	
228-21	45876-45878	by	_	
228-22	45879-45882	the	_	
228-23	45883-45892	influence	_	
228-24	45893-45895	of	_	
228-25	45896-45902	common	_	
228-26	45903-45909	source	_	
228-27	45910-45912	in	_	
228-28	45913-45923	comparison	_	
228-29	45924-45926	to	_	
228-30	45927-45930	i.e	_	
228-31	45930-45931	.	_	
228-32	45932-45947	synchronization	_	
228-33	45948-45958	likelihood	_	
228-34	45959-45961	or	_	
228-35	45962-45967	phase	_	
228-36	45968-45977	coherence	_	
228-37	45977-45978	.	_	

#Text=Reconstruction of the neural networks: a Minimum Spanning Tree
#Text=a
#Text=The minimum spanning tree is built on the basis of Kruskal’s algorithm.
229-1	45979-45993	Reconstruction	_	
229-2	45994-45996	of	_	
229-3	45997-46000	the	_	
229-4	46001-46007	neural	_	
229-5	46008-46016	networks	_	
229-6	46016-46017	:	_	
229-7	46018-46019	a	_	
229-8	46020-46027	Minimum	_	
229-9	46028-46036	Spanning	_	
229-10	46037-46041	Tree	_	
229-11	46042-46043	a	_	
229-12	46044-46047	The	_	
229-13	46048-46055	minimum	_	
229-14	46056-46064	spanning	_	
229-15	46065-46069	tree	_	
229-16	46070-46072	is	_	
229-17	46073-46078	built	_	
229-18	46079-46081	on	_	
229-19	46082-46085	the	_	
229-20	46086-46091	basis	_	
229-21	46092-46094	of	_	
229-22	46095-46102	Kruskal	_	
229-23	46102-46103	’	_	
229-24	46103-46104	s	_	
229-25	46105-46114	algorithm	_	
229-26	46114-46115	.	_	

#Text=It starts by ordering the weight of all edges and then the stronger edges, ie. with highest PLI, became connected, however, excluding those connections that form loops.
230-1	46116-46118	It	_	
230-2	46119-46125	starts	_	
230-3	46126-46128	by	_	
230-4	46129-46137	ordering	_	
230-5	46138-46141	the	_	
230-6	46142-46148	weight	_	
230-7	46149-46151	of	_	
230-8	46152-46155	all	_	
230-9	46156-46161	edges	_	
230-10	46162-46165	and	_	
230-11	46166-46170	then	_	
230-12	46171-46174	the	_	
230-13	46175-46183	stronger	_	
230-14	46184-46189	edges	_	
230-15	46189-46190	,	_	
230-16	46191-46193	ie	_	
230-17	46193-46194	.	_	
230-18	46195-46199	with	_	
230-19	46200-46207	highest	_	
230-20	46208-46211	PLI	_	
230-21	46211-46212	,	_	
230-22	46213-46219	became	_	
230-23	46220-46229	connected	_	
230-24	46229-46230	,	_	
230-25	46231-46238	however	_	
230-26	46238-46239	,	_	
230-27	46240-46249	excluding	_	
230-28	46250-46255	those	_	
230-29	46256-46267	connections	_	
230-30	46268-46272	that	_	
230-31	46273-46277	form	_	
230-32	46278-46283	loops	_	
230-33	46283-46284	.	_	

#Text=These steps are performed as many times as possible and at the end, the final tree contains 19 nodes and 18 edges, considering the number of all electrodes used in our EEG recording.
231-1	46285-46290	These	_	
231-2	46291-46296	steps	_	
231-3	46297-46300	are	_	
231-4	46301-46310	performed	_	
231-5	46311-46313	as	_	
231-6	46314-46318	many	_	
231-7	46319-46324	times	_	
231-8	46325-46327	as	_	
231-9	46328-46336	possible	_	
231-10	46337-46340	and	_	
231-11	46341-46343	at	_	
231-12	46344-46347	the	_	
231-13	46348-46351	end	_	
231-14	46351-46352	,	_	
231-15	46353-46356	the	_	
231-16	46357-46362	final	_	
231-17	46363-46367	tree	_	
231-18	46368-46376	contains	_	
231-19	46377-46379	19	_	
231-20	46380-46385	nodes	_	
231-21	46386-46389	and	_	
231-22	46390-46392	18	_	
231-23	46393-46398	edges	_	
231-24	46398-46399	,	_	
231-25	46400-46411	considering	_	
231-26	46412-46415	the	_	
231-27	46416-46422	number	_	
231-28	46423-46425	of	_	
231-29	46426-46429	all	_	
231-30	46430-46440	electrodes	_	
231-31	46441-46445	used	_	
231-32	46446-46448	in	_	
231-33	46449-46452	our	_	
231-34	46453-46456	EEG	_	
231-35	46457-46466	recording	_	
231-36	46466-46467	.	_	

#Text=The MST metrics were calculated based on all PLI matrix, in every frequency band, separately.
232-1	46468-46471	The	_	
232-2	46472-46475	MST	_	
232-3	46476-46483	metrics	_	
232-4	46484-46488	were	_	
232-5	46489-46499	calculated	_	
232-6	46500-46505	based	_	
232-7	46506-46508	on	_	
232-8	46509-46512	all	_	
232-9	46513-46516	PLI	_	
232-10	46517-46523	matrix	_	
232-11	46523-46524	,	_	
232-12	46525-46527	in	_	
232-13	46528-46533	every	_	
232-14	46534-46543	frequency	_	
232-15	46544-46548	band	_	
232-16	46548-46549	,	_	
232-17	46550-46560	separately	_	
232-18	46560-46561	.	_	

#Text=The MST enables computation of many parameters, however, they are strongly correlated and, therefore, redundant.
233-1	46562-46565	The	_	
233-2	46566-46569	MST	_	
233-3	46570-46577	enables	_	
233-4	46578-46589	computation	_	
233-5	46590-46592	of	_	
233-6	46593-46597	many	_	
233-7	46598-46608	parameters	_	
233-8	46608-46609	,	_	
233-9	46610-46617	however	_	
233-10	46617-46618	,	_	
233-11	46619-46623	they	_	
233-12	46624-46627	are	_	
233-13	46628-46636	strongly	_	
233-14	46637-46647	correlated	_	
233-15	46648-46651	and	_	
233-16	46651-46652	,	_	
233-17	46653-46662	therefore	_	
233-18	46662-46663	,	_	
233-19	46664-46673	redundant	_	
233-20	46673-46674	.	_	

#Text=The limitation of the number of MST metrics included in statistical analysis was also guided by an attempt to avoid type 1 error.
234-1	46675-46678	The	_	
234-2	46679-46689	limitation	_	
234-3	46690-46692	of	_	
234-4	46693-46696	the	_	
234-5	46697-46703	number	_	
234-6	46704-46706	of	_	
234-7	46707-46710	MST	_	
234-8	46711-46718	metrics	_	
234-9	46719-46727	included	_	
234-10	46728-46730	in	_	
234-11	46731-46742	statistical	_	
234-12	46743-46751	analysis	_	
234-13	46752-46755	was	_	
234-14	46756-46760	also	_	
234-15	46761-46767	guided	_	
234-16	46768-46770	by	_	
234-17	46771-46773	an	_	
234-18	46774-46781	attempt	_	
234-19	46782-46784	to	_	
234-20	46785-46790	avoid	_	
234-21	46791-46795	type	_	
234-22	46796-46797	1	_	
234-23	46798-46803	error	_	
234-24	46803-46804	.	_	

#Text=According to van Diessen et al. (2016), MST diameter and leaf number or leaf fraction, are two most straightforward global metrics informative of the MST network topology.
235-1	46805-46814	According	_	
235-2	46815-46817	to	_	
235-3	46818-46821	van	_	
235-4	46822-46829	Diessen	_	
235-5	46830-46832	et	_	
235-6	46833-46835	al	_	
235-7	46835-46836	.	_	
235-8	46837-46838	(	_	
235-9	46838-46842	2016	_	
235-10	46842-46843	)	_	
235-11	46843-46844	,	_	
235-12	46845-46848	MST	_	
235-13	46849-46857	diameter	_	
235-14	46858-46861	and	_	
235-15	46862-46866	leaf	_	
235-16	46867-46873	number	_	
235-17	46874-46876	or	_	
235-18	46877-46881	leaf	_	
235-19	46882-46890	fraction	_	
235-20	46890-46891	,	_	
235-21	46892-46895	are	_	
235-22	46896-46899	two	_	
235-23	46900-46904	most	_	
235-24	46905-46920	straightforward	_	
235-25	46921-46927	global	_	
235-26	46928-46935	metrics	_	
235-27	46936-46947	informative	_	
235-28	46948-46950	of	_	
235-29	46951-46954	the	_	
235-30	46955-46958	MST	_	
235-31	46959-46966	network	_	
235-32	46967-46975	topology	_	
235-33	46975-46976	.	_	

#Text=Moreover, they are sufficient to classify the networks as more line-like, in which case the diameter increases and the leaf number decreases, or star-like, with high leaf number and low diameter.
236-1	46977-46985	Moreover	_	
236-2	46985-46986	,	_	
236-3	46987-46991	they	_	
236-4	46992-46995	are	_	
236-5	46996-47006	sufficient	_	
236-6	47007-47009	to	_	
236-7	47010-47018	classify	_	
236-8	47019-47022	the	_	
236-9	47023-47031	networks	_	
236-10	47032-47034	as	_	
236-11	47035-47039	more	_	
236-12	47040-47049	line-like	_	
236-13	47049-47050	,	_	
236-14	47051-47053	in	_	
236-15	47054-47059	which	_	
236-16	47060-47064	case	_	
236-17	47065-47068	the	_	
236-18	47069-47077	diameter	_	
236-19	47078-47087	increases	_	
236-20	47088-47091	and	_	
236-21	47092-47095	the	_	
236-22	47096-47100	leaf	_	
236-23	47101-47107	number	_	
236-24	47108-47117	decreases	_	
236-25	47117-47118	,	_	
236-26	47119-47121	or	_	
236-27	47122-47131	star-like	_	
236-28	47131-47132	,	_	
236-29	47133-47137	with	_	
236-30	47138-47142	high	_	
236-31	47143-47147	leaf	_	
236-32	47148-47154	number	_	
236-33	47155-47158	and	_	
236-34	47159-47162	low	_	
236-35	47163-47171	diameter	_	
236-36	47171-47172	.	_	

#Text=A degree parameter is defined as the number of links connected to a node, calculated for each node separately.
237-1	47173-47174	A	_	
237-2	47175-47181	degree	_	
237-3	47182-47191	parameter	_	
237-4	47192-47194	is	_	
237-5	47195-47202	defined	_	
237-6	47203-47205	as	_	
237-7	47206-47209	the	_	
237-8	47210-47216	number	_	
237-9	47217-47219	of	_	
237-10	47220-47225	links	_	
237-11	47226-47235	connected	_	
237-12	47236-47238	to	_	
237-13	47239-47240	a	_	
237-14	47241-47245	node	_	
237-15	47245-47246	,	_	
237-16	47247-47257	calculated	_	
237-17	47258-47261	for	_	
237-18	47262-47266	each	_	
237-19	47267-47271	node	_	
237-20	47272-47282	separately	_	
237-21	47282-47283	.	_	

#Text=In this study a maximal degree value was computed to characterize the degree of the whole tree.
238-1	47284-47286	In	_	
238-2	47287-47291	this	_	
238-3	47292-47297	study	_	
238-4	47298-47299	a	_	
238-5	47300-47307	maximal	_	
238-6	47308-47314	degree	_	
238-7	47315-47320	value	_	
238-8	47321-47324	was	_	
238-9	47325-47333	computed	_	
238-10	47334-47336	to	_	
238-11	47337-47349	characterize	_	
238-12	47350-47353	the	_	
238-13	47354-47360	degree	_	
238-14	47361-47363	of	_	
238-15	47364-47367	the	_	
238-16	47368-47373	whole	_	
238-17	47374-47378	tree	_	
238-18	47378-47379	.	_	

#Text=A leaf fraction refers to the number of nodes on the tree with degree = 1, it can be defined as Lf = L/m, where L is the leaf number.
239-1	47380-47381	A	_	
239-2	47382-47386	leaf	_	
239-3	47387-47395	fraction	_	
239-4	47396-47402	refers	_	
239-5	47403-47405	to	_	
239-6	47406-47409	the	_	
239-7	47410-47416	number	_	
239-8	47417-47419	of	_	
239-9	47420-47425	nodes	_	
239-10	47426-47428	on	_	
239-11	47429-47432	the	_	
239-12	47433-47437	tree	_	
239-13	47438-47442	with	_	
239-14	47443-47449	degree	_	
239-15	47450-47451	=	_	
239-16	47452-47453	1	_	
239-17	47453-47454	,	_	
239-18	47455-47457	it	_	
239-19	47458-47461	can	_	
239-20	47462-47464	be	_	
239-21	47465-47472	defined	_	
239-22	47473-47475	as	_	
239-23	47476-47478	Lf	_	
239-24	47479-47480	=	_	
239-25	47481-47482	L	_	
239-26	47482-47483	/	_	
239-27	47483-47484	m	_	
239-28	47484-47485	,	_	
239-29	47486-47491	where	_	
239-30	47492-47493	L	_	
239-31	47494-47496	is	_	
239-32	47497-47500	the	_	
239-33	47501-47505	leaf	_	
239-34	47506-47512	number	_	
239-35	47512-47513	.	_	

#Text=The leaf number ranges from 2 (typical of a line-like topology) and a maximum value m = N-1 (a star-like topology).
240-1	47514-47517	The	_	
240-2	47518-47522	leaf	_	
240-3	47523-47529	number	_	
240-4	47530-47536	ranges	_	
240-5	47537-47541	from	_	
240-6	47542-47543	2	_	
240-7	47544-47545	(	_	
240-8	47545-47552	typical	_	
240-9	47553-47555	of	_	
240-10	47556-47557	a	_	
240-11	47558-47567	line-like	_	
240-12	47568-47576	topology	_	
240-13	47576-47577	)	_	
240-14	47578-47581	and	_	
240-15	47582-47583	a	_	
240-16	47584-47591	maximum	_	
240-17	47592-47597	value	_	
240-18	47598-47599	m	_	
240-19	47600-47601	=	_	
240-20	47602-47603	N	_	
240-21	47603-47604	-	_	
240-22	47604-47605	1	_	
240-23	47606-47607	(	_	
240-24	47607-47608	a	_	
240-25	47609-47618	star-like	_	
240-26	47619-47627	topology	_	
240-27	47627-47628	)	_	
240-28	47628-47629	.	_	

#Text=The leaf number is associated with the tree diameter (d), defined as the largest distance between any two nodes.
241-1	47630-47633	The	_	
241-2	47634-47638	leaf	_	
241-3	47639-47645	number	_	
241-4	47646-47648	is	_	
241-5	47649-47659	associated	_	
241-6	47660-47664	with	_	
241-7	47665-47668	the	_	
241-8	47669-47673	tree	_	
241-9	47674-47682	diameter	_	
241-10	47683-47684	(	_	
241-11	47684-47685	d	_	
241-12	47685-47686	)	_	
241-13	47686-47687	,	_	
241-14	47688-47695	defined	_	
241-15	47696-47698	as	_	
241-16	47699-47702	the	_	
241-17	47703-47710	largest	_	
241-18	47711-47719	distance	_	
241-19	47720-47727	between	_	
241-20	47728-47731	any	_	
241-21	47732-47735	two	_	
241-22	47736-47741	nodes	_	
241-23	47741-47742	.	_	

#Text=The upper limit of the diameter is defined as dmax = m-L + 2, so, the largest possible diameter decreases when the leaf number increases.
242-1	47743-47746	The	_	
242-2	47747-47752	upper	_	
242-3	47753-47758	limit	_	
242-4	47759-47761	of	_	
242-5	47762-47765	the	_	
242-6	47766-47774	diameter	_	
242-7	47775-47777	is	_	
242-8	47778-47785	defined	_	
242-9	47786-47788	as	_	
242-10	47789-47793	dmax	_	
242-11	47794-47795	=	_	
242-12	47796-47799	m-L	_	
242-13	47800-47801	+	_	
242-14	47802-47803	2	_	
242-15	47803-47804	,	_	
242-16	47805-47807	so	_	
242-17	47807-47808	,	_	
242-18	47809-47812	the	_	
242-19	47813-47820	largest	_	
242-20	47821-47829	possible	_	
242-21	47830-47838	diameter	_	
242-22	47839-47848	decreases	_	
242-23	47849-47853	when	_	
242-24	47854-47857	the	_	
242-25	47858-47862	leaf	_	
242-26	47863-47869	number	_	
242-27	47870-47879	increases	_	
242-28	47879-47880	.	_	

#Text=To compare the groups with regard to network hub measure, the betweenness centrality (BC) was also computed, defined as the number of the shortest paths between any pair of nodes i and j in the network passing through  node u, divided by the total number of paths between i and j.
243-1	47881-47883	To	_	
243-2	47884-47891	compare	_	
243-3	47892-47895	the	_	
243-4	47896-47902	groups	_	
243-5	47903-47907	with	_	
243-6	47908-47914	regard	_	
243-7	47915-47917	to	_	
243-8	47918-47925	network	_	
243-9	47926-47929	hub	_	
243-10	47930-47937	measure	_	
243-11	47937-47938	,	_	
243-12	47939-47942	the	_	
243-13	47943-47954	betweenness	_	
243-14	47955-47965	centrality	_	
243-15	47966-47967	(	_	
243-16	47967-47969	BC	_	
243-17	47969-47970	)	_	
243-18	47971-47974	was	_	
243-19	47975-47979	also	_	
243-20	47980-47988	computed	_	
243-21	47988-47989	,	_	
243-22	47990-47997	defined	_	
243-23	47998-48000	as	_	
243-24	48001-48004	the	_	
243-25	48005-48011	number	_	
243-26	48012-48014	of	_	
243-27	48015-48018	the	_	
243-28	48019-48027	shortest	_	
243-29	48028-48033	paths	_	
243-30	48034-48041	between	_	
243-31	48042-48045	any	_	
243-32	48046-48050	pair	_	
243-33	48051-48053	of	_	
243-34	48054-48059	nodes	_	
243-35	48060-48061	i	_	
243-36	48062-48065	and	_	
243-37	48066-48067	j	_	
243-38	48068-48070	in	_	
243-39	48071-48074	the	_	
243-40	48075-48082	network	_	
243-41	48083-48090	passing	_	
243-42	48091-48098	through	_	
243-43	48100-48104	node	_	
243-44	48105-48106	u	_	
243-45	48106-48107	,	_	
243-46	48108-48115	divided	_	
243-47	48116-48118	by	_	
243-48	48119-48122	the	_	
243-49	48123-48128	total	_	
243-50	48129-48135	number	_	
243-51	48136-48138	of	_	
243-52	48139-48144	paths	_	
243-53	48145-48152	between	_	
243-54	48153-48154	i	_	
243-55	48155-48158	and	_	
243-56	48159-48160	j	_	
243-57	48160-48161	.	_	

#Text=BC values range from 0 for the leaf node and 1 for the central node in a star-like network where it has the highest load.
244-1	48162-48164	BC	_	
244-2	48165-48171	values	_	
244-3	48172-48177	range	_	
244-4	48178-48182	from	_	
244-5	48183-48184	0	_	
244-6	48185-48188	for	_	
244-7	48189-48192	the	_	
244-8	48193-48197	leaf	_	
244-9	48198-48202	node	_	
244-10	48203-48206	and	_	
244-11	48207-48208	1	_	
244-12	48209-48212	for	_	
244-13	48213-48216	the	_	
244-14	48217-48224	central	_	
244-15	48225-48229	node	_	
244-16	48230-48232	in	_	
244-17	48233-48234	a	_	
244-18	48235-48244	star-like	_	
244-19	48245-48252	network	_	
244-20	48253-48258	where	_	
244-21	48259-48261	it	_	
244-22	48262-48265	has	_	
244-23	48266-48269	the	_	
244-24	48270-48277	highest	_	
244-25	48278-48282	load	_	
244-26	48282-48283	.	_	

#Text=Additional parameter has been provided, a maximal betweenness centrality (BCmax), an indicator of the hub’s strength, which is representative for the node(s) with the highest BC in the tree.
245-1	48284-48294	Additional	_	
245-2	48295-48304	parameter	_	
245-3	48305-48308	has	_	
245-4	48309-48313	been	_	
245-5	48314-48322	provided	_	
245-6	48322-48323	,	_	
245-7	48324-48325	a	_	
245-8	48326-48333	maximal	_	
245-9	48334-48345	betweenness	_	
245-10	48346-48356	centrality	_	
245-11	48357-48358	(	_	
245-12	48358-48363	BCmax	_	
245-13	48363-48364	)	_	
245-14	48364-48365	,	_	
245-15	48366-48368	an	_	
245-16	48369-48378	indicator	_	
245-17	48379-48381	of	_	
245-18	48382-48385	the	_	
245-19	48386-48389	hub	_	
245-20	48389-48390	’	_	
245-21	48390-48391	s	_	
245-22	48392-48400	strength	_	
245-23	48400-48401	,	_	
245-24	48402-48407	which	_	
245-25	48408-48410	is	_	
245-26	48411-48425	representative	_	
245-27	48426-48429	for	_	
245-28	48430-48433	the	_	
245-29	48434-48438	node	_	
245-30	48438-48439	(	_	
245-31	48439-48440	s	_	
245-32	48440-48441	)	_	
245-33	48442-48446	with	_	
245-34	48447-48450	the	_	
245-35	48451-48458	highest	_	
245-36	48459-48461	BC	_	
245-37	48462-48464	in	_	
245-38	48465-48468	the	_	
245-39	48469-48473	tree	_	
245-40	48473-48474	.	_	

#Text=Because the previously discussed research indicates that the network of SZ patients is more randomly organized than in the case of healthy individuals, a set of MST metrics computed in this study included a degree correlation (R), estimating how strong the degree of a node is dependent on the degree of its neighbouring vertices to which it is connected.
246-1	48475-48482	Because	_	
246-2	48483-48486	the	_	
246-3	48487-48497	previously	_	
246-4	48498-48507	discussed	_	
246-5	48508-48516	research	_	
246-6	48517-48526	indicates	_	
246-7	48527-48531	that	_	
246-8	48532-48535	the	_	
246-9	48536-48543	network	_	
246-10	48544-48546	of	_	
246-11	48547-48549	SZ	_	
246-12	48550-48558	patients	_	
246-13	48559-48561	is	_	
246-14	48562-48566	more	_	
246-15	48567-48575	randomly	_	
246-16	48576-48585	organized	_	
246-17	48586-48590	than	_	
246-18	48591-48593	in	_	
246-19	48594-48597	the	_	
246-20	48598-48602	case	_	
246-21	48603-48605	of	_	
246-22	48606-48613	healthy	_	
246-23	48614-48625	individuals	_	
246-24	48625-48626	,	_	
246-25	48627-48628	a	_	
246-26	48629-48632	set	_	
246-27	48633-48635	of	_	
246-28	48636-48639	MST	_	
246-29	48640-48647	metrics	_	
246-30	48648-48656	computed	_	
246-31	48657-48659	in	_	
246-32	48660-48664	this	_	
246-33	48665-48670	study	_	
246-34	48671-48679	included	_	
246-35	48680-48681	a	_	
246-36	48682-48688	degree	_	
246-37	48689-48700	correlation	_	
246-38	48701-48702	(	_	
246-39	48702-48703	R	_	
246-40	48703-48704	)	_	
246-41	48704-48705	,	_	
246-42	48706-48716	estimating	_	
246-43	48717-48720	how	_	
246-44	48721-48727	strong	_	
246-45	48728-48731	the	_	
246-46	48732-48738	degree	_	
246-47	48739-48741	of	_	
246-48	48742-48743	a	_	
246-49	48744-48748	node	_	
246-50	48749-48751	is	_	
246-51	48752-48761	dependent	_	
246-52	48762-48764	on	_	
246-53	48765-48768	the	_	
246-54	48769-48775	degree	_	
246-55	48776-48778	of	_	
246-56	48779-48782	its	_	
246-57	48783-48795	neighbouring	_	
246-58	48796-48804	vertices	_	
246-59	48805-48807	to	_	
246-60	48808-48813	which	_	
246-61	48814-48816	it	_	
246-62	48817-48819	is	_	
246-63	48820-48829	connected	_	
246-64	48829-48830	.	_	

#Text=A positive value of degree correlation indicates that the graph is assortative and a negative value means that the graph is disassortative.
247-1	48831-48832	A	_	
247-2	48833-48841	positive	_	
247-3	48842-48847	value	_	
247-4	48848-48850	of	_	
247-5	48851-48857	degree	_	
247-6	48858-48869	correlation	_	
247-7	48870-48879	indicates	_	
247-8	48880-48884	that	_	
247-9	48885-48888	the	_	
247-10	48889-48894	graph	_	
247-11	48895-48897	is	_	
247-12	48898-48909	assortative	_	
247-13	48910-48913	and	_	
247-14	48914-48915	a	_	
247-15	48916-48924	negative	_	
247-16	48925-48930	value	_	
247-17	48931-48936	means	_	
247-18	48937-48941	that	_	
247-19	48942-48945	the	_	
247-20	48946-48951	graph	_	
247-21	48952-48954	is	_	
247-22	48955-48969	disassortative	_	
247-23	48969-48970	.	_	

#Text=The regional betweenness centrality was computed separately, as averaged BC for nodes assigned as belonging to anterior (nodes: Fp1, Fp2, F7, F8, F3, F4, Fz) and posterior areas (nodes: T5, T6, P3, P4, Pz, O1, O2).
248-1	48971-48974	The	_	
248-2	48975-48983	regional	_	
248-3	48984-48995	betweenness	_	
248-4	48996-49006	centrality	_	
248-5	49007-49010	was	_	
248-6	49011-49019	computed	_	
248-7	49020-49030	separately	_	
248-8	49030-49031	,	_	
248-9	49032-49034	as	_	
248-10	49035-49043	averaged	_	
248-11	49044-49046	BC	_	
248-12	49047-49050	for	_	
248-13	49051-49056	nodes	_	
248-14	49057-49065	assigned	_	
248-15	49066-49068	as	_	
248-16	49069-49078	belonging	_	
248-17	49079-49081	to	_	
248-18	49082-49090	anterior	_	
248-19	49091-49092	(	_	
248-20	49092-49097	nodes	_	
248-21	49097-49098	:	_	
248-22	49099-49102	Fp1	_	
248-23	49102-49103	,	_	
248-24	49104-49107	Fp2	_	
248-25	49107-49108	,	_	
248-26	49109-49111	F7	_	
248-27	49111-49112	,	_	
248-28	49113-49115	F8	_	
248-29	49115-49116	,	_	
248-30	49117-49119	F3	_	
248-31	49119-49120	,	_	
248-32	49121-49123	F4	_	
248-33	49123-49124	,	_	
248-34	49125-49127	Fz	_	
248-35	49127-49128	)	_	
248-36	49129-49132	and	_	
248-37	49133-49142	posterior	_	
248-38	49143-49148	areas	_	
248-39	49149-49150	(	_	
248-40	49150-49155	nodes	_	
248-41	49155-49156	:	_	
248-42	49157-49159	T5	_	
248-43	49159-49160	,	_	
248-44	49161-49163	T6	_	
248-45	49163-49164	,	_	
248-46	49165-49167	P3	_	
248-47	49167-49168	,	_	
248-48	49169-49171	P4	_	
248-49	49171-49172	,	_	
248-50	49173-49175	Pz	_	
248-51	49175-49176	,	_	
248-52	49177-49179	O1	_	
248-53	49179-49180	,	_	
248-54	49181-49183	O2	_	
248-55	49183-49184	)	_	
248-56	49184-49185	.	_	

#Text=Exactly the same electrodes assigned as covering anterior or posterior regions were chosen in the study of Symond et al. of task-related gamma synchrony in first-episode schizophrenia.
249-1	49186-49193	Exactly	_	
249-2	49194-49197	the	_	
249-3	49198-49202	same	_	
249-4	49203-49213	electrodes	_	
249-5	49214-49222	assigned	_	
249-6	49223-49225	as	_	
249-7	49226-49234	covering	_	
249-8	49235-49243	anterior	_	
249-9	49244-49246	or	_	
249-10	49247-49256	posterior	_	
249-11	49257-49264	regions	_	
249-12	49265-49269	were	_	
249-13	49270-49276	chosen	_	
249-14	49277-49279	in	_	
249-15	49280-49283	the	_	
249-16	49284-49289	study	_	
249-17	49290-49292	of	_	
249-18	49293-49299	Symond	_	
249-19	49300-49302	et	_	
249-20	49303-49305	al	_	
249-21	49305-49306	.	_	
249-22	49307-49309	of	_	
249-23	49310-49322	task-related	_	
249-24	49323-49328	gamma	_	
249-25	49329-49338	synchrony	_	
249-26	49339-49341	in	_	
249-27	49342-49355	first-episode	_	
249-28	49356-49369	schizophrenia	_	
249-29	49369-49370	.	_	

#Text=The central region (C3, C4, Cz) was not included in the statistical analysis because the aim of the study was to identify the nodes/hubs as unambiguously frontal or non-frontal.
250-1	49371-49374	The	_	
250-2	49375-49382	central	_	
250-3	49383-49389	region	_	
250-4	49390-49391	(	_	
250-5	49391-49393	C3	_	
250-6	49393-49394	,	_	
250-7	49395-49397	C4	_	
250-8	49397-49398	,	_	
250-9	49399-49401	Cz	_	
250-10	49401-49402	)	_	
250-11	49403-49406	was	_	
250-12	49407-49410	not	_	
250-13	49411-49419	included	_	
250-14	49420-49422	in	_	
250-15	49423-49426	the	_	
250-16	49427-49438	statistical	_	
250-17	49439-49447	analysis	_	
250-18	49448-49455	because	_	
250-19	49456-49459	the	_	
250-20	49460-49463	aim	_	
250-21	49464-49466	of	_	
250-22	49467-49470	the	_	
250-23	49471-49476	study	_	
250-24	49477-49480	was	_	
250-25	49481-49483	to	_	
250-26	49484-49492	identify	_	
250-27	49493-49496	the	_	
250-28	49497-49502	nodes	_	
250-29	49502-49503	/	_	
250-30	49503-49507	hubs	_	
250-31	49508-49510	as	_	
250-32	49511-49524	unambiguously	_	
250-33	49525-49532	frontal	_	
250-34	49533-49535	or	_	
250-35	49536-49547	non-frontal	_	
250-36	49547-49548	.	_	

#Text=The inclusion of an equal number of nodes in two areas should also reduce any bias in computing a regional centrality.
251-1	49549-49552	The	_	
251-2	49553-49562	inclusion	_	
251-3	49563-49565	of	_	
251-4	49566-49568	an	_	
251-5	49569-49574	equal	_	
251-6	49575-49581	number	_	
251-7	49582-49584	of	_	
251-8	49585-49590	nodes	_	
251-9	49591-49593	in	_	
251-10	49594-49597	two	_	
251-11	49598-49603	areas	_	
251-12	49604-49610	should	_	
251-13	49611-49615	also	_	
251-14	49616-49622	reduce	_	
251-15	49623-49626	any	_	
251-16	49627-49631	bias	_	
251-17	49632-49634	in	_	
251-18	49635-49644	computing	_	
251-19	49645-49646	a	_	
251-20	49647-49655	regional	_	
251-21	49656-49666	centrality	_	
251-22	49666-49667	.	_	

#Text=Data analysis and statistics
#Text=To compare the groups in terms of demographical and clinical variables χ2 test and one-way ANOVA were applied with partial eta squared (ηp2) as an effect size indicator.
252-1	49668-49672	Data	_	
252-2	49673-49681	analysis	_	
252-3	49682-49685	and	_	
252-4	49686-49696	statistics	_	
252-5	49697-49699	To	_	
252-6	49700-49707	compare	_	
252-7	49708-49711	the	_	
252-8	49712-49718	groups	_	
252-9	49719-49721	in	_	
252-10	49722-49727	terms	_	
252-11	49728-49730	of	_	
252-12	49731-49744	demographical	_	
252-13	49745-49748	and	_	
252-14	49749-49757	clinical	_	
252-15	49758-49767	variables	_	
252-16	49768-49770	χ2	_	
252-17	49771-49775	test	_	
252-18	49776-49779	and	_	
252-19	49780-49787	one-way	_	
252-20	49788-49793	ANOVA	_	
252-21	49794-49798	were	_	
252-22	49799-49806	applied	_	
252-23	49807-49811	with	_	
252-24	49812-49819	partial	_	
252-25	49820-49823	eta	_	
252-26	49824-49831	squared	_	
252-27	49832-49833	(	_	
252-28	49833-49836	ηp2	_	
252-29	49836-49837	)	_	
252-30	49838-49840	as	_	
252-31	49841-49843	an	_	
252-32	49844-49850	effect	_	
252-33	49851-49855	size	_	
252-34	49856-49865	indicator	_	
252-35	49865-49866	.	_	

#Text=The between-group differences in terms of cognitive variables (the sum of correctly matched stimuli, mean RT, iSD and the number of errors committed in the processing speed task), including ex-Gaussian parameters (μ, σ, τ) were tested with ANCOVA, including age, education and premorbid IQ as controlled covariates.
253-1	49867-49870	The	_	
253-2	49871-49884	between-group	_	
253-3	49885-49896	differences	_	
253-4	49897-49899	in	_	
253-5	49900-49905	terms	_	
253-6	49906-49908	of	_	
253-7	49909-49918	cognitive	_	
253-8	49919-49928	variables	_	
253-9	49929-49930	(	_	
253-10	49930-49933	the	_	
253-11	49934-49937	sum	_	
253-12	49938-49940	of	_	
253-13	49941-49950	correctly	_	
253-14	49951-49958	matched	_	
253-15	49959-49966	stimuli	_	
253-16	49966-49967	,	_	
253-17	49968-49972	mean	_	
253-18	49973-49975	RT	_	
253-19	49975-49976	,	_	
253-20	49977-49980	iSD	_	
253-21	49981-49984	and	_	
253-22	49985-49988	the	_	
253-23	49989-49995	number	_	
253-24	49996-49998	of	_	
253-25	49999-50005	errors	_	
253-26	50006-50015	committed	_	
253-27	50016-50018	in	_	
253-28	50019-50022	the	_	
253-29	50023-50033	processing	_	
253-30	50034-50039	speed	_	
253-31	50040-50044	task	_	
253-32	50044-50045	)	_	
253-33	50045-50046	,	_	
253-34	50047-50056	including	_	
253-35	50057-50068	ex-Gaussian	_	
253-36	50069-50079	parameters	_	
253-37	50080-50081	(	_	
253-38	50081-50082	μ	_	
253-39	50082-50083	,	_	
253-40	50084-50085	σ	_	
253-41	50085-50086	,	_	
253-42	50087-50088	τ	_	
253-43	50088-50089	)	_	
253-44	50090-50094	were	_	
253-45	50095-50101	tested	_	
253-46	50102-50106	with	_	
253-47	50107-50113	ANCOVA	_	
253-48	50113-50114	,	_	
253-49	50115-50124	including	_	
253-50	50125-50128	age	_	
253-51	50128-50129	,	_	
253-52	50130-50139	education	_	
253-53	50140-50143	and	_	
253-54	50144-50153	premorbid	_	
253-55	50154-50156	IQ	_	
253-56	50157-50159	as	_	
253-57	50160-50170	controlled	_	
253-58	50171-50181	covariates	_	
253-59	50181-50182	.	_	

#Text=In this case, all between-group comparisons performed with controlled covariates were carried out individually for each dependent cognitive variable.
254-1	50183-50185	In	_	
254-2	50186-50190	this	_	
254-3	50191-50195	case	_	
254-4	50195-50196	,	_	
254-5	50197-50200	all	_	
254-6	50201-50214	between-group	_	
254-7	50215-50226	comparisons	_	
254-8	50227-50236	performed	_	
254-9	50237-50241	with	_	
254-10	50242-50252	controlled	_	
254-11	50253-50263	covariates	_	
254-12	50264-50268	were	_	
254-13	50269-50276	carried	_	
254-14	50277-50280	out	_	
254-15	50281-50293	individually	_	
254-16	50294-50297	for	_	
254-17	50298-50302	each	_	
254-18	50303-50312	dependent	_	
254-19	50313-50322	cognitive	_	
254-20	50323-50331	variable	_	
254-21	50331-50332	.	_	

#Text=The Bonferroni correction was applied to establish statistical significance threshold resulting from multiple testing of controlled covariates.
255-1	50333-50336	The	_	
255-2	50337-50347	Bonferroni	_	
255-3	50348-50358	correction	_	
255-4	50359-50362	was	_	
255-5	50363-50370	applied	_	
255-6	50371-50373	to	_	
255-7	50374-50383	establish	_	
255-8	50384-50395	statistical	_	
255-9	50396-50408	significance	_	
255-10	50409-50418	threshold	_	
255-11	50419-50428	resulting	_	
255-12	50429-50433	from	_	
255-13	50434-50442	multiple	_	
255-14	50443-50450	testing	_	
255-15	50451-50453	of	_	
255-16	50454-50464	controlled	_	
255-17	50465-50475	covariates	_	
255-18	50475-50476	.	_	

#Text=After determining the distributional parameters significantly differentiating the groups, correlations between these parameters were calculated separately for SZ and HC groups to verify the potential dependencies between ex-Gaussian indicators.
256-1	50477-50482	After	_	
256-2	50483-50494	determining	_	
256-3	50495-50498	the	_	
256-4	50499-50513	distributional	_	
256-5	50514-50524	parameters	_	
256-6	50525-50538	significantly	_	
256-7	50539-50554	differentiating	_	
256-8	50555-50558	the	_	
256-9	50559-50565	groups	_	
256-10	50565-50566	,	_	
256-11	50567-50579	correlations	_	
256-12	50580-50587	between	_	
256-13	50588-50593	these	_	
256-14	50594-50604	parameters	_	
256-15	50605-50609	were	_	
256-16	50610-50620	calculated	_	
256-17	50621-50631	separately	_	
256-18	50632-50635	for	_	
256-19	50636-50638	SZ	_	
256-20	50639-50642	and	_	
256-21	50643-50645	HC	_	
256-22	50646-50652	groups	_	
256-23	50653-50655	to	_	
256-24	50656-50662	verify	_	
256-25	50663-50666	the	_	
256-26	50667-50676	potential	_	
256-27	50677-50689	dependencies	_	
256-28	50690-50697	between	_	
256-29	50698-50709	ex-Gaussian	_	
256-30	50710-50720	indicators	_	
256-31	50720-50721	.	_	

#Text=The next step was to perform regression analysis with the overall result in the DST test as a dependent variable and ex-Gaussian parameters, which differed the groups as independent variables to determine which of them could account for cognitive slowdown in the SZ group.
257-1	50722-50725	The	_	
257-2	50726-50730	next	_	
257-3	50731-50735	step	_	
257-4	50736-50739	was	_	
257-5	50740-50742	to	_	
257-6	50743-50750	perform	_	
257-7	50751-50761	regression	_	
257-8	50762-50770	analysis	_	
257-9	50771-50775	with	_	
257-10	50776-50779	the	_	
257-11	50780-50787	overall	_	
257-12	50788-50794	result	_	
257-13	50795-50797	in	_	
257-14	50798-50801	the	_	
257-15	50802-50805	DST	_	
257-16	50806-50810	test	_	
257-17	50811-50813	as	_	
257-18	50814-50815	a	_	
257-19	50816-50825	dependent	_	
257-20	50826-50834	variable	_	
257-21	50835-50838	and	_	
257-22	50839-50850	ex-Gaussian	_	
257-23	50851-50861	parameters	_	
257-24	50861-50862	,	_	
257-25	50863-50868	which	_	
257-26	50869-50877	differed	_	
257-27	50878-50881	the	_	
257-28	50882-50888	groups	_	
257-29	50889-50891	as	_	
257-30	50892-50903	independent	_	
257-31	50904-50913	variables	_	
257-32	50914-50916	to	_	
257-33	50917-50926	determine	_	
257-34	50927-50932	which	_	
257-35	50933-50935	of	_	
257-36	50936-50940	them	_	
257-37	50941-50946	could	_	
257-38	50947-50954	account	_	
257-39	50955-50958	for	_	
257-40	50959-50968	cognitive	_	
257-41	50969-50977	slowdown	_	
257-42	50978-50980	in	_	
257-43	50981-50984	the	_	
257-44	50985-50987	SZ	_	
257-45	50988-50993	group	_	
257-46	50993-50994	.	_	

#Text=In the SZ group, associations between the mentioned ex-Gaussian parameters and clinical variables were also identified with application of two-tailed Spearman correlation (R).
258-1	50995-50997	In	_	
258-2	50998-51001	the	_	
258-3	51002-51004	SZ	_	
258-4	51005-51010	group	_	
258-5	51010-51011	,	_	
258-6	51012-51024	associations	_	
258-7	51025-51032	between	_	
258-8	51033-51036	the	_	
258-9	51037-51046	mentioned	_	
258-10	51047-51058	ex-Gaussian	_	
258-11	51059-51069	parameters	_	
258-12	51070-51073	and	_	
258-13	51074-51082	clinical	_	
258-14	51083-51092	variables	_	
258-15	51093-51097	were	_	
258-16	51098-51102	also	_	
258-17	51103-51113	identified	_	
258-18	51114-51118	with	_	
258-19	51119-51130	application	_	
258-20	51131-51133	of	_	
258-21	51134-51144	two-tailed	_	
258-22	51145-51153	Spearman	_	
258-23	51154-51165	correlation	_	
258-24	51166-51167	(	_	
258-25	51167-51168	R	_	
258-26	51168-51169	)	_	
258-27	51169-51170	.	_	

#Text=Next, raw PLI and MST results averaged across the epochs per subject were log-transformed [y = ln(x)] to ensure distributional normality of these variables.
259-1	51171-51175	Next	_	
259-2	51175-51176	,	_	
259-3	51177-51180	raw	_	
259-4	51181-51184	PLI	_	
259-5	51185-51188	and	_	
259-6	51189-51192	MST	_	
259-7	51193-51200	results	_	
259-8	51201-51209	averaged	_	
259-9	51210-51216	across	_	
259-10	51217-51220	the	_	
259-11	51221-51227	epochs	_	
259-12	51228-51231	per	_	
259-13	51232-51239	subject	_	
259-14	51240-51244	were	_	
259-15	51245-51260	log-transformed	_	
259-16	51261-51262	[	_	
259-17	51262-51263	y	_	
259-18	51264-51265	=	_	
259-19	51266-51268	ln	_	
259-20	51268-51269	(	_	
259-21	51269-51270	x	_	
259-22	51270-51271	)	_	
259-23	51271-51272	]	_	
259-24	51273-51275	to	_	
259-25	51276-51282	ensure	_	
259-26	51283-51297	distributional	_	
259-27	51298-51307	normality	_	
259-28	51308-51310	of	_	
259-29	51311-51316	these	_	
259-30	51317-51326	variables	_	
259-31	51326-51327	.	_	

#Text=To avoid zeros in transformed data, they were computed with additional 1 · 10−24 correction.
260-1	51328-51330	To	_	
260-2	51331-51336	avoid	_	
260-3	51337-51342	zeros	_	
260-4	51343-51345	in	_	
260-5	51346-51357	transformed	_	
260-6	51358-51362	data	_	
260-7	51362-51363	,	_	
260-8	51364-51368	they	_	
260-9	51369-51373	were	_	
260-10	51374-51382	computed	_	
260-11	51383-51387	with	_	
260-12	51388-51398	additional	_	
260-13	51399-51400	1	_	
260-14	51401-51402	·	_	
260-15	51403-51405	10	_	
260-16	51405-51406	−	_	
260-17	51406-51408	24	_	
260-18	51409-51419	correction	_	
260-19	51419-51420	.	_	

#Text=Group differences regarding individual PLI and MST (diameter, leaf fraction, degree correlation, BCmax, and global BC as whole-brain network metrics, and anterior and posterior BC as regional metrics) results were tested with ANCOVA, again, with age, education and premorbid IQ as controlled covariates and ηp2 as a measure of effect size.
261-1	51421-51426	Group	_	
261-2	51427-51438	differences	_	
261-3	51439-51448	regarding	_	
261-4	51449-51459	individual	_	
261-5	51460-51463	PLI	_	
261-6	51464-51467	and	_	
261-7	51468-51471	MST	_	
261-8	51472-51473	(	_	
261-9	51473-51481	diameter	_	
261-10	51481-51482	,	_	
261-11	51483-51487	leaf	_	
261-12	51488-51496	fraction	_	
261-13	51496-51497	,	_	
261-14	51498-51504	degree	_	
261-15	51505-51516	correlation	_	
261-16	51516-51517	,	_	
261-17	51518-51523	BCmax	_	
261-18	51523-51524	,	_	
261-19	51525-51528	and	_	
261-20	51529-51535	global	_	
261-21	51536-51538	BC	_	
261-22	51539-51541	as	_	
261-23	51542-51553	whole-brain	_	
261-24	51554-51561	network	_	
261-25	51562-51569	metrics	_	
261-26	51569-51570	,	_	
261-27	51571-51574	and	_	
261-28	51575-51583	anterior	_	
261-29	51584-51587	and	_	
261-30	51588-51597	posterior	_	
261-31	51598-51600	BC	_	
261-32	51601-51603	as	_	
261-33	51604-51612	regional	_	
261-34	51613-51620	metrics	_	
261-35	51620-51621	)	_	
261-36	51622-51629	results	_	
261-37	51630-51634	were	_	
261-38	51635-51641	tested	_	
261-39	51642-51646	with	_	
261-40	51647-51653	ANCOVA	_	
261-41	51653-51654	,	_	
261-42	51655-51660	again	_	
261-43	51660-51661	,	_	
261-44	51662-51666	with	_	
261-45	51667-51670	age	_	
261-46	51670-51671	,	_	
261-47	51672-51681	education	_	
261-48	51682-51685	and	_	
261-49	51686-51695	premorbid	_	
261-50	51696-51698	IQ	_	
261-51	51699-51701	as	_	
261-52	51702-51712	controlled	_	
261-53	51713-51723	covariates	_	
261-54	51724-51727	and	_	
261-55	51728-51731	ηp2	_	
261-56	51732-51734	as	_	
261-57	51735-51736	a	_	
261-58	51737-51744	measure	_	
261-59	51745-51747	of	_	
261-60	51748-51754	effect	_	
261-61	51755-51759	size	_	
261-62	51759-51760	.	_	

#Text=Similarly as in the case of cognitive variables comparisons, the Bonferroni correction was used to set a statistical significance threshold.
262-1	51761-51770	Similarly	_	
262-2	51771-51773	as	_	
262-3	51774-51776	in	_	
262-4	51777-51780	the	_	
262-5	51781-51785	case	_	
262-6	51786-51788	of	_	
262-7	51789-51798	cognitive	_	
262-8	51799-51808	variables	_	
262-9	51809-51820	comparisons	_	
262-10	51820-51821	,	_	
262-11	51822-51825	the	_	
262-12	51826-51836	Bonferroni	_	
262-13	51837-51847	correction	_	
262-14	51848-51851	was	_	
262-15	51852-51856	used	_	
262-16	51857-51859	to	_	
262-17	51860-51863	set	_	
262-18	51864-51865	a	_	
262-19	51866-51877	statistical	_	
262-20	51878-51890	significance	_	
262-21	51891-51900	threshold	_	
262-22	51900-51901	.	_	

#Text=After establishing the functional connectivity and network indicators differentiating the studied groups, they were correlated with the ex-Gaussian parameters being significant predictors of cognitive speed in the SZ sample.
263-1	51902-51907	After	_	
263-2	51908-51920	establishing	_	
263-3	51921-51924	the	_	
263-4	51925-51935	functional	_	
263-5	51936-51948	connectivity	_	
263-6	51949-51952	and	_	
263-7	51953-51960	network	_	
263-8	51961-51971	indicators	_	
263-9	51972-51987	differentiating	_	
263-10	51988-51991	the	_	
263-11	51992-51999	studied	_	
263-12	52000-52006	groups	_	
263-13	52006-52007	,	_	
263-14	52008-52012	they	_	
263-15	52013-52017	were	_	
263-16	52018-52028	correlated	_	
263-17	52029-52033	with	_	
263-18	52034-52037	the	_	
263-19	52038-52049	ex-Gaussian	_	
263-20	52050-52060	parameters	_	
263-21	52061-52066	being	_	
263-22	52067-52078	significant	_	
263-23	52079-52089	predictors	_	
263-24	52090-52092	of	_	
263-25	52093-52102	cognitive	_	
263-26	52103-52108	speed	_	
263-27	52109-52111	in	_	
263-28	52112-52115	the	_	
263-29	52116-52118	SZ	_	
263-30	52119-52125	sample	_	
263-31	52125-52126	.	_	

#Text=In this case, the Pearson’s r correlation coefficient was applied.
264-1	52127-52129	In	_	
264-2	52130-52134	this	_	
264-3	52135-52139	case	_	
264-4	52139-52140	,	_	
264-5	52141-52144	the	_	
264-6	52145-52152	Pearson	_	
264-7	52152-52153	’	_	
264-8	52153-52154	s	_	
264-9	52155-52156	r	_	
264-10	52157-52168	correlation	_	
264-11	52169-52180	coefficient	_	
264-12	52181-52184	was	_	
264-13	52185-52192	applied	_	
264-14	52192-52193	.	_	

#Text=To control for the hypothetical impact of clinical independent variables on cognitive–network relationships in the SZ group, a multivariate regression analysis was performed with ex-Gaussian parameters as dependent variables and MST results as independent variables, including the duration of illness, duration of untreated psychosis, and the risperidone equivalent as controlled predictors.
265-1	52194-52196	To	_	
265-2	52197-52204	control	_	
265-3	52205-52208	for	_	
265-4	52209-52212	the	_	
265-5	52213-52225	hypothetical	_	
265-6	52226-52232	impact	_	
265-7	52233-52235	of	_	
265-8	52236-52244	clinical	_	
265-9	52245-52256	independent	_	
265-10	52257-52266	variables	_	
265-11	52267-52269	on	_	
265-12	52270-52287	cognitive–network	_	
265-13	52288-52301	relationships	_	
265-14	52302-52304	in	_	
265-15	52305-52308	the	_	
265-16	52309-52311	SZ	_	
265-17	52312-52317	group	_	
265-18	52317-52318	,	_	
265-19	52319-52320	a	_	
265-20	52321-52333	multivariate	_	
265-21	52334-52344	regression	_	
265-22	52345-52353	analysis	_	
265-23	52354-52357	was	_	
265-24	52358-52367	performed	_	
265-25	52368-52372	with	_	
265-26	52373-52384	ex-Gaussian	_	
265-27	52385-52395	parameters	_	
265-28	52396-52398	as	_	
265-29	52399-52408	dependent	_	
265-30	52409-52418	variables	_	
265-31	52419-52422	and	_	
265-32	52423-52426	MST	_	
265-33	52427-52434	results	_	
265-34	52435-52437	as	_	
265-35	52438-52449	independent	_	
265-36	52450-52459	variables	_	
265-37	52459-52460	,	_	
265-38	52461-52470	including	_	
265-39	52471-52474	the	_	
265-40	52475-52483	duration	_	
265-41	52484-52486	of	_	
265-42	52487-52494	illness	_	
265-43	52494-52495	,	_	
265-44	52496-52504	duration	_	
265-45	52505-52507	of	_	
265-46	52508-52517	untreated	_	
265-47	52518-52527	psychosis	_	
265-48	52527-52528	,	_	
265-49	52529-52532	and	_	
265-50	52533-52536	the	_	
265-51	52537-52548	risperidone	_	
265-52	52549-52559	equivalent	_	
265-53	52560-52562	as	_	
265-54	52563-52573	controlled	_	
265-55	52574-52584	predictors	_	
265-56	52584-52585	.	_	

#Text=Only the variables which significantly differentiated the studied groups and uncorrelated predictors were included.
266-1	52586-52590	Only	_	
266-2	52591-52594	the	_	
266-3	52595-52604	variables	_	
266-4	52605-52610	which	_	
266-5	52611-52624	significantly	_	
266-6	52625-52639	differentiated	_	
266-7	52640-52643	the	_	
266-8	52644-52651	studied	_	
266-9	52652-52658	groups	_	
266-10	52659-52662	and	_	
266-11	52663-52675	uncorrelated	_	
266-12	52676-52686	predictors	_	
266-13	52687-52691	were	_	
266-14	52692-52700	included	_	
266-15	52700-52701	.	_	

#Text=Additionally, the potential correlations between MST parameters and psychopathology assessed with the PANSS scale were verified.
267-1	52702-52714	Additionally	_	
267-2	52714-52715	,	_	
267-3	52716-52719	the	_	
267-4	52720-52729	potential	_	
267-5	52730-52742	correlations	_	
267-6	52743-52750	between	_	
267-7	52751-52754	MST	_	
267-8	52755-52765	parameters	_	
267-9	52766-52769	and	_	
267-10	52770-52785	psychopathology	_	
267-11	52786-52794	assessed	_	
267-12	52795-52799	with	_	
267-13	52800-52803	the	_	
267-14	52804-52809	PANSS	_	
267-15	52810-52815	scale	_	
267-16	52816-52820	were	_	
267-17	52821-52829	verified	_	
267-18	52829-52830	.	_	

#Text=Due to the fact that the PANSS results deviated from the normal distribution, the two-tailed Spearman R coefficient was used.
268-1	52831-52834	Due	_	
268-2	52835-52837	to	_	
268-3	52838-52841	the	_	
268-4	52842-52846	fact	_	
268-5	52847-52851	that	_	
268-6	52852-52855	the	_	
268-7	52856-52861	PANSS	_	
268-8	52862-52869	results	_	
268-9	52870-52878	deviated	_	
268-10	52879-52883	from	_	
268-11	52884-52887	the	_	
268-12	52888-52894	normal	_	
268-13	52895-52907	distribution	_	
268-14	52907-52908	,	_	
268-15	52909-52912	the	_	
268-16	52913-52923	two-tailed	_	
268-17	52924-52932	Spearman	_	
268-18	52933-52934	R	_	
268-19	52935-52946	coefficient	_	
268-20	52947-52950	was	_	
268-21	52951-52955	used	_	
268-22	52955-52956	.	_	

#Text=For all correlations coefficients, p values of less than 0.01 were regarded as statistically significant.
269-1	52957-52960	For	_	
269-2	52961-52964	all	_	
269-3	52965-52977	correlations	_	
269-4	52978-52990	coefficients	_	
269-5	52990-52991	,	_	
269-6	52992-52993	p	_	
269-7	52994-53000	values	_	
269-8	53001-53003	of	_	
269-9	53004-53008	less	_	
269-10	53009-53013	than	_	
269-11	53014-53018	0.01	_	
269-12	53019-53023	were	_	
269-13	53024-53032	regarded	_	
269-14	53033-53035	as	_	
269-15	53036-53049	statistically	_	
269-16	53050-53061	significant	_	
269-17	53061-53062	.	_	

#Text=Establishing this threshold for correlation resulted from an attempt to avoid false positive effects, which could have been a consequence of potential redundancy or similarity of the analyzed MST parameters.
270-1	53063-53075	Establishing	_	
270-2	53076-53080	this	_	
270-3	53081-53090	threshold	_	
270-4	53091-53094	for	_	
270-5	53095-53106	correlation	_	
270-6	53107-53115	resulted	_	
270-7	53116-53120	from	_	
270-8	53121-53123	an	_	
270-9	53124-53131	attempt	_	
270-10	53132-53134	to	_	
270-11	53135-53140	avoid	_	
270-12	53141-53146	false	_	
270-13	53147-53155	positive	_	
270-14	53156-53163	effects	_	
270-15	53163-53164	,	_	
270-16	53165-53170	which	_	
270-17	53171-53176	could	_	
270-18	53177-53181	have	_	
270-19	53182-53186	been	_	
270-20	53187-53188	a	_	
270-21	53189-53200	consequence	_	
270-22	53201-53203	of	_	
270-23	53204-53213	potential	_	
270-24	53214-53224	redundancy	_	
270-25	53225-53227	or	_	
270-26	53228-53238	similarity	_	
270-27	53239-53241	of	_	
270-28	53242-53245	the	_	
270-29	53246-53254	analyzed	_	
270-30	53255-53258	MST	_	
270-31	53259-53269	parameters	_	
270-32	53269-53270	.	_	

#Text=Supplementary information
#Text=Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
271-1	53271-53284	Supplementary	_	
271-2	53285-53296	information	_	
271-3	53297-53306	Publisher	_	
271-4	53306-53307	’	_	
271-5	53307-53308	s	_	
271-6	53309-53313	note	_	
271-7	53313-53314	:	_	
271-8	53315-53323	Springer	_	
271-9	53324-53330	Nature	_	
271-10	53331-53338	remains	_	
271-11	53339-53346	neutral	_	
271-12	53347-53351	with	_	
271-13	53352-53358	regard	_	
271-14	53359-53361	to	_	
271-15	53362-53376	jurisdictional	_	
271-16	53377-53383	claims	_	
271-17	53384-53386	in	_	
271-18	53387-53396	published	_	
271-19	53397-53401	maps	_	
271-20	53402-53405	and	_	
271-21	53406-53419	institutional	_	
271-22	53420-53432	affiliations	_	
271-23	53432-53433	.	_	

#Text=Supplementary information
#Text=Supplementary information accompanies this paper at 10.1038/s41598-019-46111-0.
272-1	53434-53447	Supplementary	_	
272-2	53448-53459	information	_	
272-3	53460-53473	Supplementary	_	
272-4	53474-53485	information	_	
272-5	53486-53497	accompanies	_	
272-6	53498-53502	this	_	
272-7	53503-53508	paper	_	
272-8	53509-53511	at	_	
272-9	53512-53519	10.1038	_	
272-10	53519-53520	/	_	
272-11	53520-53526	s41598	_	
272-12	53526-53527	-	_	
272-13	53527-53530	019	_	
272-14	53530-53531	-	_	
272-15	53531-53536	46111	_	
272-16	53536-53537	-	_	
272-17	53537-53538	0	_	
272-18	53538-53539	.	_	

#Text=Author Contributions
#Text=Paweł Krukow: formulating research problems, study design, statistical analysis, collecting the cognitive and clinical data, preparation of the manuscript.
273-1	53540-53546	Author	_	
273-2	53547-53560	Contributions	_	
273-3	53561-53566	Paweł	_	
273-4	53567-53573	Krukow	_	
273-5	53573-53574	:	_	
273-6	53575-53586	formulating	_	
273-7	53587-53595	research	_	
273-8	53596-53604	problems	_	
273-9	53604-53605	,	_	
273-10	53606-53611	study	_	
273-11	53612-53618	design	_	
273-12	53618-53619	,	_	
273-13	53620-53631	statistical	_	
273-14	53632-53640	analysis	_	
273-15	53640-53641	,	_	
273-16	53642-53652	collecting	_	
273-17	53653-53656	the	_	
273-18	53657-53666	cognitive	_	
273-19	53667-53670	and	_	
273-20	53671-53679	clinical	_	
273-21	53680-53684	data	_	
273-22	53684-53685	,	_	
273-23	53686-53697	preparation	_	
273-24	53698-53700	of	_	
273-25	53701-53704	the	_	
273-26	53705-53715	manuscript	_	
273-27	53715-53716	.	_	

#Text=Kamil Jonak: study design, mathematical analysis of EEG data, preparation of figures and the manuscript.
274-1	53717-53722	Kamil	_	
274-2	53723-53728	Jonak	_	
274-3	53728-53729	:	_	
274-4	53730-53735	study	_	
274-5	53736-53742	design	_	
274-6	53742-53743	,	_	
274-7	53744-53756	mathematical	_	
274-8	53757-53765	analysis	_	
274-9	53766-53768	of	_	
274-10	53769-53772	EEG	_	
274-11	53773-53777	data	_	
274-12	53777-53778	,	_	
274-13	53779-53790	preparation	_	
274-14	53791-53793	of	_	
274-15	53794-53801	figures	_	
274-16	53802-53805	and	_	
274-17	53806-53809	the	_	
274-18	53810-53820	manuscript	_	
274-19	53820-53821	.	_	

#Text=Robert Karpiński: collecting EEG recordings, mathematical analysis of EEG data.
275-1	53822-53828	Robert	_	
275-2	53829-53838	Karpiński	_	
275-3	53838-53839	:	_	
275-4	53840-53850	collecting	_	
275-5	53851-53854	EEG	_	
275-6	53855-53865	recordings	_	
275-7	53865-53866	,	_	
275-8	53867-53879	mathematical	_	
275-9	53880-53888	analysis	_	
275-10	53889-53891	of	_	
275-11	53892-53895	EEG	_	
275-12	53896-53900	data	_	
275-13	53900-53901	.	_	

#Text=Hanna Karakuła-Juchnowicz: study design, analysis of clinical data, preparation and correction of the final version of the manuscript.
276-1	53902-53907	Hanna	_	
276-2	53908-53927	Karakuła-Juchnowicz	_	
276-3	53927-53928	:	_	
276-4	53929-53934	study	_	
276-5	53935-53941	design	_	
276-6	53941-53942	,	_	
276-7	53943-53951	analysis	_	
276-8	53952-53954	of	_	
276-9	53955-53963	clinical	_	
276-10	53964-53968	data	_	
276-11	53968-53969	,	_	
276-12	53970-53981	preparation	_	
276-13	53982-53985	and	_	
276-14	53986-53996	correction	_	
276-15	53997-53999	of	_	
276-16	54000-54003	the	_	
276-17	54004-54009	final	_	
276-18	54010-54017	version	_	
276-19	54018-54020	of	_	
276-20	54021-54024	the	_	
276-21	54025-54035	manuscript	_	
276-22	54035-54036	.	_	

#Text=Competing Interests
#Text=The authors declare no competing interests.
277-1	54037-54046	Competing	_	
277-2	54047-54056	Interests	_	
277-3	54057-54060	The	_	
277-4	54061-54068	authors	_	
277-5	54069-54076	declare	_	
277-6	54077-54079	no	_	
277-7	54080-54089	competing	_	
277-8	54090-54099	interests	_	
277-9	54099-54100	.	_	

#Text=References
#Text=Neurocognitive deficit in schizophrenia: a quantitative review of evidence
#Text=Kraepelin, E.
278-1	54101-54111	References	_	
278-2	54112-54126	Neurocognitive	_	
278-3	54127-54134	deficit	_	
278-4	54135-54137	in	_	
278-5	54138-54151	schizophrenia	_	
278-6	54151-54152	:	_	
278-7	54153-54154	a	_	
278-8	54155-54167	quantitative	_	
278-9	54168-54174	review	_	
278-10	54175-54177	of	_	
278-11	54178-54186	evidence	_	
278-12	54187-54196	Kraepelin	_	
278-13	54196-54197	,	_	
278-14	54198-54199	E	_	
278-15	54199-54200	.	_	

#Text=Memoirs.
279-1	54201-54208	Memoirs	_	
279-2	54208-54209	.	_	

#Text=(Springer-Verlag, 1987).
280-1	54210-54211	(	_	
280-2	54211-54226	Springer-Verlag	_	
280-3	54226-54227	,	_	
280-4	54228-54232	1987	_	
280-5	54232-54233	)	_	
280-6	54233-54234	.	_	

#Text=Schizophrenia: a disconnection syndrome?
281-1	54235-54248	Schizophrenia	_	
281-2	54248-54249	:	_	
281-3	54250-54251	a	_	
281-4	54252-54265	disconnection	_	
281-5	54266-54274	syndrome	_	
281-6	54274-54275	?	_	

#Text=What is a disconnection syndrome?
282-1	54276-54280	What	_	
282-2	54281-54283	is	_	
282-3	54284-54285	a	_	
282-4	54286-54299	disconnection	_	
282-5	54300-54308	syndrome	_	
282-6	54308-54309	?	_	

#Text=Functional connectivity and brain networks in schizophrenia
#Text=What can spontaneous fluctuations of the blood oxygenation-level-dependent signal tell us about psychiatric disorders?
283-1	54310-54320	Functional	_	
283-2	54321-54333	connectivity	_	
283-3	54334-54337	and	_	
283-4	54338-54343	brain	_	
283-5	54344-54352	networks	_	
283-6	54353-54355	in	_	
283-7	54356-54369	schizophrenia	_	
283-8	54370-54374	What	_	
283-9	54375-54378	can	_	
283-10	54379-54390	spontaneous	_	
283-11	54391-54403	fluctuations	_	
283-12	54404-54406	of	_	
283-13	54407-54410	the	_	
283-14	54411-54416	blood	_	
283-15	54417-54444	oxygenation-level-dependent	_	
283-16	54445-54451	signal	_	
283-17	54452-54456	tell	_	
283-18	54457-54459	us	_	
283-19	54460-54465	about	_	
283-20	54466-54477	psychiatric	_	
283-21	54478-54487	disorders	_	
283-22	54487-54488	?	_	

#Text=Overall brain connectivity maps show cortico - subcortical abnormalities in schizophrenia
#Text=Functional and effective connectivity in neuroimaging: a synthesis
#Text=Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry
#Text=Dysfunction of large-scale brain networks in schizophrenia: a meta-analysis of resting-state functional connectivity
#Text=Complexity and coherency: integrating information in the brain
#Text=Complex brain networks: graph theoretical analysis of structural and functional systems
#Text=The organization of physiological brain networks
#Text=Brain networks in schizophrenia
#Text=Measuring alterations in oscillatory brain networks in schizophrenia with resting-state MEG: state-of-the-art and methodological challenges
#Text=Aberrant functional whole-brain network architecture in patients with schizophrenia: a meta-analysis
#Text=Small-world networks and disturbed functional connectivity in schizophrenia
#Text=Small-world properties of nonlinear brain activity in schizophrenia
#Text=Distinct disruptions of resting-state functional brain networks in familial and sporadic schizophrenia
#Text=The economy of brain network organization
#Text=A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs
#Text=Identifying the brain’s most globally connected regions
#Text=Schizophrenia and abnormal brain network hubs
#Text=Schizophrenia, neuroimaging and connectomics
#Text=Graph-based network analysis in schizophrenia
#Text=Investigating the electrophysiological basis of resting state networks using magnetoencephalography
#Text=The trees and the forest: characterization of complex brain networks with minimum spanning trees
#Text=Minimum spanning tree analysis of the human connectome
#Text=Epilepsy surgery outcome and functional network alternations in longitudinal MEG: a minimum spanning tree analysis
#Text=Electroencephalography based functional network in newly diagnosed childhood epilepsies
#Text=Evidence for a resting state network abnormality in adults who stutter
#Text=Declining functional connectivity strength and changing hubs locations in Alzheimer’s disease: an EEG study
#Text=Growing trees in child brain: graph theoretical analysis of electroencephalography-derived minimum spanning tree in 5- and 7-year-old children reflects brain maturation
#Text=Structural brain network disturbances in the psychosis spectrum
#Text=The temporal organization of functional brain connectivity is abnormal in schizophrenia but does not correlate with symptomology
#Text=Quantitative and Qualitative Comparison of EEG-Based Neural Network Organization in Two Schizophrenia Groups Differing in the Duration of Illness and Disease Burden: Graph Analysis With Application of the Minimum Spanning Tree
#Text=Cognitive dysfunction in first-episode psychosis: the processing speed hypothesis
#Text=Hierarchical structure of the cognitive process in schizophrenia: the fundamental role of processing speed
#Text=Processing speed is associated with differences in IQ and cognitive profiles between patients with schizophrenia and their healthy siblings
#Text=Processing speed impairment in schizophrenia is mediated by white matter integrity
#Text=Diffusion-weighted imaging uncovers likely sources of processing-speed deficits in schizophrenia
#Text=Disrupted resting-state functional connectivity in minimally treated chronic schizophrenia
#Text=Intra-individual variability in high-functioning patients with schizophrenia
#Text=Increased intra-individual variability of cognitive processing in subjects at risk mental state and schizophrenia patients
#Text=Increased intra-subject reaction time variability in the volitional control of movement in schizophrenia
#Text=Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
#Text=Intrinsic fluctuations within the cortical systems account for intertrial variability in human behavior
#Text=Staying on the job: the frontal lobes control individual performance variability
#Text=The functional neuroanatomical correlates of response variability: evidence from response inhibition task
#Text=Graph analysis of EEG resting state functional networks in dyslexic readers
#Text=Functional structure of cortical neuronal networks grown in vitro
#Text=The minimum spanning tree: an unbiased method for brain network analysis
#Text=Emergence of scaling in random networks
#Text=Aberrant frontal and temporal cortex network structure in schizophrenia: a graph theoretical analysis
#Text=EEG-based functional networks in schizophrenia
#Text=The anatomical distance of functional connections predicts brain network topology in health and schizophrenia
#Text=Disrupted brain anatomical connectivity in medication-naïve patients with first-episode schizophrenia
#Text=Competition between functional brain networks mediates behavioral variability
#Text=RT distributional analysis of cognitive control-related brain activity in first episode schizophrenia
#Text=Synchronous gamma activity: a review and contribution to an integrative neuroscience model of schizophrenia
#Text=Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia
#Text=Gamma oscillation deficit and the onset of early progression of schizophrenia
#Text=NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia
#Text=Abnormal gamma oscillation in N-Methyl-D-Aspartate receptor hypofunction models of schizophrenia
#Text=The positive and negative syndrome scale (PANSS) for schizophrenia
#Text=Polish Adult Reading Test – PART – construction of Polish test for estimate the level of premorbid intelligence in schizophrenia
#Text=Cognitive inconsistency in bipolar patients is determined by increased intra-individual variability in initial phase of task performance
#Text=Disturbed functional connectivity within the left prefrontal cortex and sensorimotor areas predicts impaired cognitive speed in patients with first-episode schizophrenia
#Text=Wechsler, D.
284-1	54489-54496	Overall	_	
284-2	54497-54502	brain	_	
284-3	54503-54515	connectivity	_	
284-4	54516-54520	maps	_	
284-5	54521-54525	show	_	
284-6	54526-54533	cortico	_	
284-7	54534-54535	-	_	
284-8	54536-54547	subcortical	_	
284-9	54548-54561	abnormalities	_	
284-10	54562-54564	in	_	
284-11	54565-54578	schizophrenia	_	
284-12	54579-54589	Functional	_	
284-13	54590-54593	and	_	
284-14	54594-54603	effective	_	
284-15	54604-54616	connectivity	_	
284-16	54617-54619	in	_	
284-17	54620-54632	neuroimaging	_	
284-18	54632-54633	:	_	
284-19	54634-54635	a	_	
284-20	54636-54645	synthesis	_	
284-21	54646-54657	Voxel-based	_	
284-22	54657-54658	,	_	
284-23	54659-54669	brain-wide	_	
284-24	54670-54681	association	_	
284-25	54682-54687	study	_	
284-26	54688-54690	of	_	
284-27	54691-54699	aberrant	_	
284-28	54700-54710	functional	_	
284-29	54711-54723	connectivity	_	
284-30	54724-54726	in	_	
284-31	54727-54740	schizophrenia	_	
284-32	54741-54751	implicates	_	
284-33	54752-54767	thalamocortical	_	
284-34	54768-54777	circuitry	_	
284-35	54778-54789	Dysfunction	_	
284-36	54790-54792	of	_	
284-37	54793-54804	large-scale	_	
284-38	54805-54810	brain	_	
284-39	54811-54819	networks	_	
284-40	54820-54822	in	_	
284-41	54823-54836	schizophrenia	_	
284-42	54836-54837	:	_	
284-43	54838-54839	a	_	
284-44	54840-54853	meta-analysis	_	
284-45	54854-54856	of	_	
284-46	54857-54870	resting-state	_	
284-47	54871-54881	functional	_	
284-48	54882-54894	connectivity	_	
284-49	54895-54905	Complexity	_	
284-50	54906-54909	and	_	
284-51	54910-54919	coherency	_	
284-52	54919-54920	:	_	
284-53	54921-54932	integrating	_	
284-54	54933-54944	information	_	
284-55	54945-54947	in	_	
284-56	54948-54951	the	_	
284-57	54952-54957	brain	_	
284-58	54958-54965	Complex	_	
284-59	54966-54971	brain	_	
284-60	54972-54980	networks	_	
284-61	54980-54981	:	_	
284-62	54982-54987	graph	_	
284-63	54988-54999	theoretical	_	
284-64	55000-55008	analysis	_	
284-65	55009-55011	of	_	
284-66	55012-55022	structural	_	
284-67	55023-55026	and	_	
284-68	55027-55037	functional	_	
284-69	55038-55045	systems	_	
284-70	55046-55049	The	_	
284-71	55050-55062	organization	_	
284-72	55063-55065	of	_	
284-73	55066-55079	physiological	_	
284-74	55080-55085	brain	_	
284-75	55086-55094	networks	_	
284-76	55095-55100	Brain	_	
284-77	55101-55109	networks	_	
284-78	55110-55112	in	_	
284-79	55113-55126	schizophrenia	_	
284-80	55127-55136	Measuring	_	
284-81	55137-55148	alterations	_	
284-82	55149-55151	in	_	
284-83	55152-55163	oscillatory	_	
284-84	55164-55169	brain	_	
284-85	55170-55178	networks	_	
284-86	55179-55181	in	_	
284-87	55182-55195	schizophrenia	_	
284-88	55196-55200	with	_	
284-89	55201-55214	resting-state	_	
284-90	55215-55218	MEG	_	
284-91	55218-55219	:	_	
284-92	55220-55236	state-of-the-art	_	
284-93	55237-55240	and	_	
284-94	55241-55255	methodological	_	
284-95	55256-55266	challenges	_	
284-96	55267-55275	Aberrant	_	
284-97	55276-55286	functional	_	
284-98	55287-55298	whole-brain	_	
284-99	55299-55306	network	_	
284-100	55307-55319	architecture	_	
284-101	55320-55322	in	_	
284-102	55323-55331	patients	_	
284-103	55332-55336	with	_	
284-104	55337-55350	schizophrenia	_	
284-105	55350-55351	:	_	
284-106	55352-55353	a	_	
284-107	55354-55367	meta-analysis	_	
284-108	55368-55379	Small-world	_	
284-109	55380-55388	networks	_	
284-110	55389-55392	and	_	
284-111	55393-55402	disturbed	_	
284-112	55403-55413	functional	_	
284-113	55414-55426	connectivity	_	
284-114	55427-55429	in	_	
284-115	55430-55443	schizophrenia	_	
284-116	55444-55455	Small-world	_	
284-117	55456-55466	properties	_	
284-118	55467-55469	of	_	
284-119	55470-55479	nonlinear	_	
284-120	55480-55485	brain	_	
284-121	55486-55494	activity	_	
284-122	55495-55497	in	_	
284-123	55498-55511	schizophrenia	_	
284-124	55512-55520	Distinct	_	
284-125	55521-55532	disruptions	_	
284-126	55533-55535	of	_	
284-127	55536-55549	resting-state	_	
284-128	55550-55560	functional	_	
284-129	55561-55566	brain	_	
284-130	55567-55575	networks	_	
284-131	55576-55578	in	_	
284-132	55579-55587	familial	_	
284-133	55588-55591	and	_	
284-134	55592-55600	sporadic	_	
284-135	55601-55614	schizophrenia	_	
284-136	55615-55618	The	_	
284-137	55619-55626	economy	_	
284-138	55627-55629	of	_	
284-139	55630-55635	brain	_	
284-140	55636-55643	network	_	
284-141	55644-55656	organization	_	
284-142	55657-55658	A	_	
284-143	55659-55668	resilient	_	
284-144	55668-55669	,	_	
284-145	55670-55683	low-frequency	_	
284-146	55683-55684	,	_	
284-147	55685-55696	small-world	_	
284-148	55697-55702	human	_	
284-149	55703-55708	brain	_	
284-150	55709-55719	functional	_	
284-151	55720-55727	network	_	
284-152	55728-55732	with	_	
284-153	55733-55739	highly	_	
284-154	55740-55749	connected	_	
284-155	55750-55761	association	_	
284-156	55762-55770	cortical	_	
284-157	55771-55775	hubs	_	
284-158	55776-55787	Identifying	_	
284-159	55788-55791	the	_	
284-160	55792-55797	brain	_	
284-161	55797-55798	’	_	
284-162	55798-55799	s	_	
284-163	55800-55804	most	_	
284-164	55805-55813	globally	_	
284-165	55814-55823	connected	_	
284-166	55824-55831	regions	_	
284-167	55832-55845	Schizophrenia	_	
284-168	55846-55849	and	_	
284-169	55850-55858	abnormal	_	
284-170	55859-55864	brain	_	
284-171	55865-55872	network	_	
284-172	55873-55877	hubs	_	
284-173	55878-55891	Schizophrenia	_	
284-174	55891-55892	,	_	
284-175	55893-55905	neuroimaging	_	
284-176	55906-55909	and	_	
284-177	55910-55922	connectomics	_	
284-178	55923-55934	Graph-based	_	
284-179	55935-55942	network	_	
284-180	55943-55951	analysis	_	
284-181	55952-55954	in	_	
284-182	55955-55968	schizophrenia	_	
284-183	55969-55982	Investigating	_	
284-184	55983-55986	the	_	
284-185	55987-56007	electrophysiological	_	
284-186	56008-56013	basis	_	
284-187	56014-56016	of	_	
284-188	56017-56024	resting	_	
284-189	56025-56030	state	_	
284-190	56031-56039	networks	_	
284-191	56040-56045	using	_	
284-192	56046-56068	magnetoencephalography	_	
284-193	56069-56072	The	_	
284-194	56073-56078	trees	_	
284-195	56079-56082	and	_	
284-196	56083-56086	the	_	
284-197	56087-56093	forest	_	
284-198	56093-56094	:	_	
284-199	56095-56111	characterization	_	
284-200	56112-56114	of	_	
284-201	56115-56122	complex	_	
284-202	56123-56128	brain	_	
284-203	56129-56137	networks	_	
284-204	56138-56142	with	_	
284-205	56143-56150	minimum	_	
284-206	56151-56159	spanning	_	
284-207	56160-56165	trees	_	
284-208	56166-56173	Minimum	_	
284-209	56174-56182	spanning	_	
284-210	56183-56187	tree	_	
284-211	56188-56196	analysis	_	
284-212	56197-56199	of	_	
284-213	56200-56203	the	_	
284-214	56204-56209	human	_	
284-215	56210-56220	connectome	_	
284-216	56221-56229	Epilepsy	_	
284-217	56230-56237	surgery	_	
284-218	56238-56245	outcome	_	
284-219	56246-56249	and	_	
284-220	56250-56260	functional	_	
284-221	56261-56268	network	_	
284-222	56269-56281	alternations	_	
284-223	56282-56284	in	_	
284-224	56285-56297	longitudinal	_	
284-225	56298-56301	MEG	_	
284-226	56301-56302	:	_	
284-227	56303-56304	a	_	
284-228	56305-56312	minimum	_	
284-229	56313-56321	spanning	_	
284-230	56322-56326	tree	_	
284-231	56327-56335	analysis	_	
284-232	56336-56358	Electroencephalography	_	
284-233	56359-56364	based	_	
284-234	56365-56375	functional	_	
284-235	56376-56383	network	_	
284-236	56384-56386	in	_	
284-237	56387-56392	newly	_	
284-238	56393-56402	diagnosed	_	
284-239	56403-56412	childhood	_	
284-240	56413-56423	epilepsies	_	
284-241	56424-56432	Evidence	_	
284-242	56433-56436	for	_	
284-243	56437-56438	a	_	
284-244	56439-56446	resting	_	
284-245	56447-56452	state	_	
284-246	56453-56460	network	_	
284-247	56461-56472	abnormality	_	
284-248	56473-56475	in	_	
284-249	56476-56482	adults	_	
284-250	56483-56486	who	_	
284-251	56487-56494	stutter	_	
284-252	56495-56504	Declining	_	
284-253	56505-56515	functional	_	
284-254	56516-56528	connectivity	_	
284-255	56529-56537	strength	_	
284-256	56538-56541	and	_	
284-257	56542-56550	changing	_	
284-258	56551-56555	hubs	_	
284-259	56556-56565	locations	_	
284-260	56566-56568	in	_	
284-261	56569-56578	Alzheimer	_	
284-262	56578-56579	’	_	
284-263	56579-56580	s	_	
284-264	56581-56588	disease	_	
284-265	56588-56589	:	_	
284-266	56590-56592	an	_	
284-267	56593-56596	EEG	_	
284-268	56597-56602	study	_	
284-269	56603-56610	Growing	_	
284-270	56611-56616	trees	_	
284-271	56617-56619	in	_	
284-272	56620-56625	child	_	
284-273	56626-56631	brain	_	
284-274	56631-56632	:	_	
284-275	56633-56638	graph	_	
284-276	56639-56650	theoretical	_	
284-277	56651-56659	analysis	_	
284-278	56660-56662	of	_	
284-279	56663-56693	electroencephalography-derived	_	
284-280	56694-56701	minimum	_	
284-281	56702-56710	spanning	_	
284-282	56711-56715	tree	_	
284-283	56716-56718	in	_	
284-284	56719-56720	5	_	
284-285	56720-56721	-	_	
284-286	56722-56725	and	_	
284-287	56726-56727	7	_	
284-288	56727-56728	-	_	
284-289	56728-56736	year-old	_	
284-290	56737-56745	children	_	
284-291	56746-56754	reflects	_	
284-292	56755-56760	brain	_	
284-293	56761-56771	maturation	_	
284-294	56772-56782	Structural	_	
284-295	56783-56788	brain	_	
284-296	56789-56796	network	_	
284-297	56797-56809	disturbances	_	
284-298	56810-56812	in	_	
284-299	56813-56816	the	_	
284-300	56817-56826	psychosis	_	
284-301	56827-56835	spectrum	_	
284-302	56836-56839	The	_	
284-303	56840-56848	temporal	_	
284-304	56849-56861	organization	_	
284-305	56862-56864	of	_	
284-306	56865-56875	functional	_	
284-307	56876-56881	brain	_	
284-308	56882-56894	connectivity	_	
284-309	56895-56897	is	_	
284-310	56898-56906	abnormal	_	
284-311	56907-56909	in	_	
284-312	56910-56923	schizophrenia	_	
284-313	56924-56927	but	_	
284-314	56928-56932	does	_	
284-315	56933-56936	not	_	
284-316	56937-56946	correlate	_	
284-317	56947-56951	with	_	
284-318	56952-56964	symptomology	_	
284-319	56965-56977	Quantitative	_	
284-320	56978-56981	and	_	
284-321	56982-56993	Qualitative	_	
284-322	56994-57004	Comparison	_	
284-323	57005-57007	of	_	
284-324	57008-57017	EEG-Based	_	
284-325	57018-57024	Neural	_	
284-326	57025-57032	Network	_	
284-327	57033-57045	Organization	_	
284-328	57046-57048	in	_	
284-329	57049-57052	Two	_	
284-330	57053-57066	Schizophrenia	_	
284-331	57067-57073	Groups	_	
284-332	57074-57083	Differing	_	
284-333	57084-57086	in	_	
284-334	57087-57090	the	_	
284-335	57091-57099	Duration	_	
284-336	57100-57102	of	_	
284-337	57103-57110	Illness	_	
284-338	57111-57114	and	_	
284-339	57115-57122	Disease	_	
284-340	57123-57129	Burden	_	
284-341	57129-57130	:	_	
284-342	57131-57136	Graph	_	
284-343	57137-57145	Analysis	_	
284-344	57146-57150	With	_	
284-345	57151-57162	Application	_	
284-346	57163-57165	of	_	
284-347	57166-57169	the	_	
284-348	57170-57177	Minimum	_	
284-349	57178-57186	Spanning	_	
284-350	57187-57191	Tree	_	
284-351	57192-57201	Cognitive	_	
284-352	57202-57213	dysfunction	_	
284-353	57214-57216	in	_	
284-354	57217-57230	first-episode	_	
284-355	57231-57240	psychosis	_	
284-356	57240-57241	:	_	
284-357	57242-57245	the	_	
284-358	57246-57256	processing	_	
284-359	57257-57262	speed	_	
284-360	57263-57273	hypothesis	_	
284-361	57274-57286	Hierarchical	_	
284-362	57287-57296	structure	_	
284-363	57297-57299	of	_	
284-364	57300-57303	the	_	
284-365	57304-57313	cognitive	_	
284-366	57314-57321	process	_	
284-367	57322-57324	in	_	
284-368	57325-57338	schizophrenia	_	
284-369	57338-57339	:	_	
284-370	57340-57343	the	_	
284-371	57344-57355	fundamental	_	
284-372	57356-57360	role	_	
284-373	57361-57363	of	_	
284-374	57364-57374	processing	_	
284-375	57375-57380	speed	_	
284-376	57381-57391	Processing	_	
284-377	57392-57397	speed	_	
284-378	57398-57400	is	_	
284-379	57401-57411	associated	_	
284-380	57412-57416	with	_	
284-381	57417-57428	differences	_	
284-382	57429-57431	in	_	
284-383	57432-57434	IQ	_	
284-384	57435-57438	and	_	
284-385	57439-57448	cognitive	_	
284-386	57449-57457	profiles	_	
284-387	57458-57465	between	_	
284-388	57466-57474	patients	_	
284-389	57475-57479	with	_	
284-390	57480-57493	schizophrenia	_	
284-391	57494-57497	and	_	
284-392	57498-57503	their	_	
284-393	57504-57511	healthy	_	
284-394	57512-57520	siblings	_	
284-395	57521-57531	Processing	_	
284-396	57532-57537	speed	_	
284-397	57538-57548	impairment	_	
284-398	57549-57551	in	_	
284-399	57552-57565	schizophrenia	_	
284-400	57566-57568	is	_	
284-401	57569-57577	mediated	_	
284-402	57578-57580	by	_	
284-403	57581-57586	white	_	
284-404	57587-57593	matter	_	
284-405	57594-57603	integrity	_	
284-406	57604-57622	Diffusion-weighted	_	
284-407	57623-57630	imaging	_	
284-408	57631-57639	uncovers	_	
284-409	57640-57646	likely	_	
284-410	57647-57654	sources	_	
284-411	57655-57657	of	_	
284-412	57658-57674	processing-speed	_	
284-413	57675-57683	deficits	_	
284-414	57684-57686	in	_	
284-415	57687-57700	schizophrenia	_	
284-416	57701-57710	Disrupted	_	
284-417	57711-57724	resting-state	_	
284-418	57725-57735	functional	_	
284-419	57736-57748	connectivity	_	
284-420	57749-57751	in	_	
284-421	57752-57761	minimally	_	
284-422	57762-57769	treated	_	
284-423	57770-57777	chronic	_	
284-424	57778-57791	schizophrenia	_	
284-425	57792-57808	Intra-individual	_	
284-426	57809-57820	variability	_	
284-427	57821-57823	in	_	
284-428	57824-57840	high-functioning	_	
284-429	57841-57849	patients	_	
284-430	57850-57854	with	_	
284-431	57855-57868	schizophrenia	_	
284-432	57869-57878	Increased	_	
284-433	57879-57895	intra-individual	_	
284-434	57896-57907	variability	_	
284-435	57908-57910	of	_	
284-436	57911-57920	cognitive	_	
284-437	57921-57931	processing	_	
284-438	57932-57934	in	_	
284-439	57935-57943	subjects	_	
284-440	57944-57946	at	_	
284-441	57947-57951	risk	_	
284-442	57952-57958	mental	_	
284-443	57959-57964	state	_	
284-444	57965-57968	and	_	
284-445	57969-57982	schizophrenia	_	
284-446	57983-57991	patients	_	
284-447	57992-58001	Increased	_	
284-448	58002-58015	intra-subject	_	
284-449	58016-58024	reaction	_	
284-450	58025-58029	time	_	
284-451	58030-58041	variability	_	
284-452	58042-58044	in	_	
284-453	58045-58048	the	_	
284-454	58049-58059	volitional	_	
284-455	58060-58067	control	_	
284-456	58068-58070	of	_	
284-457	58071-58079	movement	_	
284-458	58080-58082	in	_	
284-459	58083-58096	schizophrenia	_	
284-460	58097-58108	Spontaneous	_	
284-461	58109-58121	fluctuations	_	
284-462	58122-58124	in	_	
284-463	58125-58130	brain	_	
284-464	58131-58139	activity	_	
284-465	58140-58148	observed	_	
284-466	58149-58153	with	_	
284-467	58154-58164	functional	_	
284-468	58165-58173	magnetic	_	
284-469	58174-58183	resonance	_	
284-470	58184-58191	imaging	_	
284-471	58192-58201	Intrinsic	_	
284-472	58202-58214	fluctuations	_	
284-473	58215-58221	within	_	
284-474	58222-58225	the	_	
284-475	58226-58234	cortical	_	
284-476	58235-58242	systems	_	
284-477	58243-58250	account	_	
284-478	58251-58254	for	_	
284-479	58255-58265	intertrial	_	
284-480	58266-58277	variability	_	
284-481	58278-58280	in	_	
284-482	58281-58286	human	_	
284-483	58287-58295	behavior	_	
284-484	58296-58303	Staying	_	
284-485	58304-58306	on	_	
284-486	58307-58310	the	_	
284-487	58311-58314	job	_	
284-488	58314-58315	:	_	
284-489	58316-58319	the	_	
284-490	58320-58327	frontal	_	
284-491	58328-58333	lobes	_	
284-492	58334-58341	control	_	
284-493	58342-58352	individual	_	
284-494	58353-58364	performance	_	
284-495	58365-58376	variability	_	
284-496	58377-58380	The	_	
284-497	58381-58391	functional	_	
284-498	58392-58407	neuroanatomical	_	
284-499	58408-58418	correlates	_	
284-500	58419-58421	of	_	
284-501	58422-58430	response	_	
284-502	58431-58442	variability	_	
284-503	58442-58443	:	_	
284-504	58444-58452	evidence	_	
284-505	58453-58457	from	_	
284-506	58458-58466	response	_	
284-507	58467-58477	inhibition	_	
284-508	58478-58482	task	_	
284-509	58483-58488	Graph	_	
284-510	58489-58497	analysis	_	
284-511	58498-58500	of	_	
284-512	58501-58504	EEG	_	
284-513	58505-58512	resting	_	
284-514	58513-58518	state	_	
284-515	58519-58529	functional	_	
284-516	58530-58538	networks	_	
284-517	58539-58541	in	_	
284-518	58542-58550	dyslexic	_	
284-519	58551-58558	readers	_	
284-520	58559-58569	Functional	_	
284-521	58570-58579	structure	_	
284-522	58580-58582	of	_	
284-523	58583-58591	cortical	_	
284-524	58592-58600	neuronal	_	
284-525	58601-58609	networks	_	
284-526	58610-58615	grown	_	
284-527	58616-58618	in	_	
284-528	58619-58624	vitro	_	
284-529	58625-58628	The	_	
284-530	58629-58636	minimum	_	
284-531	58637-58645	spanning	_	
284-532	58646-58650	tree	_	
284-533	58650-58651	:	_	
284-534	58652-58654	an	_	
284-535	58655-58663	unbiased	_	
284-536	58664-58670	method	_	
284-537	58671-58674	for	_	
284-538	58675-58680	brain	_	
284-539	58681-58688	network	_	
284-540	58689-58697	analysis	_	
284-541	58698-58707	Emergence	_	
284-542	58708-58710	of	_	
284-543	58711-58718	scaling	_	
284-544	58719-58721	in	_	
284-545	58722-58728	random	_	
284-546	58729-58737	networks	_	
284-547	58738-58746	Aberrant	_	
284-548	58747-58754	frontal	_	
284-549	58755-58758	and	_	
284-550	58759-58767	temporal	_	
284-551	58768-58774	cortex	_	
284-552	58775-58782	network	_	
284-553	58783-58792	structure	_	
284-554	58793-58795	in	_	
284-555	58796-58809	schizophrenia	_	
284-556	58809-58810	:	_	
284-557	58811-58812	a	_	
284-558	58813-58818	graph	_	
284-559	58819-58830	theoretical	_	
284-560	58831-58839	analysis	_	
284-561	58840-58849	EEG-based	_	
284-562	58850-58860	functional	_	
284-563	58861-58869	networks	_	
284-564	58870-58872	in	_	
284-565	58873-58886	schizophrenia	_	
284-566	58887-58890	The	_	
284-567	58891-58901	anatomical	_	
284-568	58902-58910	distance	_	
284-569	58911-58913	of	_	
284-570	58914-58924	functional	_	
284-571	58925-58936	connections	_	
284-572	58937-58945	predicts	_	
284-573	58946-58951	brain	_	
284-574	58952-58959	network	_	
284-575	58960-58968	topology	_	
284-576	58969-58971	in	_	
284-577	58972-58978	health	_	
284-578	58979-58982	and	_	
284-579	58983-58996	schizophrenia	_	
284-580	58997-59006	Disrupted	_	
284-581	59007-59012	brain	_	
284-582	59013-59023	anatomical	_	
284-583	59024-59036	connectivity	_	
284-584	59037-59039	in	_	
284-585	59040-59056	medication-naïve	_	
284-586	59057-59065	patients	_	
284-587	59066-59070	with	_	
284-588	59071-59084	first-episode	_	
284-589	59085-59098	schizophrenia	_	
284-590	59099-59110	Competition	_	
284-591	59111-59118	between	_	
284-592	59119-59129	functional	_	
284-593	59130-59135	brain	_	
284-594	59136-59144	networks	_	
284-595	59145-59153	mediates	_	
284-596	59154-59164	behavioral	_	
284-597	59165-59176	variability	_	
284-598	59177-59179	RT	_	
284-599	59180-59194	distributional	_	
284-600	59195-59203	analysis	_	
284-601	59204-59206	of	_	
284-602	59207-59216	cognitive	_	
284-603	59217-59232	control-related	_	
284-604	59233-59238	brain	_	
284-605	59239-59247	activity	_	
284-606	59248-59250	in	_	
284-607	59251-59256	first	_	
284-608	59257-59264	episode	_	
284-609	59265-59278	schizophrenia	_	
284-610	59279-59290	Synchronous	_	
284-611	59291-59296	gamma	_	
284-612	59297-59305	activity	_	
284-613	59305-59306	:	_	
284-614	59307-59308	a	_	
284-615	59309-59315	review	_	
284-616	59316-59319	and	_	
284-617	59320-59332	contribution	_	
284-618	59333-59335	to	_	
284-619	59336-59338	an	_	
284-620	59339-59350	integrative	_	
284-621	59351-59363	neuroscience	_	
284-622	59364-59369	model	_	
284-623	59370-59372	of	_	
284-624	59373-59386	schizophrenia	_	
284-625	59387-59392	Gamma	_	
284-626	59393-59402	synchrony	_	
284-627	59402-59403	:	_	
284-628	59404-59411	towards	_	
284-629	59412-59413	a	_	
284-630	59414-59427	translational	_	
284-631	59428-59437	biomarker	_	
284-632	59438-59441	for	_	
284-633	59442-59445	the	_	
284-634	59446-59465	treatment-resistant	_	
284-635	59466-59474	symptoms	_	
284-636	59475-59477	of	_	
284-637	59478-59491	schizophrenia	_	
284-638	59492-59497	Gamma	_	
284-639	59498-59509	oscillation	_	
284-640	59510-59517	deficit	_	
284-641	59518-59521	and	_	
284-642	59522-59525	the	_	
284-643	59526-59531	onset	_	
284-644	59532-59534	of	_	
284-645	59535-59540	early	_	
284-646	59541-59552	progression	_	
284-647	59553-59555	of	_	
284-648	59556-59569	schizophrenia	_	
284-649	59570-59574	NMDA	_	
284-650	59575-59583	receptor	_	
284-651	59584-59596	hypofunction	_	
284-652	59596-59597	,	_	
284-653	59598-59618	parvalbumin-positive	_	
284-654	59619-59626	neurons	_	
284-655	59626-59627	,	_	
284-656	59628-59631	and	_	
284-657	59632-59640	cortical	_	
284-658	59641-59646	gamma	_	
284-659	59647-59659	oscillations	_	
284-660	59660-59662	in	_	
284-661	59663-59676	schizophrenia	_	
284-662	59677-59685	Abnormal	_	
284-663	59686-59691	gamma	_	
284-664	59692-59703	oscillation	_	
284-665	59704-59706	in	_	
284-666	59707-59727	N-Methyl-D-Aspartate	_	
284-667	59728-59736	receptor	_	
284-668	59737-59749	hypofunction	_	
284-669	59750-59756	models	_	
284-670	59757-59759	of	_	
284-671	59760-59773	schizophrenia	_	
284-672	59774-59777	The	_	
284-673	59778-59786	positive	_	
284-674	59787-59790	and	_	
284-675	59791-59799	negative	_	
284-676	59800-59808	syndrome	_	
284-677	59809-59814	scale	_	
284-678	59815-59816	(	_	
284-679	59816-59821	PANSS	_	
284-680	59821-59822	)	_	
284-681	59823-59826	for	_	
284-682	59827-59840	schizophrenia	_	
284-683	59841-59847	Polish	_	
284-684	59848-59853	Adult	_	
284-685	59854-59861	Reading	_	
284-686	59862-59866	Test	_	
284-687	59867-59868	–	_	
284-688	59869-59873	PART	_	
284-689	59874-59875	–	_	
284-690	59876-59888	construction	_	
284-691	59889-59891	of	_	
284-692	59892-59898	Polish	_	
284-693	59899-59903	test	_	
284-694	59904-59907	for	_	
284-695	59908-59916	estimate	_	
284-696	59917-59920	the	_	
284-697	59921-59926	level	_	
284-698	59927-59929	of	_	
284-699	59930-59939	premorbid	_	
284-700	59940-59952	intelligence	_	
284-701	59953-59955	in	_	
284-702	59956-59969	schizophrenia	_	
284-703	59970-59979	Cognitive	_	
284-704	59980-59993	inconsistency	_	
284-705	59994-59996	in	_	
284-706	59997-60004	bipolar	_	
284-707	60005-60013	patients	_	
284-708	60014-60016	is	_	
284-709	60017-60027	determined	_	
284-710	60028-60030	by	_	
284-711	60031-60040	increased	_	
284-712	60041-60057	intra-individual	_	
284-713	60058-60069	variability	_	
284-714	60070-60072	in	_	
284-715	60073-60080	initial	_	
284-716	60081-60086	phase	_	
284-717	60087-60089	of	_	
284-718	60090-60094	task	_	
284-719	60095-60106	performance	_	
284-720	60107-60116	Disturbed	_	
284-721	60117-60127	functional	_	
284-722	60128-60140	connectivity	_	
284-723	60141-60147	within	_	
284-724	60148-60151	the	_	
284-725	60152-60156	left	_	
284-726	60157-60167	prefrontal	_	
284-727	60168-60174	cortex	_	
284-728	60175-60178	and	_	
284-729	60179-60191	sensorimotor	_	
284-730	60192-60197	areas	_	
284-731	60198-60206	predicts	_	
284-732	60207-60215	impaired	_	
284-733	60216-60225	cognitive	_	
284-734	60226-60231	speed	_	
284-735	60232-60234	in	_	
284-736	60235-60243	patients	_	
284-737	60244-60248	with	_	
284-738	60249-60262	first-episode	_	
284-739	60263-60276	schizophrenia	_	
284-740	60277-60285	Wechsler	_	
284-741	60285-60286	,	_	
284-742	60287-60288	D	_	
284-743	60288-60289	.	_	

#Text=Wechsler Adult Intelligence Scale—Revised.
285-1	60290-60298	Wechsler	_	
285-2	60299-60304	Adult	_	
285-3	60305-60317	Intelligence	_	
285-4	60318-60331	Scale—Revised	_	
285-5	60331-60332	.	_	

#Text=(The Psychological Corporation, 1987).
286-1	60333-60334	(	_	
286-2	60334-60337	The	_	
286-3	60338-60351	Psychological	_	
286-4	60352-60363	Corporation	_	
286-5	60363-60364	,	_	
286-6	60365-60369	1987	_	
286-7	60369-60370	)	_	
286-8	60370-60371	.	_	

#Text=The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
#Text=Psychological interpretation of the ex-Gaussian and shifted Wald parameters: a diffusion model analysis
#Text=Intraindividual variability in inhibitory function in adults with ADHD – and ex-Gaussian approach
#Text=Luce, R.
287-1	60372-60375	The	_	
287-2	60376-60381	Brief	_	
287-3	60382-60392	Assessment	_	
287-4	60393-60395	of	_	
287-5	60396-60405	Cognition	_	
287-6	60406-60408	in	_	
287-7	60409-60422	Schizophrenia	_	
287-8	60422-60423	:	_	
287-9	60424-60435	reliability	_	
287-10	60435-60436	,	_	
287-11	60437-60448	sensitivity	_	
287-12	60448-60449	,	_	
287-13	60450-60453	and	_	
287-14	60454-60464	comparison	_	
287-15	60465-60469	with	_	
287-16	60470-60471	a	_	
287-17	60472-60480	standard	_	
287-18	60481-60495	neurocognitive	_	
287-19	60496-60503	battery	_	
287-20	60504-60517	Psychological	_	
287-21	60518-60532	interpretation	_	
287-22	60533-60535	of	_	
287-23	60536-60539	the	_	
287-24	60540-60551	ex-Gaussian	_	
287-25	60552-60555	and	_	
287-26	60556-60563	shifted	_	
287-27	60564-60568	Wald	_	
287-28	60569-60579	parameters	_	
287-29	60579-60580	:	_	
287-30	60581-60582	a	_	
287-31	60583-60592	diffusion	_	
287-32	60593-60598	model	_	
287-33	60599-60607	analysis	_	
287-34	60608-60623	Intraindividual	_	
287-35	60624-60635	variability	_	
287-36	60636-60638	in	_	
287-37	60639-60649	inhibitory	_	
287-38	60650-60658	function	_	
287-39	60659-60661	in	_	
287-40	60662-60668	adults	_	
287-41	60669-60673	with	_	
287-42	60674-60678	ADHD	_	
287-43	60679-60680	–	_	
287-44	60681-60684	and	_	
287-45	60685-60696	ex-Gaussian	_	
287-46	60697-60705	approach	_	
287-47	60706-60710	Luce	_	
287-48	60710-60711	,	_	
287-49	60712-60713	R	_	
287-50	60713-60714	.	_	

#Text=D.
288-1	60715-60716	D	_	
288-2	60716-60717	.	_	

#Text=Response times: Their role in inferring elementary mental organization.
289-1	60718-60726	Response	_	
289-2	60727-60732	times	_	
289-3	60732-60733	:	_	
289-4	60734-60739	Their	_	
289-5	60740-60744	role	_	
289-6	60745-60747	in	_	
289-7	60748-60757	inferring	_	
289-8	60758-60768	elementary	_	
289-9	60769-60775	mental	_	
289-10	60776-60788	organization	_	
289-11	60788-60789	.	_	

#Text=(Oxford University Press, 1986).
290-1	60790-60791	(	_	
290-2	60791-60797	Oxford	_	
290-3	60798-60808	University	_	
290-4	60809-60814	Press	_	
290-5	60814-60815	,	_	
290-6	60816-60820	1986	_	
290-7	60820-60821	)	_	
290-8	60821-60822	.	_	

#Text=RTSYS: A DOS application for the analysis of reaction time data
#Text=Drifting from slow to “D’oh!”
291-1	60823-60828	RTSYS	_	
291-2	60828-60829	:	_	
291-3	60830-60831	A	_	
291-4	60832-60835	DOS	_	
291-5	60836-60847	application	_	
291-6	60848-60851	for	_	
291-7	60852-60855	the	_	
291-8	60856-60864	analysis	_	
291-9	60865-60867	of	_	
291-10	60868-60876	reaction	_	
291-11	60877-60881	time	_	
291-12	60882-60886	data	_	
291-13	60887-60895	Drifting	_	
291-14	60896-60900	from	_	
291-15	60901-60905	slow	_	
291-16	60906-60908	to	_	
291-17	60909-60910	“	_	
291-18	60910-60911	D	_	
291-19	60911-60912	’	_	
291-20	60912-60914	oh	_	
291-21	60914-60915	!	_	
291-22	60915-60916	”	_	

#Text=working memory capacity and mind wandering predict extreme reaction times and executive-control errors
#Text=On the link between mind wandering and task performance over time
#Text=How to use MATLAB to fit the ex-Gaussian and other probability functions to a distribution of response times.
292-1	60917-60924	working	_	
292-2	60925-60931	memory	_	
292-3	60932-60940	capacity	_	
292-4	60941-60944	and	_	
292-5	60945-60949	mind	_	
292-6	60950-60959	wandering	_	
292-7	60960-60967	predict	_	
292-8	60968-60975	extreme	_	
292-9	60976-60984	reaction	_	
292-10	60985-60990	times	_	
292-11	60991-60994	and	_	
292-12	60995-61012	executive-control	_	
292-13	61013-61019	errors	_	
292-14	61020-61022	On	_	
292-15	61023-61026	the	_	
292-16	61027-61031	link	_	
292-17	61032-61039	between	_	
292-18	61040-61044	mind	_	
292-19	61045-61054	wandering	_	
292-20	61055-61058	and	_	
292-21	61059-61063	task	_	
292-22	61064-61075	performance	_	
292-23	61076-61080	over	_	
292-24	61081-61085	time	_	
292-25	61086-61089	How	_	
292-26	61090-61092	to	_	
292-27	61093-61096	use	_	
292-28	61097-61103	MATLAB	_	
292-29	61104-61106	to	_	
292-30	61107-61110	fit	_	
292-31	61111-61114	the	_	
292-32	61115-61126	ex-Gaussian	_	
292-33	61127-61130	and	_	
292-34	61131-61136	other	_	
292-35	61137-61148	probability	_	
292-36	61149-61158	functions	_	
292-37	61159-61161	to	_	
292-38	61162-61163	a	_	
292-39	61164-61176	distribution	_	
292-40	61177-61179	of	_	
292-41	61180-61188	response	_	
292-42	61189-61194	times	_	
292-43	61194-61195	.	_	

#Text=Tutorials in Quantitative Methods for
#Text=EEGLAB: and open source toolbox for analysis of single-trial EEG dynamics including independent component analysis
#Text=Opportunities and methodological challenges in EEG and MEG resting state functional brain network research
#Text=Increased resting-state gamma-band connectivity in first-episode schizophrenia
#Text=Spontaneous gamma activity in schizophrenia
#Text=Phase Lag Index: assessment of functional connectivity from multi-channel EEG and MEG with diminished bias from common sources
#Text=The correlation of metrics in complex networks with applications in functional brain networks
#Text=Hierarchical organization of human cortical networks in health and schizophrenia
#Text=Gamma synchrony” in first-episode schizophrenia: a disorder of temporal connectivity?
293-1	61196-61205	Tutorials	_	
293-2	61206-61208	in	_	
293-3	61209-61221	Quantitative	_	
293-4	61222-61229	Methods	_	
293-5	61230-61233	for	_	
293-6	61234-61240	EEGLAB	_	
293-7	61240-61241	:	_	
293-8	61242-61245	and	_	
293-9	61246-61250	open	_	
293-10	61251-61257	source	_	
293-11	61258-61265	toolbox	_	
293-12	61266-61269	for	_	
293-13	61270-61278	analysis	_	
293-14	61279-61281	of	_	
293-15	61282-61294	single-trial	_	
293-16	61295-61298	EEG	_	
293-17	61299-61307	dynamics	_	
293-18	61308-61317	including	_	
293-19	61318-61329	independent	_	
293-20	61330-61339	component	_	
293-21	61340-61348	analysis	_	
293-22	61349-61362	Opportunities	_	
293-23	61363-61366	and	_	
293-24	61367-61381	methodological	_	
293-25	61382-61392	challenges	_	
293-26	61393-61395	in	_	
293-27	61396-61399	EEG	_	
293-28	61400-61403	and	_	
293-29	61404-61407	MEG	_	
293-30	61408-61415	resting	_	
293-31	61416-61421	state	_	
293-32	61422-61432	functional	_	
293-33	61433-61438	brain	_	
293-34	61439-61446	network	_	
293-35	61447-61455	research	_	
293-36	61456-61465	Increased	_	
293-37	61466-61479	resting-state	_	
293-38	61480-61490	gamma-band	_	
293-39	61491-61503	connectivity	_	
293-40	61504-61506	in	_	
293-41	61507-61520	first-episode	_	
293-42	61521-61534	schizophrenia	_	
293-43	61535-61546	Spontaneous	_	
293-44	61547-61552	gamma	_	
293-45	61553-61561	activity	_	
293-46	61562-61564	in	_	
293-47	61565-61578	schizophrenia	_	
293-48	61579-61584	Phase	_	
293-49	61585-61588	Lag	_	
293-50	61589-61594	Index	_	
293-51	61594-61595	:	_	
293-52	61596-61606	assessment	_	
293-53	61607-61609	of	_	
293-54	61610-61620	functional	_	
293-55	61621-61633	connectivity	_	
293-56	61634-61638	from	_	
293-57	61639-61652	multi-channel	_	
293-58	61653-61656	EEG	_	
293-59	61657-61660	and	_	
293-60	61661-61664	MEG	_	
293-61	61665-61669	with	_	
293-62	61670-61680	diminished	_	
293-63	61681-61685	bias	_	
293-64	61686-61690	from	_	
293-65	61691-61697	common	_	
293-66	61698-61705	sources	_	
293-67	61706-61709	The	_	
293-68	61710-61721	correlation	_	
293-69	61722-61724	of	_	
293-70	61725-61732	metrics	_	
293-71	61733-61735	in	_	
293-72	61736-61743	complex	_	
293-73	61744-61752	networks	_	
293-74	61753-61757	with	_	
293-75	61758-61770	applications	_	
293-76	61771-61773	in	_	
293-77	61774-61784	functional	_	
293-78	61785-61790	brain	_	
293-79	61791-61799	networks	_	
293-80	61800-61812	Hierarchical	_	
293-81	61813-61825	organization	_	
293-82	61826-61828	of	_	
293-83	61829-61834	human	_	
293-84	61835-61843	cortical	_	
293-85	61844-61852	networks	_	
293-86	61853-61855	in	_	
293-87	61856-61862	health	_	
293-88	61863-61866	and	_	
293-89	61867-61880	schizophrenia	_	
293-90	61881-61886	Gamma	_	
293-91	61887-61896	synchrony	_	
293-92	61896-61897	”	_	
293-93	61898-61900	in	_	
293-94	61901-61914	first-episode	_	
293-95	61915-61928	schizophrenia	_	
293-96	61928-61929	:	_	
293-97	61930-61931	a	_	
293-98	61932-61940	disorder	_	
293-99	61941-61943	of	_	
293-100	61944-61952	temporal	_	
293-101	61953-61965	connectivity	_	
293-102	61965-61966	?	_	
